PDB;Smiles;Paffinity;ProteinName;LigandName
2ydk;c1ccccc1-c(sc2NC(=O)N)cc2C(=O)N[C@@H]3C[NH2+]CCC3;8.1499996;SERINE/THREONINE-PROTEIN KINASE CHK1;YDK
2ydj;c1c(F)cccc1-c2cc(NC(=O)N)c(s2)C(=O)N[C@H]3CCC[NH2+]C3;8.3000002;SERINE/THREONINE-PROTEIN KINASE CHK1;YDJ
2ydi;NC(=O)Nc1sc(cc1C(=O)N)-c2ccc(cc2)OCC[NH+](C)C;6.8200002;SERINE/THREONINE-PROTEIN KINASE CHK1;YDI
1g5s;C1CCCC1n2cnc(c23)c(NCc4ccccc4)nc(n3)N[C@@H]5CC[C@@H]([NH3+])CC5;7.3200002;CELL DIVISION PROTEIN KINASE 2;I17
4yve;COc1cccc(c1)CC(=O)Nc2nc(cs2)-c3ccncc3;7;Rho-associated protein kinase 1;4KK
4yvc;c1cnccc1-c(cs2)nc2NC(=O)c3ccccc3F;5.96;Rho-associated protein kinase 1;4KH
5jsm;CCCS(=O)(=O)Nc(ccc1F)c(F)c1C(=O)c(c[nH]2)c(c23)cc(cn3)-c(cc4)ccc4OCCOCCOCCOc5ccc(cc5)-c(c6)cnc(c67)[nH]cc7C(=O)c8c(F)ccc(c8F)NS(=O)(=O)CCC;6.5900002;Serine/threonine-protein kinase B-raf;6NB
1vyw;C1CC1c2cc(n[nH]2)NC(=O)Cc(c3)ccc(c34)cccc4;7.4299998;CELL DIVISION PROTEIN KINASE 2;292
1vyz;C1CC1c2cc(n[nH]2)NC(=O)c3ccccc3;6.54;CELL DIVISION PROTEIN KINASE 2;N5B
3agl;n1cnc(N)c(c12)ncn2[C@@H]([C@H](O)[C@@H]3O)O[C@@H]3C(=O)NCCCCCC(=O)N[C@H](C)C(=O)NCCCCCC(=O)N[C@H](CCC[NH+]=C(N)N)C(=O)N[C@@H](C(=O)N)CCC[NH+]=C(N)N;7.8000002;cAMP-dependent protein kinase catalytic subunit alpha;A03
5a9u;N#Cc1n(C)nc(c1c23)CN(C)C(=O)c4c(cc(F)cc4)[C@@H](C)Oc(c2)c(N)nc3;10.1;ALK TYROSINE KINASE RECEPTOR;5P8
2wev;Nc1nc(C)c(s1)-c2nc(ncc2)Nc3cccc(c3)N(=O)=O;8;CELL DIVISION PROTEIN KINASE 2;CK7
4a9s;NC(=O)c(c1)ccc(c12)[nH]c(n2)-c3ccc(cc3)Oc4cccc(c4)O;7.21;SERINE/THREONINE-PROTEIN KINASE CHK2;RU9
1v1k;Fc1ccc(C(F)(F)F)cc1Nc2cc(ncn2)Nc3ccc(cc3)OC[C@H](O)C[NH+](C)C;4.46;CELL DIVISION PROTEIN KINASE 2;3FP
1y6a;CCS(=O)(=O)c1ccc(OC)c(c1)Nc2ncc(o2)-c3cccc(c3)-c4ccccn4;7.6599998;Vascular endothelial growth factor receptor 2;AAZ
1y6b;C1CC1CNS(=O)(=O)c2ccc(OC)c(c2)Nc3oc(cn3)-c4cc(ccc4)-c5cnccc5;7.4200001;Vascular endothelial growth factor receptor 2;AAX
5i9z;c1ccccc1[C@@H](OC)C(=O)n(c2)cc(c23)c(n[nH]3)NC(=O)c4ccc(cc4)N5CC[NH+](C)CC5;8.0500002;Ephrin type-A receptor 2;627
3qrj;n1cccc(c12)cc(cc2)-n(n3)c(cc3C(C)(C)C)NC(=O)Nc(c(F)c4)ccc4Oc(c5)ccnc5C(=O)NC;8.3999996;Tyrosine-protein kinase ABL1;919
3qrk;Clc1c(Cl)c(ccc1)NC(=O)Nc2cc(C(C)(C)C)nn2-c(cc3)cc(c34)C[C@@H](C(=O)[O-])[NH2+]C4;7.2399998;Tyrosine-protein kinase ABL1;9DP
3qri;n1cccc(c12)cc(cc2)-n(n3)c(cc3C(C)(C)C)NC(=O)Nc(c(F)c4)ccc4Oc(c5)ccnc5C(=O)NC;9.1000004;Tyrosine-protein kinase ABL1;919
4fk6;[C@@H]12C[C@H](CC2)C[C@H]1n3c(CNS(=O)(=O)C)nc4cnc(c5c34)[nH]cc5;9.6999998;Tyrosine-protein kinase JAK1;0UJ
4k9y;n1cnc(N)c(c12)ncn2-c(cc3)ccc3NC(=O)Nc(cc(n4)C(C)(C)C)n4-c5ccc(C)cc5;6.9499998;Focal adhesion kinase 1;K9Y
4f4p;C1C[NH2+]CCN1c2cc(ccc2)-c3nc(ccc3)Nc(cc4C(F)(F)F)ncc4;9.2200003;Tyrosine-protein kinase SYK;0SB
4m3q;CCCCNc1ncc(-c2ccccn2)c(n1)N[C@@H]3CC[C@@H](O)CC3;7.77;Tyrosine-protein kinase Mer;24K
3pup;c1cccc2c1c3c(C(=O)NC4=O)c4c(C=C(CN56)N)c5c3n2[Ru]67(Cl)(C=O)N8C(C[NH2+]7)=CCC=C8;8.2200003;Glycogen synthase kinase-3 beta;OS1
3heg;c1cc(Cl)c(C(F)(F)F)cc1NC(=O)Nc2ccc(cc2)Oc(ccn3)cc3C(=O)NC;6.7399998;Mitogen-activated protein kinase 14;BAX
3hec;c1ncccc1-c2ccnc(n2)Nc3c(C)ccc(c3)NC(=O)c4ccc(cc4)C[N@H+]5CC[NH+](C)CC5;4.4699998;Mitogen-activated protein kinase 14;STI
3ue4;Clc1cc(Cl)c(cc1OC)Nc(c(C#N)cn2)c(c23)cc(OC)c(c3)OCCC[N@@H+]4CC[N@H+](C)CC4;8.96;Tyrosine-protein kinase ABL1;DB8
2z7r;CO[C@@H]1[C@H]([NH2+]C)C[C@@H](O2)n3c(cccc4)c4c(c3c5n6[C@]12C)c7c(CNC7=O)c5c8c6cccc8;9.5228786;Ribosomal protein S6 kinase alpha-1;STU
1pf8;c1nc[nH]c1/C=C(\C(=O)N2)c(c23)cc(cc3)OC;7.5100002;Cell division protein kinase 2;SU9
4mf1;C[NH+](C)Cc1ccc(cc1)[C@H]2C[C@@H]2C(=O)Nc(n3)sc(c34)cc(cc4)-c5c[nH]nc5;8.2200003;Tyrosine-protein kinase ITK/TSK;29Y
4mf0;C[NH+](C)Cc1ccc(cc1)[C@H]2C[C@@H]2C(=O)Nc(n3)sc(c34)cc(cc4)-c5cccnc5;8.0799999;Tyrosine-protein kinase ITK/TSK;29Z
3ezv;c1cc(N)ccc1-c(c2)ccc(c23)c([nH]n3)-c([nH]4)nc(c45)c(ccc5)N6CC[NH+](C)CC6;5.9829664;Cell division protein kinase 2;EZV
3k3j;c1cnccc1-c(n2)cc(c(=O)n2-c3ccc(F)cc3)C(=O)NCc4ccccc4C(F)(F)F;4.9000001;Mitogen-activated protein kinase 14;F4C
3k3i;c1cccc(c12)C[C@H]([NH2+]C2)c3nc(c[nH]3)-c4ccc(Br)cc4;5.7212462;Mitogen-activated protein kinase 14;JZJ
5j9z;c1cccc(c12)n(C)cc2-c(c(c34)c(N)ncn3)nn4[C@H](CCC5)CN5C(=O)CC;7.8000002;Epidermal growth factor receptor;6HJ
5j9y;CCC(=O)N1C[C@@H](CCC1)n2nc(c(c23)c(N)ncn3)-c4cccc(c45)cccc5;7.2399998;Epidermal growth factor receptor;6HL
2xm9;C1C[NH2+]C[C@H]1Nc(c(c23)cccc2)nc(n3)-c4c(O)ccc(c4)-c5cc[nH]n5;8.0500002;SERINE/THREONINE-PROTEIN KINASE CHK2;LWH
2xm8;C1C[NH2+]C[C@H]1Nc(c(c23)cccc2)nc(n3)-c4c(O)cccc4;6.8000002;SERINE/THREONINE-PROTEIN KINASE CHK2;B4W
3uzp;Nc1nccc(n1)-c2n(C3CCCCC3)cnc2-c(cc4)ccc4F;7.8899999;Casein kinase I isoform delta;0CK
5kup;CC(C)(C)c(c1)cc(F)c(c12)c(=O)n(nc2)-c3c(CO)c(ccn3)C4=C[C@@H](C(=O)N(C4)C)Nc5ccncn5;8.1400003;Tyrosine-protein kinase BTK;6XL
2x6d;C1COCC[NH+]1Cc2ccc(cc2)-c(n3)[nH]c(c34)ncc(Br)c4N5CC[NH+](CC5)Cc6ccc(Cl)cc6;7.9200001;SERINE/THREONINE-PROTEIN KINASE 6;X6D
2x6e;Cc1cc(no1)C[NH+]2CCN(CC2)c(c(Br)cn3)c(c34)[nH]c(n4)-c5ccc(cc5)N6CC[NH+](C)CC6;7.8200002;SERINE/THREONINE-PROTEIN KINASE 6;YM4
4jps;FC(F)(F)C(C)(C)c1cc(ccn1)-c(c2C)sc(n2)NC(=O)N3[C@H](C(=O)N)CCC3;8.3000002;Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform;1LT
5cep;n1ccc(C(F)(F)F)cc1Nc(nn2C(C)C)cc2C3CC[NH2+]CC3;6.8400002;Mitogen-activated protein kinase kinase kinase 12;50E
2xmy;Cc1n(C)c(=O)sc1-c2nc(ncc2)Nc3ccc(cc3)S(=O)(=O)NCCOC;9.96;CELL DIVISION PROTEIN KINASE 2;CDK
5ceo;n1ccc(C#N)cc1Nc(n2)cc(cc2N(C3)CCC3(F)F)[C@H]4CC[N@@H+](CC4)C5COC5;9.3000002;Mitogen-activated protein kinase kinase kinase 12;50D
5cei;CNC(=O)c(c1)sc(c12)cncc2Oc3ccc(I)cc3;8.2799997;Cyclin-dependent kinase 8;50R
1urw;C[NH+](C)CCCNS(=O)(=O)c(cc1)ccc1Nc(n2)nccc2C(=CN3)N([C@H]34)N=CC=C4;8.5200005;CELL DIVISION PROTEIN KINASE 2;I1P
4r5y;FC(F)(F)c(c1)ccc(c12)[nH]c(n2)[C@H]3[C@@H]([C@@H]34)c5c(O4)ccc(c5)Oc(ccn6)c(c67)CCC(=O)N7;6.5999999;Serine/threonine-protein kinase B-raf;3K3
4o0y;n1c(N)ncnc1-n(c(n2)NCC)c(c23)cc(cc3)C#CC(C)(C)O;7.2199998;Serine/threonine-protein kinase PAK 4;2OO
4o0x;n1c(N)ncnc1-n(c(n2)C)c(c23)cc(cc3)C#CC4(O)CCCCC4;7.1700001;Serine/threonine-protein kinase PAK 4;2OQ
4o0v;COCCNc(n1)n(-c2ccnc(n2)N)c(c13)cc(cc3)C#CC4(O)CCCCC4;8.4799995;Serine/threonine-protein kinase PAK 4;2OL
4o0t;COCCNc(n1)n(-c2ccnc(n2)N)c(c13)cc(cc3)C#CC4(O)CCCCC4;5.54;Serine/threonine-protein kinase PAK 1;2OL
5ih9;C1C[NH2+]CCC1COc2cnccc2-c3cn(nc3)-c(cc4)ccc4N5CC[NH+](C)CC5;8.6999998;Maternal embryonic leucine zipper kinase;6BF
5ih6;n1c(N)nc(N)c(c12)nc(c(n2)N)-c3cccc(Br)c3;5.5999999;Casein kinase I isoform delta;AUG
3vby;c1cccc(c12)[nH]cc2C(=O)c3occc3;4.5500002;Serine/threonine-protein kinase pim-1;0FR
3vbx;O=C(O1)CC(=O)c(c12)cc(Br)cc2;4.77;Serine/threonine-protein kinase pim-1;0FO
3vbq;O=C1NC(=O)SC/1=C\c2cccc(c2)-c3nc(cnc3)N[C@H]4CC[C@H]([NH3+])CC4;9.3299999;Serine/threonine-protein kinase pim-1;0F5
3vbt;n1[nH]ccc1-c2cc(Cl)ccc2O;4.4299998;Serine/threonine-protein kinase pim-1;0F9
3vbw;O=C1C(C#N)C(=O)c(c12)cccc2;5.2199998;Serine/threonine-protein kinase pim-1;0FN
3vbv;c1cc(C(=O)N)nc(c12)c(O)ccc2;5;Serine/threonine-protein kinase pim-1;0FK
4rx7;[NH3+][C@H]1CCCC[C@H]1Nc2nnc(C(=O)N)c(n2)Nc3cccc(c3)-n4nccn4;8.3000002;Tyrosine-protein kinase SYK;3YV
3nrm;c1n[nH]cc1-c2cnc(n23)c(ncc3)Nc4snc(c4)C;8.3999996;Serine/threonine-protein kinase 6;NRM
4ytf;FC(F)(F)CNC(=O)[C@H](C)Nc1c(F)cnc(n1)-c2c[nH]c(c23)ncc(Cl)c3;8.1499996;Tyrosine-protein kinase JAK2;4HZ
4ytc;c1ccccc1Nc2cc(ncn2)-n3nc(nc3N)Nc4ccccc4;7.8899999;Tyrosine-protein kinase JAK2;4HW
4yth;c1c(Cl)cnc(c12)[nH]cc2-c(ncc3F)nc3NC(C)(C)C(=O)NCC(F)(F)F;8.6999998;Tyrosine-protein kinase JAK2;467
1w12;c1ccccc1CS(=O)(=O)N[C@@H](N=C(c(c23)cccc3)c4ccccc4)C(=O)N2CC(=O)N[C@H](C=O)CCC[NH+]=C(N)N;7.8538718;UROKINASE-TYPE PLASMINOGEN ACTIVATOR;SL1
1h07;C[NH+](C)CC(O)COc(cc1)ccc1Nc2cc(ncn2)N(C=[C]#N)c(cc3)c(Br)cc3C;5.52;CELL DIVISION PROTEIN KINASE 2;MFP
1h01;C[NH+](C)C[C@H](O)COc(cc1)ccc1Nc2nccc(n2)Nc3cc(Cl)ccc3Cl;4.6599998;CYCLIN-DEPENDENT KINASE 2;FAL
3o8p;Cn1nc(C(C)(C)C)cc1NC(=O)Nc2ccc(Cl)cc2;6.46;Mitogen-activated protein kinase 14;BMU
1h08;C[NH+](C)C[C@@H](O)COc(cc1)ccc1Nc2ncc(Br)c(n2)Nc3ccccc3;4.5500002;CELL DIVISION PROTEIN KINASE 2;BYP
4x21;CCNC(=O)N1CCC(CC1)Nc2nc(c(I)cn2)-c(c[nH]3)c(c34)cccc4;7.4400001;Mitogen-activated protein kinase 10;3WH
1h0w;[nH]1cnc(c12)c(nc(c2)N)OC[C@H]3CCC=CC3;4.8899999;CELL DIVISION PROTEIN KINASE 2;207
2np8;C1CC1C(=O)Nc2cc(ccc2)Nc3nccc(n3)Nc4cc(C(F)(F)F)ccc4;7.3800001;Serine/threonine-protein kinase 6;CC3
4ksp;FC(F)(F)c1cccc(c1)CC(=O)Nc2cc(ccc2F)Oc(cc3)c(C#N)c(c34)sc(n4)NC(=O)C5CC5;8.8000002;Serine/threonine-protein kinase B-raf;1SU
4ksq;C1CC1C(=O)Nc(n2)sc(c23)c(C#N)c(cc3)Oc(ccc4F)cc4NC(=O)Nc5cccc(c5)C(F)(F)F;7.3099999;Serine/threonine-protein kinase B-raf;1SW
3m2w;c1cccc(c1F)-c(c2)ncc(cc3)c2c([nH]4)c3c(C(=O)NC5)c4[C@@]56C[N@H+](C6)C;8.5200005;MAP kinase-activated protein kinase 2;L8I
2yfx;Clc1ccc(F)c(Cl)c1[C@@H](C)Oc2cc(cnc2N)-c3cnn(c3)C4CC[NH2+]CC4;8.0900002;TYROSINE-PROTEIN KINASE RECEPTOR;VGH
2c0o;C1CN(C(=O)C)CC[NH+]1[C@H](CC2)CC[C@@H]2n(c(c34)ncnc4N)nc3-c5cc(OC)c(cc5)NC(=O)c(n6C)cc(c67)cccc7;5.9099998;TYROSINE-PROTEIN KINASE HCK;L2G
1ijr;[O-]C(=O)COc(cc1)c(P([O-])(O)O)cc1C[C@H](NC(=O)C)C(=O)N[C@@H](C)c2cc(C(=O)N)c(cc2)OCC3CCCCC3;5.4400001;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE LCK;CC0
3qtq;CCCNc(nc1N)sc1[C@H](O)c2cnccc2;5.5100002;Cyclin-dependent kinase 2;X35
3qtr;c1ccccc1Nc(nc2N)sc2[C@H](O)c3ccccc3;6.0300002;Cyclin-dependent kinase 2;X36
3qts;COc1cccc(c1)[C@@H](O)c2sc(nc2N)Nc3ccccc3;5.5100002;Cyclin-dependent kinase 2;X46
3qtu;NS(=O)(=O)c(cc1)ccc1Nc(s2)nc(N)c2C(=O)c3ccc(cc3)S(=O)(=O)N;7.1500001;Cyclin-dependent kinase 2;X44
3qtw;c1ccccc1Nc(nc2N)sc2[C@H](O)c3cnccc3;6.1900001;Cyclin-dependent kinase 2;X3A
3qtx;c1cc(S(=O)(=O)N)ccc1Nc(nc2N)sc2[C@H](O)c3cc(N(=O)=O)ccc3;7.1500001;Cyclin-dependent kinase 2;X43
3qtz;NS(=O)(=O)c(cc1)ccc1Nc(s2)nc(N)c2C(=O)c3cccc(F)c3;7.3000002;Cyclin-dependent kinase 2;X42
1oiu;NS(=O)(=O)c1cccc(c1)Nc(nc(c23)[nH]cn3)nc2OCC4CCCCC4;6.6799998;CELL DIVISION PROTEIN KINASE 2;N76
2zdt;c1ccccc1-c(c(c23)cc(Cl)cc2)c(C(=O)CC)n(c3=O)Cc4ccc(C(=O)[O-])cc4;8.0177288;Mitogen-activated protein kinase 10;46C
5t68;Cc1[nH]nc(c12)cc(cc2)Nc(n3)nc(c(c34)occ4)NC5CC5;7.6399999;Tyrosine-protein kinase SYK;77V
2zdx;c1cc(O)cc(O)c1-c2n[nH]c(C)c2-c3ccc(cc3)OC;3.1900001;Pyruvate dehydrogenase kinase isozyme 4;P4A
4cfu;C1CCCCC1COc(nc(n2)N)c(c23)[nH]c(n3)-c4cccc(C(=O)[O-])c4C;4;CYCLIN-DEPENDENT KINASE 2;2WC
4cfw;C1CCCCC1COc(nc(n2)N)c(c23)[nH]c(n3)-c4cccc(c4C)S(=O)(=O)N;6.29;CYCLIN-DEPENDENT KINASE 2;SQ9
4cfv;C1CCCCC1COc(nc(n2)N)c(c23)[nH]c(n3)-c4cccc(O)c4C;4.6300001;CYCLIN-DEPENDENT KINASE 2;75X
5edq;c1[nH]ncc1-c(nc(c23)C(C)(C)OC3)nc2Nc4n[nH]c(c45)c(Cl)ccc5;8.6999998;Epidermal growth factor receptor;5N3
4cfx;C1CCCCC1COc(nc(n2)N)c(c23)[nH]c(n3)-c4cccc(c4)S(=O)(=O)N;5.0599999;CYCLIN-DEPENDENT KINASE 2;G6T
4cfe;c1cn(C)c(c12)ccc(c2)-c(c(Cl)c3)cc(c34)[nH]c(n4)Oc5ccc(C)c(c5)C(=O)[O-];7.2199998;5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2;992
4cff;Oc1c(C#N)c(O)nc(c12)scc2-c3ccc(cc3)-c4ccccc4O;6.4000001;5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2;C1V
4cfm;C1CCCCC1COc(nc(n2)N)c(c23)nc([nH]3)-c4ccccc4C;4.7399998;CYCLIN-DEPENDENT KINASE 2;4QE
3s3i;C1CC1NC(=O)c(ccc2C)cc2-c(c3)ccn(c34)c(nn4)C(C)(C)C;7.8000002;Mitogen-activated protein kinase 14;CQ0
1jvp;c1cnccc1-c([nH]n2)c(c23)Cc4c3cccc4;5.8000002;Cell division protein kinase 2;LIG
2zaz;O=Cc1scc(n1)-c(cc2)cc(c23)nccc3Nc4c(C)ccc(c4)O;6.3979402;Mitogen-activated protein kinase 14;GK1
3ugc;C1C[N@H+](C)CC[N@H+]1Cc(c2C(F)(F)F)ccc(c2)NC(=O)n(cc3)c(c34)ccc(c4)Oc5ncnc(c5)NC(=O)C;6.02;Tyrosine-protein kinase JAK2;046
2ow3;O=C1NC(=O)C(=C12)c3c4c(cccc4)n(c3)CCCCc5ccc(nc5N(C)C)CCCn6c7c(c2c6)cccc7;8.5228786;Glycogen synthase kinase-3 beta;BIM
4m12;NC(=O)Nc(c1)c(C(=O)N)nn1-c2cccc(c23)ccc(c3)OCC;6.0500002;Tyrosine-protein kinase ITK/TSK;1YZ
4m13;NC(=O)Nc(c1)c(C(=O)N)nn1-c2cccc(c23)ccc(c3)OCCC;6.6999998;Tyrosine-protein kinase ITK/TSK;1E0
4m14;NC(=O)Nc(c1)c(C(=O)N)nn1-c2cccc(c23)ccc(c3)OC(C)C;6.6999998;Tyrosine-protein kinase ITK/TSK;QWS
3ug2;C1COCC[NH+]1CCCOc(c2)c(OC)cc(c23)ncnc3Nc4cc(Cl)c(F)cc4;8.25;Epidermal growth factor receptor;IRE
2owb;c1ccsc1CC(=O)N(C2)Cc(c23)c([nH]n3)NC(=O)c4ccc(cc4)N5CC[NH+](C)CC5;6.3600001;Serine/threonine-protein kinase PLK1;626
3skc;COc1[nH]nc(c12)ncc(c2)NC(=O)c3c(F)c(ccc3F)NS(=O)(=O)c4ccccc4;8.8000002;Serine/threonine-protein kinase B-raf;BR2
1pxp;s1c(C)nc(C)c1-c(n2)ccnc2Nc3ccc(cc3)N(C)C;6.6599998;Cell division protein kinase 2;CK8
1pxo;Nc1nc(C)c(s1)-c2nc(ncc2)Nc3cccc(c3)N(=O)=O;8.6999998;Cell division protein kinase 2;CK7
1pxn;Cc1nc(NC)sc1-c2ccnc(n2)Nc3ccc(O)cc3;7.1500001;Cell division protein kinase 2;CK6
1pxm;Oc1cc(ccc1)Nc2nccc(n2)-c3c(C)nc(s3)C;7.2199998;Cell division protein kinase 2;CK5
1pxl;FC(F)(F)c1ccc(cc1)Nc2nccc(n2)-c3sc(C)nc3C;6.0500002;Cell division protein kinase 2;CK4
1pxk;Cc1sc(c(n1)C)-c2nc(ncc2)N/C=N\O;5.6599998;Cell division protein kinase 2;CK3
1pxj;Cc1sc(c(n1)C)-c2nc(N)ncc2;4.8899999;Cell division protein kinase 2;CK2
1pxi;Clc1cc(c(s1)Cl)-c2nc(N)ncc2;4.77;Cell division protein kinase 2;CK1
4nj3;c1ccc(Cl)cc1-c(c2)ccc(c23)nc(cc3C(=O)[O-])C(=O)N[C@H](C(=O)OC)Cc4ccc(O)cc4;6.52;Cyclin-dependent kinase 2;2KD
4py1;c1n(C)ncc1-c(nn2)n(c23)nc(cc3)Sc(c4)c(OC)ccc4OC;7.1900001;Non-receptor tyrosine-protein kinase TYK2;2YK
2zyb;Cc1cccc(C)c1Nc2ncc([n+](c23)c[nH]c3)-c4ccccc4;7.6989698;Proto-oncogene tyrosine-protein kinase LCK;KSL
4yo6;c1ccnc(n12)c(cn2)C(=O)Nc3cc(C)nn3-c4ccccc4;5.6599998;Interleukin-1 receptor-associated kinase 4;4GD
1wzy;c1ccccc1-c([nH]2)c(c(c23)cccc3)-c(c4)nnc(c45)n(nc5N)CCC;6.25;Mitogen-activated protein kinase 1;F29
4njd;c1[nH]nc(c12)ccc(c2)Nc3nc(nc(n3)OC)NCCc4c[nH]c(c45)cccc5;2.8399999;Serine/threonine-protein kinase PAK 4;NJD
2x4z;c1ccccc1[C@@H](C[NH+](C)C)NC(=O)N(C2)C(C)(C)c(c23)[nH]nc3Nc4nc(C)nc(c45)ccs5;8.5699997;SERINE/THREONINE-PROTEIN KINASE PAK 4;7KC
3dbs;[nH]1ncc(c12)c(ccc2)-c(n3)nc(N4CCOCC4)c(c35)sc(c5)C[NH+]6CCN(CC6)S(=O)(=O)C;7.124939;Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;GD9
3my5;c1c(Cl)c(Cl)cc(c12)ncn2[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O;4.1900001;Cell division protein kinase 2;RFZ
2xck;Cc(c1)nccc1CNC(=O)c2nn(C)c(c23)c4c(cc3)cnc(n4)Nc5ccc(cc5)N6CC[NH+](C)CC6;6.1500001;3-PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1;MH4
2xch;C1C[NH2+]CCC1Cn(nc2C(=O)N)c(c23)c4c(cc3)cnc(n4)Nc5ccccc5;6.4299998;3-PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1;CKG
4qp1;n1c[nH]c(c12)c(ncn2)NCc3ccccc3;3.6099999;Mitogen-activated protein kinase 1;EMU
2ym5;[NH3+]C[C@H]1CN(CCO1)c(ncn2)c(c23)c(c[nH]3)-c4cccc(c4)CO;6.3699999;SERINE/THREONINE-PROTEIN KINASE CHK1;YM5
2ym7;C1C[NH2+]CCC1CNc2cc(ncn2)Nc3cnc(C#N)cn3;6.8899999;SERINE/THREONINE-PROTEIN KINASE CHK1;YM7
3gvu;c1ncccc1-c2ccnc(n2)Nc3c(C)ccc(c3)NC(=O)c4ccc(cc4)C[N@H+]5CC[N@H+](C)CC5;8;Tyrosine-protein kinase ABL2;STI
2w1d;n1[nH]ccc1-c(n2)[nH]c(c23)cccc3;6.0409584;SERINE/THREONINE-PROTEIN KINASE 6;L0D
2w1e;c1ccccc1NC(=O)Nc2c[nH]nc2-c(n3)[nH]c(c34)ccc(c4)C[NH+]5CCOCC5;7.9208188;SERINE/THREONINE-PROTEIN KINASE 6;L0E
4ach;C[NH+]1CCN(CC1)S(=O)(=O)c2ccc(cc2)-c3cnc(N)c(n3)C(=O)NCCCOC;7.6599998;GLYCOGEN SYNTHASE KINASE-3 BETA;KDI
4acm;C[NH+](C)CCNS(=O)(=O)c1ccc(cc1)-c2cnc(N)c(n2)C(=O)Nc3cccnc3;6.6799998;CYCLIN-DEPENDENT KINASE 2;7YG
4acd;C[NH+]1CCN(CC1)S(=O)(=O)c2ccc(cc2)-c3cnc(N)c(n3)C(=O)Nc4cccnc4;8.3100004;GLYCOGEN SYNTHASE KINASE-3 BETA;GR9
4acg;C[NH+]1CCN(CC1)S(=O)(=O)c2ccc(cc2)-c3cc(c(N)nc3)C(=O)Nc4cnccc4C[NH+]5CCCC5;9.6599998;GLYCOGEN SYNTHASE KINASE-3 BETA;6LQ
5iug;CC(C)(C)c(c1)onc1NC(=O)Nc2c(C)cc(cc2)-c3[nH]nc(c3)NC(=O)c4ccc(cc4)C[N@@H+]5CC[N@@H+](C)CC5;7.3299999;ALK tyrosine kinase receptor;729
5iui;Nc1ccc(cc1C)-c([nH]n2)cc2NC(=O)c3ccc(cc3)C[NH+]4CC[N+](=C)CC4;5;ALK tyrosine kinase receptor;45Q
5iuh;CC(C)c(c1)onc1NC(=O)Nc2ccc(cc2C)-c3cc(n[nH]3)NC(=O)c4ccc(cc4)C[N@@H+]5CC[N@H+](C)CC5;6.4000001;ALK tyrosine kinase receptor;34Y
4dhf;C1CCCC1n(c(c2)C(=O)N)c(c23)nc(nc3)Nc4cn(C)c(c4)C(=O)N5CC[NH+](C)CC5;7.5500002;Aurora kinase A;0K6
4rfm;C[C@]12[C@@H](C2(F)F)Cc3c(C1)n[nH]c3C(=O)Nc4cnn(c4)[C@@H]([C@H](S5(=O)=O)CCCC5)c6ccccc6;10.05;Tyrosine-protein kinase ITK/TSK;3P6
5iu2;C1COCC[NH+]1CCNc(s2)nc(c23)ccc(c3)-n(cn4)c(c45)c6c(nc5)cnc(c6)-c7ccccc7;7.8000002;Mitogen-activated protein kinase kinase kinase 8;6DA
3wf5;c1[nH]nc(c12)ncnc2N3CCC(CC3)c([nH]4)nc(c45)cccc5;7.0900002;Ribosomal protein S6 kinase beta-1;FZ8
3wf6;c1[nH]nc(c12)ncnc2N3CC=C(CC3)c4c[nH]c(c45)cccc5;7.48;Ribosomal protein S6 kinase beta-1;FZ9
3wf7;[nH]1cnc(c12)ncnc2N3CCC(CC3)C(=O)Nc4cc(C(F)(F)F)ccc4;6.6900001;Ribosomal protein S6 kinase beta-1;FS9
3wf8;C1CCCCc(n2)c1c(c(c23)cccc3)C(=O)OCC(=O)Nc4ccc(S(=O)(=O)N)cc4;6.6300001;Ribosomal protein S6 kinase beta-1;F76
3wf9;C1[C@@H](C)CCc(n2)c1c(c(c23)cccc3)C(=O)O[C@@H](C)C(=O)Nc4ccc(S(=O)(=O)N)cc4;6.25;Ribosomal protein S6 kinase beta-1;FS7
4rfz;C1COCCN1C(=O)c(cn2)ccc2Nc(c3=O)cc(cn3C)-c4cccc(c4CO)-n(c5=O)ccc(c56)cc(cc6F)N(C)C;7.4000001;Tyrosine-protein kinase BTK;3OV
4rfy;C1COCCN1C(=O)c(cn2)ccc2Nc(c3=O)cc(cn3C)-c4cccc(c4CO)N(C5=O)CCc(c56)cc(cc6)N(C)C;7;Tyrosine-protein kinase BTK;3OU
4eoh;Cn1c(=O)n(C)c(=O)c(c12)[nH]cn2;4.3000002;Pyridoxal Kinase;TEP
4eoi;s1cccc1CNC(=NC2=O)S[C@@H]2Cc(cc3)cc(c34)cccn4;6.0500002;Cyclin-dependent kinase 2;1RO
4eol;s1cccc1CNC(=NC2=O)S[C@@H]2Cc(cc3)cc(c34)cccn4;6.0500002;Cyclin-dependent kinase 2;1RO
4eon;s1cccc1CNC(=NC2=O)SC\2=C\c(cc3)cc(c34)cccn4;6.0500002;Cyclin-dependent kinase 2;1RO
3gcv;c1cc(N)cc(c12)c(ncn2)Nc(ccc3)cc3NC(=O)Nc4cc(C(C)(C)C)nn4-c(cc5C)ccc5;7.1307683;Mitogen-activated protein kinase 14;SS6
3gcu;c1c(N)ccc(c12)ncnc2Nc3cc(ccc3)NC(=O)Nc4cc(C(C)(C)C)nn4-c5ccc(C)cc5;6.782516;Mitogen-activated protein kinase 14;R48
4eos;s1cccc1CNC(=NC2=O)S[C@@H]2Cc(cc3)cc(c34)cccn4;6.0500002;Cyclin-dependent kinase 2;1RO
3gcq;c1cc(N)cc(c12)c(ncn2)Nc(cc3)ccc3NC(=O)Nc4cc(C(C)(C)C)nn4-c(cc5C)ccc5;6.4659739;Mitogen-activated protein kinase 14;1BU
3gcp;O[S@@H](C)c1ccc(cc1)-c2nc(c([nH]2)-c(cc3)ccc3F)-c4ccncc4;7.8239088;Mitogen-activated protein kinase 14;SB2
2ojg;CN(C)C(=O)c1cc(c[nH]1)-c2[nH]ncc2-c3ccccc3;5.6399999;Mitogen-activated protein kinase 1;19A
4bcn;CNC1=N[C@H](C)[C@H](S1)c2nc(ncc2C#N)Nc3cc(O)ccc3;7.9200001;CYCLIN-DEPENDENT KINASE 2;T9N
4bcm;CNc1nc(C)c(s1)-c2nc(ncc2C#N)Nc3cc(c(C)cc3)S(=O)(=O)N4CCOCC4;6.9099998;CYCLIN-DEPENDENT KINASE 2;T7Z
4bck;CNc1nc(C)c(s1)-c2nc(ncc2C#N)Nc3cc(S(=O)(=O)N)ccc3;8.3999996;CYCLIN-DEPENDENT KINASE 2;T3E
4bcj;CNc1nc(C)c(s1)-c2nc(ncc2C#N)Nc3cc(O)ccc3;7.96;CYCLIN-DEPENDENT KINASE 9;T9N
4bci;CNc1nc(C)c(s1)-c2nc(ncc2C#N)Nc3cc(S(=O)(=O)N)ccc3;8.2200003;CYCLIN-DEPENDENT KINASE 9;T3E
4bch;CNc1nc(C)c(s1)-c2nc(ncc2C#N)Nc3cc(c(C)cc3)S(=O)(=O)N4CCOCC4;7.6599998;CYCLIN-DEPENDENT KINASE 9;T7Z
4bcg;CNc1nc(C)c(s1)-c2nc(ncc2C#N)Nc3cccc(c3)N4CCC[NH2+]CC4;8.1499996;CYCLIN-DEPENDENT KINASE 9;T3C
4bcf;CNc1nc(C)c(s1)-c2nc(ncc2C#N)Nc3cccc(c3)N4CCCN(C(=O)C)CC4;8.1499996;CYCLIN-DEPENDENT KINASE 9;T6Q
2ojj;c1c(Cl)cccc1-c(cn[nH]2)c2-c(c[nH]3)cc3C(=O)N[C@H](CO)c4ccc(F)c(Cl)c4;8.6999998;Mitogen-activated protein kinase 1;82A
2oji;Clc1cccc(c1)-c2c[nH]nc2-c3c[nH]c(c3)C(=O)NCc4ccccc4;7.0700002;Mitogen-activated protein kinase 1;33A
2wih;CNC(=O)c(nn1C)c(c12)C(C)(C)Cc3c2nc(nc3)Nc4ccc(cc4)N5CC[NH+](C)CC5;7.3467875;CELL DIVISION PROTEIN KINASE 2;P48
4bcp;CNc1nc(C)c(s1)-c2nc(ncc2C#N)Nc3cccc(c3)N4CCC[NH2+]CC4;6.25;CYCLIN-DEPENDENT KINASE 2;T3C
3r7r;O=C(C)Nc(cc1)cc(c12)OCCc3c2sc(c3)C(=O)N(C)c4ccccc4Cl;8.7399998;Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;FAZ
2fb8;O\N=C(\CC1)c(c12)ccc(c2)-c3c(-c4ccncc4)nc([nH]3)-c5ccc(cc5)OCC[NH+](C)C;9.8000002;B-Raf proto-oncogene serine/threonine-protein kinase;215
2pl0;c1ncccc1-c2ccnc(n2)Nc3c(C)ccc(c3)NC(=O)c4ccc(cc4)C[N@H+]5CC[N@H+](C)CC5;7.21;Proto-oncogene tyrosine-protein kinase LCK;STI
5afv;c1ccccc1CN[n+]2cnn(c2)Cc3ccccc3;5.5900002;CHOLINE KINASE ALPHA;JH5
3fc2;C1CC1C[N@H+](CC2)CC[N@@H+]2[C@H](CC3)CC[C@@H]3NC(=O)c(cc4OC)ccc4Nc(nc5)nc(c56)N(C(C)C)[C@H](CC)C(=O)N6C;9.0600004;Serine/threonine-protein kinase PLK1;IBI
3fc1;Fc1ccc(c(F)c1)SC(=CC=2)NN(C23)C=NC(=O)[C@H]3c4c(Cl)cccc4Cl;8;Mitogen-activated protein kinase 14;52P
3f5p;OCC[N@@H+](C)CCCOc(c1)c(OC)cc(c12)c(c(cn2)C#N)Nc3ccc(c(Cl)c3)Sc4nccn4C;6.8538718;Insulin-like growth factor 1 receptor;741
4nw6;COc1c(OC)cc(cc1OC)Nc(n2)oc(c23)c(ccc3)-c4cccc(c45)nc[nH]5;8.2799997;Ribosomal protein S6 kinase alpha-3;2NS
4f08;c1c[nH]c(nc2)c1c(c23)n(cn3)C4CC[NH2+]CC4;6.5999999;Tyrosine-protein kinase JAK2;1RS
4f09;c1c[nH]c(nc2)c1c(c23)n(c(n3)C)C4CC[NH2+]CC4;6.6999998;Tyrosine-protein kinase JAK2;JAK
2y8q;OP([O-])(O)OP([O-])(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n(cn2)c(c23)ncnc3N;5.8200002;5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-1;ADP
3s1h;COc1ccc(cc1)[C@@H](O)c2sc(nc2N)Nc3ccc(S(=O)(=O)N)cc3;4.77;Cyclin-dependent kinase 2;56Z
4wag;c1cc(OC)c(OC)cc1-c(c(n2)C)n(c23)nc(Cl)cc3N;7.0799999;Phosphatidylinositol 4-kinase beta,Phosphatidylinositol 4-kinase beta;3K7
4nwm;c1cc(C(C)(C)C)ccc1C(=O)Nc(c2C)cccc2-c(nc(c34)nc[nH]4)nc3Nc(cc5)ccc5C(=O)N6CCOCC6;8.3999996;Tyrosine-protein kinase BTK;2P5
3cgo;CNC(=O)C[N@@H+]1CC[C@H](CC1)Nc2nc(ccn2)-c3cnc(n34)cccc4;5.5228791;Mitogen-activated protein kinase 10;JNO
3cgf;C1CCCCC1N(C)c2nc(ccn2)-c3cnc(n34)cccc4;6.5686359;Mitogen-activated protein kinase 10;JNF
3piz;c1cccc(C)c1-n2c(N)c(cn2)C(=O)c3cc(ccc3)C4CCN(CC4)S(=O)(=O)C;5.46;Tyrosine-protein kinase BTK;03C
3pix;[nH]1nc(C)cc1Nc(nn(c2=O)C(C)C)c(c23)ccc(c3)N4CC[NH+](C)CC4;7;Tyrosine-protein kinase BTK;027
3piy;N1C(=O)C(C)(C)Oc(c12)ccc(n2)Nc3nc(ncc3F)Nc(cc4OC)cc(OC)c4OC;6.54;Tyrosine-protein kinase BTK;585
2uzl;O=S(=O)(N)c1c(C(F)(F)F)cc(cc1)-c2oc(cc2)/C=C3\S/C(=N/[H])NC3=O;6.21;CELL DIVISION PROTEIN KINASE 2;C94
2uzo;O=S(=O)(N)c1ccc(cc1)-c2oc(cc2)/C=C3\SC(=O)NC3=O;4.5700002;CELL DIVISION PROTEIN KINASE 2;C62
2uzn;O=S(=O)(N)c1ccc(cc1)-c2oc(cc2)/C(C)=C3\S/C(=N/[H])NC3=O;7.52;CELL DIVISION PROTEIN KINASE 2;C96
2uze;O=C([O-])c1ccc(cc1)-c2oc(cc2)/C=C3\S/C(=N/[H])NC3=O;4.3299999;CELL DIVISION PROTEIN KINASE 2;C95
2uzd;O=S(=O)(N)c1ccc(cc1)-c2oc(cc2)/C=C3\S/C(=N/[H])NC3=O;6.7399998;CELL DIVISION PROTEIN KINASE 2;C85
2uzb;CNS(=O)(=O)c1ccc(cc1)-c2oc(cc2)/C=C3\S/C(=N/[H])NC3=O;6.9200001;CELL DIVISION PROTEIN KINASE 2;C75
2ou7;OP([O-])(O)NP([O-])(O)OP([O-])(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n(cn2)c(c23)ncnc3N;3.8099999;Serine/threonine-protein kinase PLK1;ANP
3l8s;Brc1cc(F)c(c(F)c1)COc2nsc(c2C(=O)N)NC(=O)NCCCC[NH+]3CCCC3;7;Mitogen-activated protein kinase 14;BFF
3l8v;Nc1nccc(c1)Oc2ccc(cc2F)Nc3c(cccn3)C(=O)Nc4ccc(F)cc4F;8.1000004;Hepatocyte growth factor receptor;L8V
3l8x;CNC(=O)c(cc1)cc(c1C)Nc(ncn2)c(c23)cnn3-c4ccccc4;8;Mitogen-activated protein kinase 14;N4D
3d83;C1CC1CNC(=O)c2ccc(cc2)-c3c(C)ccc(c3)NC(=O)c4cc(ncc4)N5CCOCC5;8.3565474;Mitogen-activated protein kinase 14;GK6
4cd0;n1ccnn1-c(ccc(F)c2)c2[C@@H](C)Oc3c(N)ncc(c3)-c4c(C)nc(s4)[C@@](O)(C)CO;9.6999998;ALK TYROSINE KINASE RECEPTOR;AWJ
3efw;CNc1nc(ccn1)-c2cccnc2Oc3c(C)cc(cc3)NC(=O)Nc4cccc(c4)C(F)(F)F;8.3979397;Serine/threonine-protein kinase 6;AK8
3khv;OCc1ccc(cc1)C[NH3+];1.8541822;Urokinase-type plasminogen activator;4AL
4hvh;C1CC1c(cn2)nc(c23)c(c[nH]3)C(=O)N[C@H](C)C(C)(C)O;7.7199998;Tyrosine-protein kinase JAK3;19R
4hvi;C1CCCCN1C(=O)[C@@H](C)NC(=O)c2c[nH]c(c23)ncc(n3)C4CC4;7.1599998;Tyrosine-protein kinase JAK3;19S
3efj;c1ccccc1Cc2ncc(c(=O)n2C)-c(cc3)cc(F)c3Oc4ccnc(c45)cc(OC)c(c5)OC;7.408936;Hepatocyte growth factor receptor;MT3
3efk;COc(c1)c(OC)cc(c12)nccc2Oc(c3F)ccc(c3)-c(c(=O)n4C)c[nH+]c4Nc(cc5)ccc5F;7.8538718;Hepatocyte growth factor receptor;MT4
4hvg;CC(C)(O)[C@H](C)NC(=O)c1c[nH]c(c12)ncc(n2)C3CC3;7.77;Tyrosine-protein kinase JAK3;19Q
4qna;n1c(N)nc(nc1N)-c2c(O)cccc2;4.6399999;SERINE/THREONINE-PROTEIN KINASE 24;X11
4y8d;C1COCCN1c(sn2)c(c23)ncc(c3)-c4cc(OC)c(N)cc4;8.0500002;Cyclin-G-associated kinase;49J
2hiw;n1c(N)ncc(c12)CN(C(=O)N2C)c3c(C)ccc(c3)NC(=O)c4cc(C(F)(F)F)ccc4;8.1000004;Proto-oncogene tyrosine-protein kinase ABL1;7MP
5j5t;c1cnccc1COc(c2N)cc(cn2)-c3cnc(s3)C4CC[NH2+]CC4;6.96;Mitogen-activated protein kinase kinase kinase kinase 3;6G2
4ymj;N#Cc1ccc(cc1)-c2cnc(n23)ccc(n3)NCc4ccccc4;7;NT-3 growth factor receptor;4EJ
4y83;S=c1[nH]nc(o1)-c(c2)c(N)ncc2-c(c3)cnc(c34)cccc4;7.77;Mitogen-activated protein kinase kinase kinase 8;49B
4y85;n1nc(N)oc1-c2c[nH]c(c23)ncc(c3)-c(c[nH]4)c(c45)cccc5;7.8899999;Mitogen-activated protein kinase kinase kinase 8;499
1uv5;c1cccc(c12)NC(\C\2=N\O)=C(/C(=O)N3)c(c34)ccc(Br)c4;8.3000002;GLYCOGEN SYNTHASE KINASE-3 BETA;BRW
5cas;C[C@@H](O)c(n1)n([C@H](C(F)(F)F)C)c(c12)cc(nc2)Nc3ccnc(n3)N4CC[C@@H]([C@H](F)C4)OC;8.8500004;Epidermal growth factor receptor;4ZQ
5caq;CC(C)n(c(n1)C)c(c12)cc(nc2)Nc3ccnc(n3)N4CC[C@@H]([C@H](F)C4)OC;8.5699997;Epidermal growth factor receptor;4ZJ
5cap;CC(C)n(c(n1)C)c(c12)cc(nc2)Nc3ccnc(n3)OCC(C)(C)S(=O)(=O)C;7.2800002;Epidermal growth factor receptor;4ZH
5cav;C[C@@H](O)c(n1)n([C@H](C(F)(F)F)C)c(c12)cc(nc2)Nc3ccnc(n3)N4CC[C@@H]([C@H](F)C4)OC;6.6700001;Epidermal growth factor receptor;4ZQ
5cau;C[C@@H](O)c(n1)n([C@H](C(F)(F)F)C)c(c12)cc(nc2)Nc3ccnc(n3)N4CC[C@H]([C@@H](F)C4)OC;8.8000002;Epidermal growth factor receptor;4ZR
3mvj;[NH3+][C@@H]1CCN(C1)c2ncnc(c23)[nH]cc3C;5.4899998;cAMP-dependent protein kinase catalytic subunit alpha;XFE
5cao;CC(C)n(c(n1)C)c(c12)cc(nc2)Nc3ccnc(n3)NCC(C)(C)S(=O)(=O)C;7.4200001;Epidermal growth factor receptor;4ZG
5can;CC(C)n(c(n1)C)c(c12)cc(nc2)Nc3ccnc(n3)N(C4)CC[C@@]4(C)C(=O)N;6.9099998;Epidermal growth factor receptor;4ZB
3mvl;CCCNC(=O)c(c1)c(C)c(n12)c(ncn2)Nc3c(C)ccc(c3)C(=O)NC4CC4;7.8899999;Mitogen-activated protein kinase 14;38P
3mvm;CCCNC(=O)c(c1)c(C)c(n12)c(ncn2)Nc3c(C)ccc(c3)C(=O)Nc4nocc4;8.4099998;Mitogen-activated protein kinase 14;39P
5auy;Oc1cc(O)ccc1-c(c(O)c2=O)oc(c23)cc(O)cc3O;5.8000002;Death-associated protein kinase 1;MRI
2xa4;Cc1cc([nH]n1)Nc2nc(ncc2Cl)N[C@@H](C)c(nc3)ncc3F;8.5200005;TYROSINE-PROTEIN KINASE JAK2;AZ5
1uvr;c1cccc(c12)n(C)cc2C(C(=O)NC3=O)=C3c(c(c45)cccc5)cn4CCC[NH3+];6;3-PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE-1;BI8
5bml;CS(=O)(=O)Nc1cccc(c1)CC(=O)Nc2cc(cs2)-c3ccnc(F)c3;8;Rho-associated protein kinase 1;4TW
4ztq;CCc(cc1)ccc1\N=C(\N(C2=O)CCOC)SC2Cc3ccncc3;6.3200002;Aurora kinase A;4RM
5auu;Oc1cc(O)cc(c12)oc(cc2=O)-c3cc(O)c(O)cc3;4.6799998;Death-associated protein kinase 1;LU2
5jrq;CCCS(=O)(=O)Nc(c1F)ccc(F)c1C(=O)c(c[nH]2)c(c23)cc(cn3)-c4ccc(cc4)OC;6.77;Serine/threonine-protein kinase B-raf;6N9
5aut;c1ccc(S([O-])(O)O)c(c12)c(ccc2)Nc3ccccc3;6.29;Death-associated protein kinase 1;2AN
4xv9;FC(F)(F)c1ccc(cc1)S(=O)(=O)Nc2c(F)c(c(F)cc2)C(=O)c3c[nH]c(c34)ncc(Cl)c4;6.7199998;Serine/threonine-protein kinase B-raf;1OO
5auw;Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)c(c3)O;5.0500002;Death-associated protein kinase 1;QUE
4ztn;C1CC[NH2+]C[C@@H]1NC2=NC(=[N+]3CCOCC3)NC(=O)[C@@H]2c(s4)nc(c45)cccc5;7.7199998;Interleukin-1 receptor-associated kinase 4;4S3
4ztl;OC[C@@H](C1)[C@@H](O)[C@@H](O)[C@@H]1Nc2nc(NCCC)ncc2-c(s3)nc(c34)cccc4;5.9200001;Interleukin-1 receptor-associated kinase 4;4S1
4xv1;CCN(C)S(=O)(=O)Nc(ccc1F)c(F)c1C(=O)c2c[nH]c(c23)ncc(c3)-c(cn4)cnc4C5CC5;8.3800001;Serine/threonine-protein kinase B-raf;904
3ot8;c1n(C)ncc1-c2cnn(c23)c(Nc4snc(c4)C)cc(n3)[C@H]5C[NH2+]CCC5;8.0500002;Serine/threonine-protein kinase Chk1;MI5
5kqd;CCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP([O-])(O)OP([O-])(O)OC[C@@H](O1)[C@@H](OP([O-])(O)O)[C@@H](O)[C@@H]1n2cnc(c23)c(N)ncn3;6.3000002;Pantothenate kinase 3;PKZ
4yp8;c1ccnc(n12)c(cn2)C(=O)Nc3cc([C@H]4CC[N@@H+](CC4)C(C)C)nn3-c5c(F)cc(cc5)C6C=C6;7.8899999;Interleukin-1 receptor-associated kinase 4;4GF
4aa0;C1C[NH+](C)CCN1c(cc2)cc(c23)c(=O)n(cn3)-c4cc(ccc4C)NC(=O)c5ccnc(c5)N6CCOCC6;7.46;MITOGEN-ACTIVATED PROTEIN KINASE 14;AA0
4aac;C[NH+]1CCN(CC1)c(cc2)cc(c23)c(=O)n(cn3)-c4cc(ccc4C)C(=O)Nc5ccon5;8.1700001;MITOGEN-ACTIVATED PROTEIN KINASE 14;AAV
4yps;Fc1cccc(c1)[C@@H]2COCCN2c(cc3)nn(c34)c(cn4)-c5ccc(C#N)cc5;7.1199999;High affinity nerve growth factor receptor;4F6
4iq6;c1ccnc(c12)[nH]cc2-c3cc(nc(Cl)c3)NC4CCCCC4;7.2399998;Glycogen synthase kinase-3 beta;IQ6
4cmt;n1ccnn1-c(ccc(F)c2)c2[C@@H](C)Oc3c(N)ncc(c3)-c4cc(S(=O)(=O)C)ccc4;9.6999998;ALK TYROSINE KINASE RECEPTOR;GWH
4cmu;c1nc(N)c(c2)O[C@H](C)c(cc(F)cc3)c3C(=O)N(C)Cc(c4c12)n(C)nc4C;9.6999998;ALK TYROSINE KINASE RECEPTOR;IV7
5a3x;CC(=O)Nc(n1)sc(c12)ccc(O)c2;6.0999999;DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE 1A;QIV
5f4n;O1CC[NH2+]C[C@@H]1CNc(c(cn2)C(=O)OC)cc2Nc3cnc(cn3)C#N;8.6599998;Serine/threonine-protein kinase Chk1;5UY
2oh4;FC(F)(F)c1cc(c(F)cc1)NC(=O)Nc(cc2)ccc2Oc(cc3)cc(c34)[nH]c(n4)NC(=O)OC;8.46;Vascular endothelial growth factor receptor 2;GIG
4u79;[NH3+][C@@H]1CC[C@H](CC1)Nc2nc(ccn2)-c3cccnc3Oc4ccc(c(c45)cccc5)NS(=O)(=O)c6ccccc6;6.4000001;Mitogen-activated protein kinase 10;3EL
2r3p;c1ccc(Cl)c(Cl)c1-c(n2)cc(n(c23)ncc3SC#N)NCc4ccncc4;6.0457568;Cell division protein kinase 2;3SC
2r3i;c1cnccc1CNc(n(c23)ncc2)cc(n3)-c4ccccc4F;6;Cell division protein kinase 2;SCF
2r3h;Cc1cnc(n12)c(ncc2)NCc3ccncc3;4.6989698;Cell division protein kinase 2;SCE
2r3k;c1ccccc1-c(c2)cc(n(c23)ncc3Br)NCc4cncnc4;7;Cell division protein kinase 2;SCQ
2r3j;c1ccccc1-c(n2)cc(n(c23)ncc3Br)NCc4cnccc4;8;Cell division protein kinase 2;SCJ
2r3m;c1nc(N)ncc1CNc(n(c23)ncc2CC)cc(n3)-c4c(F)cccc4F;8;Cell division protein kinase 2;SCX
2r3l;c1ccccc1-c(c2)cc(c(n23)ncc3Br)NCc4cncnc4;7;Cell division protein kinase 2;SCW
2r3o;c1ccccc1-c(n2)cc(n(c23)ncc3CO)NCc4cnccc4;6.221849;Cell division protein kinase 2;2SC
2r3n;c1ccccc1-c(n2)cc(n(c23)ncc3C4CC4)NCc5cnccc5;7.154902;Cell division protein kinase 2;SCZ
2r3f;c1cnccc1CNc(n(c23)ncc2)cc(n3)-c4cccc(Cl)c4Cl;6.3010302;Cell division protein kinase 2;SC8
3r9n;O=N(=O)c1cccc(c1)[C@@H](O)c2sc(nc2N)NC3CCCCC3;5.8499999;Cyclin-dependent kinase 2;Z68
3r9o;Fc1cc(F)cc(c1)NC(=O)c2c(N)nc(s2)Nc(cc3)ccc3S(=O)(=O)N;4;Cyclin-dependent kinase 2;Z71
3r9d;NS(=O)(=O)c(cc1)ccc1Nc(s2)nc(N)c2C(=O)Nc3cccc(F)c3;4.1500001;Cyclin-dependent kinase 2;X6B
3ig7;CC(=O)N[C@H](C1)C[C@H]1n2cc(nc2)NC(=O)Cc3ccc(OC)cc3;7.2006593;Cell division protein kinase 2;EFP
3ig6;[NH3+]Cc(c1)cccc1-c2cc(ccc2)Oc3nc(c(F)c(c3F)N4C[C@@H](CC4)[NH+](C)C)Oc5cc(N(C)C)ccc5C(=O)[O-];7.6020598;Urokinase-type plasminogen activator;438
3igg;O[C@@H](C1)C[C@@H]1n2cc(nc2)NC(=O)Cc3ccc(OC)cc3;7.1771784;Cell division protein kinase 2;EFQ
4twc;FC(F)(F)c(c1)ccc(c12)[nH]c(n2)NC(=O)c3nc(sc3)NC(=O)c4ccccc4OC(F)(F)F;7.4000001;Casein kinase I isoform delta;37J
4twp;CNC(=O)c1ccccc1Sc(c2)ccc(c23)c([nH]n3)/C=C/c4ncccc4;10;Tyrosine-protein kinase ABL1;AXI
4nus;c1c(F)c(O)c(F)cc1-c2cnccc2-c3ccc(cc3)N4CC[NH+](C)CC4;8.3000002;Ribosomal protein S6 kinase alpha-3;2NK
1r78;O[C@H](C)[C@H]([NH3+])[C@H](O)C#Cc1c(F)ccc(c12)NC(=O)C\2=C/c3c(OC)cc[nH]3;8.5200005;Cell division protein kinase 2;FMD
3poz;FC(F)(F)c1cc(ccc1)Oc(c(Cl)c2)ccc2Nc3ncnc(c34)ccn4CCNC(=O)CC(C)(O)C;7.6399999;Epidermal growth factor receptor;03P
2bpm;O=C1NCCN1c(cc2)ccc2[C@H](C)C(=O)Nc3[nH]nc(c3)C4CC4;8.6999998;CELL DIVISION PROTEIN KINASE 2;529
2g01;Cn1nc(C)c(c12)c(=O)c3c(n2O)ccc(Cl)c3;5.9099998;Mitogen-activated protein kinase 8;73Q
4rj6;COC1CCN(CC1)c2nccc(n2)Nc(c3)ncc(c34)nc([nH]4)-c5cn[nH]c5;7.1199999;Epidermal growth factor receptor;3R0
4rj7;OC[C@H](C)Nc(n1)nc(C)cc1Nc2cc(ccn2)NC(=O)c3c(Cl)cccc3Cl;7.6599998;Epidermal growth factor receptor;3R1
1xws;C[NH+](C)CCCn1cc(c(c12)cccc2)[C@H]3C(=O)NC(=O)[C@H]3c4c[nH]c(c45)cccc5;8;Proto-oncogene serine/threonine-protein kinase Pim-1;BI1
4mh7;CCCCNc1ncc(C(=O)N(C)CCCC)c(n1)N[C@@H]2CC[C@@H](O)CC2;5.23;Tyrosine-protein kinase Mer;MH7
1f92;CC(C)c1cc(C(C)C)cc(C(C)C)c1S(=O)(=O)N[C@@H](Cc2cc(C(=[NH2+])N)ccc2)C(=O)N3CCN(CC3)C(=O)CC[NH3+];6.1900001;UROKINASE-TYPE PLASMINOGEN ACTIVATOR;UKP
1yhs;c1cccc(c1n2[C@]34C)c5c2c6n([C@H](O4)C[C@@H]([NH2+]C)[C@H]3OC)c7c(cccc7)c6c8c5CNC8=O;8;Proto-oncogene serine/threonine-protein kinase Pim-1;STU
3blr;C[N@H+]1CC[C@@H]([C@@H](C1)O)c2c(O)cc(O)c(c23)c(=O)cc(o3)-c4c(Cl)cccc4;8.1899996;Cell division protein kinase 9;CPB
1ung;Oc1ccc(cc1)-c([nH]2)c(c(c23)nccn3)CCCC;6.8000002;CELL DIVISION PROTEIN KINASE 5;ALH
4mha;CCCCNc1ncc(c(n1)N[C@@H]2CC[C@@H](O)CC2)C(=O)NCc3ccc(cc3)S(=O)(=O)N;9.1499996;Tyrosine-protein kinase Mer;4MH
5csx;CC[N@H+]1CC[C@@H](CC1)N(C)c(n2)ccc(c23)n(cc3-c4cncnc4)-c5c(F)ccc(c5F)NS(=O)(=O)CCC;8.2200003;Serine/threonine-protein kinase B-raf;54J
2bu5;FC(F)(F)[C@](C)(O)C(=O)N1[C@@H](C)CN([C@@H](C1)C)C(=O)c2ccc(C#N)cc2;7.7800002;PYRUVATE DEHYDROGENASE KINASE ISOENZYME 2;TF1
3up7;O=C([O-])c1ccc(cc1)Nc2nc(ccn2)Nc3ccccc3C(=O)[O-];8.21;Aurora kinase A;0C9
5hfu;N#Cc1ccc(cc1)S(=O)(=O)NC[C@@H](O[C@@H]2O)[C@@H](O)[C@H](O)[C@H]2NC(=O)c(c3)cccc3-c4ccccc4;6.8899999;Hexokinase-2;603
5csh;Clc1cc(C[NH3+])ccc1-c2ccccc2;6.54;Casein kinase II subunit alpha;54E
4ykn;COc1ccc(cn1)-c2cc(cc(c2)C(=O)[O-])CNc(cc3)ccc3S(=O)(=O)Nc4nnc(s4)C;8;Phosphatidylinositol 3-kinase regulatory subunit alpha,Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform fusion protein;4EL
3tkh;c1ncccc1-c2sc(nc2)Nc3nccc(c3)N4CC[NH+](CC4)CC(=O)N5CCOCC5;7.3299999;Serine/threonine-protein kinase Chk1;07S
3tki;C1COCCN1c(c2)ccnc2Nc3sc(cn3)-c4cc(cnc4)C(=O)NCC[NH3+];10.3;Serine/threonine-protein kinase Chk1;S25
3new;c1ccc(C(F)(F)F)cc1-c2[nH]nc(c23)[nH]c(=O)cc3C(F)(F)F;5;Mitogen-activated protein kinase 14;3NE
3tku;c1nccc(c12)c(ccc2)S(=O)(=O)N3CC[NH2+]CCC3;5.7199998;Serine/threonine-protein kinase MRCK beta;M77
3mpm;c1cc(O)ccc1C(=C2N)CN=C(N23)C(=CN3)c4cc(ccc4)N5CC[NH+](C)CC5;7.52;Tyrosine-protein kinase Lck;5LK
3mpt;Cc1ccccc1C(=O)c2c[nH]c(c2)C(=O)NCc3ccco3;6.5999999;Mitogen-activated protein kinase 14;1GK
1tvo;c1ccccc1C(N2)=C([C@@H](N23)C=CC=C3)c(c4)nnc(c45)[nH]nc5N;6.8499999;Mitogen-activated protein kinase 1;FRZ
4bzn;CC(C)(C)CNC(=O)C[C@H]1CNC(=O)c(n12)cc(c2)-c3cscc3;5.8400002;SERINE/THREONINE-PROTEIN KINASE PIM-1;UGX
4bzo;c1ccccc1[C@@H](C[NH3+])NC(=O)C[C@H]2CNC(=O)c(n23)cc(c3)-c4cc(F)ncc4;7.8899999;SERINE/THREONINE-PROTEIN KINASE PIM-1;676
4a4l;NC(=O)c(c1)cn(C)c1-c(n2)ccnc2Nc3c(OC(F)(F)F)ccc(c3)N4CC[NH+](C)CC4;7.8200002;SERINE/THREONINE-PROTEIN KINASE PLK1;939
4a4o;O=C1NCCc(c12)n(C)c(c2)-c(n3)ccnc3Nc4c(OC(F)(F)F)ccc(c4)N5CC[NH+](C)CC5;8.0500002;SERINE/THREONINE-PROTEIN KINASE PLK1;664
4o6e;Fc1ccc(cc1Cl)[C@@H](CO)NC(=O)N(CC2)Cc(c23)nc(nc3)NC4CCOCC4;9;Mitogen-activated protein kinase 1;2SH
3fxz;FC(=C1)C=C2C(C(=O)NC3=O)=C3C4c(cc(O)cc5)c5[NH+]6C4=C2N1[Ru]67([CH2]=O)([ClH2])N8C(=CCC=C8)C[NH+]7c9ccccc9;6.8860564;Serine/threonine-protein kinase PAK 1;FLL
4a4x;FC(F)(F)c1ccccc1[C@@H](C)Oc2cc(ccc2C(=O)N)-c3cc(cnc3N)-c4cc(cs4)C[NH+](C)C;7.23;SERINE/THREONINE-PROTEIN KINASE NEK2;JUP
3fxw;O=C1NCCc(c12)[nH]c(c2)-c3cc(ncc3)-c4ccccc4F;5.96;MAP kinase-activated protein kinase 3;F10
3wzj;C1CC1NC(=O)c2ccc(cc2)-c(cn3)n(c34)nc(NC5CCCCC5)cc4NCC6CCOCC6;8.1800003;Dual specificity protein kinase TTK;O43
3wzk;C1CC1NC(=O)c2ccc(cc2)C3=CNC(N34)=C(NC=C4)NCc5sccc5;7.2399998;Dual specificity protein kinase TTK;O23
4dli;Nc(c1)ccc(c12)c(NC3CC3)nc(n2)-c4ccccc4;5.6199999;Mitogen-activated protein kinase 14;IRG
4dlj;c1ccccc1-c(n2)nc(c(c23)ccc(N)c3)NCCc4ccccc4;5.9200001;Mitogen-activated protein kinase 14;6RG
2viw;C1CCCCN1c2cc(Cl)c(OCC)c(c2)NC(=O)c3cc(C)c(c(C)c3)OCC[NH3+];7.1426668;UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B;D56
2viv;C1CCCCN1c2cc(Cl)cc(c2)NC(=O)c3cc(C)c(c(C)c3)OCC[NH3+];6.2839971;UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B;VG2
4aof;CC(=O)Nc(n1)nc(n12)ccc(c2)-c3cc(S(=O)(=O)C)cnc3;7.0999999;PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM;7L0
2viq;CCOc1ccc(OCC)c(c1)NC(=O)c2cc(C)c(c(C)c2)OCC[NH3+];5.8860559;UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B;D55
2vip;CC(C)Oc1cccc(c1)NC(=O)c2cc(Cl)c(c(Cl)c2)OCC[NH3+];5.2839971;UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B;L1R
2vio;[NH3+]CCOc1c(Cl)cc(C(=O)[O-])cc1Cl;4.3979402;UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B;L1O
2vin;C[C@@H]([NH3+])COc1c(C)cccc1C;3;UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B;505
5ih8;c1cnccc1-c2cn(nc2)-c(cc3)ccc3C(=O)NCc4ccccn4;6.7399998;Maternal embryonic leucine zipper kinase;6BJ
3ezr;Nc1ccc(c(c1)OC)-c(cc2)cc(c23)n[nH]c3-c([nH]4)nc(c45)cccc5N6CC[NH+](C)CC6;5;Cell division protein kinase 2;EZR
3hrf;c1ccccc1/C(=C\C(=O)[O-])CCc2ccc(Cl)cc2;4.9871626;3-phosphoinositide-dependent protein kinase 1;P47
3hrb;c1cc(F)cc(F)c1C(=O)C2=CCN(O)C(=C2N)c3c(C)cccc3;7.6777806;Mitogen-activated protein kinase 14;I39
5fgk;[nH]1nc(N)c(c12)ccc(c2)-c3cncc(Cl)c3N(CC4)CCC45CCNC5=O;8.7700005;Cyclin-dependent kinase 8;5XG
5a14;Nc(n1)nccc1Oc(cc2)ccc2NC(=O)Nc3ccc(c(C(F)(F)F)c3)C[N@H+]4CC[N@H+](C)CC4;7.3000002;CYCLIN-DEPENDENT KINASE 2;LQ5
2wmx;c1ccccc1-c(cn2)c(c(c23)cn[nH]3)N4C[C@H](C[NH3+])OCC4;6.0700002;SERINE/THREONINE-PROTEIN KINASE CHK1;ZY6
2wmv;n1c[nH]c(c12)ncnc2N3C[C@H](C[NH3+])OCC3;5.04;SERINE/THREONINE-PROTEIN KINASE CHK1;ZYV
2wmw;[nH]1ncc(c12)c(c(Br)cn2)N3C[C@H](C[NH3+])OCC3;6.4099998;SERINE/THREONINE-PROTEIN KINASE CHK1;ZYW
2wmu;C1COCCN1c(ncn2)c(c23)[nH]cn3;4.3800001;SERINE/THREONINE-PROTEIN KINASE CHK1;ZYU
2wmr;O=c1[nH]cnc2sc(c3c12)CCCC3;4.2800002;SERINE/THREONINE-PROTEIN KINASE CHK1;ZYR
4zlz;Cc1ccncc1-c(ccc2)c(c23)nnc(c3N)C(=O)N;7;Tyrosine-protein kinase BTK;4RV
4bgg;COc1c(OC)c(OC)cc(c1)-c2cc(cnc2)-c3ccc(cc3)N4CC[NH2+]CC4;7.8200002;ACTIVIN RECEPTOR TYPE-1;844
4bgh;OC[C@@H](C)Nc1nc(ncc1Br)Nc2ccc(cc2)S(=O)(=O)N;8.3999996;CYCLIN-DEPENDENT KINASE 2;3I6
1kv2;c1cc(C)ccc1-n2nc(C(C)(C)C)cc2NC(=O)Nc3ccc(c(c34)cccc4)OCC[NH+]5CCOCC5;10;p38 MAP kinase;B96
3w2o;FC(F)(F)c1cc(ccc1)Oc(c(Cl)c2)ccc2Nc3ncnc(c34)ccn4CCNC(=O)CC(C)(O)C;5.0799999;Epidermal growth factor receptor;03P
4msu;s1cccc1S(=O)(=O)N2CCN(CC2)c(cc3)ccc3C(C(F)(F)F)(C(F)(F)F)O;5.8499999;Glucokinase regulatory protein;2EU
4fc0;C1CC1C(=O)Nc(n2)sc(c23)nc(cc3)N(C)c4ccc(F)c(c4)NC(=O)c5cccc(c5Cl)OC(C)(C)C#N;7.1599998;Serine/threonine-protein kinase B-raf;0T2
4li5;CCC(=O)Nc(c1)ccc(OC)c1Nc2nc(c(Cl)cn2)-c3c[nH]c(c34)cccc4;6.2600002;Epidermal growth factor receptor;1WY
3w2p;FC(F)(F)c(c1)cccc1Oc(cc2)c(Cl)cc2Nc(ncn3)c(c34)n(cc4)CCNC(=O)CCC[NH+](C)C;5.0900002;Epidermal growth factor receptor;W2P
3w2q;C[NH+](C)CCCC(=O)Nc(c1)c(OCC)cc(c12)ncc(C#N)c2Nc3ccc(c(Cl)c3)OCc4ccccn4;7.1799998;Epidermal growth factor receptor;HKI
3w2r;C1CCCCC1NC(=O)Nc2cccc(c2)Oc(c(Cl)c3)ccc3Nc(ncn4)c(c45)n(cc5)CCOCCO;7.7199998;Epidermal growth factor receptor;W2R
3w2s;C1CCCCC1NC(=O)Nc2cccc(c2)Oc(c(Cl)c3)ccc3Nc(ncn4)c(c45)n(cc5)CCOCCO;8.1599998;Epidermal growth factor receptor;W2R
2i40;COc(c1)c(OC)cc(c12)n(cn2)-c3cc(c(s3)C(=O)N)O[C@H](C)c4ccccc4Cl;5.8000002;Cell division protein kinase 2;BLZ
4alu;Clc1ccccc1-c(n2)[nH]c(=O)c3oc(c4c23)ccc(Br)c4;7.77;SERINE/THREONINE-PROTEIN KINASE PIM-1;79O
2zb0;N#Cc1cccc(c1)NC(=O)c2ccc(cc2)-c3cc(-c4oc(C)nn4)ccc3C;6.6197891;Mitogen-activated protein kinase 14;GK3
2zb1;C1CC1CNC(=O)c2ccc(cc2)-c3c(C)ccc(c3)-c4nnc(o4)C;6.318759;Mitogen-activated protein kinase 14;GK4
1w82;Clc1ccc(cc1)NC(=O)Nc2cc(C(C)(C)C)nn2-c3ccccc3;6.71;MITOGEN-ACTIVATED PROTEIN KINASE 14;L10
1w83;c1ccncc1OCc2cc(ccc2Cl)NC(=O)c3cc(F)cc(c3)N4CCOCC4;7.1900001;MITOGEN-ACTIVATED PROTEIN KINASE 14;L11
1w84;c1cccc(c12)[nH]cc2CCc3ccncc3;4.46;MITOGEN-ACTIVATED PROTEIN KINASE 14;L12
3ccn;c1ccccc1-c(n2)ccc(n23)nnc3Cc4ccc(O)cc4;6.9208188;Hepatocyte growth factor receptor;LKG
3umx;C1CCCCC[NH+]1Cc2c(O)ccc(c23)C(=O)C(O3)Cc4c[nH]c(c45)cccc5;6.6199999;Proto-oncogene serine/threonine-protein kinase pim-1;Q18
1gjb;c1cc(C(N)=[NH2+])cc(c12)[nH]c(n2)-c3cccc(c3O)-c4ccccc4;6.3499999;UROKINASE-TYPE PLASMINOGEN ACTIVATOR;130
4umt;C1C[NH2+]CC[NH+]1Cc2ccc(cc2OC)OCC#Cc(cc3)cc(c34)cncc4;6.1399999;MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE;47W
4umu;CCOc1cc(ccc1C[NH3+])OCC#Cc(cc2)cc(c23)cncc3;6.1900001;MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE;0V0
4umr;Fc1ccc(cc1)C(=O)Nc(cc2)cc(c23)C[NH2+]CC3;3.8;MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE;QBB
4umq;COc1cc(O)cc(c1)Nc2ccc(c(c2)OCCC[NH3+])C(=O)Nc3ccccc3;5.3800001;MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE;B5S
3hmp;C1CC1CNc2ncnc(c23)cc(Cl)cc3;5.4899998;Dual specificity protein kinase TTK;CX4
3hmo;CO[C@@H]1[C@H]([NH2+]C)C[C@@H](O2)n3c(cccc4)c4c(c3c5n6[C@]12C)c7c(CNC7=O)c5c8c6cccc8;7.52;Dual specificity protein kinase TTK;STU
3hmm;Cc1cccc(n1)-c(nc(c23)cccc3)nc2Nc4ccncc4;7.6020598;TGF-beta receptor type-1;855
5bvf;c1ccc(Cl)cc1[C@@H](CO)N(C2=O)CCCn(c23)cc(c3)-c4ccnc(n4)N[C@@H]5C[C@H](O)CC5;9.7200003;Mitogen-activated protein kinase 1;4VJ
5bve;c1ccc(Cl)cc1[C@@H](CO)N(C2=O)CCCn(c23)cc(c3)-c(ccn4)nc4NC5CCOCC5;11;Mitogen-activated protein kinase 1;4VG
5bvd;c1ccc(Cl)cc1[C@@H](CO)N(C2=O)CCn(c23)cc(c3)-c(ccn4)nc4NC5CCOCC5;9.8000002;Mitogen-activated protein kinase 1;4VF
4op3;c1ccccc1Nc2nc(S(=O)(=O)c3ccc(N)nc3)ccc2-c4ccc(cn4)[C@](C(F)(F)F)(C)O;8.1499996;Glucokinase Regulatory Protein;2UY
4op2;Nc1ccc(cn1)S(=O)(=O)c2ccc(cc2)-c3ccc(cc3)[C@](C(F)(F)F)(C)O;5.9299998;Glucokinase Regulatory Protein;2UX
4op1;Nc1ccc(cn1)S(=O)(=O)c2sc(cc2)-c3c(Cl)cc(cn3)[C@](C(F)(F)F)(C)O;6.8899999;Glucokinase Regulatory Protein;2UW
3e5a;C[NH+]1CCN(CC1)c2cc(Nc3cc(C)n[nH]3)nc(n2)Sc4ccc(cc4)NC(=O)C5CC5;8.2291479;Serine/threonine-protein kinase 6;VX6
5j1w;c1cncc(c2)c1cc(c23)nc(N)nc3;6.7199998;Dual specificity protein kinase CLK1;6FB
3ti1;CC[NH+](CC)CCNC(=O)c1c(C)[nH]c(c1C)\C=C\2C(=O)Nc(c23)ccc(F)c3;3.8900001;Cyclin-dependent kinase 2;B49
1ogu;NC(=O)c1ccc(cc1)Nc2nc(c(N=O)c(n2)N)OCC3CCCCC3;7.4699998;CELL DIVISION PROTEIN KINASE 2;ST8
3nga;O=C([O-])c(c1)ccc(c12)c3c(ccnc3)c(n2)Nc4cc(Cl)ccc4;8;Casein kinase II subunit alpha;3NG
3tiz;c1cc(O)ccc1NCc(c(O)cc2)c(c23)cccc3;3.8199999;Cyclin-dependent kinase 2;3TI
5j18;COc1cc(OC)cc(OC)c1CCS(=O)(=O)Cc(ccc2OC)cc2NCC(=O)[O-];9.1499996;Serine/threonine-protein kinase B-raf;6FS
3tiy;Oc1c(O)c(O)cc(c12)cccc(c2=O)O;4.77;Cyclin-dependent kinase 2;TIY
3gxl;Cc1cccc(n1)-c(nc(c23)cccc3)nc2Nc(cc4)cc(c45)c[nH]n5;7.6020598;TGF-beta receptor type-1;QIG
2xey;c1cccc(c12)[nH]cc2-c(cn3)n(c34)cc(nc4)-c5cn[nH]c5;5.1900001;SERINE/THREONINE-PROTEIN KINASE CHK1;YVQ
2xez;c1[nH]ncc1-c(c2)ncc(n23)ncc3-c4ccn[nH]4;5.8200002;SERINE/THREONINE-PROTEIN KINASE CHK1;XEZ
1gj7;c1c(Cl)c(C(N)=[NH2+])cc(c12)cc([nH]2)-c3cccc(c3O)-c4ccccc4;7.8899999;UROKINASE-TYPE PLASMINOGEN ACTIVATOR;132
4jx7;FC(F)(F)c1cc(ccc1)Nc2nc(nc(c23)CC=NC3=O)N[C@H]4CC[C@H]([NH3+])CC4;8.1000004;Serine/threonine-protein kinase pim-1;1N6
3q4c;C1=C(C)CN2c3c1c(C(=O)NC4=O)c4c(c5c6cccc5)c3n6[Ru]12789(Cl)C2C7=C8C9=C1C=2C(=O)[O-];6.4299998;Serine/threonine-protein kinase B-raf;RSW
3fzr;c1cccc(N(C)S(=O)(=O)C)c1CNc2nc(ncc2C(F)(F)F)Nc(cc3)cc(c34)CC(=O)N4;7.96;Protein tyrosine kinase 2 beta;3JZ
3anr;c1cnc(C)c(c12)[nH]c3c2ccc(c3)OC;6.46;Dual specificity tyrosine-phosphorylation-regulated kinase 1A;HRM
3fzt;Cc1ccc(cc1)-n(n2)c(cc2C(C)(C)C)NC(=O)Nc3cc([nH]n3)COc4cccnc4;6.1999998;Protein tyrosine kinase 2 beta;4JZ
3anq;O=C(C)Cc([n+]1CC)sc(c12)ccc(c2)O;6.7399998;Dual specificity tyrosine-phosphorylation-regulated kinase 1A;EHB
4rx8;[NH3+][C@H]1CCCC[C@H]1Nc(nn2)nc(c2C(=O)N)Nc3cccc(c34)cc[nH]4;7.46;Tyrosine-protein kinase SYK;3YX
4rx9;[NH3+][C@H]1CCCC[C@H]1Nc(ncc2C(=O)N)nc2Nc3cccc(c3)-n4nccn4;7.6399999;Tyrosine-protein kinase SYK;3YT
4y46;CC(C)NC(=O)N[C@@H](CC1)CC[C@H]1Nc(nc2)nc(c23)n(c(=O)cc3)C4CCCC4;7.96;Mitogen-activated protein kinase 10;4F2
3fz1;COc(c1)ccc2sc(c3c12)C(=O)N[C@@H](CN3)C[NH3+];7.9208188;Cell division protein kinase 2;B98
3oxi;COC(=O)c1sccc1NC(=O)Cc2sccc2;5.6599998;Mitogen-activated protein kinase 10;SYY
3vzd;Oc1ccc(cc1)Nc2nc(cs2)-c3ccc(Cl)cc3;6.3000002;Sphingosine kinase 1;UUL
5ceq;n1ccc(C#N)cc1Nc2cc(n(n2)C3CCCC3)[C@@H]4CC[N@H+](CC4)C5COC5;7.3800001;Mitogen-activated protein kinase kinase kinase 12;50F
4im0;C1CCC1C(=O)NCCCNc2nc(ncc2C3CC3)Nc4cc(ccc4)C[NH+]5CCOCC5;7.7199998;Serine/threonine-protein kinase TBK1;1FV
3nzs;O=S1(=O)CCN(CC1)c(nc(c23)n(C)nc3)nc2Nc4cc(OC)ccc4;7.1199999;Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;NZS
3nzu;O=S(=O)(C)CCCNc(c(c12)cnn1C)nc(n2)-c(ccc3)c(c34)cn[nH]4;8.8500004;Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;NZU
3hp5;Fc1ccc(c(F)c1)SC(=CC=2)NN(C23)C=NC(=O)[C@@H]3c4c(Cl)cccc4Cl;7.154902;Mitogen-activated protein kinase 14;52P
3hp2;c1ccccc1Cn2c(=O)c(Br)c(cc2)OCc3ccccc3;6.167491;Mitogen-activated protein kinase 14;P36
3gen;C1CCCC1n2cc(c(c23)c(N)ncn3)-c4ccc(cc4)Oc5ccccc5;9.1400003;Tyrosine-protein kinase BTK;B43
2fvd;CS(=O)(=O)N1CCC(CC1)Nc2ncc(c(n2)N)C(=O)c3c(F)c(F)ccc3OC;8.5200005;Cell division protein kinase 2;LIA
3g0e;NC(=O)c1c(C)[nH]c(c1C)\C=C\2C(=O)Nc(c23)ccc(F)c3;7.6989698;Mast/stem cell growth factor receptor;B49
2i6a;Nc1ncnc(c12)n(cc2I)[C@@H]([C@H](O)[C@@H]3O)O[C@@H]3C;9.0500002;Adenosine kinase;5I5
2i6b;c1cc(N(C)C)ccc1-c2c(N)ncnc2C#Cc(cc3)cnc3N4CCOCC4;7.1700001;Adenosine kinase;89I
4mq2;COc(n1)ncc(c12)cc(c(=O)[nH]2)C(=O)Nc3c(Cl)ccc(c3)C(=O)OC;7.0100002;Dual specificity tyrosine-phosphorylation-regulated kinase 1A;2C4
4rwk;C1[C@H](C)[NH2+][C@H](C)CN1c2ccc(cc2)C(=O)Nc3n[nH]c(c3)CCc4cc(OC)cc(c4)OC;7.1900001;Fibroblast growth factor receptor 1;66T
4mq1;COc(n1)ncc(c12)cc(c(=O)[nH]2)C(=O)Nc3c(Cl)ccc(c3)C(=O)N[C@H](CC[NH3+])c4cc(Cl)ccc4;7.9200001;Dual specificity tyrosine-phosphorylation-regulated kinase 1A;2C3
5tkd;Cc1cc(cc(c1)C)Nc(cc2NC)nn(c23)c(cn3)C(=O)N;8.1499996;Non-receptor tyrosine-protein kinase TYK2;7GL
4rwl;CNC(=O)c1cccc(c12)cc(cc2)Oc3ccnc(c34)cc(c(c4)OC)OCC5([NH3+])CC5;8.1000004;Fibroblast growth factor receptor 1;3ZC
3i60;Clc1ccccc1Nc(ncc2C)nc2-c3c[nH]c(c3)C(=O)N[C@H](CO)c4ccccc4;8.6999998;Mitogen-activated protein kinase 1;E86
1x8b;C1=CC(=O)Cc(c12)c3c([nH]2)cc(c4c3C(=O)NC4=O)-c5ccccc5;7.0100002;Wee1-like protein kinase;824
4mqu;Nc1ccc(cn1)S(=O)(=O)N2C[C@H](C#CC)N(CC2)c3ccc(cc3)C(C(F)(F)F)(C(F)(F)F)O;8.3999996;Glucokinase regulatory protein;MG9
1ove;Clc1cccc(Cl)c1N(C(=O)CC2)c(c23)cc(C4C=CNC=C4)cc3-c5ccc(F)cc5F;9.1300001;Mitogen-activated protein kinase 14;358
3r2b;C1C[NH2+]CCC12c3c(C(=O)NC2)cc([nH]3)-c4ccnc(n4)-c(c5)ccc(c56)OCO6;8.3999996;MAP kinase-activated protein kinase 2;05B
3ika;C[NH+]1CCN(CC1)c2cc(OC)c(cc2)Nc3nc(c(Cl)cn3)Oc4cc(ccc4)NC(=O)CC;7.8499999;Epidermal growth factor receptor;0UN
3be2;C[NH+](C)CCCc1cc(cc(c1)C(F)(F)F)NC(=O)c2cc(c(C)cc2)Nc3ncccc3-c4ccncn4;8.6989698;Vascular endothelial growth factor receptor 2;RAJ
4h42;O=C([O-])CNC(=O)c(c1)ccc(c12)nc(s2)N;3.47;Urokinase-type plasminogen activator;11E
4j6i;CC(C)(O)Cn1cc(cn1)-c(cc2)cc(c23)OCCc4c3nc(s4)-c5ncnn5CC(F)(F)F;8.8500004;Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;1JV
3bel;c1ccc(F)cc1Cn2ncc(c23)cc(cc3)Nc4ncnc(N)c4/C=N/OCCOC;7.8538718;Epidermal growth factor receptor;POX
5d9l;c1cc(O)ccc1-c2c(n[nH]c2)-c(cc3)ccc3O;7.6199999;Ribosomal protein S6 kinase alpha-3;583
2rl5;COc(c1)c(OC)cc(c12)c(ccn2)Oc(c3)ccc(c34)N(CCO4)C(=O)Nc5ccc(Cl)cc5;8.3979397;Vascular endothelial growth factor receptor 2;2RL
5lvl;c1cccc(c12)C(=O)c3c4c(n[nH]c24)ccc3;5.9000001;3-phosphoinositide-dependent protein kinase 1;537
5lvn;OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n(cn2)c(c23)ncnc3N;4.6999998;3-phosphoinositide-dependent protein kinase 1;ADN
3uo5;O=C([O-])c1ccc(cc1)Nc2nccc(n2)Nc3ccccc3;7.4099998;Serine/Threonine-Protein Kinase 6;0BX
3uo4;c1cc(C(=O)[O-])ccc1Nc2nccc(n2)Nc3ccccc3-c4ccccc4;6.52;Aurora kinase A;0C0
3uo6;O=C([O-])c1ccc(cc1)Nc2nc(ccn2)Nc3ccccc3Cl;7.8200002;Aurora kinase A;0BY
1f5k;NC(=[NH2+])c1ccccc1;3.74;UROKINASE-TYPE PLASMINOGEN ACTIVATOR;BAM
1f5l;Nc1nc(N)c(Cl)nc1C(=O)NC(N)=[NH2+];5.2800002;UROKINASE-TYPE PLASMINOGEN ACTIVATOR;AMR
3uod;c1cc(C(=O)[O-])ccc1Nc2nccc(n2)Nc3ccccc3C(F)(F)F;7.3099999;Aurora kinase A;0C3
3uol;Clc1ccccc1Nc2ccnc(n2)Nc3ccc(cc3)-c4[nH]nnn4;8.5100002;Aurora kinase A;0C7
3uoh;Brc1ccccc1Nc(ccn2)nc2Nc(cc3)ccc3C(=O)[O-];7.8899999;Aurora kinase A;0C4
3uok;Clc1ccccc1Nc2c(F)cnc(n2)Nc3ccc(C(=O)[O-])cc3;9.1000004;Aurora kinase A;0C6
3uoj;O=C([O-])c1ccc(cc1)Nc2nc(ccn2)Nc3ccccc3C#N;7.29;Aurora kinase A;0C5
5dfp;Cc(n1)cncc1-c(cc2)cc(Cl)c2C(=C(O)N3CC)Cc(c34)cnc(n4)NCC[C@@H]5CC[N@H+](C)CC5;7.6599998;Serine/threonine-protein kinase PAK 1;59U
3e7o;[nH]1ncnc1-c(c2)ccc(c23)[nH]nc3-c4cccc(c4)NC(=O)c5occc5;6.9208188;Mitogen-activated protein kinase 9;35F
1o44;O=C([O-])c(c1)c(C(C(=O)[O-])C(=O)[O-])ccc1C[C@H](NC(=O)C)C(=O)N[C@@H]2C(=O)N(CCCC2)Cc3ccc(cc3)-c4ccccc4;8.5200005;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC;852
1o45;OP([O-])(O)Oc1ccc(cc1CO)C[C@H](NC(=O)C)C(=O)N[C@H]2CCCCN(C2=O)Cc3ccc(cc3)-c4ccccc4;9.6000004;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC;687
1o46;COC(=O)c(c1)c(C(F)(C(=O)[O-])C(=O)[O-])ccc1C[C@H](NC(=O)C)C(=O)N[C@@H]2C(=O)N(CCCC2)Cc3ccc(cc3)-c4ccccc4;8;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC;903
1o47;OP([O-])(O)C(F)(F)c(cc1)ccc1C[C@H](NC(=O)C)C(=O)N[C@@H]2C(=O)N(CCCC2)Cc3ccc(cc3)-c4ccccc4;8.3999996;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC;822
1o42;OP([O-])(O)Oc1ccc(cc1)C[C@H](NC(=O)C)C(=O)N[C@H]2CCCCN(C2=O)Cc3ccc(cc3)-c4ccccc4;8.0500002;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC;843
1o43;O=C([O-])Cc(c(c1)CO)ccc1/C=C(\NC(=O)C)C(=O)N[C@H]2CCCCN(C2=O)Cc3ccc(cc3)-c4ccccc4;5.6599998;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC;821
5hbj;c1nn(C)c(c12)ccc(c2)-c3cnc(N)c(Cl)c3N(CC4)CCC45CCNC5=O;8.6400003;Cyclin-dependent kinase 8;5Y8
1o48;O=C([O-])c(c1)c(CC(=O)[O-])ccc1C[C@H](NC(=O)C)C(=O)N[C@@H]2C(=O)N(CCCC2)Cc3ccc(cc3)-c4ccccc4;6.3499999;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC;853
1o49;[O-]C(=O)COc1ccc(cc1P([O-])(O)O)C[C@H](NC(=O)C)C(=O)N[C@H]2CCCCN(C2=O)Cc3ccc(cc3)-c4ccccc4;6.3600001;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC;493
3sc1;OCc1ccccc1-c(cc2)cc(c23)cc[nH]c3=O;4.3800001;3-phosphoinositide-dependent protein kinase 1;3S1
4o0r;c1ccccc1[C@@H](C[NH+](C)C)NC(=O)N(C2)C(C)(C)c(c23)n[nH]c3Nc4nc(C)nc(c45)ccs5;7.4400001;Serine/threonine-protein kinase PAK 1;7KC
1o4d;OCc1ccccc1OP([O-])(O)O;3.52;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC;262
1o4e;Cc1cc(CO)c(c(c1)CO)OP([O-])(O)O;3.3;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC;299
1o4f;C1CCNc(c12)c(ccc2)OP([O-])(O)O;3.52;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC;790
1o4g;c1cccc(c12)c(ccc2)[C@@H](O)P([O-])(O)O;2.3;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC;I59
1o4a;O=C([O-])c1ccc(cc1CO)C[C@H](NC(=O)C)C(=O)N[C@H]2CCCCN(C2=O)Cc3ccc(cc3)-c4ccccc4;6.9200001;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC;197
1o4b;[O-]P([O-])(O)c1ccc(cc1P([O-])(O)O)C[C@H](NC(=O)C)C(=O)N[C@H]2CCCCN(C2=O)Cc3ccc(cc3)-c4ccccc4;5.6999998;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC;876
1o4l;O=C([O-])CC(O)(C(=O)[O-])CC(=O)[O-];1.4;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC;CIT
1o4m;O=C([O-])CC(=O)[O-];1.4;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC;MLA
1o4n;O=[C](=O)C([O-])[O-];1.4;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC;OXD
1o4o;c1ccccc1OP([O-])(O)O;2.46;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC;HPS
1o4h;c1ccc(OP([O-])(O)O)c(c12)nc(C#N)cc2;2.4400001;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC;772
1o4i;OCc1ccccc1OP([O-])(O)OCC2CCCCC2;2.6400001;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC;219
1o4k;OCc1ccccc1OP([O-])(O)OCc2ccccc2;2.9200001;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC;PSN
1o4q;c1ccccc1C([C](=O)=O)S([O-])([O-])O;2.49;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC;256
1o4r;c1ccccc1C(P([O-])([O-])O)P([O-])(O)O;2.4100001;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC;787
3twj;c1ccc(O)cc1CNC(=O)Nc2nc(cs2)-c3ccncc3;7.8400002;Rho-associated protein kinase 1;07R
5c26;c1ccc(C(=O)N)cc1-c(cn(c23)ccn3)nc2Nc(cc4OC)ccc4OC;6.77;Tyrosine-protein kinase SYK;50H
4ly9;C[C@H]1COCC[N@H+]1C[C@H]2CN(S(=O)(=O)c3cccs3)CCN2c4ccc(cc4)[C@@](C(F)(F)F)(C)O;8.1499996;Glucokinase regulatory protein;1YY
1vj9;c1cc(C(=[NH2+])N)ccc1CNC(=O)[C@H](COCc2ccccc2)NC(=O)[C@@H](CO)NS(=O)(=O)Cc3ccccc3;7.5500002;plasminogen activator, urokinase;5IN
1o41;OP([O-])(O)Oc1c(CO)cccc1OC;3.05;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC;300
2a4z;O=C1NC(=O)SC\1=C/c(c2)ccc(c23)OC(O3)(F)F;6.5999999;Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit, gamma isoform;BYM
5hbh;COCC[N@H+]1CCCC12CCN(CC2)c3c(Cl)cncc3-c(c4)ccc(c45)N(C)S(=O)(=O)C5;7.3099999;Cyclin-dependent kinase 8;5Y7
3elj;O=C(N)c1c(F)cccc1Nc2nc(nc(c23)[nH]cc3)Nc4c(OC)cc(cc4)CS(=O)(=O)C;5.3010302;Mitogen-activated protein kinase 8;GS7
5ko1;c1cc(F)ccc1NC(=O)[C@@H](c2ccccc2)OC(=O)c3nccnc3N;6.6399999;Mixed lineage kinase domain-like protein;6UY
4k8a;[nH]1nnnc1-c2cc(Br)cnc2;6.9099998;Focal adhesion kinase 1;K8A
3c1x;Fc1ccc(cc1)CC(=O)NC(=O)Nc(cc2F)ccc2Oc3ncnn(c34)ccc4C[N@H+]5CC[C@H]([NH3+])CC5;7.346787;Hepatocyte growth factor receptor;CKK
3lj3;C1C[NH+](C)CCN1c2ccnc(c23)n(C)cc3/C=C(C4=O)\Oc(c45)cc(O)cc5O;9.0299997;Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;WYE
5a4t;O=C(C)Nc(n1)sc(c12)cc(C#N)cc2;5.8899999;DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION- REGULATED KINASE 1A;AJG
2cn8;O=C1NCC/C(c(c12)cc[nH]2)=C3/[NH+]=C(N)NC3=O;5.46;SERINE/THREONINE-PROTEIN KINASE CHK2;DBQ
5a4q;O=C(C)Nc(n1)sc(c12)cc(Cl)cc2;5.54;DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE 1A;Y3L
5jgd;C[NH+]1CCN(CC1)C(=O)c2c(OC(C)C)c(ccc2)NC(=O)c(cs3)c(c34)nc[nH]c4=O;7.96;TAK1 kinase - TAB1 chimera fusion protein;6KD
3iph;C1CC1NC(=O)c(ccc2C)cc2-c3ccc(cn3)C(=O)NCC4C=C4;7.6003261;Mitogen-activated protein kinase 14;G11
5jgb;n1c[nH]c(=O)c(c12)scc2C(=O)Nc(c(c3)OC)ccc3C(=O)NCCC[N@H+]4CC[N@H+](C)CC4;7.8899999;TAK1 kinase - TAB1 chimera fusion protein;6JV
4n70;O[C@H]1[C@H]([NH3+])CN(C[C@@H]1C)c2ccncc2NC(=O)c3ccc(F)c(n3)-c4c(F)cccc4F;12;Serine/threonine-protein kinase pim-1;2HX
3ipx;[H]\N=c1\[nH]c(=O)n(cc1F)[C@@H]2O[C@@H]([C@@H](O)C2)CO;6.9200001;Deoxycytidine kinase;B86
3ipy;c1cccn1C(=O)C[NH+]2CCN(CC2)c3cc(ncn3)-c(s4)cc(c45)cccc5;6.29;Deoxycytidine kinase;B87
1vja;c1cc(C(=[NH2+])N)ccc1CNC(=O)[C@H](CO)NC(=O)[C@@H](CO)NS(=O)(=O)Cc2ccccc2;7.6999998;plasminogen activator, urokinase;7IN
3rzb;O=C(N)c1sc(nc1N)Nc2ccccc2;4;Cyclin-dependent kinase 2;02Z
1o4j;CCc1ccc(cc1)NC(=O)P([O-])(O)O;2.3599999;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC;IS2
3hv3;Cc1cc(ccc1)-n2nc(C(C)(C)C)cc2NC(=O)Nc3ccc(cc3)Nc4ccnc(c45)ccc(c5)N;6.3299999;Mitogen-activated protein kinase 14;R49
3hv7;c1cccc(c12)cccc2NC(=O)Nc3cc(C(C)(C)C)nn3-c4cc(N)ccc4;7.9200001;Mitogen-activated protein kinase 14;1AU
3hv6;C1COCC[NH+]1CCOc2ccc(cc2)NC(=O)Nc3cc(C(C)(C)C)nn3-c4ccc(C)cc4;5.6399999;Mitogen-activated protein kinase 14;R39
3hv5;O=N(=O)c(c1)ccc(c12)nccc2Nc3cc(ccc3)NC(=O)Nc4cc(C(C)(C)C)nn4-c5ccc(C)cc5;7.02;Mitogen-activated protein kinase 14;R24
3hv4;c1c(N)ccc(c12)nccc2Nc3cc(ccc3)NC(=O)Nc4cc(C(C)(C)C)nn4-c5ccc(C)cc5;6.5100002;Mitogen-activated protein kinase 14;L51
1o4p;c1ccccc1C(C(=O)[O-])C(=O)[O-];2.5999999;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC;791
3hvc;c1cnccc1-c2cn[nH]c2-c3ccc(F)cc3;6.221849;Mitogen-activated protein kinase 14;GG5
2wqb;Nc1ncnc(c12)sc(n2)-c(c3-c4ccccc4)n(cn3)CC5CCCCC5;6.2676063;ANGIOPOIETIN-1 RECEPTOR;QQ1
5a54;CC(=O)Nc(n1)sc(c12)cc(N(=O)=O)cc2;6.1500001;DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE 1A;5PW
2obj;Oc1ccc(Br)cc1-c2nc(O)c(C#N)c(c2)-c3ccccc3;7.3000002;Proto-oncogene serine/threonine-protein kinase Pim-1;VRV
4lmu;Oc1cc(O)cc(c12)oc(c(c2=O)O)C3=CC=C(O)C(=O)C3;7.2600002;Serine/threonine-protein kinase pim-1;QUE
2i0h;Clc1ccccc1-n2nc(ccc2=O)N(c3ccc(F)cc3Cl)CCCN(C4=O)C(=O)c(c45)cccc5;8.0500002;Mitogen-activated protein kinase 14;222
2i0y;CC1CCN(CC1)c2ccc(CO)cc2NC(=O)c3ccc(o3)C#N;7.6199999;cFMS Tyrosine Kinase;5CN
4lmn;[NH2+]1CCCC[C@H]1C2(O)CN(C2)C(=O)c3ccc(F)c(F)c3Nc4ccc(I)cc4F;10.3;Dual specificity mitogen-activated protein kinase kinase 1;EUI
4lm5;Oc1ccccc1-c(nc(c23)cccc3)nc2NCCC[NH3+];6.8200002;Serine/threonine-protein kinase pim-1;Q17
3rhx;n1c(N)ncc(c12)C[C@@H](c3ccccc3)c4c2cccc4;6.0799999;Basic fibroblast growth factor receptor 1;3RH
1c5z;[NH2+]=C(N)c1ccccc1;4.0100002;PROTEIN (UROKINASE-TYPE PLASMINOGEN ACTIVATOR);BAM
1c5y;[NH2+]=C(N)c(s1)cc(c12)cccn2;4.1999998;PROTEIN (UROKINASE-TYPE PLASMINOGEN ACTIVATOR);ESP
1c5x;[NH2+]=C(N)c(s1)cc(c12)c(I)ccc2;6.6799998;PROTEIN (UROKINASE-TYPE PLASMINOGEN ACTIVATOR);ESI
3zh8;c1ccccc1C[C@H]([NH3+])CNc(c(c23)c4c(s2)CCCC4)nc(n3)-c5ccncc5;6.4699998;PROTEIN KINASE C IOTA TYPE;C58
1bl7;C1C[NH2+]CCC1n2cnc(-c(cc3)ccc3F)c2-c4ccnc(n4)N;7.7199998;PROTEIN (MAP KINASE P38);SB4
1bl6;Fc1ccc(cc1)-c(nc2)c(n2CC3CC3)-c4ccncc4;6.8000002;PROTEIN (MAP KINASE P38);SB6
3ptg;c1cccc(c12)CCC(=O)N2CC(=O)Nc3scc(C)c3-c4nnc[nH]4;7.5999999;Mitogen-activated protein kinase 10;932
2gmx;COc1cc(Br)c(OC)cc1CC(=O)Nc2nc(c(C#N)c(c2)N)OCC;7.1100001;Mitogen-activated protein kinase 8;877
2gmv;n1cn(C)cc1S(=O)(=O)Nc2ccc(cc2)Cc(n3)[nH]c(c34)n(CCCC)c(=O)n(c4=O)Cc5c(F)cccc5;6.1999998;Phosphoenolpyruvate carboxykinase, cytosolic;UN8
4ual;C1C[NH2+]CCC1n2nc(c(Cl)c2)C(=O)Nc3cn[nH]c3-c4ncccc4;8.3999996;Serine/threonine-protein kinase MRCK beta;3FV
3bgp;Nc1nccc(n1)-c(cc2)cc(c23)c(on3)-c4ccc(Cl)cc4;7.0409579;Proto-oncogene serine/threonine-protein kinase Pim-1;VX1
3bgq;FC(F)(F)c1cccc(c1)-c(nn2)n(c23)nc(cc3)NC4CCCCC4;7.9586072;Proto-oncogene serine/threonine-protein kinase Pim-1;VX2
1u6q;c1cc(C(=[NH2+])N)cc(c12)ccc(c2)[C@H]3[C@@H](C3)c4ccccc4;5.8800001;Urokinase-type plasminogen activator;745
3bgz;O=C([O-])c1cccc(c12)c(-c3ccccc3)c([nH]2)-c4ccccc4;6.2596369;Proto-oncogene serine/threonine-protein kinase Pim-1;VX3
5ct7;c1cc(C(F)(F)F)ccc1Nc(n2)n(C)c(c23)ccc(c3)Oc4cc(ncc4)-c5ncc(C(F)(F)F)[nH]5;7.1500001;Serine/threonine-protein kinase B-raf;55J
4g16;N#Cc(c1)ccc(c12)nc([nH]2)Nc(cc3)ccc3Oc4ncccc4C(F)(F)F;6.8499999;Casein kinase I isoform gamma-3;0VM
4g17;N#Cc(c1)ccc(c12)nc([nH]2)Nc(cc3)ccc3C(C)(C)C;6.6799998;Casein kinase I isoform gamma-3;0VN
4g11;c1ccccc1NC(=O)Cc2[nH]c(=O)cc(n2)N3CCOCC3;5;Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;0W7
3pa3;c1cc(Cl)ccc1-c(s2)cc(c23)c(nnc3C(=O)N)N[C@@H]4C[NH2+]CCC4;9;Serine/threonine-protein kinase Chk1;C70
5dh3;s1ccc(N2C)c1C(=O)N(C)c(c23)cnc(n3)Nc4ccc(S(=O)(=O)N)cc4;7.4200001;Serine/threonine-protein kinase 3;5BS
3pa4;c1cc(Cl)ccc1-c(s2)cc(c23)c(ncc3C(=O)N)N[C@@H]4C[NH2+]CCC4;8.5200005;Serine/threonine-protein kinase Chk1;C72
3pa5;c1cc(Cl)ccc1-c(sc2NC(=O)N)cc2C(=O)N[C@@H]3C[NH2+]CCC3;8.6999998;Serine/threonine-protein kinase Chk1;C73
2esm;c1nccc(c12)c(ccc2)S(=O)(=O)N3CC[NH2+]CCC3;6.2800002;Rho-associated protein kinase 1;M77
3ocg;c1ccccc1-n2ncc(c2N)C(=O)Nc3c(C)ccc(c3)C(=O)Nc4nocc4;8.5200005;Mitogen-activated protein kinase 14;OCG
5dhj;c1ncccc1-c(c2)ncc(c23)[nH]nc3C;6.6999998;Serine/threonine-protein kinase pim-1;5E5
4yti;FC(F)(F)CNC(=O)[C@@](C)(CC)Nc1ccnc(n1)-c(c[nH]2)c(c23)cccn3;7.8899999;Tyrosine-protein kinase JAK2;VJK
3oct;Cc1cccc(Cl)c1NC(=O)c2cnc(s2)Nc3cc(nc(n3)C)N(CC4)CC[NH+]4CCO;8.3000002;Tyrosine-protein kinase BTK;1N1
3uix;Oc1ccccc1-c(nc(c23)cccc3)nc2NCCC[NH3+];6.8200002;Proto-oncogene serine/threonine-protein kinase pim-1;Q17
5hlw;s1cccc1-c(cc2)nn(c23)c(nn3)Sc(c4)ccc(c45)nc(s5)NC(=O)NCC[C@@H]6CC[N@@H+](CC6)CC;7.6399999;Hepatocyte growth factor receptor;62E
3zw3;CC(=O)Nc(c1)nc(n12)ccc(c2)/C=C3\SC(=O)NC3=O;7.4699998;PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM;ZW3
5hlp;Cc1n[nH]c(N2)c1[C@@H](C(=C23)C(=O)CC(C)(C3)C)c4ccccc4OC;7.27;Glycogen synthase kinase-3 beta;65A
3l08;Fc1ccc(c(F)c1)S(=O)(=O)Nc(c(nc2)OC)cc2-c(cc3)cc(c34)c(ccn4)-c5ccnnc5;10.22;Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;ZIG
2hyy;c1ncccc1-c2ccnc(n2)Nc3c(C)ccc(c3)NC(=O)c4ccc(cc4)C[N@H+]5CC[N@H+](C)CC5;6.77;Proto-oncogene tyrosine-protein kinase ABL1;STI
4ot6;C1COCCN1C(=O)c(cc2)ccc2Nc3nc(cn(c34)ccn4)-c5cc(ccc5)NC(=O)c6ccc(cc6)S(=O)(=O)C;5.9200001;Tyrosine-protein kinase BTK;2V1
4otg;c1cccc2c1c3c(CNC4=O)c4c(c5c3n2[C@@]67C)c8c(cccc8)n5[C@H](O6)C[C@]7(O)CO;7.5900002;Serine/threonine-protein kinase N1;2V9
4oti;N#CCC(=O)N(CC[C@H]1C)C[C@@H]1N(C)c2ncnc(c23)[nH]cc3;7.3699999;Serine/threonine-protein kinase N1;MI1
4oth;[NH2+]=C(N)SCCCn(c(c12)cccc2)cc1C(C(=O)NC3=O)=C3c(cn4C)c(c45)cccc5;8.0500002;Serine/threonine-protein kinase N1;DRN
3ncz;C1C[C@@H]([NH3+])CC[C@H]1C(=O)Nc(c(Cl)c2)cc(c23)cc[nH]c3=O;7.8200002;Rho-associated protein kinase 1;3NC
6op9;Clc1cc(Cl)c(cc1OC)Nc(c(C#N)cn2)c(c23)cc(OC)c(c3)OCCC[N@@H+]4CC[N@@H+](C)CC4;9.2799997;Receptor tyrosine-protein kinase erbB-3;DB8
2hy0;c1[nH]ncc1-c(c2)ccc(c23)[nH]c(=O)c(c3)-c(c4)[nH]c(c45)ccc(c5)C[NH+]6CCCCC6;9.1899996;Serine/threonine-protein kinase Chk1;306
3c7q;COC(=O)c(cc1)cc(c12)NC(=O)C\2=C(\c3ccccc3)Nc4ccc(cc4)N(C)C(=O)C[N@H+]5CC[N@H+](C)CC5;7.6777811;Vascular endothelial growth factor receptor 2;XIN
4hn2;OP([O-])(O)O[C@@H]1[C@H](OP([O-])([O-])O)[C@H](OP([O-])(O)O)[C@@H](OP([O-])([O-])O)[C@@H]([C@H]1OP([O-])([O-])O)OC(=O)CP([O-])(O)O;6.8899999;Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2;0EJ
2xyn;C[NH+]1CCN(CC1)c2cc(Nc3cc(C)n[nH]3)nc(n2)Sc4ccc(cc4)NC(=O)C5CC5;8.3999996;TYROSINE-PROTEIN KINASE ABL2;VX6
2no3;c1c(O)cccc1Nc2nc(ccn2)Nc3c(C(=O)N)cccc3;8.0500002;Mitogen-activated protein kinase 8;859
5ci7;[NH3+]CCCNc1c(I)cnc(n1)Nc2cccc(c2)NC(=O)N3CCCC3;6.9200001;Serine/threonine-protein kinase ULK1;51W
4hnf;c1ccc(Cl)cc1OCc(c(c23)c(N)ncn2)nn3C4CCOCC4;6.1500001;Casein kinase I isoform delta;16W
4hni;c1ccc(Cl)cc1OCc(c(c23)c(N)ncn2)nn3C4CCOCC4;7.4899998;Casein kinase I isoform epsilon;16W
3lhj;C1CC1NC(=O)c(ccc2C)cc2-c(c(=O)n3C)cc(c34)cnn4-c(c5F)ccc(F)c5;9.5100002;Mitogen-activated protein kinase 14;LHJ
1h00;C[NH+](C)C[C@H](O)COc(cc1)ccc1Nc2cc(ncn2)Nc3c(F)cccc3F;4.4200001;CELL DIVISION PROTEIN KINASE 2;FAP
3fv8;C=CC[NH+](CC1)CCN1c2c(Cl)cccc2NC(=O)c(o3)ccc3Br;6.7958798;Mitogen-activated protein kinase 10;JK3
4dbn;C1CC1C(=O)Nc(n2)sc(c23)nc(cc3)Oc(ccc4F)cc4NC(=O)c5cccc(c5Cl)C6(C#N)CC6;8.1499996;Serine/threonine-protein kinase B-raf;0JA
2clx;Oc1ccc(cc1)/N=N\c2c(N)n[nH]c2N;4.8800001;CELL DIVISION PROTEIN KINASE 2;F18
2izx;O[C@H]1CSSC[C@@H]1O;9.3999996;CAMP-DEPENDENT PROTEIN KINASE TYPE II-ALPHA REGULATORY SUBUNIT;DTD
2bkz;c1cc(S(=O)(=O)N)ccc1-n2nc(C(=O)N)c(c23)CCc4c3cn[nH]4;8.1499996;CELL DIVISION PROTEIN KINASE 2;SBC
3rjc;c1ccc(F)cc1Nc(nc2N)sc2C(=O)c3ccccc3;5.2399998;Cyclin-dependent kinase 2;06Z
4ei4;c1c[nH]c(nc2)c1c(c23)n(c(n3)C)[C@@H]4CCC[C@H](C4)O;8.7399998;Tyrosine-protein kinase JAK1;0Q2
3io7;CCN(CC)C(=O)[C@H]1CCCN(C1)c2cc(ncn2)-c3c(N)nn(c34)cccn4;7.7695513;Tyrosine-protein kinase JAK2;1P5
3iop;COc(c1)c(OC)cc2ncc(c3c12)c(N)nc(c3)-c4cc(cnc4)OC[C@H]([NH3+])Cc5ccccc5;7.77;3-phosphoinositide-dependent protein kinase 1;8I1
2b54;c1cc(O)c(O)cc1Cc(n2)[nH]c(=O)c(c23)c(CC)nn3-c4c(Cl)cc(Cl)cc4Cl;7.6999998;Cell division protein kinase 2;D05
2b53;c1ccc(cc1N)-c(cc2)cc(c23)c(nc(n3)C(F)(F)F)NC(C)(C)C;6.2199998;Cell division protein kinase 2;D23
2b52;C1C[N@H+](C)CC[N@H+]1NC(=O)Nc(ccc2)c(c23)C(=O)c4c3[nH]nc4-c5sc(C)nc5C;8.1000004;Cell division protein kinase 2;D42
3iok;c1cc(F)ccc1[C@H](C)Nc2ncnc(c2)-c3c(N)nn(c34)cccn4;7.9586072;Tyrosine-protein kinase JAK2;1P6
3ion;COc(c1)c(OC)cc2ncc(c3c12)c(N)nc(c3)-c4cc(cnc4)OC[C@@H]([NH3+])Cc5ccccc5;8.1000004;3-phosphoinositide-dependent protein kinase 1;8H1
2v7a;c1ccccc1[C@@H](OC)C(=O)N(C2)Cc(c23)c(n[nH]3)NC(=O)c4ccc(cc4)N5CC[NH+](C)CC5;8.3010302;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1;627
5l2i;C1CCCC1n(c(=O)c(C(=O)C)c2C)c(c23)nc(nc3)Nc4ncc(cc4)N5CC[NH2+]CC5;7.4000001;Cyclin-dependent kinase 6;LQQ
5l2t;C1CCCC1n(c(c2)C(=O)N(C)C)c(c23)nc(nc3)Nc(cc4)ncc4N5CC[NH2+]CC5;6.1900001;Cyclin-dependent kinase 6;6ZZ
5l2w;CCc(cn1)c(n12)nc(N(CCCC3)[C@@H]3CCO)cc2NCC4=CC=CN(C4)O;6.6799998;Cyclin-dependent kinase 2;1QK
5toz;c1c[nH]c(c12)ncnc2N[C@H](CC[C@@H]3C)CN3C(=O)CC;9.46;Tyrosine-protein kinase JAK3;7H4
5l2s;CC[N@@H+]1CC[N@@H+](CC1)Cc2ccc(nc2)Nc3ncc(F)c(n3)-c(cc4F)cc(c45)n(c(n5)C)C(C)C;7.0799999;Cyclin-dependent kinase 6;6ZV
4jai;c1cccc(c12)c3c([nH]c2=O)nccc3Nc4ccc(cc4)NC(=O)c5ccccc5;8.3999996;Aurora kinase A;XU2
4jaj;c1cccc2c(=O)[nH]c(c3c12)nccc3;5.2600002;Aurora kinase A;XU1
1nvs;O=C1NC(=O)c2c3c(cccc4)c4n([C@H]5O[C@@H]6CC5)c3c7n6c(c8c7c12)cccc8;7.8200002;Serine/threonine-protein kinase Chk1;UCM
1nvr;CO[C@@H]1[C@H]([NH2+]C)C[C@@H](O2)n3c(cccc4)c4c(c3c5n6[C@]12C)c7c(CNC7=O)c5c8c6cccc8;8.1099997;Serine/threonine-protein kinase Chk1;STU
3biz;C[NH+](C)CCCOC(C(=O)C1)=Cc(c12)n(C)c3c2c4c(C(=O)NC4=O)c(c3)-c5ccccc5Cl;7.2399998;Wee1-like protein kinase;61E
3bi6;C1CCC[NH+]1CCNC(=O)c(c(O)c2)cc(c23)n(C)c4c3c5c(C(=O)NC5=O)c(c4)-c6ccccc6Cl;7.8200002;Wee1-like protein kinase;396
2euf;C1CCCC1n(c(=O)c(C(=O)C)c2C)c(c23)nc(nc3)Nc4ncc(cc4)N5CC[NH2+]CC5;7.8200002;viral Cyclin;LQQ
4gfm;Clc1cccc(Cl)c1C(=O)NC(=CC=N2)CC2=O;7.2199998;Tyrosine-protein kinase JAK2;0X2
4g31;n1cnc(N)c(c12)c(cn2C)-c(cc3)cc(c34)ccn4C(=O)Cc5cccc(c5)C(F)(F)F;9.3999996;Eukaryotic translation initiation factor 2-alpha kinase 3;0WH
4g34;c1cnc(N)c(c12)c(cs2)-c(cc3)cc(c34)ccn4C(=O)Cc5ccccc5;7.9299998;Eukaryotic translation initiation factor 2-alpha kinase 3;924
5ljj;C1CCCCC1Nc2nc(nc(c23)nc[nH]3)Nc4ccc(cc4)N5CCOCC5;7.21;Dual specificity protein kinase TTK;AD5
5idn;Clc1ccc(cc1)[C@H]2N(CCC2)C(=O)c(c3)cnc(c34)[nH]nc4C;8.5900002;Cyclin-dependent kinase 8;6A7
3ds6;Cc1ccccc1-c(nnc2)c(c23)ccc(c3)-c(c(C)cc4)cc4C(=O)NC5CC5;9.0969105;Mitogen-activated protein kinase 14;A17
3oaw;n1c(N)nc(C)c(c12)nc(c(=O)n2C(C)C)-c3cn[nH]c3;8.1499996;Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;OAW
5hng;COc(c1)ccc(c12)nc([nH]2)-c3ccn[nH]3;4.0300002;3-phosphoinositide-dependent protein kinase 1;62O
4yc8;c1ccccc1Oc(cc2)ccc2NC(=O)c3cnc(s3)Nc4cc(nc(n4)C)N5CC[NH2+]CC5;3.5699999;Tyrosine-protein kinase ABL1;4B7
3e3b;O=C([O-])Cc(cc1)cn1-c(n2)cncc2-n3ncc(c34)ccc(c4)NC(C)C;7.9586072;Casein kinase II subunit alpha';CCK
2bmc;CCc1cccc(CC)c1NC(=O)n(c2)cc(c23)[C@@H]([NH2+]N3)NC(=O)c4ccc(cc4)N5CC[NH+](C)CC5;7.5686364;SERINE THREONINE-PROTEIN KINASE 6;MPY
4at5;c1nc(N)nc(N)c1Cc2ccc(c(c2)OC)OCc3ccc(cc3)OC;7.4200001;BDNF/NT-3 GROWTH FACTORS RECEPTOR;MUJ
3f82;c1cc(F)ccc1-n(c2=O)ccc(OCC)c2C(=O)Nc3ccc(c(F)c3)Oc4ccnc(c4Cl)N;8.3372421;hepatocyte growth factor receptor;353
4jq7;c1ccccc1-c2c(-c3ccccc3)oc(c24)ncnc4N[C@H](CO)c5ccccc5;6.4099998;Epidermal growth factor receptor;KJQ
4at3;c1cccc(c12)[C@@H](CCCC2)Sc(c3C(=O)N)nsc3NC(=O)N;8.3999996;BDNF/NT-3 GROWTH FACTORS RECEPTOR;LTI
3c5u;CC(C)Nc(s1)nc(c12)ccc(c2)-c3c(nco3)-c4ccccc4F;8.19382;Mitogen-activated protein kinase 14;P41
4kb8;Fc1ccc(cc1)-c(nn2C)c(c2)-c3ccnc(c3)C[NH2+]C;7.8899999;Casein kinase I isoform delta;1QN
4qt1;CC(C)CS(=O)(=O)N1C[C@H](CCC1)NC(=O)Nc(cn2)nc(c23)cc[nH]3;8.1499996;Tyrosine-protein kinase JAK3;3C9
3mhw;c1cccc(c12)sc(n2)N;2.3;Urokinase-type plasminogen activator;ABV
3v8w;CCC(O)(CC)c(cc1)cc(c12)[nH]c(c2)-c([nH]n3)c(c34)sc(c4)-c5ccccc5;8.0699997;Tyrosine-protein kinase ITK/TSK;0G2
3v8t;CCC(O)(CC)c(cc1)cc(c12)[nH]c(c2)-c([nH]n3)c(c34)sc(c4)C(F)F;9.5200005;Tyrosine-protein kinase ITK/TSK;477
4kba;c1cc(F)ccc1-c(nn2C)c(c2)-c(ccn3)c(c34)OCC[NH2+]C4;4.02;Casein kinase I isoform delta;1QM
4kbc;OCc1nccc(c1)-c2c[nH]nc2-c3ccc(F)cc3;7.8499999;Casein kinase I isoform delta;1QJ
4qtd;c1cnccc1-c2[nH]nc(c23)ccc(c3)NC(=O)[C@@H]4CC[N@@H+](C4)CC(=O)N5CCN(CC5)c6ccc(cc6)-c7ncccn7;5.9699998;Mitogen-activated protein kinase 8;38Z
4kbk;[NH2+]1CCOC[C@@H]1c(c2)nccc2-c3cn(C)nc3-c(cc4)ccc4F;8.1800003;Casein kinase I isoform delta;1QG
4qta;c1cnccc1-c2[nH]nc(c23)ccc(c3)NC(=O)[C@@H]4CC[N@H+](C4)CC(=O)N5CCN(CC5)c6ccc(cc6)-c7ncccn7;6.6999998;Mitogen-activated protein kinase 1;38Z
4qtc;c1cnccc1-c2[nH]nc(c23)ccc(c3)NC(=O)[C@@H]4CC[N@@H+](C4)CC(=O)N5CCN(CC5)c6ccc(cc6)-c7ncccn7;6.4000001;Serine/threonine-protein kinase haspin;38Z
4qtb;c1cnccc1-c2[nH]nc(c23)ccc(c3)NC(=O)[C@@H]4CC[N@H+](C4)CC(=O)N5CCN(CC5)c6ccc(cc6)-c7ncccn7;6.6999998;Mitogen-activated protein kinase 3;38Z
3lfn;c1cc(O)ccc1-c(c2)c(-c3ccccc3)cc(c24)c(n[nH]4)NC(=O)CCC;5.5;Cell division protein kinase 2;A27
3fpm;c1ccccc1[C@@H](C)/N=C(\C(=O)C2=O)C\2=N\c3ccncc3;5.0506101;MAP kinase-activated protein kinase 2;793
3lfs;c1ccccc1-c(c(Cl)c2)cc(c23)c([nH]n3)NC(=O)CCC;5.5999999;Cell division protein kinase 2;A07
5jga;n1c[nH]c(=O)c(c12)scc2C(=O)Nc(c(c3)-c4ccccc4)ccc3C(=O)N5CC[NH+](C)CC5;8.6400003;TAK1 kinase - TAB1 chimera fusion protein;6KC
4cqe;Fc1ccc(F)cc1S(=O)(=O)Nc2c(F)c(ccc2)-c3nc([C@H]4CC[N@H+](CC4)C5CC5)sc3-c6cc(ncc6)NC(=O)C;8.4300003;SLC45A3-BRAF FUSION PROTEIN;CQE
1m7q;Clc1cccc(Cl)c1-n(c(=O)nc2)c(c23)cc(N4CC[NH2+]CC4)cc3-c5ccc(F)cc5F;8.5900002;Mitogen-activated protein kinase 14;DQO
3itz;C1CC1NC(=O)c(ccc2Cl)cc2Nc(nnc3)c(c34)cnn4-c5c(F)cccc5F;8.8500004;Mitogen-activated protein kinase 14;P66
1q5k;n1cc(N(=O)=O)sc1NC(=O)NCc2ccc(cc2)OC;7.4200001;Glycogen synthase kinase-3 beta;TMU
2itz;C1COCC[NH+]1CCCOc(c2)c(OC)cc(c23)ncnc3Nc4cc(Cl)c(F)cc4;8.5850267;EPIDERMAL GROWTH FACTOR RECEPTOR;IRE
2ity;C1COCC[NH+]1CCCOc(c2)c(OC)cc(c23)ncnc3Nc4cc(Cl)c(F)cc4;7.271646;EPIDERMAL GROWTH FACTOR RECEPTOR;IRE
2itt;CC[N@@H+]1CC[N@H+](CC1)Cc2ccc(cc2)-c(c3)[nH]c(c34)ncnc4N[C@H](C)c5ccccc5;8.7695513;EPIDERMAL GROWTH FACTOR RECEPTOR;AEE
2itp;CC[N@@H+]1CC[N@H+](CC1)Cc2ccc(cc2)-c(c3)[nH]c(c34)ncnc4N[C@H](C)c5ccccc5;7.9469209;EPIDERMAL GROWTH FACTOR RECEPTOR PRECURSOR;AEE
2ito;C1COCC[NH+]1CCCOc(c2)c(OC)cc(c23)ncnc3Nc4cc(Cl)c(F)cc4;6.9079809;EPIDERMAL GROWTH FACTOR RECEPTOR;IRE
1xkk;CS(=O)(=O)CC[NH2+]Cc1ccc(o1)-c(cc2)cc(c23)c(ncn3)Nc4ccc(c(Cl)c4)OCc5cccc(F)c5;8.5200005;Epidermal growth factor receptor;FMM
2of4;C1C[NH2+]CC[NH+]1CCNc(ncn2)c(c23)c(-c4ccccc4)c(o3)-c5ccccc5;7.0900002;Proto-oncogene tyrosine-protein kinase LCK;979
4uzd;CCOC(=O)c1[nH]cc(c12)[C@@H](C3=C(N2)CCCC3=O)c4cc(ccc4)Oc([nH]5)nc(c56)cccc6;9.2200003;AURORA KINASE A;QMN
3v6s;c1ccncc1-c2nc(ncc2)Nc3ccc(cc3)NC(=O)c4cccc(c4)NC(=O)CCC[NH+](C)C;9.1199999;Mitogen-activated protein kinase 10;0F0
3v6r;c1ccncc1-c2nc(ncc2)Nc3cc(ccc3)NC(=O)c4ccc(cc4)NC(=O)CCC[NH+](C)C;6.1500001;Mitogen-activated protein kinase 10;CQQ
4uzh;C1[NH2+]CC(=O)C(=C12)[C@H](c3c(N2)n[nH]c3)c4c(F)cccc4;5.0100002;AURORA 2 KINASE DOMAIN;JVE
2ofv;c1nc(N)nc(c12)ccc(c2)-c3cc(ccc3C)C(=O)Nc4cc(C(F)(F)F)ccc4;9.6999998;Proto-oncogene tyrosine-protein kinase LCK;242
2ofu;Cc1cccc(C)c1OC(=O)N(c2c(OC)cc(cc2)OC)c(ccn3)nc3Nc4cc(OC)c(c(c4)OC)OCCC[N@H+](CC5)CC[N@H+]5C;9;Proto-oncogene tyrosine-protein kinase LCK;1N9
5edr;Cn1nccc1-c(nc(c23)C(C)(C)OC3)nc2Nc4n[nH]c(c45)cccc5;7.46;Epidermal growth factor receptor;5N4
3qbn;C1CC1Nc(n2)c(Cl)cnc2Nc3ccc(cc3)OCCOC;8.2299995;Serine/threonine-protein kinase 6;E9Z
3zc6;c1cc(F)cc(c12)n(C)nc2-c(cn3)nc(c34)c(c[nH]4)C(=O)N[C@H](C)C(=O)N5CC(C5)C#N;9.2200003;TYROSINE-PROTEIN KINASE JAK3;VFC
3zly;c1ccc(C#N)c(c12)c([nH]n2)N;3.52;DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1;YSO
3zlx;C1C[NH2+]C[C@@H]1CO[C@@H]([C@H](Cl)C=2)C=C(C23)C=CN[C@@H]3O;3.8;DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1;5EZ
3zls;c1ccnc(c12)[nH]cc2C(=O)OC;4.4000001;DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1;92P
3zlw;C1C[C@](O)(C)c2cccc(c2N13)CCC3=O;3.7;DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 MAPK/ERK KINASE 1, MEK 1, MEK1;MT8
4puz;C1COCCN1c2ccc(cc2)Nc(c(n34)ncc4)nc(c3)-c(cc5)cc(c56)n[nH]c6;8.1099997;Tyrosine-protein kinase SYK;CG9
4yfi;[nH]1cnc(c12)c(ncn2)Nc3cc(ccc3)S(=O)(=O)NC;6.3000002;Serine/threonine-protein kinase TNNI3K;4CW
2b7a;c1c[nH]c(=O)c2c(cc(F)cc3)c3c(c4c12)[nH]c(n4)C(C)(C)C;9;Tyrosine-protein kinase JAK2;IZA
1w0x;n1cn(C)c(c12)nc(NCCO)nc2NCc3ccccc3;5.3000002;CYCLIN-DEPENDENT KINASE 2;OLO
1w0z;[NH2+]=C(N)c1ccc(cc1)CNC(=O)[C@H](C)NC(=O)[C@@H](CO)NS(=O)(=O)CCCC;7.6777811;UROKINASE-TYPE PLASMINOGEN ACTIVATOR;SI1
3p23;OP([O-])(O)OP([O-])(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n(cn2)c(c23)ncnc3N;4.4200001;Serine/threonine-protein kinase/endoribonuclease IRE1;ADP
3l1s;COc1ccc(cc1OC)C2=NNC(=O)C\2=N\Nc3ccc(Cl)cc3;8.6999998;Glycogen synthase kinase-3 beta;Z92
4jg8;OCC(C)(C)NC(=O)[C@H](C#N)Cc(cc1)cc(c12)c(n[nH]2)-c3cc(OC)c(OC)c(c3)OC;8.6000004;Ribosomal protein S6 kinase alpha-3;1LE
2zjw;c12c3c4c(oc1=O)c(O)c(O)cc4c(=O)oc3c(O)c(c2)O;7.6989698;Casein kinase II subunit alpha;REF
3pe2;n1cncc(c12)c3c(cc(C(=O)[O-])cc3)nc2Nc(c4)cccc4C#C;9.7600002;Casein kinase II subunit alpha;E1B
3pe1;O=C([O-])c(c1)ccc(c12)c3c(ccnc3)c(n2)Nc4cc(Cl)ccc4;9.6499996;Casein kinase II subunit alpha;3NG
5dls;c1ccccc1Cn(nc2)cc2C(=O)Nc3c[nH]c(=O)c(c3)-c([nH]4)cc(c45)cc(cc5)OCC(C)(C)C[NH+](C)C;8.3599997;Serine/threonine-protein kinase Chk1;5CV
4j8m;FC(F)(F)c(c1)cccc1NC(=O)Nc2ccc(cc2)Nc3nccc(n3)Nc4n[nH]c(c4)C5CCCC5;7.3200002;Aurora kinase A;CJ5
2uvm;OP([O-])(O)Oc1c(OP([O-])([O-])O)c(OP([O-])(O)O)ccc1OP([O-])([O-])O;7.0999999;RAC-ALPHA SERINE/THREONINE-PROTEIN KINASE;GVF
3c39;O=C([O-])[C@H](O)COP([O-])(O)O;3.96;Phosphoglycerate kinase 1;3PG
4ark;Fc1cc(I)ccc1Nc2c(C(=O)N)c(cc(F)c2)OCC[C@@H](O)CO;7.1999998;DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1;M3K
4ohp;CNS(=O)(=O)c1ccc(cc1)N2[C@@H](C#CC)CN(CC2)S(=O)(=O)c3ccc(N)nc3;7.46;Glucokinase regulatory protein;2TJ
4oho;Nc1ccc(cn1)S(=O)(=O)N2C[C@H](C#CC)N(CC2)c3ccc(cc3)[S@](=O)(C(F)(F)F)=N;7.77;Glucokinase regulatory protein;2TG
4ohm;Nc1ccc(cn1)S(=O)(=O)N2C[C@H](C#CC)N(CC2)c3ccc(cc3)[C@](C(F)(F)F)(O)CO;7.5500002;Glucokinase regulatory protein;2TF
4ohk;CCCC[C@@](C(F)(F)F)(O)c1ccc(cc1)N2[C@@H](C#CC)CN(CC2)S(=O)(=O)c3ccc(N)nc3;8.3000002;Glucokinase regulatory protein;2TE
3h0y;c1cc(O)ccc1Nc(ncc2F)nc2Nc3ccc(cc3)NC(=O)c4c(Cl)cccc4;8.2218485;Serine/threonine-protein kinase 6;48B
3h0z;Clc1ccccc1NC(=O)c2ccc(cc2)Nc3nc(ncc3F)Nc4ccc(cc4)CC(=O)N5CCN(CC5)C(=O)C;8.3665314;Serine/threonine-protein kinase 6;45B
1b38;OP([O-])(O)OP([O-])(O)OP([O-])(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n(cn2)c(c23)ncnc3N;6.5999999;PROTEIN (CELL DIVISION PROTEIN KINASE 2);ATP
5c8k;COC1CCN(CC1)c2nccc(n2)Nc(c3)ncc(c34)ncn4C5CCCC5;7.6999998;Epidermal growth factor receptor;4YV
5c8m;CC(C)n(c(n1)C)c(c12)cc(nc2)Nc3ccnc(n3)N4CCC(CC4)S(=O)(=O)C;7.1900001;Epidermal growth factor receptor;4YW
5c8n;CC(C)n(c(n1)C)c(c12)cc(nc2)Nc3ccnc(n3)N(CC4)CCC4(OC)CC[NH3+];7.5500002;Epidermal growth factor receptor;4YX
3mj2;C1CN(C(=O)C)CCN1C(=O)c(c2OC)cc(c(c2)C)Sc3cnc(s3)NC(=O)c4ccc(cc4)C[NH2+][C@@H](C)C(C)(C)C;7.8200002;Tyrosine-protein kinase ITK/TSK;MJG
3mj1;C1COCCC1n(c2=O)nc(Nc3n[nH]c(c3)C)c(c24)ccc(c4)C[N@@H+]5CC[N@H+](C)CC5;7.8200002;Tyrosine-protein kinase ITK/TSK;614
3gp0;c1nc(C)cn1-c(cc(c2)C(F)(F)F)cc2NC(=O)c3ccc(C)c(c3)Nc4nccc(n4)-c5cccnc5;7.4400001;Mitogen-activated protein kinase 11;NIL
4qrc;n1cccc(n12)ncc2C#Cc3c(C)ccc(c3)C(=O)Nc4ccc(c(c4)C(F)(F)F)C[N@H+]5CC[N@H+](C)CC5;6.3400002;Fibroblast growth factor receptor 4;0LI
2i0e;c1cccc(c12)[nH]c(C)c2C(C(=O)NC3=O)=C3c4c(C)n(c(c45)cccc5)CCC[NH+](C)C;8.6999998;Protein Kinase C-beta II;PDS
4dfn;c1nn(C)cc1-c(ccc2)cc2-c(cn3)nc(c3N)C(=O)N[C@H]([C@H](C4)C5)[C@@H](C6)C[C@H]5C[C@]46O;7.6999998;Tyrosine-protein kinase SYK;0K1
4dfl;c1ccc(NS(=O)(=O)C)cc1-c2cnc(N)c(n2)C(=O)NCC3CC[NH2+]CC3;6.1700001;Tyrosine-protein kinase SYK;0K0
5es1;C1CC[C@@H]([NH3+])[C@H](C1(F)F)NC(=O)c2cc(c(s2)CC)-c(cn3)c(n34)ncc(c4)C(F)(F)F;8.3400002;MAP/microtubule affinity-regulating kinase 4;5RC
4rpv;Fc1cccc(F)c1-c(c2)ccc(c23)n[nH]c3-c(n4)cncc4N5C[C@@H]([NH3+])CCC5;8.5200005;Serine/threonine-protein kinase pim-1;3UR
2i0v;o1nc(C)cc1[C@@H](C(=O)N2)[C@H](c(c23)cc(Cl)cc3)c4ccccc4;6.8000002;cFMS tyrosine kinase;6C3
3ot3;c1n(C)ncc1-c2cnn(c23)c(N)c(Br)c(n3)[C@H]4C[C@@H]([NH3+])CCC4;8.3000002;Serine/threonine-protein kinase Chk1;22K
2chx;c1ccncc1C(=O)Nc(n2)n(ccn3)c3c(c24)ccc(OC)c4OC;7.7399998;PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM;090
2chz;OCCNS(=O)(=O)c1c(Cl)ccc(c1)-c2c(C)nc(s2)NC(=O)C;7.8000002;PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM;093
3emg;OC[C@H](C)NC(=O)c1sc(nc1C)-c2ccnc(n2)Nc3cc(C)cc(C)c3;8.0457573;Tyrosine-protein kinase SYK;685
4eyj;Cn1nc(C(C)(C)C)cc1NC(=O)Nc2ccc(cc2)Oc3ccncc3;6.21;Mitogen-activated protein kinase 13;N61
4eym;C1COCCN1c(ncc2)cc2C(=O)Nc3ccc(cc3)Oc4ccncc4;4.0100002;Mitogen-activated protein kinase 13;0RX
4uxl;N#Cc1n(C)nc(c1c23)CN(C)C(=O)c4c(cc(F)cc4)[C@@H](C)Oc(c2)c(N)nc3;10.6;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS;5P8
4anv;COc1ccc(cc1)-c2cc(ccc2)S(=O)(=O)N3CCN(CC3)c4nccnc4-c5ccc(OC)cc5;6.3600001;PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM;751
3rni;c1ccc(S(=O)(=O)N)cc1Nc(s2)nc(N)c2C(=O)c3ccccc3;5.1700001;Cyclin-dependent kinase 2;21Z
1pmn;C1C[N@@H+](C)CC[C@@H]1c(n2CCC)nc(-c3cc(Cl)c(Cl)cc3)c2-c4ccnc(n4)NC5CC5;8.1499996;Mitogen-activated protein kinase 10;984
1pme;c1cc(S(=O)C)ccc1-c2[nH]c(c(n2)-c(cc3)ccc3F)-c4ccncc4;9.3999996;ERK2;SB2
1pmu;c1nccc(c12)ccc3c2cc(cn3)-c4ccc(O)cc4;6.23;Mitogen-activated protein kinase 10;9HP
1pmv;c1cccc(c12)C(=O)c3c4c([nH]nc24)ccc3;6.8200002;Mitogen-activated protein kinase 10;537
3qd0;c1ccccc1NC(=O)[C@H]2CC[C@@H](C)N(C2)c(nc(n3)N)cc3-c(cc4)cc(c45)n[nH]c5N;8.5;3-phosphoinositide-dependent protein kinase 1;3Q4
3qd3;Nc1[nH]nc(c12)cc(cc2)-c3cc(nc(n3)N)N(C4)[C@@H](C)CC[C@H]4NC(=O)OC(C)(C)C;8;3-phosphoinositide-dependent protein kinase 1;3Q5
3qd4;Nc1[nH]nc(c12)cc(cc2)-c3cc(nc(n3)N)N(C4)C[C@@H](C[C@H]4C)NC(=O)OC(C)(C)C;8.1999998;3-phosphoinositide-dependent protein kinase 1;3Q6
3pxf;c1ccc(S([O-])(O)O)c(c12)c(ccc2)Nc3ccccc3;4.4299998;Cell division protein kinase 2;2AN
3pxy;Nc1nc(N)nc(n1)-c2c(O)ccc(c2)OC;5.23;Cell division protein kinase 2;JWS
3pxz;Nc1nc(N)nc(n1)-c2c(O)ccc(c2)OC;5.23;Cell division protein kinase 2;JWS
3pxq;c1ccc(S([O-])(O)O)c(c12)c(ccc2)Nc3ccccc3;4.4299998;Cell division protein kinase 2;2AN
1oth;O=C([O-])[C@@H]([NH3+])CCCNC(=O)CP([O-])(O)O;7;PROTEIN (ORNITHINE TRANSCARBAMOYLASE);PAO
4wov;COCC(=O)NCc1nc(ccc1)-c(c2)[nH]c(c2c(c34)n(cn3)C)nc4NC;7.1399999;Non-receptor tyrosine-protein kinase TYK2;3SM
4fyo;COc1ccc(cc1OC)Nc(c(c23)ncs3)nc(n2)N4C[C@H](CC4)NC(=O)c5ccc(C(=O)[O-])cc5;7.3299999;Tyrosine-protein kinase SYK;0VF
3cy2;C1C[NH2+]CCC12NC(=O)c3c([C@H]2C#N)c4c(n3C)cc(Cl)cc4;7.2199998;Proto-oncogene serine/threonine-protein kinase Pim-1, Isoform 2;MB9
5l6p;c1ccccc1Nc2ncnc(c23)cc(cc3)NC(=O)C;7.2600002;Ephrin type-B receptor 3;6P8
3g9l;C1OCOc(c12)c(cc(F)c2)CN3C(=O)/C(=N\O)c(c34)c(ccc4)/C=C/c5ccccc5;6.1307683;Mitogen-activated protein kinase 10;J67
3g9n;c1ccccc1-c(ccc2)c(c23)C(=N\O)\C(=O)N3Cc(cc(F)c4)c(c45)OCOC5;5.7447276;Mitogen-activated protein kinase 10;J88
4i6q;C1CC1[C@H](C)NC(=O)c2c[nH]c(c23)ncc(n3)Oc4ccccc4;7.52;Tyrosine-protein kinase JAK3;1DT
3ewh;CNc1nc(ccn1)-c2cccnc2Oc3ccc(c(c34)cccc4)Nc([nH]5)nc(c56)ccc(c6)C(F)(F)F;7.1611509;vascular endothelial growth factor receptor 2;K11
2b1p;C[NH+](C)CCCC(=O)Nc(cc(c1)C(=O)[O-])cc1-c2n[nH]c(c23)cc(cc3)Nc4c(Cl)cccc4;8.5200005;Mitogen-activated protein kinase 10;AIZ
4xg4;O[C@H]1C[N@H+](CC1)Cc2cn(cc2C)-c3c(F)cnc(n3)Nc4cc(C)c(c(c4)C)OCCO;7.6700001;Tyrosine-protein kinase SYK;X4G
4xg7;C1[C@@H](O)C[N@H+]1Cc(c(n2)C)cn2-c3ccnc(n3)Nc(c4)ccc(c45)n(C)nc5;7.4899998;Tyrosine-protein kinase SYK;X7G
4xg6;C1[C@@H](O)C[N@H+]1Cc(c(n2)C)cn2-c3ccnc(n3)Nc(cc4C)cc(c4)C;8.0100002;Tyrosine-protein kinase SYK;X6G
4xg3;C1C[C@@H](O)C[N@H+]1Cc(c(c2)C)cn2-c3c(F)cnc(n3)Nc(cc4C)cc(C)c4OS(=O)(=O)C;7.7600002;Tyrosine-protein kinase SYK;X3G
4xg9;O[C@@H]1C[N@H+](C1)Cc2cn(nc2C)-c3ccnc(n3)Nc(c4)ccc(c45)n(C)c(c5Cl)C;9.1499996;Tyrosine-protein kinase SYK;X9G
4xg8;O[C@@H]1C[N@H+](C1)Cc2cn(nc2C)-c3ccnc(n3)Nc(c4)ccc(c45)n(C)nc5Cl;8.7200003;Tyrosine-protein kinase SYK;X8G
5ihc;c1cccc(F)c1-n(c2)ncc2-c3ccncc3OCC4CC[NH2+]CC4;7.8899999;Maternal embryonic leucine zipper kinase;6BB
5iha;CC(C)COc1cnccc1-c2cn(nc2)-c(cc3)ccc3N4CC[NH+](C)CC4;8.0500002;Maternal embryonic leucine zipper kinase;6BE
4gj3;F[C@@H]1C[C@@H]1C(=O)Nc2nccc(c2)NC(=O)c3c(Cl)cc(C#N)cc3Cl;8.8500004;Non-receptor tyrosine-protein kinase TYK2;0XP
4gj2;Clc1cccc(Cl)c1C(=O)Nc2ccnc(c2)NC(=O)[C@H]3C[C@H]3F;8.6000004;Non-receptor tyrosine-protein kinase TYK2;0XH
5ih5;n1c(N)nc(N)c(c12)nc(c(n2)N)-c3cccc(Cl)c3;6.3000002;Casein kinase I isoform delta;AUE
5bq0;CCN(CC)C(=O)c(cc1)cc([nH]2)c1c(c23)c(ccc3C(=O)N)-c4ccccc4Cl;7.8200002;Tyrosine-protein kinase BTK;4US
3vid;c1cccc(c12)[nH]c3c4c(cn[nH]4)CCCc23;6.21;Vascular endothelial growth factor receptor 2;4TT
4l02;Clc1ccc(cc1Cl)-c2nc(sc2)Nc3ccc(cc3)CC[N@H+]4CC[C@H](O)C[C@@H]4CO;7.6999998;Sphingosine kinase 1;1V2
1oir;C1C=CCN(C=12)C(=C(C)N2)c3ccnc(n3)Nc4ccc(cc4)OC[C@@H](O)C[NH+](C)C;7.4899998;CELL DIVISION PROTEIN KINASE 2;HDY
1oiq;O=C(C)Nc1nc(ccn1)C2=C(C)NC(N23)=CCC=C3;5.54;CELL DIVISION PROTEIN KINASE 2;HDU
4ap7;c1cc(F)ccc1-c(n2)cnc(n23)nnc3Cc4ccc(O)cc4;7.96;HEPATOCYTE GROWTH FACTOR RECEPTOR;F47
1oit;c1cc(S(=O)(=O)N)ccc1Nc(n2)nccc2C3=CNC(N34)=CCC=C4;8.5200005;CELL DIVISION PROTEIN KINASE 2;HDT
1oiy;NC(=O)c1ccc(cc1)Nc(nc(c23)[nH]cn3)nc2OCC4CCCCC4;7.1900001;CELL DIVISION PROTEIN KINASE 2;N41
4w7p;c1nccc(c12)c(NCC(C)(C)[NH3+])nc(n2)-c(cc3)cc(c34)c[nH]n4;6.46;Rho-associated protein kinase 1;3J7
4app;c1ccccc1Oc(ccc2)cc2C(=O)Nc(n[nH]3)c(c34)CN(C4(C)C)C(=O)N5[C@H](C[N@@H+](C)CC5)Cc6ccccc6;7.1900001;SERINE/THREONINE-PROTEIN KINASE PAK 4;N53
2jiu;CC[N@@H+]1CC[N@H+](CC1)Cc2ccc(cc2)-c(c3)[nH]c(c34)ncnc4N[C@H](C)c5ccccc5;7.5590911;EPIDERMAL GROWTH FACTOR RECEPTOR;AEE
1oi9;Oc1ccc(cc1)Nc(nc(c23)[nH]cn3)nc2OCC4CCCCC4;7.1599998;CELL DIVISION PROTEIN KINASE 2;N20
2ym4;[NH3+]C[C@H](C1)OCCN1c(c(cn2)C(=O)OCC)c(c23)c(n[nH]3)-c4cccc(C#N)c4;5.8200002;SERINE/THREONINE-PROTEIN KINASE CHK1;4YM
2w1c;Fc1ccc(cc1)C(=O)Nc2c[nH]nc2-c(n3)[nH]c(c34)cc(cc4)C[NH+]5CCOCC5;8;SERINE/THREONINE-PROTEIN KINASE 6;L0C
2ym6;[NH3+]C[C@@H]1CN(CCO1)c(ncn2)c(c23)c4c([nH]3)cncc4;6.0599999;SERINE/THREONINE-PROTEIN KINASE CHK1;YM6
4qp2;n1c(N)oc(c12)ccc(Cl)c2;3.03;Mitogen-activated protein kinase 1;36R
2w1f;c1ccccc1C(=O)Nc2c[nH]nc2-c(n3)[nH]c(c34)cccc4;8.2291479;SERINE/THREONINE-PROTEIN KINASE 6;L0F
2w1g;C1CC1NC(=O)Nc2c[nH]nc2-c(n3)[nH]c(c34)ccc(c4)C[NH+]5CCOCC5;8.5228786;SERINE/THREONINE-PROTEIN KINASE 6;L0G
2ym3;CCOC(=O)c(cn1)c(c(c12)cn[nH]2)N3C[C@H](C[NH3+])OCC3;6;SERINE/THREONINE-PROTEIN KINASE CHK1;YM3
4qp9;CCCn(nc1)cc1-c(c[nH]2)c(c23)nc(cn3)-c4ccncc4;7.1500001;Mitogen-activated protein kinase 1;35X
4qp8;c1ccncc1-c(c[nH]2)c(c23)nc(cn3)-c4cn[nH]c4;6.5500002;Mitogen-activated protein kinase 1;362
2w1h;c1ccccc1C(=O)Nc2c[nH]nc2-c(n3)[nH]c(c34)cccc4;7.2839966;CELL DIVISION PROTEIN KINASE 2;L0F
2ym8;C[NH+](C)C[C@@H](C)Oc1nc(cnc1C#N)Nc(c2)ncc(c23)c(Cl)ccc3;7.8899999;SERINE/THREONINE-PROTEIN KINASE CHK1;YM8
1gi9;c1cc(C(N)=[NH2+])cc(c12)[nH]c(n2)-c3cc(OC)ccc3O;5.2199998;UROKINASE-TYPE PLASMINOGEN ACTIVATOR;123
1gi8;c1cc(C(N)=[NH2+])cc(c12)[nH]c(n2)-c3ccccc3O;5.0500002;UROKINASE-TYPE PLASMINOGEN ACTIVATOR;BMZ
1gi7;c1cc(C(N)=[NH2+])cc(c12)nc([nH]2)-c3ccc[nH]c3=O;4.5100002;UROKINASE-TYPE PLASMINOGEN ACTIVATOR;120
4qpa;c1ccccc1Cn(nc2)cc2-c(c[nH]3)c(c34)nc(cn4)-c5ccncc5;7.4299998;Mitogen-activated protein kinase 1;35W
2w17;CC(C)n1c(C)ncc1-c2nc(ncc2F)Nc3ccc(cc3)C(=O)N4CC[C@@H](C4)[NH+](C)C;8.6989698;CELL DIVISION PROTEIN KINASE 2;I19
4knb;Fc1ccc(Cl)c(c1Cl)[C@@H](C)Oc2c(N)ncc(c23)c(co3)-c4cn(nc4)C5CC[NH2+]CC5;7.3299999;Hepatocyte growth factor receptor;1RU
4qps;c1ccccc1Nc2cncc(n2)-n3cnc(c34)ccc(c4)NC(=O)CC;6.52;Tyrosine-protein kinase JAK3;37Q
1ke7;c1ncoc1-c(cc2)cc(c23)C(\C(=O)N3)=C\Nc(c4)ccc(c45)CS(=O)(=O)C5;8.0500002;Cell division protein kinase 2;LS3
1ke6;s1cnc(c12)ccc3c2C(\C(=O)N3)=N\Nc4ccc(cc4)CS(=O)(=O)NC;8.2399998;Cell division protein kinase 2;LS2
1ke5;c1cccc(c12)C(\C(=O)N2)=C\Nc3ccc(cc3)S(=O)(=O)NC;6.25;Cell division protein kinase 2;LS1
1ke9;c1cccc(c12)C(\C(=O)N2)=C\Nc3ccc(cc3)S(=O)(=O)NC(N)=[NH2+];6.1799998;Cell division protein kinase 2;LS5
1ke8;c1cccc(c12)C(\C(=O)N2)=C\Nc3ccc(cc3)S(=O)(=O)Nc4sccn4;6;CELL DIVISION PROTEIN KINASE 2;LS4
2ok1;Clc1cccc(c1)-c2cn[nH]c2-c3c[nH]c(c3)C(=O)NCc4ccccc4;6.2600002;Mitogen-activated protein kinase 10;33A
4rvt;Oc1ccc(cc1)-c2c[nH]c(=O)c(c2O)C(=O)CCCCC;5.7199998;Mitogen-activated protein kinase kinase kinase kinase 4;3XM
5i0b;CC(C)c1nn(C)cc1-c([nH]2)nc(c23)ncc(Br)c3;5.0599999;Serine/threonine-protein kinase PAK 4;67U
5aux;Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3ccc(O)cc3;5;Death-associated protein kinase 1;KMP
5auz;Oc1cc(O)cc(c12)occ(c2=O)-c3ccc(O)cc3;4.0100002;Death-associated protein kinase 1;GEN
4rvk;N#Cc(c1)ncc2[nH]c(c3c12)ncc(c3)-c4cc(NC(=O)C)ccc4;7.8699999;Serine/threonine-protein kinase Chk1;3XK
4rvl;N#Cc(nc1)cc(c12)c3c([nH]2)ncc(c3)-c4ccccc4O;7.3800001;Serine/threonine-protein kinase Chk1;3XL
4rvm;N#Cc(nc1)cc(c12)c3c([nH]2)ncc(c3)-c4ccc(cc4)C[NH+]5CCCCC5;9;Serine/threonine-protein kinase Chk1;3X7
5auv;Oc1ccc(cc1)-c(cc2=O)oc(c23)cc(O)cc3O;4.5100002;Death-associated protein kinase 1;AGI
4k6z;c1[nH]ncc1-c(n2)nc(c(c23)cc[nH]c3=O)N[C@H]4CCC[C@H]4C#N;8.6999998;Tyrosine-protein kinase JAK1;1Q3
2vu3;C1C[NH2+]CCC1NC(=O)c2[nH]ncc2NC(=O)c3c(Cl)cccc3Cl;7.3299999;CELL DIVISION PROTEIN KINASE 2;LZE
4cmo;c1c(F)ccc(C(=O)NC)c1[C@@H](C)Oc2c(N)ncc(n2)-c3c(OC)nccc3;9.0699997;ALK TYROSINE KINASE RECEPTOR;YPW
5j79;Oc1ccc(C)c(c1)Nc2ccnc(c23)ccc(c3)S(=O)(=O)C;8.5200005;Receptor-interacting serine/threonine-protein kinase 2;6GE
4txc;COc1cc(ccc1O)C(N2)=CC=C(N23)NC=C3c4cc(ccc4)[C@@H](O)[NH2+]CC[NH+](C)C;6.6199999;Death-associated protein kinase 1;38G
2a5u;n1ccnc(c12)ccc(c2)/C=C(/C3=O)SC(=O)N3;8.1000004;Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit, gamma isoform;QYT
5ar4;O[S@H](C)c1ccc(cc1)-c2nc(c([nH]2)-c(cc3)ccc3F)-c4ccncc4;6.6999998;RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2;SB2
1zyj;c1cccnc1CNC(=O)c2ccc(cc2)Oc3ccccc3;5.8200002;Mitogen-activated protein kinase 14;BI5
3bpr;Clc1cc(ccc1)Nc2nc(NCCO)nc(c23)n(cn3)C(C)C;4.9499998;Proto-oncogene tyrosine-protein kinase MER;OLP
3rpv;NS(=O)(=O)c(cc1)ccc1Nc(s2)nc(N)c2C(=O)c3cccc(N)c3;7.1500001;Cyclin-dependent kinase 2;26Z
3rpr;FC(F)(F)c1cccc(c1)[C@@H](O)c2sc(nc2N)Nc3ccccc3;4;Cyclin-dependent kinase 2;25Z
3rpy;O=C(N)c1sc(nc1N)Nc2ccc(S(=O)(=O)N)cc2;5.3200002;Cyclin-dependent kinase 2;27Z
5aaa;Clc1ccc(F)c(Cl)c1[C@@H](C)Oc2cc(cnc2N)-c3cnn(c3)C4CC[NH2+]CC4;9.4200001;ALK TYROSINE KINASE RECEPTOR;VGH
5d9k;c1c(F)c(O)c(F)cc1Nc(n2)ncc(c23)N(C)C(=O)[C@@H](C)N3CCC(C)C;8.3999996;Ribosomal protein S6 kinase alpha-3;584
4eh5;c1ccccc1COC(=O)c2cccnc2;3.0899999;Mitogen-activated protein kinase 14;0OM
4eh4;C1CCCCN1C(=O)c2ccccc2;2.8099999;Mitogen-activated protein kinase 14;0OL
4eh6;c1ccccc1NC(=O)c2cccnc2;2.46;Mitogen-activated protein kinase 14;0ON
3gb2;O[S@@H](C)c1ccc(cc1)-c2coc(c23)ccc(c3)-c4oc(C)nn4;7.4699998;Glycogen synthase kinase-3 beta;G3B
2vnt;Clc1cnc(NC(=[NH2+])N)c(c12)cc(cc2)S(=O)(=O)N3CCC[C@@H]3C(=O)[O-];8.004365;UROKINASE-TYPE PLASMINOGEN ACTIVATOR;QGG
2zv2;c12c3cccc1c(=O)n4c5c(cccc5)nc4c2ccc3C(=O)[O-];6.3000002;Calcium/calmodulin-dependent protein kinase kinase 2;609
2rfn;C1COCC[NH+]1CCCOc(c(c2)OC)cc(c23)nccc3Oc4ccc(cc4F)-c(c(=O)n5C)cnc5Cc6ccccc6;8.3010302;Hepatocyte growth factor receptor;AM7
4pqn;c1ccccc1[C@H](CC[NH+](C)C)n2ncc(c2)NC(=O)c3[nH]nc(c34)CC(C)(C)CC4;9.1499996;Tyrosine-protein kinase ITK/TSK;2W6
2h96;COc1ccc(OC)cc1CNC(=O)c2nc(c(C#N)cc2)OCC;6.6399999;Mitogen-activated protein kinase 8;893
3kgp;O=C([O-])c1ccc(cc1)C[NH3+];2.5718653;Urokinase-type plasminogen activator;4AZ
3eqb;Fc1cc(I)ccc1Nc(c(F)c2F)c(cc2)-c3nnc(o3)NCC[NH3+];1.823909;Dual specificity mitogen-activated protein kinase kinase 1;LUG
3kga;[nH]1ccc(c12)ccc(c2)-c(ccc3)cc3-n4nc(N)c(c4)-c(c5)ccc(c56)C(=O)NCC6;7.21;MAP kinase-activated protein kinase 2;LX9
2o2u;Fc1ccccc1C(=O)Nc(s2)c(C#N)c(c23)CCCC3;6.4000001;Mitogen-activated protein kinase 10;738
5aa8;N#Cc1n(C)nc(c1c23)CN(C)C(=O)c4c(cc(F)cc4)[C@@H](C)Oc(c2)c(N)nc3;8.0699997;ALK TYROSINE KINASE RECEPTOR;5P8
4hgl;c1cccc(c12)ncc(c2)-c3nc(c(cn3)OC)-c([nH]4)cc(c45)C(=O)NCC5;8.1000004;Casein kinase I isoform gamma-3;0YO
4ehz;c1c[nH]c(nc2)c1c(c23)n(c(n3)C)C4CC[NH2+]CC4;8;Tyrosine-protein kinase JAK1;JAK
4o91;[nH]1ccc(c12)c(ccn2)Oc3cc(ccc3C)C(=O)Nc4ccc(c(C(F)(F)F)c4)C[N@@H+]5CC[N@H+](CC5)CC;6.8299999;Mitogen-activated protein kinase kinase kinase 7/TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 chimera;NG2
2x9e;CCc1cccc(CC)c1NC(=O)c2nn(C)c(c23)c4c(CC3)cnc(n4)Nc5c(OC(F)(F)F)cc(cc5)C(=O)N[C@@H]6CC[N@@H+](C)CC6;6.7399998;DUAL SPECIFICITY PROTEIN KINASE TTK;SVE
2x9f;CS(=O)(=O)c1cccc(c1)Nc2nccc(n2)Nc(ccc3)c(c34)c[nH]n4;7.21;EPHRIN TYPE-B RECEPTOR 4;X9F
4g9c;COc1[nH]nc(c12)ncc(c2)NC(=O)c3c(F)c(ccc3F)NC(=O)c4cccc(c4)C(C)(C)C#N;8.6400003;Serine/threonine-protein kinase B-raf;0WP
4l23;c1ccnc(c12)oc3c2nc(-c4cccc(O)c4)nc3N5CCOCC5;7.75;Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform;X6K
3f66;c1c(O)cccc1-c2cc(C(F)(F)F)cc(c23)ncc(n3)N4CC[NH+](C)CC4;6.0457568;Hepatocyte growth factor receptor;IHX
5htc;Nc1ncnc(c12)n(cn2)[C@H]3[C@H](O)[C@H](O)[C@H](O3)C(=O)NCCCCCC(=O)N[C@@H](C(=O)[O-])CC=O;6.8200002;Serine/threonine-protein kinase haspin;66M
5htb;Nc1ncnc(c12)n(cn2)[C@H]3[C@H](O)[C@H](O)[C@H](O3)C(=O)NCCCCCC(=O)N[C@H](CC=O)C(=O)N;6.77;Serine/threonine-protein kinase haspin;6L5
1oky;c1cccc(c1n2[C@]34C)c5c2c6n([C@H](O4)C[C@@H]([NH2+]C)[C@H]3OC)c7c(cccc7)c6c8c5C=NC8=O;8.1899996;3-PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1;STU
1okz;c1cccc2c1c3c([C@@H](O)NC4=O)c4c(c5c3n2[C@@]67C)c8c(cccc8)n5[C@H](O6)C[C@@H]([NH2+]C)[C@H]7OC;8.3000002;3-PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1;UCN
5jzn;c1cccc(S(=O)(=O)C(C)C)c1Nc(c2Cl)nc(nc2)Nc3ccc(cc3OC)N4CCC(CC4)[N@@H+]5CC[N@@H+](C)CC5;5.96;Serine/threonine-protein kinase DCLK1;GUI
4w9x;c1c[nH]c(c12)ncnc2-c(cn3)cn3C4(CC#N)CN(C4)S(=O)(=O)CC;7.4000001;BMP-2-inducible protein kinase;3JW
1y57;C1C[N@@H+](C)CC[N@@H+]1Cc(cc2)ccc2C(=O)Nc3cccc(c3)Nc4nccc(n4)-c5cccnc5;5.79;Proto-oncogene tyrosine-protein kinase Src;MPZ
4olh;Nc1ccc(cn1)S(=O)(=O)N2CCN(CC2)c3ncc(C(C(F)(F)F)(C(F)(F)F)O)cc3-c4cccnc4;8.3000002;Glucokinase Regulatory Protein;2TO
2w7x;O=N(=O)c1cccc(c12)cc([nH]2)C(=O)Nc3ccc(cc3)/C(C)=N/[NH+]=C(N)N;7.6199999;SERINE/THREONINE-PROTEIN KINASE CHK2;D1A
3u9c;Oc(c1)ccc(c12)Nc3c(O2)cc(O)cc3;5.8899999;Casein kinase II subunit alpha;04G
5k4i;n1ccc(n1C)Nc2nccc(n2)C3=CCN(C(=O)C3)[C@H](CO)c(cc4F)ccc4Cl;8.5100002;Mitogen-activated protein kinase 1;6QB
5k4j;n1ccc(n1C)Nc2nccc(n2)C3=CCN(C(=O)C3)[C@H](CO)c(cc4F)ccc4Cl;7.1100001;Cyclin-dependent kinase 2;6QB
5f9e;c1ccccc1CN(C(C)(C)NC2=O)c(c23)cc(cc3)-n4c(=O)[nH]c(c45)nccc5;9.3400002;Protein kinase C theta type;5VS
3u9n;C1C[NH2+]CCN1c2ccccc2NC(=O)c3nc(sc3)-c(cc4)cc(c45)cco5;7;Serine/threonine-protein kinase Chk1;09H
4btm;COC(=O)c1cc(ccc1Br)Nc2ncnc(c23)[nH]cc3;5.3899999;TAU-TUBULIN KINASE 1;F8E
5f94;C1=CC1C(=O)Nc(ncc2)cc2C(=O)Nc3cnccc3OC;8.4700003;Glycogen synthase kinase-3 beta;3UO
5f95;C1=CC1C(=O)Nc(ncc2)cc2C(=O)Nc3cnccc3-c4ccccc4;8.0100002;Glycogen synthase kinase-3 beta;3UP
3at3;O=C([O-])Cc(cc1)cn1-c(cnc2)nc2-n3ncc(c34)ccc(c4)NC5CCCC5;8.04;Casein kinase II subunit alpha;ATK
4z3v;c1n[nH]c(c12)cc(c(C)c2)-c(ccc3)c(c34)nnc(c4N)C(=O)N;8.3199997;Tyrosine-protein kinase BTK;4L6
4k0y;Fc1ccc(cc1)NC(=O)c(cn2)c(n23)nc(cc3O)C4CC[NH2+]CC4;7.8200002;Serine/threonine-protein kinase pim-1;1OA
3vw6;c1nccn1C(=C2)C=CC(N23)NC(=C3)NC(=O)c4ccc(C(C)(C)C)cc4;7.8499999;Mitogen-activated protein kinase kinase kinase 5;IM6
2vwu;C1CCCC[NH+]1CCCOc(c(c2)OC)cc(c23)ncnc3Nc4c(Cl)ccc(c45)OCO5;6.4559321;EPHRIN TYPE-B RECEPTOR 4;7X1
2vww;COc1c(OC)cc(cc1OC)Nc2nccc(n2)Nc3c(Cl)ccc(c34)OCO4;6.6197891;EPHRIN TYPE-B RECEPTOR 4;7X2
2vwv;COc1ccc(cc1Cl)Nc2ncnc(n2)Nc3cc(OC)c(OC)c(c3)OC;4.7958798;EPHRIN TYPE-B RECEPTOR 4;7X3
4i6h;C1CCCC1N([C@H](CC)C(=O)N2C)c(c23)nc(nc3)-n4ccnc4-c5cscn5;8.3000002;Serine/threonine-protein kinase PLK2;1C8
4i6f;C1C=CCC1N([C@H](CC)C(=O)N2C)c(c23)nc(nc3)-n4ccnc4-c5ccccc5;8.3000002;Serine/threonine-protein kinase PLK2;1C7
4i6b;c1ncnc(c12)N([C@H](CC)C(=O)N2C)C3CCCC3;5.9299998;Serine/threonine-protein kinase PLK2;11G
3du8;FCC[C@H]1CNC(=O)c(c12)cc([nH]2)-c3ccnc(n3)N;6.8356471;Glycogen synthase kinase-3 beta;553
5eob;c1ccnc(c12)ccc(c2)C(F)(F)c(nn3)n(c34)nc(cn4)-c(cc5)ccc5F;9.6199999;Hepatocyte growth factor receptor;5QQ
5eom;c1cc(=N/[H])\[nH]c(=O)n1[C@H]2[C@H](O)[C@H](O)[C@H](O2)COP([O-])(O)OP([O-])(O)OP([O-])(O)O;6.3899999;Protein mab-21-like 1;CTP
5eol;O=C1NC[C@@H](c2c13)C/C=C\[C@@H](C)Nc4nc5c(c(c3)[nH]2)cccc5nc4C;9.5200005;Serine/threonine-protein kinase pim-1;5QO
3a2c;C1[NH2+]CCC[C@@H]1Nc(n2)c(C)c(n(c23)ncc3)Nc4ccc(cc4)OCC;6.9000001;MAP kinase-activated protein kinase 2;PDY
5dwr;C[C@@H]1C[C@H]([NH3+])C[C@@H](C1)c2ccncc2NC(=O)c3ccc(F)c(n3)-c4c(F)cccc4F;11.22;Serine/threonine-protein kinase pim-1;5H7
4wsy;c1cccc(c12)ncc(c2)-c3[nH]nc(c34)ccc(c4)-c5sc(N)nc5;7.77;Serine/threonine-protein kinase pim-1;3U5
3zbf;Clc1ccc(F)c(Cl)c1[C@@H](C)Oc2cc(cnc2N)-c3cnn(c3)C4CC[NH2+]CC4;7.52;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS;VGH
3srv;Cc1ccc(cc1)Nc2nc(ncc2C(=O)N)N[C@@H]3CCOC[C@@H]3[NH3+];7.5;Tyrosine-protein kinase SYK;S19
3zbx;c1ccnc(c12)ccc(c2)Cc3nnc(n34)ncc(n4)-c(cc5)ccc5F;8.2200003;HEPATOCYTE GROWTH FACTOR RECEPTOR;6XE
5b0x;c1cc(C(=O)[O-])ccc1-c2cnc(s2)NC(=O)c3ccc(cc3)OC;7.6999998;Casein kinase II subunit alpha;HCK
4jia;COc1ccc(cc1)C2=CC=CC(N23)NC(=N3)Nc4ccc(cc4)N5CC[NH+](C)CC5;9.2200003;Tyrosine-protein kinase JAK2;1K3
4jik;c1cc(Cl)ccc1-c(c2)nc(n23)c(cnc3C(=O)N)N[C@@H]4C[NH2+]CCC4;7.7399998;Serine/threonine-protein kinase Chk1;1KO
4acc;C[NH+](C)CCNS(=O)(=O)c1ccc(cc1)-c2cnc(N)c(n2)C(=O)Nc3cccnc3;7.6999998;GLYCOGEN SYNTHASE KINASE-3 BETA;7YG
4e5w;CC(C)[N@@H+]1CCC[C@H]1C(=O)N2CCC(CC2)n(cn3)c(c34)c5c(nc4)[nH]cc5;7.6599998;Tyrosine-protein kinase JAK1;0NT
1ejn;C1[C@@H](C2)C[C@@H](C3)C[C@H]1CC23NC(=O)NCc4ccc(cc4)[NH+]=C(N)N;5.6199999;UROKINASE-TYPE PLASMINOGEN ACTIVATOR;AGB
4ps3;CCCn1cc(nc1)CCNC(=O)Nc(n2)sc(c23)cc(cc3)-c4cc(OC)cnc4;8.6999998;Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;2WH
2xj1;[NH3+][C@@H]1CC[C@H](CC1)Nc2nc(cnc2)-c3cc(ccc3)/C=C/C(=O)[O-];7.5500002;PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE PIM-1;XJ1
4ps7;CC(=O)Nc(n1)sc(c12)cc(cc2)-c3cccnc3;7.4099998;Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;2WJ
4ps8;CC(=O)Nc(n1)sc(c12)cc(cc2)-c3cc(OC)c(nc3)OC;9;Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;2WK
2o0u;C1CCCC[NH+]1CCC(=O)N(CC2)Cc(c23)sc(c3C#N)NC(=O)c4cccc(c45)cccc5;5.4899998;Mitogen-activated protein kinase 10;C0M
3wig;n1cccnc1Oc(c2)ccc(c23)c(C)c(c(o3)=O)Cc(c4F)ccnc4NS(=O)(=O)NC;8.6400003;Dual specificity mitogen-activated protein kinase kinase 1;CHU
4rio;c1ccc(n12)c(c(cn2)C(=O)N)N[C@@H]([C@]3(F)C)CCC3;9;Tyrosine-protein kinase JAK3;3QX
3wi6;C1[NH2+]CCC[C@@H]1Nc2nc(ccn3)n3c(c24)[nH]cc4;5.3299999;MAP kinase-activated protein kinase 2;YRZ
4xcu;CCC(=O)Nc1cccc(C)c1Nc(nc2)nc(c23)ccc(c3)-c4c(Cl)c(OC)cc(c4Cl)OC;8.2200003;Fibroblast growth factor receptor 4;40M
5hvy;CNc(n1)nccc1N(CC2)C[C@H]2NC(=O)Nc3ccc(c(c3)C(F)(F)F)C[NH+]4CCOCC4;7.7600002;Cyclin-dependent kinase 8;66X
3nuu;c1cccc(c12)C(=O)NCC2;3.77;PkB-like;JOZ
3nus;c1cccc(c12)n[nH]c2N;3.51;phosphoinositide-dependent kinase-1;JNZ
3nuy;c1cccc(c12)nc[nH]c2=O;3.46;PkB-like;JPZ
3v01;OC[C@@H](O)CONC(=O)c(oc(c12)ccnc1)c2Nc3ccc(I)cc3F;7.5999999;Dual specificity mitogen-activated protein kinase kinase 1;3V0
1b55;OP([O-])(O)O[C@@H]1[C@H](O)[C@H](OP([O-])([O-])O)[C@@H](OP([O-])(O)O)[C@@H]([C@H]1O)OP([O-])([O-])O;7.4000001;TYROSINE-PROTEIN KINASE BTK;4IP
3v04;OCCONC(=O)c(ccc(c12)n[nH]c2)c1Nc3ccc(I)cc3F;7.8899999;Dual specificity mitogen-activated protein kinase kinase 1;V04
3nc9;C1C[NH2+]CCC1C(=O)Nc(cc2)cc(c23)n(nc3SC)-c4ccccc4;6.48;Ketohexokinase;TR3
5hln;[nH]1c(C)cnc1-c2c(-c(cc3)c(Cl)cc3Cl)nc(nc2)NCCNc4ccc(cn4)C#N;11.52;Glycogen synthase kinase-3 beta;65C
3fi2;c1ccccc1N[C@H](O)[NH2+][C@H](C[NH2+]2)CN2c(c3)cccc3C(=O)Nc4cc(OC)c(OC)c(c4)OC;7.5999999;Mitogen-activated protein kinase 10;JK1
2yix;CCNC(=O)NCc1ccccc1Sc(cc2)cn(c23)c(nn3)C(C)C;8.4799995;MITOGEN-ACTIVATED PROTEIN KINASE 14;YIX
2yiq;[nH]1ccc(c12)ccc(c2)NC(=O)c(c3)[nH]c(c34)ccc(c4)/C(C)=N/[NH+]=C(N)N;7.9000001;SERINE/THREONINE-PROTEIN KINASE CHK2;YIQ
2yir;c1ccc(N(=O)=O)c(c12)[nH]c(c2)C(=O)Nc(c3)ccc(c34)c(ccc4)/N=[NH+]/C(=[NH2+])N;9.7700005;SERINE/THREONINE-PROTEIN KINASE CHK2;YIR
2yis;Clc(c1)c(O)ccc1-n(n2)c(cc2C(C)(C)C)NC(=O)NCc3ccccc3Sc(cc4)cn(c45)c(nn5)-c6ccccc6SCCO;8.7700005;MITOGEN-ACTIVATED PROTEIN KINASE 14;YIS
2yiw;CC(C)c(nn1)n(c12)cc(cc2)Sc3ccccc3CNC(=O)Nc4cc(C(C)(C)C)nn4-c5ccccc5;9.1000004;MITOGEN-ACTIVATED PROTEIN KINASE 14;YIW
3vry;C1CCCC1n2cc(c(c23)c(N)ncn3)-c4ccc(cc4)Oc5ccccc5;8.1099997;Tyrosine-protein kinase HCK;B43
5d1j;C1C[NH2+]CCC1C(=O)Nc2sc(cn2)SCc3oc(cn3)C(C)(C)C;7.3200002;Cyclin-dependent kinase 2;56H
2p2h;COc1c(OC)cc(cc1OC)Nc2nc(ncn2)-c3cccnc3Nc4ccccc4;7.1700001;Vascular endothelial growth factor receptor 2;994
2p2i;c1ccccc1Oc(cc2)ccc2NC(=O)c3cccnc3NCc4ccncc4;7.4200001;Vascular endothelial growth factor receptor 2;608
4z16;C1C[NH+](C)CCN1c(cc2)cc(OC)c2Nc3nc(c(Cl)cn3)NCc(ccc4)cc4NC(=O)CC;7.8499999;Tyrosine-protein kinase JAK3;4LH
3pj3;c1ccccc1-c(n2)[nH]c(c23)cc(cn3)NC(=O)c4cc(ccc4C)NC(=O)/C=C/c5ccccc5;5.25;Tyrosine-protein kinase BTK;04L
4i4e;CN1S(=O)(=O)c(cn[nH]2)c2c(c13)cc(cc3)-c4ccc(cc4)C(=O)N5CCC(CC5)CCO;6.3000002;Focal adhesion kinase 1;1BQ
4i4f;Cn1ncc(S(=O)(=O)N2C)c1c(c23)cc(cc3)NCc4ccc(cc4)C(C)(C)C;6.1900001;Focal adhesion kinase 1;1BR
4b2d;OC[C@H]([NH3+])C(=O)[O-];3.7;PYRUVATE KINASE ISOZYMES M1/M2;SER
4otf;C1CCCc(c12)sc(c2)C(=O)Nc3cccc(c3C)-c4cn(C)c(=O)c(n4)Nc5ccc(cc5)[C@@H]6C(=O)N(C)CC[N@H+]6C;8.2200003;Tyrosine-protein kinase BTK;2VL
4zji;C1C[NH+](C)CCN1C(c2c(N3CC)ccc(Cl)c2)=Nc(c34)cc(F)cc4;6.4699998;Serine/threonine-protein kinase PAK 1;4OQ
4zjj;c1cc(F)cc(c12)N=C(c3c(N2CC)ccc(Cl)c3)N[C@@H]4CN(CC4)C(=O)NC(C)(C)C;8;Serine/threonine-protein kinase PAK 1;4OR
4fny;COc(c1)c(OC)cc(c12)nccc2Oc(cc3)cc(c34)nc(o4)Nc5ccc(Cl)cc5;7.8000002;ALK tyrosine kinase receptor;I3K
4fnz;COc1c(OC)cc(cc1OC)Nc2nc(ccn2)N3C[C@H](CCC3)C(=O)NCc4cc(OC(F)(F)F)ccc4;7.8000002;ALK tyrosine kinase receptor;NZF
4ztr;CCc1ccc(cc1)/N=C2\SC(C(=O)N2C)Cc3cc(ncc3)Nc4ccc(cn4)C(=O)[O-];8.3000002;Aurora kinase A;4RJ
5em8;C[NH+]1CCN(CC1)c(cc2)ccc2NC(=O)c3c(cc[nH]c3=O)Nc4ccccc4OC;5.96;Epidermal growth factor receptor;5Q4
5em5;C[NH+]1CCN(CC1)c(cc2)ccc2NC(=O)c3c(cc[nH]c3=O)NCCc4ccc(Cl)cc4;6.5799999;Epidermal growth factor receptor;5Q2
5em7;C[NH+]1CCN(CC1)c(cc2)ccc2NC(=O)c3c(cc[nH]c3=O)Nc4ccccc4OC;7.7199998;Epidermal growth factor receptor;5Q4
5em6;C[NH+]1CCN(CC1)c(cc2)ccc2NC(=O)c3c(cc[nH]c3=O)Nc4ccnc(n4)N;8.3999996;Epidermal growth factor receptor;5Q3
4zts;CCc1ccc(cc1)/N=C2\SC(C(=O)N2C)Cc3cc(ncc3)Nc4ccc(cc4)-c5n[nH]nn5;7.5999999;Aurora kinase A;4RK
2xj0;O=C([O-])/C=C/c1cnc(N)nc1;2.8199999;PROTO-ONCOGENE SERINE/THREONINE PROTEIN KINASE PIM-1;XJ0
2xj2;O=C([O-])\C=C\c(c1)cccc1-c2nc(cnc2)N3CC[N@@H+](C)CCC3;7.1799998;PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE PIM-1;985
3a4p;CNC(=O)/C=C/c(c1)cnc(c12)ccc(c2)O[C@H](C)c3c(Cl)c(F)ccc3Cl;7.5500002;Hepatocyte growth factor receptor;DFQ
3rtp;c1cccc(c12)CCC(=O)N2CC(=O)Nc3scc(C#N)c3-c4[nH]ncn4;8.1499996;Mitogen-activated protein kinase 10;34I
3a4o;CO[C@@H]1[C@H]([NH2+]C)C[C@@H](O2)n3c(cccc4)c4c(c3c5n6[C@]12C)c7c(CNC7=O)c5c8c6cccc8;8.8860569;Tyrosine-protein kinase Lyn;STU
4gu9;c1cccc(F)c1Nc2ncnc(c23)[nH]nc3;4.3699999;Focal adhesion kinase 1;4GU
3prf;Clc1ccc(cc1O)Nc(c(c23)ccnc2)c(o3)-c4ncccn4;8.8500004;Serine/threonine-protein kinase B-raf;FP3
4gu6;c1ccccc1-c(c2)[nH]c(c23)ncc(C#N)c3NCc4cccnc4N(C)S(=O)(=O)C;7.3600001;Focal adhesion kinase 1;10N
1wcc;Nc1cncc(Cl)n1;3.46;CELL DIVISION PROTEIN KINASE 2;CIG
3cst;c1c(O)ccc([NH+]23)c1c(c4c(C(=O)N(C)C4=O)c5C=C(F)C6)c2c5N6[RuH]3789([CH2]=O)[CH]=1[CH2]9[CH]8=[CH]7C1C(=O)NC(C)(CO)CO;7.408936;Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;E52
4nct;c1cccc2c1c3c(CNC4=O)c4c(c5c3n2[C@]67C)c8c(cccc8)n5[C@H](O7)C[C@H]([C@H]6OC)N(C)C(=O)c9ccccc9;7.5500002;Dual specificity tyrosine-phosphorylation-regulated kinase 1A;2K2
4m0y;c1cccc(c12)cccc2-n3cc(c(n3)C(=O)N)NC(=O)N;6.46;Tyrosine-protein kinase ITK/TSK;M0Y
4joa;Fc1cc(c(F)cc1)Cn2cc(cn2)-c(c[nH]3)c(c34)cc(cn4)-c5cn(C)nc5;7.54;ALK tyrosine kinase receptor;3DK
5cxh;COc1ccc(cc1OC)-c(cc(c23)ncs3)nc2O[C@H](C)[C@@H](CN4)CC4=O;8.3000002;Tyrosine-protein kinase SYK;55M
5m55;c1ccccc1Nc(n2)nc(c(c23)[nH]cn3)/C=C\N(CC)CC;6.6199999;Serine/threonine-protein kinase Nek2;7GG
5cxz;CN(C)c1ccc(cc1)-c(cc(c23)nccc2)nc3NCCC[NH3+];6.2600002;Tyrosine-protein kinase SYK;55U
5m51;O=C(N)c1cccc(c1)Nc(n2)nc(c(c23)[nH]cn3)OCC4CCCCC4;4.7199998;Serine/threonine-protein kinase Nek2;NU6
5m53;C1CCCCC1COc(c(c23)[nH]cn3)nc(n2)Nc4cc(ccc4)C(=O)N(C)C;6.21;Serine/threonine-protein kinase Nek2;7GJ
2o63;Oc1cc(O)cc(c12)oc(c(c2=O)O)-c3cc(O)c(O)c(c3)O;6.1100001;Proto-oncogene serine/threonine-protein kinase Pim-1;MYC
2o65;c1c(O)c(O)c(O)cc1-c(cc2=O)oc(c23)cc(O)cc3O;6.1900001;Proto-oncogene serine/threonine-protein kinase Pim-1;MYF
2o64;C1=CC(=O)[C@H](O)C=C1c(c(c2=O)O)oc(c23)cc(O)c(O)c3O;6.4699998;Proto-oncogene serine/threonine-protein kinase Pim-1;MYU
3kc3;c1cccc(c12)oc(c2)-c(c(c34)[nH]nc4)cc(c3)Nc5ccnc(n5)N;6.8000002;MAP kinase-activated protein kinase 2;MK2
4b0g;Cc1cc(no1)C[NH+]2CCN(CC2)c(c(Br)cn3)c(c34)nc([nH]4)-c5cncn5C;7.8200002;AURORA KINASE A;VEK
1z5m;O=C(N)C(C)(C)C(=O)NCCCNc(c1Br)nc(nc1)Nc2cc(ccc2)NC(=O)N3CCCC3;7.52;3-phosphoinositide dependent protein kinase-1;LI8
2xh5;[nH]1ccc(c12)c(ncn2)N(CC3)CCC3([NH3+])Cc4ccc(cc4)C(C)(C)C;7.5700002;RAC-BETA SERINE/THREONINE-PROTEIN KINASE;X37
3kck;Clc1cc(O)ccc1-c(nc2c3cccc2)c4cnc(c4c35)[nH]cc5;9.0969105;Tyrosine-protein kinase JAK2;3KC
5kx8;c1n(C)nc(C(=O)N)c1NC(=O)c(cn2)c(n23)nc(cc3)N4CC[NH2+]CC4;7.4200001;Interleukin-1 receptor-associated kinase 4;6YE
5kx7;NC(=O)c1nn(C)cc1NC(=O)c2nc(ccc2)-c3cnn(c3)C;7.4400001;Interleukin-1 receptor-associated kinase 4;6YD
3nw6;C1CC1c([nH]n2)cc2Nc(c(n34)ccc3)nc(n4)[C@H]5N(CCC5)C(=O)c6ccc(F)nc6;8.1499996;Insulin-like growth factor 1 receptor;LGW
3nw7;C1CC1c2cc([nH]n2)Nc3nc(nn(c34)ccc4)CNC(=O)c5ccc(F)nc5;8.2799997;Insulin-like growth factor 1 receptor;LGV
3nw5;C1=CC1c([nH]n2)cc2Nc(c(n34)ccc3)nc(n4)[C@@H]5N(CCC5)C(=O)c6ccc(F)nc6;5.0799999;Insulin-like growth factor 1 receptor;LGX
4izy;C1C[C@H](O)CC[C@H]1Nc2nccc(n2)-n(cc3)c(c34)cccc4N5CCC(CC5)S(=O)(=O)C;8.5200005;Mitogen-activated protein kinase 8;1J2
3nww;CC(C)Nc(s1)ncc1-c2cc(nc(n2)NCC[NH+](C)C)-c3c(cccc3)CNC(=O)NCC;8.1499996;Mitogen-activated protein kinase 14;3NW
4aze;c1ccccc1NC2=NC(=O)C(=N2)Cc(c3)ccc(c34)OCO4;8.1099997;DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE 1A;3RA
3f2a;O=C([O-])\C=C\c(c1)cccc1-c2nc(cnc2)N3CC[N@@H+](C)CCC3;7.2441254;Proto-oncogene serine/threonine-protein kinase Pim-1;985
3mbl;Ic1cc(F)c(cc1)Nc2n(C)c(C(=O)C)cc2C(=O)NOCCO;7.7399998;Dual specificity mitogen-activated protein kinase kinase 1;LSG
1b39;OP([O-])(O)OP([O-])(O)OP([O-])(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n(cn2)c(c23)ncnc3N;6.9200001;PROTEIN (CELL DIVISION PROTEIN KINASE 2);ATP
3mb6;O=C([O-])c(c1)oc(c12)cc3c(c2)ccc4c3cc(o4)C([O-])=O;7;Casein kinase II subunit alpha;01I
4eok;NS(=O)(=O)c1ccc(cc1)Nc(nc(c23)[nH]cn3)nc2OCC4CCCCC4;5.0700002;Cyclin-dependent kinase 2;4SP
4bhn;c1n[nH]cc1-c(c2)ccc(n23)nc(c3)NC(=O)c4ccc(cc4)C(C)(C)C;8.1999998;MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5;BH9
2c5x;n1cncn1Cc2cc(ccc2)-c3nc(ncc3)Nc4cc(N(=O)=O)ccc4;6.5999999;CELL DIVISION PROTEIN KINASE 2;MTW
2c5y;n1cncn1Cc2cc(ccc2)-c3nc(ncc3)Nc4cc(N(=O)=O)ccc4;6.5999999;CELL DIVISION PROTEIN KINASE 2;MTW
2c5n;s1c(C)nc(C)c1-c(n2)ccnc2Nc3ccc(cc3)N(C)C;6.6599998;CELL DIVISION PROTEIN KINASE 2;CK8
2c5o;Cc1sc(c(n1)C)-c2nc(N)ncc2;5.1900001;CELL DIVISION PROTEIN KINASE 2;CK2
4z7h;c1cc(C(=O)N)c(OC)cc1-c(cn2)n(c23)nc(cc3)NC(C)C;6.6599998;Serine/threonine-protein kinase/endoribonuclease IRE1;4L5
4eop;s1cccc1CNC(=NC2=O)SC\2=C\c(cc3)cc(c34)cccn4;6.0500002;Cyclin-dependent kinase 2;1RO
4eor;NS(=O)(=O)c1ccc(cc1)Nc(nc(c23)[nH]cn3)nc2OCC4CCCCC4;6.3000002;Cyclin-dependent kinase 2;4SP
3gcs;c1cc(Cl)c(C(F)(F)F)cc1NC(=O)Nc2ccc(cc2)Oc(ccn3)cc3C(=O)NC;7.251812;Mitogen-activated protein kinase 14;BAX
2pe1;c1cc[nH]c1[C@H](C)[C@@H]2C(=O)Nc(c23)ccc(c3)NC(=O)N;8.3000002;3-phosphoinositide-dependent protein kinase 1;517
2pe0;c1cc(O)cc(c12)C(\C(=O)N2)=C(/C)c3ccc[nH]3;7.0999999;3-phosphoinositide-dependent protein kinase 1;39Z
2pe2;C1CCCC[NH+]1CCNC(=O)c2cc(ccc2)-c3cc([nH]c3)/C=C/4C(=O)Nc(c45)ccc(c5)NC(=O)N;8.3999996;3-phosphoinositide-dependent protein kinase 1;464
2in6;O=C([O-])CCn1c(ccc(O)c2)c2c(c13)c4c(C(=O)NC4=O)c(c3)-c5ccccc5;7.6399999;Wee1-like protein kinase;839
4fl2;OP([O-])(O)NP([O-])(O)OP([O-])(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n(cn2)c(c23)ncnc3N;3.6600001;Tyrosine-protein kinase SYK;ANP
4fl3;OP([O-])(O)NP([O-])(O)OP([O-])(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n(cn2)c(c23)ncnc3N;3.8199999;Tyrosine-protein kinase SYK;ANP
4fl1;OP([O-])(O)NP([O-])(O)OP([O-])(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n(cn2)c(c23)ncnc3N;3.28;Tyrosine-protein kinase SYK;ANP
4f9w;c1cnccc1-c(c2)c(nnc2N(C)C)-c(c3)ccc(c34)cccc4;6.9400001;Mitogen-activated protein kinase 14;LM4
4f9y;c1cnccc1-c(c2)c(nnc2N(C)C)-c3cccc(c34)cccc4;6.7399998;Mitogen-activated protein kinase 14;LM3
1jsv;Nc1ncnc(c1)Nc2ccc(cc2)S(=O)(=O)N;5.6999998;CELL DIVISION PROTEIN KINASE 2;U55
2j4z;c1ccsc1CC(=O)N(C2)Cc(c23)c(n[nH]3)NC(=O)c4ccc(cc4)N5CC[NH+](C)CC5;7.1900001;SERINE THREONINE-PROTEIN KINASE 6;626
4flh;COc1c(F)cc(cn1)Nc2ncc([C@@H](C)[NH+]3CCN(CC3)S(=O)(=O)C)cc2-c4nc(N)nc(n4)C;9;Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;14K
5fut;C1C=C(N(C)C)C=CN1Cc(cc2)ccc2CCCCc(cc3)ccc3CN4C=CC(=CC4)N5CCCC5;6.4499998;CHOLINE KINASE ALPHA;PQ7
3bv3;c1ccccc1[C@H](C)NC(=O)c(c2)c(C)c(n23)c(ncn3)Nc4c(C)ccc(c4)NC(=O)c5cc(ccc5)N6CCOCC6;9.3372421;Mitogen-activated protein kinase 14;P39
5eko;c1nc(C)cn1-c(c2)cccc2C(=O)Nc3ccc(cc3)Oc4ccncc4;4.8000002;Mitogen-activated protein kinase 13;N17
5ekn;Cn1nc(C(C)(C)C)cc1NC(=O)Nc2ccc(cc2)Sc3ccncc3;5.7199998;Mitogen-activated protein kinase 13;N58
4ckj;OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n(cn2)c(c23)ncnc3N;4.8400002;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET;ADN
4cki;OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n(cn2)c(c23)ncnc3N;5.96;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET;ADN
4ckr;CC[N@@H+]1CC[N@H+](CC1)Cc2ccc(cc2C(F)(F)F)C(=O)Nc3ccc(C)c(c3)Oc(cc4)cc(c45)CC(=O)N5;6.98;EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1;DI1
3rvg;C1[NH2+][N@@H+](C)C[C@@H]1[C@H](CC2)C[C@@H]([C@H]23)[NH2+][C@@H]4[C@@H]3[C@H]([NH2+]C[C@H]4C(=O)N)[NH2+]C5CCCCC5;8.3000002;Tyrosine-protein kinase JAK2;17P
3pp1;OC[C@H](O)CN(CN1)C(=O)C(C=12)=C(C(F)C(=O)N2C)Nc3ccc(I)cc3F;8.4899998;Dual specificity mitogen-activated protein kinase kinase 1;IZG
3pp0;OCCOCCn(cc1)c(c12)c(ncn2)Nc3cnc(c(Cl)c3)Oc4cccc(c4)C(F)(F)F;7.96;Receptor tyrosine-protein kinase erbB-2;03Q
3ppk;c1cncnc1NC(=O)c(o2)c(c(c23)ccnc3)Nc(cc4)cc(c45)cccc5O;8.8500004;Serine/threonine-protein kinase B-raf;FNI
3ppj;c1nccc(c12)c(c(o2)C(=O)OC)Nc(cc3)cc(c34)CCC\4=N/O;8.6999998;Serine/threonine-protein kinase B-raf;FOI
3gc7;Clc1cccc(Cl)c1N(C(=O)NC2)c(c23)cc([C@H]4CC[N@@H+](CC4)C(C)C)cc3-c5ccc(F)cc5Cl;9.2200003;Mitogen-activated protein kinase 14;B45
4eqc;s1cncc1-c(cc2Cl)ccc2-c(c3)c(=O)n(CC)c(c34)nc(nc4)Nc5ccc(cc5)N6CC[NH+](C)CC6;8.1000004;Serine/threonine-protein kinase PAK 1;XR1
4gw8;c1ccccc1NC2=NC(=O)C(=N2)Cc(c3)ccc(c34)OCO4;6.0599999;Serine/threonine-protein kinase pim-1;3RA
4p7e;O=S1(=O)CC[NH+](CC1)Cc2ccc(cc2)C(=CC=C3)N(C34)N=C(N4)NC(=O)C5CC5;4.7600002;Tyrosine-protein kinase JAK2;2HB
4wwn;[nH]1cnc(c12)ncnc2N[C@@H](C)c(c3)c(-c4ccccn4)nc(c35)cc(F)cc5;6.0700002;Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;3VC
4wwo;[nH]1cnc(c12)ncnc2N[C@@H](C)c(c3)c(nc(c34)c(Cl)ccc4)-c5cc(F)ccc5;7.4200001;Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;3VD
3pjc;c1cccc(c12)c(c[nH]2)C3=C(C(=O)NC3=O)c(c4C(F)(F)F)nc(nc4)N5CCC(=O)CC5;7.5700002;Tyrosine-protein kinase JAK3;PJC
4wwp;Cc1ncccc1-c(n2)c(cc(c23)cccc3Cl)[C@H](C)Nc4ncnc(c45)nc[nH]5;6.9200001;Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;3VE
3cqu;c1c[nH]c(c12)ncnc2Nc3ccccc3-c(n[nH]4)nc4C;6.821023;RAC-alpha serine/threonine-protein kinase;CQU
3cqw;[nH]1cc(Cl)c(c12)c(ncn2)N(CC3)Cc(c34)nc[nH]4;7.3767509;RAC-alpha serine/threonine-protein kinase;CQW
3psb;O[NH2+]C1CCc(c12)cc(cc2)Nc3c(C(=O)OCC)sc(c34)cncc4;8.5200005;B-RAF PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE;SM6
2xnm;FC(F)(F)c1ccccc1[C@@H](C)Oc2cc(sc2C(=O)N)-n(cn3)c(c34)cc(cc4)O[C@@H]5CC[N@H+](C)CC5;6.8000002;SERINE/THREONINE-PROTEIN KINASE NEK2;WGZ
2xnn;FC(F)(F)c1ccccc1[C@@H](C)Oc2cc(sc2C(=O)N)-n(cn3)c(c34)cccc4;4.3000002;SERINE/THREONINE-PROTEIN KINASE NEK2;430
2xno;C[N@H+]1CC[C@@H](CC1)Oc(cc2)cc(c23)n(cn3)C(C)SC(C(=O)N)COCc4ccccc4C(F)(F)F;5.9299998;SERINE/THREONINE-PROTEIN KINASE NEK2;ED8
2xnb;C1C[NH2+]CCN1c2ccc(cc2)Nc3nc(ccn3)-c4sc(=O)n(C)c4C;6.8299999;CELL DIVISION PROTEIN KINASE 2;Y8L
3r7q;c1cccc(c12)c3c(CO2)cc(s3)C(=O)N(C)c4ccccc4Cl;6.9699998;Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;FAV
2xne;c1ncccc1-c(cn(c23)c(Cl)cn3)nc2Nc(cc4)ccc4N5CCOCC5;6.7199998;SERINE/THREONINE-PROTEIN KINASE 6;ASH
2xng;O=S(=O)(C)NCc(ccc1)cc1[C@@H](C[NH+](C23)C(Cl)C[NH2+]2)[NH2+]C3NC4=CCC(C=C4)[NH+]5CCOCC5;7.2199998;SERINE/THREONINE-PROTEIN KINASE 6;A0H
2xnp;FC(F)(F)c1ccccc1[C@@H](C)Oc2cc(ccc2C(=O)N)-n3cnc(c34)cc(cc4)O[C@@H]5CC[N@H+](C)CC5;6.4400001;SERINE/THREONINE-PROTEIN KINASE NEK2;WCX
5kz0;CN(C)C(=O)c1ccc(F)cc1[C@@H](C)Oc(c(N)nc2)cc2-c3cn(C)nc3C;7.6599998;ALK tyrosine kinase receptor;6YL
2x39;[nH]1ccc(c12)c(ncn2)N(CC3)CCC3([NH3+])C(=O)NCc4ccc(Cl)cc4;8.6599998;RAC-BETA SERINE/THREONINE-PROTEIN KINASE;X39
5ipj;O=C1N[C@H](C)c(c12)[nH]c(c2)-c(ccc3)c(c34)[nH]c(\n(c4=O)C)=[NH+]/C(C)(C)C;8.8900003;Serine/threonine-protein kinase pim-1;6CD
5kzi;Fc1cccc(F)c1-c(n2)ccc(n23)cnc3Nc4cnccc4N5C[C@@H]([NH3+])CCC5;10;Serine/threonine-protein kinase pim-1;6YN
4eh9;c1ccc(=O)n(c12)C[C@@H]3CN(C[C@H]2C3)C(=O)c4ccc(C(F)(F)F)cc4;2.26;Mitogen-activated protein kinase 14;0OQ
2bak;C1CCC[NH+]1CCOc(c(c2)OC)cc(c23)c(ncn3)Nc4cc(ccc4C)NC(=O)c5ccnc(c5)N6CCOCC6;7.4299998;Mitogen-activated protein kinase 14;AQZ
2baj;c1ccc(Cl)c(Cl)c1NC(=O)Nc2cc(C(C)(C)C)nn2-c3ccccc3;8.3999996;Mitogen-activated protein kinase 14;1PP
2bal;c1cc(F)ccc1-n2ncc(c2N)C(=O)c3cccc(c3)OC4CC[NH2+]CC4;6.3099999;Mitogen-activated protein kinase 14;PQA
3q92;CSc1ccccc1Nc(nc(n2)N3CC[NH2+]CC3)c(c24)ncnc4NCC5CC5;7.9200001;Ketohexokinase;XNB
2hk5;Oc1ccc(C)c(c1)Nc2nc(nc(c2)NCC[NH+](CC)CC)-n3cnc(c34)cccc4;7.3400002;Tyrosine-protein kinase HCK;1BM
4obp;Nc1ncnc(c12)ccc(n2)-c3ccnc(F)c3;7.77;Mitogen-activated protein kinase kinase kinase kinase 4;2QU
4axa;c1cc(Cl)ccc1[C@](O)(C[NH3+])c2ccc(cc2)-c3cn[nH]c3;8;CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;RKD
4l8m;c1ccccc1C(=O)Nc(c2)c(F)ccc2Nc(cc3)cc(OC4)c3C(=O)c(c45)cc(cc5)OCC[NH+]6CCOCC6;9;Mitogen-activated protein kinase 14;F46
4obo;Clc(c1)cccc1-c(cc2)cc(c23)c(N)ncn3;7.1100001;Mitogen-activated protein kinase kinase kinase kinase 4;2QV
5f20;Cc1ccccc1-n(c(=O)c(c23)c(N)n[nH]3)cc2-c4ccn(n4)C;7.52;Non-receptor tyrosine-protein kinase TYK2;5U4
5jt2;CCCS(=O)(=O)Nc(c1F)ccc(F)c1C(=O)c(c[nH]2)c(c23)cc(cn3)-c4ccc(cc4)CNC(=O)COCC(=O)NCc(cc5)ccc5-c(c6)cnc(c67)[nH]cc7C(=O)c(c8F)c(F)ccc8NS(=O)(=O)CCC;7.4699998;Serine/threonine-protein kinase B-raf;6NC
2r4b;Fc1cccc(c1)COc2ccc(cc2Cl)Nc(ncn3)c(c34)sc(c4)C=C;7.1804562;Receptor tyrosine-protein kinase erbB-4;GW7
2yex;[nH]1cccc1-c(cc2)cc(c23)N4C(C=C3C)NNC4=O;10;SERINE/THREONINE-PROTEIN KINASE CHK1;YEX
3vap;C1=CNCC(F)=C1NC(=O)Cn(c2)ncc2C(=CN3)N(C3=4)C=C(C)NC4Nc(sn5)cc5C[N@@H+](C6)CCC[C@H]6C;8.3999996;Aurora kinase A;0FY
5amn;COc(c1)c(OC)cc(c12)c(ncn2)Nc3cc(O)ccc3;8.3500004;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET;DTQ
3qqk;C=CCNc1nc(N)c(s1)C(=O)c2ccccc2;4.8200002;Cyclin-dependent kinase 2;X02
4x7q;Fc1cccc(F)c1-c(n2)scc2C(=O)Nc3cnccc3O[C@@H]4C[NH2+]CC4;7.8499999;Serine/threonine-protein kinase pim-2;3YR
4x7n;c1cc(C)nc(c12)ccc(c2)-c3c(N)c(ccc3C)C(=O)c4c(=O)n(-c5ccccc5)n(C)c4-c6ccccc6;8.2200003;Eukaryotic translation initiation factor 2-alpha kinase 3,Eukaryotic translation initiation factor 2-alpha kinase 3;3Z5
4x7h;COc(c1)c(OC)cc(c12)c(ccn2)Oc(cn3)ccc3NC(=O)c(c4=O)c(-c5ccncc5)n(C)n4-c6ccccc6;7.3800001;Eukaryotic translation initiation factor 2-alpha kinase 3,Eukaryotic translation initiation factor 2-alpha kinase 3;3Z2
4x7k;c1ccccc1C2=[N+](C)N(c3ccccc3)C(=O)[C@@H]2C(=O)c4c(N)c(c(C)cc4)-c(cc5)c(F)c(c56)cnc(n6)NC;8.3999996;Eukaryotic translation initiation factor 2-alpha kinase 3,Eukaryotic translation initiation factor 2-alpha kinase 3;3Z3
4x7j;CNc(nc1)nc(c12)ccc(c2)-c3c(N)c(ccc3C)C(=O)Nc4cc(C(F)(F)F)c(cc4)OC;7.3899999;Eukaryotic translation initiation factor 2-alpha kinase 3,Eukaryotic translation initiation factor 2-alpha kinase 3;3Z1
1y91;[NH3+][C@H]1CC[C@@H](CC1)NC(N=2)=CC(N(C23)NC=C3C(C)C)Nc4ccc(cc4)S(=O)(=O)N(C)C;7.23;Cell division protein kinase 2;CT9
4f7n;OCCCCCNC(=O)Nc1n(nc(c1)C(C)(C)C)-c2ccc(C)cc2;7.0999999;Cyclin-dependent kinase 8;0SV
4f7l;CC(C)(C)OC(=O)NCCCNC(=O)Nc1cc(C(C)(C)C)nn1-c2ccc(C)cc2;8;Cyclin-dependent kinase 8;0SO
4f7j;OCCNC(=O)Nc1cc(C(C)(C)C)nn1-c2ccc(C)cc2;5.2399998;Cyclin-dependent kinase 8;0SU
3r01;O=C([O-])c(c1)oc(c12)c(OC)cc(Br)c2;5.2399998;Proto-oncogene serine/threonine-protein kinase pim-1;UNE
3r00;O=C([O-])c(c1)oc(c12)ccc(Br)c2;5.0700002;Proto-oncogene serine/threonine-protein kinase pim-1;UNJ
4tpt;OC[C@@H](O)c(cc1)ccc1CN(C)C(=O)c2ccc(cc2)S(=O)(=O)Nc3ccccc3;7.04;LIM domain kinase 2;35H
3s4q;c1ccccc1C(=O)c(c2)c(C)c(n23)c(ncn3)Nc4cc(ccc4C)C(=O)NC5C=C5;8.3999996;Mitogen-activated protein kinase 14;NK0
3cjf;COc(c1)c(OC)c(OC)cc1Nc2nccc(n2)Nc(c3)ccc(c34)c(C)[nH]n4;8.2006598;Vascular endothelial growth factor receptor 2;SAV
2j6m;CC[N@@H+]1CC[N@H+](CC1)Cc2ccc(cc2)-c(c3)[nH]c(c34)ncnc4N[C@H](C)c5ccccc5;7.962574;EPIDERMAL GROWTH FACTOR RECEPTOR;AEE
4i0s;c1c(Cl)ccc(c12)c(nn2C)-c(n3)cnc(c34)[nH]cc4C(=O)NC(C)C;7.4400001;Tyrosine-protein kinase SYK;1B5
4i0r;COc(c1)c(OC)c(OC)cc1-c(cn2)nc(c23)c(c[nH]3)C(=O)NC(C)C;7.8499999;Tyrosine-protein kinase SYK;1B4
4i0t;C1CCCc(n12)c(nc2)-c(n3)cnc(c34)[nH]cc4C(=O)NC(C)(C)C;7.5900002;Tyrosine-protein kinase SYK;1B6
3fdn;CC(=O)Nc1cc(ccc1)NC(=O)c2c(C)[nH]nc2/N=N/Cc3ccc(OC)cc3;7.4814858;Serine/threonine-protein kinase 6;MMH
3r0t;C1CC1Nc(n2)ncc(c23)c4c(cc(C(=O)[O-])cc4)nc3Nc5cccc(c5)C(F)(F)F;9.04;Casein kinase II subunit alpha;FU9
2c3i;C1CC1CNc(n2)ccc(n23)ncc3-c4cc(C(=O)C)ccc4;7.5999999;PIMTIDE;IYZ
2c3j;O=C1NCC/C(c(c12)cc[nH]2)=C3/N=C(N)NC3=O;6.1799998;SERINE/THREONINE-PROTEIN KINASE CHK1;DBQ
2c3k;COc1cc(ccc1O)-c(cc2)cc(c23)[nH]nc3-c([nH]4)nc(c45)cccc5;7.5900002;SERINE/THREONINE-PROTEIN KINASE CHK1;ABO
2c3l;c1cccc(c12)[nH]nc2-c(n3)[nH]c(c34)cccc4;5.0700002;SERINE/THREONINE-PROTEIN KINASE CHK1;IDZ
4nw5;Fc1cccc(OC)c1-c(ccc2)c(c23)oc(n3)Nc4cc(OC)c(OC)c(c4)OC;7.6999998;Ribosomal protein S6 kinase alpha-3;2NR
3apc;C1COCCN1c(n2)nc(c(c23)ccn3S(=O)(=O)C)-c4cnc(N)nc4;7.4400001;Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;MMD
4fjz;c1cc(F)cc(c12)nc(-c3ccccn3)c(C)c2N(C4)c(c5C46CCOCC6)cc(cn5)N7CCOCC7;6.29;Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;4FJ
4f70;C1COCC[NH+]1CCNC(=O)Nc2cc(C(C)(C)C)nn2-c3ccc(C)cc3;5.7399998;Cyclin-dependent kinase 8;0ST
5ei2;Cn(c1)ncc1-c(ncc2)c(c23)nc(nc3)Nc(c(c4)OC)ccc4OC;7.3400002;Dual specificity protein kinase TTK;5O7
5ei6;Cn(c1)ncc1-c(ccc2)c(c23)cc(nc3)Nc4ccc(OC)cc4OC;7;Dual specificity protein kinase TTK;5OQ
5ei8;Cn1cc(cn1)-c(ncc2)c(c23)nc(nc3)Nc4c(OC)cc(cc4)-c5cnn(C)c5;8.1000004;Dual specificity protein kinase TTK;5OE
4wa9;CNC(=O)c1ccccc1Sc(c2)ccc(c23)c(n[nH]3)/C=C/c4ncccc4;8.4200001;Tyrosine-protein kinase ABL1;AXI
3bx5;CNC(=O)c1ccc(C)c(c1)NC(=O)c2cnc(s2)N[C@H](C)CC;8.4559317;Mitogen-activated protein kinase 14;304
1yqj;c1ccccc1C[C@H]2CN(CC[NH2+]2)c3nnc(c(c3)-c4ccncc4)-c(c5)ccc(c56)cccc6;8.1400003;Mitogen-activated protein kinase 14;6NP
1gjc;c1cc(C(N)=[NH2+])cc(c12)[nH]c(n2)-c3cccc(c3O)-c4ccccc4;6.3499999;UROKINASE-TYPE PLASMINOGEN ACTIVATOR;130
2yit;c1cc(OC)cc(c12)cc([nH]2)C(=O)Nc3ccc(cc3)/C(CCC)=N/[NH+]=C(N)N;9.54;SERINE/THREONINE-PROTEIN KINASE CHK2;YIT
3jxw;C[NH+](C)Cc(n1)[nH]c(=O)c2sc(c3c12)ccc(c3)/C=C/C4CC4;9;Proto-oncogene serine/threonine-protein kinase Pim-1;LXG
4ewh;C[NH+](C)CCOc1ccc(cc1)-c([nH]2)c(-c3ccccc3)c(c24)c(ncn4)NCC5SCCS5;8.1499996;Activated CDC42 kinase 1;T77
3zxz;OCCn1cc(cn1)-c(n2)cnc(c23)nnn3Cc(c4)ccc(c45)nccc5;8.3999996;HEPATOCYTE GROWTH FACTOR RECEPTOR;KRW
4oys;C[C@@H]1COCC[N+]\1=C(\CC2=O)[NH+]=C(N23)N([C@H](C(F)(F)F)CC3)Cc4cc(Cl)cnc4;8.8199997;Phosphatidylinositol 3-kinase catalytic subunit type 3;1TT
3f9n;c1cccc(c12)c(=O)[n+](-c3cccc(Cl)c3)c([nH]2)S[C@@H](CCCC)C(=O)N(C4)CCC[C@@]45C[NH2+]CCC5;5.8860564;Serine/threonine-protein kinase Chk1;38M
2jld;c1c(O)ccc(n23)c1c(c4c(C(=O)NC4=O)c5C=C(F)C6)c2c5N6[RuH]3789(C=O)C=1[C@@H]9C8=C7C1C(=O)N[C@@H](C)C(=O)[O-];10.4;GLYCOGEN SYNTHASE KINASE-3 BETA;AG1
3c4c;CCCS(=O)(=O)Nc1c(F)c(c(F)cc1)C(=O)c2c[nH]c(c23)ncc(Cl)c3;6.7958798;B-Raf proto-oncogene serine/threonine-protein kinase;324
3myg;c1[nH]ncc1-c2cnc(n23)c(nc(c3)C)Nc4snc(c4)C[N@@H+](CC)C(C)(C)CO;10.7;Serine/threonine-protein kinase 6;EML
3zvv;Cc1cc(C)nc(n12)cc(n2)N;3.04;PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM;XAZ
3fhr;c1cccc(c12)ncc(c2)-c3cc(ccn3)-c(c4)[nH]c(c45)CCNC5=O;6.6777806;MAP kinase-activated protein kinase 3;P4O
4hyi;C1C[NH2+]CCN1c2ccccc2NC(=O)c3nc(sc3)-n(nc4)c(c45)cccc5;8.5200005;Serine/threonine-protein kinase Chk1;1AO
4hyh;C1C[NH2+]CCN1c2ccncc2NC(=O)c3nc(sc3)N(C4=O)Cc(c45)ccc(c5)OC;9;Serine/threonine-protein kinase Chk1;1AM
3eyg;N#CCC(=O)N(CC[C@H]1C)C[C@@H]1N(C)c2ncnc(c23)[nH]cc3;8.7958803;Tyrosine-protein kinase;MI1
3eyh;C1C=NC(=O)c2c(cc(F)cc3)c3c(c4c12)[nH]c(n4)C(C)(C)C;7.6989698;Tyrosine-protein kinase;IZA
4hys;C1C[C@H](O)CC[C@H]1Nc2nccc(n2)-n(nc3)c(c34)cccc4;7.2600002;Mitogen-activated protein kinase 8;1BJ
3my1;c1c(Cl)c(Cl)cc(c12)ncn2[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O;5.4499998;Cell division protein kinase 9;RFZ
4hyu;C1C[C@H](O)CC[C@H]1Nc2nccc(n2)-n3ncc(c34)c(ccc4)OCCCS(=O)(=O)C;8.21;Mitogen-activated protein kinase 8;1BK
3os3;OCCONC(=O)c1cc(C[NH2+]OCCO)c(F)c(F)c1Nc(c(F)c2)ccc2C#C;6.6300001;Dual specificity mitogen-activated protein kinase kinase 1;3OS
4o1l;O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1n(cc2C#C)c(c23)ncnc3N;6.6999998;Adenosine kinase;HO4
3uyt;Nc1nccc(n1)-c2n(C3CCCCC3)cnc2-c(cc4)ccc4F;7.8499999;Casein kinase I isoform delta;0CK
1sc8;[NH2+]=C(N)c1ccc(cc1)CNC(=O)CNC(=O)[C@@H](CO)NS(=O)(=O)Cc2ccccc2;7.4400001;plasminogen activator, urokinase;2IN
4af3;C[NH+]1CCN(CC1)c2cc(Nc3cc([nH]n3)C)nc(n2)Sc4ccc(cc4)NC(=O)C5CC5;7.5100002;AURORA KINASE B;VX6
4ivd;N#CCC[C@H](CC1)CC[C@@H]1n2c([C@@H](C)O)nc(c23)cnc4c3cc[nH]4;9.5200005;Tyrosine-protein kinase JAK1;15T
4ivc;N#CC[C@H](CC1)CC[C@@H]1n2c([C@@H](C)O)nc(c23)cnc4c3cc[nH]4;10;Tyrosine-protein kinase JAK1;1J6
4ivb;C1C[C@@H](C#N)CC[C@@H]1n2c([C@@H](C)O)nc(c23)cnc4c3cc[nH]4;8.7200003;Tyrosine-protein kinase JAK1;1J5
4iva;C1C[C@@H](C#N)CC[C@@H]1n2c([C@@H](C)O)nc(c23)cnc4c3cc[nH]4;7.1599998;Tyrosine-protein kinase JAK2;1J5
5jrs;c1cc(C(C)(C)O)cc([nH]2)c1c(c23)c(ccc3C(=O)N)-c(c4F)cccc4-n(cn5)c(=O)c(c56)cccc6;8.3999996;Tyrosine-protein kinase BTK;6MV
5ghv;C1[C@@H](O)C[N@H+]1Cc(c(c2)C)cn2-c3ccnc(n3)Nc(cc4C)cc(C)c4OCC[NH+]5CCCC5;7.9200001;Tyrosine-protein kinase SYK;X5G
4zs0;c1c(O)ccc(c12)n(c(=O)[nH]2)-c(n3)[nH]c(c34)cccc4;5.6399999;Aurora kinase A;4QV
4yur;O=N(=O)c1cccc(c1F)CS(=O)(=O)c2ccc(c(F)c2)Sc(nc(c3OC)Nc4[nH]nc(C)c4)nc3N5CCOCC5;9.8000002;Serine/threonine-protein kinase PLK4;4J7
4afe;FC(F)(F)/C=C\[C@@H](C)Oc1cc(ccc1C(=O)N)-c2cc(cnc2N)-c3cc(cs3)C[NH+](C)C;7.1399999;SERINE/THREONINE-PROTEIN KINASE NEK2;GGY
4afj;c1cc(OC)ccc1-c2c(nco2)C(=O)NCc3ccncc3;6.4000001;GLYCOGEN SYNTHASE KINASE-3 BETA;SJJ
4zsg;CC(C)NC(=O)n1nc(N)nc1Nc(cc2)ccc2Cl;5;Mitogen-activated protein kinase 7;4QX
4zsa;CC[NH+]1CCN(CC1)c(cc2)ccc2C(=O)Nc(n[nH]3)c(c34)ccc(c4)-c5cccc(c5)OC;7.8200002;Fibroblast growth factor receptor 1;4UT
4zsl;c1ccccc1[C@H](C)NC(=O)n2nc(N)nc2Nc3ccc(Cl)cc3;5;Mitogen-activated protein kinase 7;4QZ
4zsj;Clc1ccc(cc1C)Nc2n(nc(n2)N)C(=O)NC(C)C;5.6399999;Mitogen-activated protein kinase 7;4R0
3ns9;n1cc(C(C)C)c(n12)nc(N[C@@H](CO)[C@H](O)CO)cc2NCc3ccccc3;8.5200005;Cell division protein kinase 2;NS9
3tt0;COc(c1Cl)cc(OC)c(Cl)c1NC(=O)N(C)c2cc(ncn2)Nc3ccc(cc3)N4CC[NH+](CC)CC4;9.0500002;Basic fibroblast growth factor receptor 1;07J
3m1s;C12C3=C4C5=C1[Ru]23456(C=O)N7C8=c9n6c1c(cc(O)cc1)c9=C1C(C(=O)NC1=O)C8=CC=C7;9;Glycogen synthase kinase-3 beta;DW1
1h1p;[nH]1cnc(c12)c(nc(n2)N)OCC3CCCCC3;4.9200001;CELL DIVISION PROTEIN KINASE 2;CMG
1h1q;c1ccccc1Nc(nc(c23)[nH]cn3)nc2OCC4CCCCC4;6;CELL DIVISION PROTEIN KINASE 2;2A6
1h1r;c1ccc(Cl)cc1Nc(nc(c23)[nH]cn3)nc2OCC4CCCCC4;5.6399999;CELL DIVISION PROTEIN KINASE 2;6CP
1h1s;NS(=O)(=O)c1ccc(cc1)Nc(nc(c23)[nH]cn3)nc2OCC4CCCCC4;8.2200003;CELL DIVISION PROTEIN KINASE 2;4SP
1unh;c1cccc(c1=2)=NC(\C2N=O)=C(/C(=O)N3)c(c34)cccc4;7;CYCLIN-DEPENDENT KINASE 5;IXM
3vc4;FC(F)(F)c1cccc(c1)\C=C\2SC(=O)NC2=O;7.6199999;Serine/threonine-protein kinase pim-1;0FS
1unl;OC[C@@H](CC)Nc(n1)nc(c(c12)ncn2C(C)C)NCc3ccccc3;6.6999998;CYCLIN-DEPENDENT KINASE 5;RRC
2wd1;O=C(N)c(c1)cnc(c12)ccn2S(=O)(=O)c3c(N(=O)=O)cccc3;7.0861859;HEPATOCYTE GROWTH FACTOR RECEPTOR;ZZY
3m11;c1ccccc1-c2c(-c3ccccc3)oc(c24)ncnc4NCCc5ccc(cc5)NC(=O)Nc6ccccc6;7.3699999;Serine/threonine-protein kinase 6;AKI
2r64;C1CCCCN1c2ccc(cc2)CC(=O)Nc([nH]n3)c(c34)cc(cc4)N(S5(=O)=O)CCC5;7.5228791;Cell division protein kinase 2;740
5d7a;C1C[C@@H](O)CC[C@H]1Oc(ccc2)c(c23)nc(nc3)Nc(c4)ccc(c45)[nH]cn5;7.6799998;TRAF2 and NCK-interacting protein kinase;58C
2r3g;c1cccc(F)c1C(=C2)NC(=C(N23)NC=C3)NCc4cccnc4;6.09691;Cell division protein kinase 2;SC9
3lq8;C1COCC[NH+]1CCCOc(c2)c(OC)cc(c23)c(ccn3)Oc4ccc(cc4F)NC(=O)C5(CC5)C(=O)Nc6ccc(F)cc6;9.3999996;Hepatocyte growth factor receptor;88Z
4ejn;O=C(C)Nc1cccc(c1)-c(n2)ccc(c23)nc(-c4c(N)nccc4)n3-c5ccc(cc5)CNC(=O)c6cc(F)ccc6;8.3000002;RAC-alpha serine/threonine-protein kinase;0R4
5f1z;[nH]1nc(N)c(c12)c(=O)n([C@@H](C)C(C)C)cc2-c3cc(n(n3)C)C(C)(C)O;8.6800003;Non-receptor tyrosine-protein kinase TYK2;5U3
3b2w;C1C[NH2+]CCN1c(cc2)ccc2Nc(n3)ncc(c3OC)C(=O)Nc4cc(ccc4C)C(=O)Nc(c5F)cccc5C(F)(F)F;9.2218475;Proto-oncogene tyrosine-protein kinase LCK;9NH
3s2p;O[C@@H](C1)[C@@H](O)CN1c(ccc2O)cc2-c3nc(N)nc(c3)C(C)C;7.1700001;Cyclin-dependent kinase 2;PMU
3r21;[NH3+]CCN(S(=O)(=O)C)c1ccc(cn1)Nc(n2)ncc(c23)cnn3C4CCCCCC4;6.7399998;Serine/threonine-protein kinase 6;D36
3r22;O=S(=O)(C)Nc(nc1)ccc1Nc(n2)ncc(c23)cnn3C4CCCCCC4;7.77;Serine/threonine-protein kinase 6;D37
4zly;NC(=O)c(nn1)c(N)c(c12)cccc2;5.46;Tyrosine-protein kinase BTK;4RU
2c1b;Clc1ccc(cc1)CO[C@H]2C[NH2+][C@@H](C2)CNS(=O)(=O)c(ccc3)c(c34)ccnc4;6.4000001;CAMP-DEPENDENT PROTEIN KINASE;CQP
4zlo;C1C[NH+](C)CCN1C(c2c(N3)ccc(F)c2)=Nc(c34)cc(F)cc4;4.9200001;Serine/threonine-protein kinase PAK 1;4PV
3hdm;c1ccccc1-c(c2)cnc(c23)[nH]cc3-c(cc4)ccc4C(=O)[O-];7.3979402;Serine/threonine-protein kinase Sgk1;MMG
3hdn;c1cccc(c12)cc(cc2)-c(c3)cnc(c34)[nH]cc4-c(cc5)ccc5CC(=O)[O-];7.2006593;Serine/threonine-protein kinase Sgk1;GMG
4cg8;Clc1ccc(cc1)N(C)C2C=CN(C=C2)Cc(cc3)ccc3CCCCc4ccc(cc4)Cn(cc5)ccc5=[N+](C)C;6.96;CHOLINE KINASE ALPHA;G8S
4cg9;C[N+](C)=c1ccn(cc1)Cc2ccc(cc2)-c3ccccc3;6.21;CHOLINE KINASE ALPHA;GQG
2e9u;c1cc(Cl)cc(c12)NC(=O)Nc3nc(cnc3)OCCCCCO2;8.1000004;Serine/threonine-protein kinase Chk1;A25
4cga;C[N+](C)=c1ccn(cc1)Cc2ccc(cc2)CCc3ccccc3;6.4000001;CHOLINE KINASE ALPHA;QLW
2xk4;CCOc1cc(ccc1C(=O)[O-])-c2nc(cnc2N)-c3cc(OC)c(OC)c(c3)OC;4.77;SERINE/THREONINE-PROTEIN KINASE NEK2;OL2
1pye;Fc1cccc(F)c1C(=O)C(=C2)C=CC(N23)NC(N)=C3C(=O)c4ccccc4;6.4099998;Cell division protein kinase 2;PM1
1q3w;c1cccc(c12)NC(=O)Cc3c2[nH]c4c3cc(N(=O)=O)cc4;8.3999996;GLYCOGEN SYNTHASE KINASE-3 BETA;ATU
3zze;c1cc(O)ccc1[C@H](C)C(=O)N[NH2+][C@H]2C(=O)Nc(c23)c(C)ccc3Cl;8.8900003;HEPATOCYTE GROWTH FACTOR RECEPTOR;6XP
2xbj;C1[NH2+]C[C@@H](C(C)(C)O)[C@@H]1Nc(c(c23)C[C@@H](OC)C(C2)OC)nc(n3)-c4c(O)ccc(F)c4;8.5200005;SERINE/THREONINE-PROTEIN KINASE CHK2;XBJ
2xba;c1ccccc1[C@@H](O)C(=O)N(C2)Cc(c23)c(n[nH]3)NC(=O)c4ccc(cc4)N5CC[NH+](C)CC5;7.6300001;ALK TYROSINE KINASE RECEPTOR;571
5cf6;OC[C@@H](O)Cn1c(C(=O)N(C2CC2)C3CC3)cc(c14)c5c(c(n4)NC)ncn5C;8.0900002;Tyrosine-protein kinase JAK2;50O
4jq8;C[NH+](C)CCC(=O)Nc1cc(ccc1)-c2c(-c3ccccc3)oc(c24)ncnc4N[C@H](CO)c5ccccc5;8.1000004;Epidermal growth factor receptor;KJ8
5cf4;C1CC1N(C2CC2)C(=O)c(c3)n(CC)c(c34)nc(c5c4n(cn5)C)NCCCOC;7.4000001;Tyrosine-protein kinase JAK2;50Y
5cf5;C1CC1N(C2CC2)C(=O)c(c3)n(CC)c(c34)nc(c5c4n(cn5)C)Nc6nc(C)c(s6)C;8.6000004;Tyrosine-protein kinase JAK2;50W
5cf8;C1CC1N(C2CC2)C(=O)c(c3)n(CC)c(c34)nc(c5c4n(C)cn5)Nc6cc(C)n(n6)C;8.96;Tyrosine-protein kinase JAK2;50V
2xb7;c1cccc(S(=O)(=O)C(C)C)c1Nc(c2Cl)nc(nc2)Nc3ccc(cc3OC)N4CCC(CC4)[N@@H+]5CC[N@@H+](C)CC5;9.1899996;ALK TYROSINE KINASE RECEPTOR;GUI
3kmm;Clc1cccc(Cl)c1N(C(=O)N2C)Cc(c23)cnc(n3)Nc4ccc(cc4)OCC[NH+](CC)CC;9.6999998;Proto-oncogene tyrosine-protein kinase LCK;LHL
1fv9;c1c(O)ccc(c12)nc([nH]2)N;5;UROKINASE;172
5fbo;C1=CC1C(=O)N([C@@H](C)CC2)C[C@@H]2c(n(c34)ccnc3N)nc4-c5c(F)cc(cc5)C(=O)Nc6nccc(c6)C(F)(F)F;9.5100002;Tyrosine-protein kinase BTK;5WH
1fvv;s1cnc(cc2)c1c(c23)=C(C(=O)N=3)CNc4ccc(cc4)S(=O)(=O)Nc5ncccc5;8;CYCLIN-DEPENDENT KINASE 2;107
1fvt;c1cc(Br)cc(c12)C(\C(=O)N2)=N\Nc3ccc(cc3)S(=O)(=O)N;7.2199998;CELL DIVISION PROTEIN KINASE 2;106
3dcv;c1cc(O)c(C)cc1-c(nc2=O)cc([nH]2)-c3ccccc3;8.5228786;Proto-oncogene serine/threonine-protein kinase Pim-1;55E
4ra5;C[N@@H+](C1)C[C@]1(C)N(C)c(c2)c(-c3ccccc3)cc(c24)OCC5N4[C@H](C)C(=O)NN=5;7.8200002;HUMAN PROTEIN KINASE C THETA;3L0
2hog;n1n[nH]c(CO)c1-c(cc2)cc(c23)n[nH]c3-c(c4)[nH]c(c45)ccc(c5)C[NH+]6CCCCC6;9.5200005;Serine/threonine-protein kinase Chk1;710
5gjf;C1C[NH+](C)CCN1C(=O)c2cc(OC(C)C)c(cc2)NC(=O)c3csc(n3)-c4cccc(c4)NC(=O)Nc5ccccc5;6.5900002;TAK1 kinase - TAB1 chimera fusion protein;6V4
5gjg;C1C[NH+](C)CCN1C(=O)c2cc(OC(C)C)c(cc2)NC(=O)c3nc(sc3)-c4cccc(c4)C(=O)Nc5ccccc5;6.21;TAK1 kinase - TAB1 chimera fusion protein;6V5
5gjd;C1C[NH+](C)CCN1c2cccc(c23)cc(cc3)NC(=O)Nc4ccc(cc4)Oc5ccnc(c56)[nH]cc6;7.9200001;TAK1 kinase - TAB1 chimera fusion protein;6V3
5itd;CC(=O)N1CCN(CC1)C(=O)c2cc(ccc2)-c(ncn3)c(c34)cc(cc4)-c5cnc(c(c5)C#N)OC;6.5799999;Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform;6CY
2yac;OCCn1nc(C(=O)N)c(cc2)c1c(c23)nc(nc3)Nc4cc(ccc4OC(F)(F)F)N5CC[NH+](C)CC5;8.6999998;SERINE/THREONINE-PROTEIN KINASE PLK1;937
2r0u;c1n[nH]cc1-c(c2)ccc(c23)c(CCC[NH3+])cc4c3c(=O)[nH]cc4C5=CC(=O)CC=C5;9;Serine/threonine-protein kinase Chk1;M54
4bbe;O=C(C)Nc1ccc(cc1)-c2ccnc(n2)Nc3ccc(cc3)N4CCOCC4;8.4399996;TYROSINE-PROTEIN KINASE JAK2;3O4
4bbf;[NH2+]1CCC[C@@H]1C(=O)Nc2ccc(cc2)-c3nc(ncc3)Nc4ccc(cc4)N5CCOCC5;8.6599998;TYROSINE-PROTEIN KINASE JAK2;O19
2yak;C1CS2CCS3CCS1[Ru]234(N=C=S)N5C6=C7N4c8c(cc(cc8)OC(C)C)[C@@H]7C9=C(C(=O)NC9=O)C6=CC(F)=C5;8.6999998;DEATH-ASSOCIATED PROTEIN KINASE 1;OSV
5to8;FC(F)(F)c1cnc(Nc(c2)cc3)nc1NCc(cccn4)c4N(S(=O)(=O)C)CCCCC(=O)n(c3c25)cc5;8.5100002;Protein-tyrosine kinase 2-beta;7FM
4iti;c1cc(OC)cc(c12)C=3[C@@H](CC2)[C@H](N(N3)C(=O)CO)c(cc4)cc(F)c4OC(F)(F)F;6.3600001;Receptor-interacting serine/threonine-protein kinase 1;1HW
4ith;O=C1N(C)C(=O)[C@H](N1)Cc2c[nH]c(c23)c(Cl)ccc3;6.5;Receptor-interacting serine/threonine-protein kinase 1;RCM
4itj;Clc1cccc(F)c1[C@H](C)NC(=O)c2ccc(C#N)n2C;6.4200001;Receptor-interacting serine/threonine-protein kinase 1;1HX
3g90;c1cc(F)cc(c12)C(=N\O)/C(=O)N2Cc(cc(F)c3)c(c34)OCOC4;6.3565474;Mitogen-activated protein kinase 10;J72
3que;OC[C@@H](O)COc(cc1)cc(c12)C(=O)c3c(CC2)cc(cc3)Nc(c(F)c4)ccc4F;8.8199997;Mitogen-activated protein kinase 14;3FF
3ral;COc1cccc(c1)[C@@H](O)c2sc(nc2N)Nc3ccc(S(=O)(=O)N)cc3;7;Cyclin-dependent kinase 2;04Z
4z9l;C1C[NH2+]CCC1c(n2CCC)nc(-c3cc(Cl)c(Cl)cc3)c2-c4ccnc(n4)NC5CCCCC5;8.8000002;Mitogen-activated protein kinase 10;880
3rah;c1cccc(c12)cc(cc2)[C@@H](O)c3sc(nc3N)NC4CCCCC4;7.9200001;Cyclin-dependent kinase 2;O1Z
3rak;c1ccccc1[C@@H](O)c2sc(nc2N)Nc3ccc(S(=O)(=O)N)cc3;6.8899999;Cyclin-dependent kinase 2;03Z
3o96;c1cccc(c12)[nH]c(=O)n2[C@H]3CC[N@@H+](CC3)Cc4ccc(cc4)-c(n5)c(-c6ccccc6)nc(c57)cc8c(c7)nc[nH]8;7.2399998;RAC-alpha serine/threonine-protein kinase;IQO
5aae;Cc1cc(no1)Cn2cc(cn2)-c(c(Cl)cn3)c(c34)[nH]c(n4)-c5cn(C)nc5C;7.46;AURORA KINASE A;7HD
5aad;Cc1nn(C)cc1-c([nH]2)nc(c23)ncc(Cl)c3-c4cn(nc4)Cc5ccccc5;6.6700001;AURORA KINASE A;5GX
5aag;C[NH+]1CCN(CC1)C(=O)c2cccc(c2)Cn3cc(cn3)-c(c(Cl)cn4)c(c45)nc([nH]5)-c6cn(C)nc6C;7.3400002;AURORA KINASE A;6F2
5aaf;CN(C)C(=O)c1cccc(c1)Cn2cc(cn2)-c(c(Cl)cn3)c(c34)nc([nH]4)-c5cn(C)nc5C;7.4400001;AURORA KINASE A;NL4
4eh8;c1ccccc1COc2cc(CO)ccc2;2.2;Mitogen-activated protein kinase 14;0OP
5aac;Clc1ccc(F)c(Cl)c1[C@@H](C)Oc2cc(cnc2N)-c3cnn(c3)C4CC[NH2+]CC4;8.8900003;ALK TYROSINE KINASE RECEPTOR;VGH
5aab;Clc1ccc(F)c(Cl)c1[C@@H](C)Oc2cc(cnc2N)-c3cnn(c3)C4CC[NH2+]CC4;9.0600004;ALK TYROSINE KINASE RECEPTOR;VGH
4eh7;c1ccccc1Oc2cc(CO)ccc2;3.28;Mitogen-activated protein kinase 14;0OO
4dtk;CC(C)Oc1cccc(/C=C2\SC(=O)NC2=O)c1N3CCC[C@@H]([NH3+])C3;8.5200005;Serine/threonine-protein kinase pim-1;7LI
2b55;[NH3+]C[C@@H]1CC[N@@H+](CC1)CC(=O)Nc(ccc2)c(c23)C(=O)c4c3[nH]nc4C5CCCCC5;7.02;Cell division protein kinase 2;D31
4eh3;Oc1cc(O)cc(c12)O[C@@H](CC2=O)c3ccc(O)cc3;3.53;Mitogen-activated protein kinase 14;NAR
4eh2;c1ccccc1-n(cn2)c(=O)c(c23)cccc3;3.1600001;Mitogen-activated protein kinase 14;0OK
3qu0;NS(=O)(=O)c(cc1)ccc1Nc(s2)nc(N)c2C(=O)c3cccnc3;7.6999998;Cyclin-dependent kinase 2;X40
4ehe;Nc1ncnc(c12)c(cs2)C(=O)Nc3c(F)c(ccc3F)NS(=O)(=O)CCC;8.4899998;Serine/threonine-protein kinase B-raf;RI8
4ehg;CCCS(=O)(=O)Nc(ccc1F)c(F)c1NC(=O)Nc2ncnc(c2)NCCO;7.1900001;Serine/threonine-protein kinase B-raf;RI9
5aa9;N#Cc1n(C)nc(c1c23)CN(C)C(=O)c4c(cc(F)cc4)[C@@H](C)Oc(c2)c(N)nc3;8.1899996;ALK TYROSINE KINASE RECEPTOR;5P8
4ehv;c1ccc(=O)n(c12)C[C@@H]3CN(C[C@H]2C3)C(=O)c4ccc(Cl)cc4;2.29;Mitogen-activated protein kinase 14;0SJ
3s0o;CCCNc(nc1N)sc1[C@H](O)c2ncccc2;4.48;Cyclin-dependent kinase 2;50Z
3at4;O=C([O-])Cc(cc1)cn1-c(n2)cncc2-n3ncc(c34)ccc(c4)NC(C)C;8.1000004;Casein kinase II subunit alpha;CCK
3idp;[nH]1cnc(c12)c(ncn2)-c3cccnc3Nc4c(C)ccc(c45)c(ncc5)Nc6ccc(Cl)cc6;8.7958803;B-Raf proto-oncogene serine/threonine-protein kinase;L1E
4urk;c1cccc(C(=O)[O-])c1N[C@H](C)c(cc(c2)C)c(n23)nc(cc3=O)N4CCOCC4;5.96;PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM;A82
2j2i;C[NH+](C)C[C@H](CC1)OCCn(c2)c(cccc3)c3c2C(C(=O)NC4=O)=C4c(c5)c(c6n15)cccc6;6.6999998;PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE PIM-1;LY4
3s00;c1cc(Cl)sc1C(=O)c2sc(nc2N)NCCC;4.9200001;Cyclin-dependent kinase 2;Z60
4hvb;c1cc(C)ncc1-c(cc2)nc(c23)c4c(cn3)n(C)c(=O)n4C5CCN(CC5)C(=O)[C@@H](O)C;9.9499998;Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;19P
4ujb;Fc1cccc(c1)C(=O)[C@H]2C[NH2+]C[C@@H]2c(c3)ccc(c34)C(=O)NCN4;7.6999998;CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;8BQ
4uja;Brc(s1)ccc1C(=O)[C@H]2C[NH2+]C[C@@H]2c(c3)ccc(c34)c(=O)[nH]cn4;9.0500002;CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;4L7
4hvd;C1CC1c(cn2)nc(c23)c(c[nH]3)C(=O)N[C@@H](C)C(C)(C)C;8.8500004;Tyrosine-protein kinase JAK3;933
4uj2;[nH]1cnc(=O)c(c12)ccc(c2)[C@H]3C[NH2+]C[C@@H]3C(=O)c4cccc(I)c4;7.0999999;CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;NVV
4uj1;[nH]1cnc(=O)c(c12)ccc(c2)[C@H]3C[NH2+]C[C@@H]3C(=O)c4cc(Cl)ccc4;6.52;CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;NVX
5ime;O=c1c(C)nccn1-c2cc(Cl)c(cc2)-c(c3)c(=O)n(CCC[NH3+])c(c34)nc(nc4)NC;8.3400002;Serine/threonine-protein kinase PAK 1;6BZ
4uj9;FC(F)(F)c1ccc(cc1)C(=O)[C@H]2C[NH2+]C[C@@H]2c(c3)ccc(c34)C(=O)NCN4;8.6999998;CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;S3N
3kvw;O=C([O-])c(cc1)cc(c12)c(NO)c([nH]2)[C@H]3C(=O)Nc(c34)c(Br)ccc4;6.8899999;Dual specificity tyrosine-phosphorylation-regulated kinase 2;IRB
3kvx;C1COCCN1c2ncn(n2)-c(cc3)ccc3Nc4nccc(n4)-c(cc5F)cc(c5)N6CCOCC6;6.8297381;Mitogen-activated protein kinase 10;FMY
2exc;c1cc(F)ccc1Nc(ncc2)cc2-c3cc(ncc3)NC(=O)[C@H]4CC[C@@H](CC4)OC;6.6300001;Mitogen-activated protein kinase 10;JNK
3pj2;CC[NH+](CC)CCOc(cc1)ccc1Nc(nc2)nc(c23)n(C)c(=O)c(c3)Oc4ccc(F)cc4;5.1399999;Tyrosine-protein kinase BTK;04K
3pj1;Clc1cccc(Cl)c1N(C(=O)N2C)Cc(c23)cnc(n3)Nc4ccc(cc4)OCC[NH+](CC)CC;7.3200002;Tyrosine-protein kinase BTK;LHL
5da3;C1COCCN1C(=O)c2ccc(cc2Cl)Nc3nc(C4CC4)cn(c35)c(cn5)-c6c[nH]nc6;7.0999999;Protein-tyrosine kinase 6;58V
2exm;CC(C)=CCNc1ncnc(c12)[nH]cn2;4.1100001;Cell division protein kinase 2;ZIP
3pj8;n1[nH]c(C(C)C)c(c12)nc(N[C@H](CC)CO)nc2NCc3ccccc3;7.4000001;Cell division protein kinase 2;404
3d9v;C1CC[NH2+]C[C@H](C)N1S(=O)(=O)c2cccc(c23)cncc3C;8.2200003;Rho-associated protein kinase 1;H52
4m0z;NC(=O)Nc(c1)c(C(=O)N)nn1-c2cccc(c23)ccc(c3)OC;5.1900001;Tyrosine-protein kinase ITK/TSK;M0Z
4mk0;Fc1ccc(cc1)[C@@H]2CC[NH2+]C[C@H]2COc(cc3)cc(c34)CNC4=O;5.1999998;Beta-adrenergic receptor kinase 1;29X
2gfs;c1cc(F)ccc1-n2ncc(c2N)C(=O)c3cccc(c3)OC[C@@H](O)CO;6.1500001;Mitogen-Activated Protein Kinase 14;PQB
4nks;Cc1cc(on1)CNc2nccc(n2)Nc3cc(n[nH]3)CCc4ccccc4;7.1700001;Fibroblast growth factor receptor 1;2M2
3tn8;Oc1ccc(cc1)/N=N/c2c(N)[nH]nc2N;6.1300001;Cyclin-dependent kinase 9;F18
3t9t;c1cccc(C)c1Nc(n2)c(cnc3)n3c(c24)cc(c(F)c4)N(C)C(=O)/C=C\C[NH+](C)C;8.71;Tyrosine-protein kinase ITK/TSK;IAQ
4nka;Cc1cc(on1)CNc(n2)nccc2Nc3[nH]nc(c3)CCc4ccc(OC)c(c4)OC;6.5100002;Fibroblast growth factor receptor 1;2K7
4yne;Fc1cccc(c1)[C@H]2CCCN2c(cc3)nn(c34)c(cn4)-c5ccccn5;8.5200005;High affinity nerve growth factor receptor;4EK
4nk9;COc1cc(cc(c1)OC)CCc2cc(n[nH]2)Nc3ccnc(n3)NCc4cc(no4)C;8.5100002;FIBROBLAST GROWTH FACTOR RECEPTOR 1;2K5
3tnh;Oc1ccc(cc1)/N=N/c2c(N)[nH]nc2N;6.46;Cyclin-dependent kinase 9;F18
3l9n;Cc1ccc(cc1)C[C@H]([NH3+])CNc2sc(nn2)-c(cc3)cc(c34)c[nH]n4;8.0699997;cAMP-dependent protein kinase catalytic subunit alpha;L9N
3l9l;O=C(N1)Cc(c12)cc(cc2)-c3sc(nc3)NC[C@@H]([NH3+])Cc(cc4)ccc4C(F)(F)F;6.7800002;cAMP-dependent protein kinase catalytic subunit alpha;L9L
3l9m;Cc1ccc(cc1)C[C@H]([NH3+])CNc2sc(nn2)-c(cc3)cc(c34)c(C)n[nH]4;7.3000002;cAMP-dependent protein kinase catalytic subunit alpha;L9M
4qo9;c1ccccc1[C@@H](OC)C(=O)N(C2)Cc(c23)c(n[nH]3)NC(=O)c4ccc(cc4)N5CC[NH+](C)CC5;6.8000002;SERINE/THREONINE-PROTEIN KINASE 24;627
5he1;c1[nH]nc(c12)ccc(c2)NC(=O)C3=C(C)NC(=O)N[C@H]3c4cc(c(F)cc4)C(=O)NCc5nccc(c56)cccc6;6.5500002;Beta-adrenergic receptor kinase 1;ZS2
5he2;c1[nH]nc(c12)ccc(c2)NC(=O)C3=C(C)NC(=O)N[C@H]3c4cc(c(F)cc4)C(=O)NCc5c(OC)cccc5OC;6.8899999;Beta-adrenergic receptor kinase 1;F0S
5he3;c1[nH]nc(c12)ccc(c2)NC(=O)[C@@H]3C(C)=NC(=O)N[C@H]3c4cc(c(F)cc4)C(=O)NCCc5c(C)cccc5C;6.5500002;Beta-adrenergic receptor kinase 1;FF1
1nvq;c1cccc2c1c3c([C@@H](O)NC4=O)c4c(c5c3n2[C@@]67C)c8c(cccc8)n5[C@H](O6)C[C@@H]([NH2+]C)[C@H]7OC;8.25;Serine/threonine-protein kinase Chk1;UCN
5hes;Clc1ccc(cc1)-c(c2)cnc(c23)[nH]cc3C(=O)c4c(F)ccc(c4F)NS(=O)(=O)CCC;7.54;Mitogen-activated protein kinase kinase kinase MLT;032
5hex;c1c(Br)cccc1C(=O)N[C@@H]2[C@@H](O)[C@H](O)[C@H](O[C@@H]2O)CNS(=O)(=O)c(cc3C(=O)[O-])oc3C;8;Hexokinase-2;604
3ow4;C1S[C@@H](C)c(c12)c(ncn2)N3CCN(CC3)C(=O)[C@H]([NH3+])Cc(c[nH]4)c(c45)cccc5;7.6599998;RAC-alpha serine/threonine-protein kinase;SMY
4bkj;c1ncccc1-c2ccnc(n2)Nc3c(C)ccc(c3)NC(=O)c4ccc(cc4)C[N@@H+]5CC[N@@H+](C)CC5;8.7200003;EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1;STI
3da6;c1cccc(c12)nc([nH]2)Nc(c(c34)cccc3)cc(C)c4Oc5ncccc5-c6nc(NC)ncc6;8.6989698;Mitogen-activated protein kinase 10;BZ9
4rg0;C1C[NH+](C)CCN1c(cn2)ccc2Nc3cc(cn(c3=O)C)-c4cccc(c4CO)N(C5=O)CCc(c56)cc(cc6F)C(C#N)(C)C;7.3000002;Tyrosine-protein kinase BTK;3P0
3lq5;OC[C@H](CC)Nc(n1)nc(c(c12)ncn2C(C)C)NCc3ccc(cc3)-c4ncccc4;6.96;Cell division protein kinase 9;SLQ
5bnj;c1nn(C)cc1-c2ccc(cc2)-c(cncc3Cl)c3N(CC4)CCC45CCNC5=O;8.6999998;Cyclin-dependent kinase 8;4TV
4a7c;FC(F)(F)Oc1cc(ccc1)-n(nn2)c(c23)nc(cc3)NCC4CC[NH2+]CC4;8.2200003;PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE PIM-1;E46
2oic;CO[C@@H]1[C@@H]([NH2+]C)C[C@@H](O2)n3c(cccc4)c4c(c3c5n6[C@]12C)c7c(CNC7=O)c5c8c6cccc8;8.3979397;Interleukin-1 receptor-associated kinase 4;STU
5hx6;c1ccccc1Cc2cc(no2)C(=O)N[C@@H](CO3)C(=O)N(C)c(c34)cccc4;8;Receptor-interacting serine/threonine-protein kinase 1;65U
2ycf;ONC(=[NH2+])/[NH+]=N/[C@@H](C)c1ccc(cc1)NC(=O)Nc2ccc(cc2)[C@@H](C)/N=[NH+]/C(N)=[NH+]/O;10.52;SERINE/THREONINE-PROTEIN KINASE CHK2;YCF
2r2w;NC(N)=[NH+]c1ccc(cc1)CC(=O)c2ccccc2;4.4699998;Plasminogen activator, urokinase;4PG
5hx8;C1C[C@H]([NH3+])CC[C@@H]1NC2=CC=NC(=O)[C@@H]2c(n3)[nH]c(c34)cccc4;10;Tyrosine-protein kinase JAK1;66P
5fbn;C1OCC1(C)C(=O)N2CCC[C@H](C2)c3nc(c(n34)c(N)ncc4)-c5ccc(cc5)C(=O)Nc6nccc(c6)C(F)(F)F;9.5699997;Tyrosine-protein kinase BTK;5WF
2ycr;N1=CCN\C1=N\N=C(C)\c(cc2)ccc2NC(=O)Nc3ccc(cc3)/C(C)=N/N[C@H]4N=CC[NH2+]4;7.1599998;SERINE/THREONINE-PROTEIN KINASE CHK2;HCW
2ycs;c1cccc(c12)c(c[nH]2)C(=O)Nc3ccc(cc3)/C(C)=N/[NH+]=C(N)N;8.8699999;SERINE/THREONINE-PROTEIN KINASE CHK2;NXP
2ycq;c1ccc(N(=O)=O)c(c12)[nH]c(c2)C(=O)Nc3ccc(cc3)/C(C)=N/Nc4ncc[nH]4;9.8500004;SERINE/THREONINE-PROTEIN KINASE CHK2;UPX
3rcd;FC(F)(F)c1cc(ccc1)Oc(c(Cl)c2)ccc2Nc3ncnc(c34)ccn4CCNC(=O)CC(C)(O)C;7.77;Receptor tyrosine-protein kinase erbB-2;03P
3rcj;c1ccnc(c12)[nH]cc2-c3nnn(c3)Cc4ccccc4;6.0999999;3-phosphoinositide-dependent protein kinase 1;3RC
4en4;Cc1ncc(CO)c(c1O)COC;5.52;Pyridoxal kinase;GT0
3prz;Nc1nc(C)nc(c12)c(ccc2)C(=O)Nc3ccn[nH]3;7.5900002;Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;3RZ
4enx;O=N(=O)c1c(O)ccc(c1)/C=C2/C(=O)N/C(S2)=N/c3c(Cl)cccc3;6.2600002;Serine/threonine-protein kinase pim-1;Z20
4f1s;CS(=O)(=O)Nc1cc(cnc1Cl)Nc2ncc(C3CCOCC3)cc2-c4nc(N)nc(n4)C;8.6999998;Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;F1S
4c4j;Cn1ncc(c1)-c(c2)n(C(=O)OC(C)(C)C)c(c23)cc(nc3)Nc4c(Cl)cc(cc4)-c(n5C)cnc5;8.5200005;DUAL SPECIFICITY PROTEIN KINASE TTK;X21
4c4i;c1ncoc1-c(n2C(=O)OC(C)(C)C)cc(c23)cnc(c3)Nc4ccc(cc4Cl)C(=O)N(C)C;7.6599998;DUAL SPECIFICITY PROTEIN KINASE TTK;X20
4c4h;CC(C)(C)OC(=O)n1c(-c2cnn(c2)C)cc(c13)cnc(c3)Nc4ccc(cc4Cl)C(=O)N(C)C;8.2200003;DUAL SPECIFICITY PROTEIN KINASE TTK;7RO
4c4g;CC(C)(C)OC(=O)n1c(-c2cnn(c2)C)cc(c13)cnc(c3)Nc4ccc(cc4Cl)C(=O)N(C)C;8.2200003;DUAL SPECIFICITY PROTEIN KINASE TTK;7RO
4c4f;COc1ccccc1Nc(c2)ncc(c23)cc([nH]3)-c4cnco4;7.5900002;DUAL SPECIFICITY PROTEIN KINASE TTK;7CE
4c4e;COc1ccc(cc1OC)Nc(c2)ncc(c23)cc([nH]3)-c4c[nH]nc4;7.5999999;DUAL SPECIFICITY PROTEIN KINASE TTK;4T9
4tv3;c1nc(OC)ccc1-c(c2)c(=O)n(c(c23)nc(N)nc3C)[C@H]4CC[C@@H](CC4)OCCO;8.7200003;Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform;ML9
3cd8;c1ccccc1-c(cc2)nn(c23)c(nn3)COc(ccn4)c(c45)ccc(c5)OC;8.0457573;Hepatocyte growth factor receptor;L5G
5idp;Fc1ccc(cc1)[C@@H]2CCCCN2C(=O)c(c3)ccc(c34)[nH]nc4N;7.3499999;Cyclin-dependent kinase 8;6A6
5cal;CC(C)n(c(n1)C)c(c12)cc(nc2)Nc3ccnc(n3)NCC(C)(C)C(=O)N;7.6599998;Epidermal growth factor receptor;4Z8
1ykr;Clc1cccc(Cl)c1C(=O)c(c2)ccc(n23)nc(c3)Nc(cc4)ccc4S(=O)(=O)N;6.25;Cell division protein kinase 2;628
2gdo;c1c(Cl)ccc(c12)[nH]c(=O)c(c2N[C@H](C[N@@H+]34)[C@H](CC3)CC4)-c([nH]5)nc(c56)cccc6;9.4899998;Serine/threonine-protein kinase Chk1;12C
2btr;c1ncccc1CC(=O)Nc2ncc(s2)C(C)C;7.02;CELL DIVISION PROTEIN KINASE 2;U73
2bts;O=S(=O)(N)c1ccc(cc1)Nc(s2)ncc2C(C)C;7.6999998;CELL DIVISION PROTEIN KINASE 2;U32
3vqh;c1nccc(c12)c(ccc2)S(=O)(=O)NCC[NH2+]C/C=C/c3ccc(Br)cc3;5.9200001;cAMP-dependent protein kinase catalytic subunit alpha;IQB
4yll;c1ccc(Br)c([nH]2)c1c(c(n3)C(=O)[O-])c2c(c34)cc(I)cc4;6.9200001;Dual specificity tyrosine-phosphorylation-regulated kinase 1A;4E3
4ylk;c1ccc(Cl)c([nH]2)c1c(c(n3)C(=O)[O-])c2c(c34)cc(I)cc4;6.7399998;Dual specificity tyrosine-phosphorylation-regulated kinase 1A;4E2
4ylj;c1ccc(I)c([nH]2)c1c(c2c34)c(C(=O)[O-])nc4cccc3;8.2200003;Dual specificity tyrosine-phosphorylation-regulated kinase 1A;4E1
1r0p;COC(=O)[C@@]1(O)C[C@@H](O2)n(c3c4n5[C@]12C)c6c(cccc6)c3c7c(CNC7=O)c4c8c5cccc8;8;Hepatocyte growth factor receptor;KSA
3tl5;C[C@H](O)C(=O)N(CC1)CC[NH+]1Cc(s2)c(C)c(c23)nc(-c4cnc(N)nc4)nc3N5CCOCC5;7.8499999;Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;980
3hhm;COC[C@H]1OC(=O)C(=C)C([C@]12C)=C(O)C(=O)[C@@H]3[C@@H]2[C@H](OC(=O)C)C[C@@]4(C)[C@H]3CCC4=O;7.9200001;Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform;KWT
5hg5;C1C[NH+](C)CCN1c2ccc(cc2)Nc(nc(c34)[nH]cc4)nc3Oc(c5)cccc5NC(=O)CC;8.6999998;Epidermal growth factor receptor;633
5hg8;c1nn(C)cc1Nc(nc(c23)[nH]cc3)nc2Oc(c4)cccc4NC(=O)CC;8.5200005;Epidermal growth factor receptor;634
5hg9;CCC(=O)N1C[C@H](C(F)(F)F)[C@H](C1)COc(c(c23)cc[nH]3)nc(n2)Nc4cn(C)nc4;7.46;Epidermal growth factor receptor;63A
4y73;[NH3+][C@H]1CCCC[C@H]1Nc(n2)ccn(c23)ncc3C(=O)Nc4c(C(F)(F)F)nn(C)c4;9.5200005;Interleukin-1 receptor-associated kinase 4;XPY
4qmz;CC[NH+](CC)CCNC(=O)c1c(C)[nH]c(c1C)\C=C\2C(=O)Nc(c23)ccc(F)c3;6.6799998;SERINE/THREONINE-PROTEIN KINASE 24;B49
4qmx;C1COCCC1Oc2cc(OCC[N@@H+](CC3)CC[N@H+]3C)cc(c24)ncnc4Nc5c(Cl)ccc(c56)OCO6;4.96;SERINE/THREONINE-PROTEIN KINASE 24;H8H
4qmy;CO[C@@H]1[C@H]([NH2+]C)C[C@@H](O2)n3c(cccc4)c4c(c3c5n6[C@]12C)c7c(C[NH2+][C@H]7O)c5c8c6cccc8;8.3999996;SERINE/THREONINE-PROTEIN KINASE 24;STU
4qms;Cc1cccc(Cl)c1NC(=O)c2cnc(s2)Nc3cc(nc(n3)C)N(CC4)CC[NH+]4CCO;5.1300001;Serine/threonine-protein kinase 24;1N1
4qmp;Fc1cccc(F)c1NC(=S)n2nc(nc2N)Nc3ccc(cc3)S(=O)(=O)N;7.8499999;Serine/threonine-protein kinase 24;DKI
4qmq;COCCOc(c1)ccc(c12)n(cn2)-c(n3)ccc(c34)cccc4N5CCC([NH3+])CC5;6.5900002;Serine/threonine-protein kinase 24;34U
4qmv;CC(=O)NCC(=O)N1[C@H](CC2)c(c3[C@@H]12)cc(cc3)Nc4ncc(C(F)(F)F)c(n4)NC5CCC5;7.6399999;SERINE/THREONINE-PROTEIN KINASE 24;34W
4qmw;C1CCCC1n2nc(c(c23)c(N)ncn3)-c(c4)cnc(c45)[nH]cc5;7.0700002;SERINE/THREONINE-PROTEIN KINASE 24;KS1
4qmt;C1CCCC[NH+]1Cc2ccc(cc2)N/C(c3ccccc3)=C/4C(=O)Nc(c45)ccc(c5)NS(=O)(=O)CC;8;Serine/threonine-protein kinase 24;H1N
4qmu;O=S(=O)(N)c(cc1)ccc1Nc(nc2N)nn2C(=O)c3c(F)cccc3F;5.8899999;SERINE/THREONINE-PROTEIN KINASE 24;SKE
4qmn;Clc1cc(Cl)c(cc1OC)Nc(c(C#N)cn2)c(c23)cc(OC)c(c3)OCCC[N@H+]4CC[N@H+](C)CC4;8.5200005;Serine/threonine-protein kinase 24;DB8
4qmo;s1cnc(c12)ccc3c2/C(C(=O)N3)=C/c4[nH]cnc4;7.7199998;Serine/threonine-protein kinase 24;34L
4qmm;C1CC1NC(=O)Nc2cn[nH]c2-c(n3)[nH]c(c34)cc(cc4)C[NH+]5CCOCC5;6.3400002;Serine/threonine-protein kinase 24;35R
3kid;CCOC(=O)c(c1)ccc(c12)nc(s2)N;3.1800001;Urokinase-type plasminogen activator;2BS
3lpb;CNS(=O)(=O)c1ccc(cc1)-c2cccc(c23)ncc(n3)-c4cc(OC)c(OC)c(c4)OC;7.3800001;Tyrosine-protein kinase JAK2;NVB
2e2b;C[NH+](C)[C@H](C1)CC[N@H+]1Cc(c(c2)C(F)(F)F)ccc2C(=O)Nc3cc(c(C)cc3)Nc(ncc4)nc4-c5cncnc5;7.96;Proto-oncogene tyrosine-protein kinase ABL1;406
2xf0;c1ccccc1-c(cn2)n(c23)cc(nc3)-c4cn[nH]c4;4.52;SERINE/THREONINE-PROTEIN KINASE CHK1;4UB
3mw1;Fc1ccc(c(F)c1)-c2cc(C3CC[NH2+]CC3)nc(c24)[C@H](N(O)C=C4)c5c(Cl)cccc5Cl;9.0900002;Mitogen-activated protein kinase 14;MIH
4xv2;n1ccc(nc1N)-c2sc(C(C)(C)C)nc2-c3c(F)c(ccc3)NS(=O)(=O)c4c(F)cccc4F;8.2700005;Serine/threonine-protein kinase B-raf;P06
4xv3;CCN(C)S(=O)(=O)Nc(c1F)cccc1-c(nc(s2)C(C)(C)C)c2-c(ccn3)nc3N;7.9200001;Serine/threonine-protein kinase B-raf;P02
4ztm;OC[C@@H](C1)[C@@H](O)[C@@H](O)[C@@H]1Nc2[nH+]c(NC3CC3)[nH]c(=O)c2-c(s4)nc(c45)cccc5;7.5999999;Interleukin-1 receptor-associated kinase 4;4S2
5ax3;OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n(cc2I)c(c23)ncnc3N;5.9200001;Mitogen-activated protein kinase 1;5ID
4dk5;COc1ccc(cn1)Nc2ncc(C[NH+]3CCN(CC3)S(=O)(=O)C)cc2-c4nc(N)nc(n4)C;8.3999996;Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;0KO
5ax9;C1COCCN1c2ccc(cc2OC)Nc3cc(ccn3)-c4cc(C#N)ccc4OC;8.1000004;TRAF2 and NCK-interacting protein kinase;4KT
3nyx;c1c(Cl)ccc(c12)c(ccn2)Sc3sc(nn3)NC(=O)c4sccc4;7.4899998;Non-receptor tyrosine-protein kinase TYK2;TZ1
3fy0;[CH2]12[CH]3=[CH]4[CH]5=[CH]1[Ru]23456([CH2]=O)N7C8=C9[NH+]6c1c(cc(O)cc1)C9=C1C(C(=O)NC1=O)C8=CC=C7;5.9625735;Serine/threonine-protein kinase PAK 1;DW1
3we4;n1cncc(CC)c1N(CC2)CC[NH+]2Cc([nH]3)nc(c34)ccc(C(F)(F)F)c4;7.8200002;Ribosomal protein S6 kinase beta-1;5FI
3fyj;c1nc(C)ccc1-c(cc2)nc3ccc4sc(c5c4c23)C(=O)N[C@H](C)CN5;8.3010302;MAP kinase-activated protein kinase 2;B97
3fyk;COc(c1)ccc2sc(c3c12)C(=O)N[C@@H](CN3)C[NH3+];7.3979402;MAP kinase-activated protein kinase 2;B98
4d0x;Clc1ccc(C(F)(F)F)cc1-c2[nH]c(cc2C(=O)N)-c3ccnc(n3)N;8.1000004;TYROSINE-PROTEIN KINASE JAK2;953
4d0w;Nc1nccc(n1)-c2[nH]c(c(c2)C(=O)N)-c3cc(Cl)ccc3C;7.6999998;TYROSINE-PROTEIN KINASE JAK2;VVQ
3f88;c1cc(OC)ccc1-n2cnc(c23)ccc(c3)-c(o4)n[nH]c4=S;8.6382723;Glycogen synthase kinase-3 beta;3HT
4at4;Nc1ncnc(c12)scc2-c3ccc(cc3)NC(=O)Nc4cc(C(F)(F)F)ccc4F;7.9200001;BDNF/NT-3 GROWTH FACTORS RECEPTOR;T6E
5hzn;c1ccccc1COc(ccc2)cc2-c3cn(c(c34)ncnc4N)[C@@H](C5)C[C@@H]5C[NH+]6CCC6;7.21;Insulin-like growth factor 1 receptor;66A
5m57;NS(=O)(=O)c1ccc(cc1)Nc(nc(c23)nc[nH]3)nc2OCC4CCCCC4;4.9200001;Serine/threonine-protein kinase Nek2;4SP
5aep;Clc1cc(c(C)cc1)-n2c(C(=O)N)cc(c2)-c(ncn3)c(n34)ccc4;7.1700001;TYROSINE-PROTEIN KINASE JAK2;QUP
3fzs;c1cc(C)ccc1-n2nc(C(C)(C)C)cc2NC(=O)Nc3ccc(c(c34)cccc4)OCC[NH+]5CCOCC5;5.8200002;Protein tyrosine kinase 2 beta;B96
1p2a;[nH]1cccc1-c2cc(NCC[NH3+])c3c(F)ccc(c3c24)NC4=O;7.9200001;Cell division protein kinase 2;5BN
4u6r;[NH3+][C@H]1CC[C@@H](CC1)Nc2nc(ccn2)-c3cccnc3Oc4c(C)cc(c(c45)cccc5)NS(=O)(=O)c6ccccc6Cl;7.8499999;Serine/threonine-protein kinase/endoribonuclease IRE1;3E4
3gfw;OC1CCN(CC1)c2cc(OC)c(cc2)Nc(n3)cc(c(c34)cc[nH]4)Nc5ccccc5S(=O)(=O)C(C)C;7.5700002;Dual specificity protein kinase TTK;S22
3b8r;C1CC1NC(=O)c(ccc2)c(c23)ccc(c3)Oc4ccnc(c45)cc(OC)c(c5)OC;9.2218475;Vascular endothelial growth factor receptor 2;887
3b8q;COc(c1)c(OC)cc(c12)nccc2Oc(c3)ccc(c34)c(ccc4)C(=O)Nc5ccc(Cl)cc5;9.3010302;Vascular endothelial growth factor receptor 2;900
3gfe;C1CC1NC(=O)c2cc(c(C)cc2)\N=C\3CC(=O)N(C)c(c34)n(nc4)-c5ccc(F)cc5F;8.4948502;Mitogen-activated protein kinase 14;P37
4c61;Fc1cnc(nc1)[C@H](C)Nc(n2)nc(c(c23)scc3C)Nc4ncn(C)c4;8.3999996;TYROSINE-PROTEIN KINASE JAK2;LMM
3r8z;CCCNc(nc1N)sc1[C@@H](O)c2ccncc2;4.3099999;Cyclin-dependent kinase 2;Z63
3r8v;CCCNc(nc1N)sc1[C@H](O)c2cc(N(=O)=O)ccc2;5.54;Cyclin-dependent kinase 2;Z62
3r8u;CCCNc1sc(c(n1)N)[C@H](O)c(c2)ccc(c23)cccc3;5.3000002;Cyclin-dependent kinase 2;Z31
3hng;Clc1ccc(cc1)NC(=O)c2c(cccc2)NCc3ccncc3;6.7399998;Vascular endothelial growth factor receptor 1;8ST
5eak;c1nn(C)cc1-c(cn2)cn(c23)ncc3-c4csc(c4)C(=O)N[C@@H]5[C@H]([NH3+])CCCC5;9.3000002;Serine/threonine-protein kinase MARK2;24R
3krr;C1COCC[NH+]1Cc(c2F)c(F)cc(c2)-c3cccc(c34)ncc(n4)-c5cn(nc5)C6CC[NH2+]CC6;9.3199997;Tyrosine-protein kinase JAK2;DQX
4p90;Clc1ccc(CO)cc1C(=O)c(c[nH]2)c(c23)cc(cn3)-c4cnn(c4)C5CC[NH2+]CC5;7.1900001;Serine/threonine-protein kinase PAK 1;2K0
4aa4;C[NH+]1CCN(CC1)c(cc2)cc(c23)c(=O)n(cn3)-c4cc(ccc4C)NC(=O)c5ccoc5;8.0500002;MITOGEN-ACTIVATED PROTEIN KINASE 14;QC0
4aa5;C[NH+]1CCN(CC1)c(c2)ccc(c23)ncn(c3=O)-c(c(C)cc4)cc4C(=O)NC5CC5;7.8000002;MITOGEN-ACTIVATED PROTEIN KINASE 14;NQB
5dey;c1ccc(C)nc1-c2ccc(c(Cl)c2)-c(cc(c34)cnc(n4)NC)c(=O)n3C[C@H]5OC[C@@H](CO5)[NH3+];8.4300003;Serine/threonine-protein kinase PAK 1;59T
3jpv;c1cccc(c12)c3c([nH]2)c4c(cc3)c(C=O)c[nH]4;6.9208188;Proto-oncogene serine/threonine-protein kinase Pim-1;1DR
4fz6;c1ccccc1-c(nn(c23)ccn3)cc2Nc(ccc4)nc4N5[C@@H](C)CCC5;6.9000001;Tyrosine-protein kinase SYK;0VG
3l54;[nH]1ncc(c12)cc(cn2)-c(cc3)cc(c34)c(ccn4)-c5ccncc5;8.1499996;Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;LXX
3tjc;C1COCCN1c(cc2)ccc2-c(c3)sc(c34)c(C(=O)NC)cnc4N;7.5100002;Tyrosine-protein kinase JAK2;0TP
3tjd;CC(C)(C)NS(=O)(=O)c(cc1)ccc1-c(c2)sc(c23)c(C(=O)NC)cnc3N;9;Tyrosine-protein kinase JAK2;6TP
3ndm;C1C=NC(=O)c(c12)cc(Cl)c(c2)NC(=O)[C@@H]3C[NH2+]C[C@H]3c4ccc(Cl)cc4;7.96;Rho-Associated Protein Kinase (ROCK1);3ND
1yi3;C1COCCN1c(cc2=O)oc(c23)c(ccc3)-c4ccccc4;5.4000001;Proto-oncogene serine/threonine-protein kinase Pim-1;LY2
3sd5;Nc1cc(C(F)(F)F)c(cn1)-c2cc(N3CCOCC3)nc(n2)N4CCOCC4;6.5799999;Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;SD5
4br3;C[N+](C)=c1ccn(cc1)Cc2ccc(cc2)-c3ccc(cc3)Cn4cnc(N)c(c45)ncn5;5.7199998;CHOLINE KINASE ALPHA;U85
4y5h;CC(C)NC(=O)N[C@@H]1CC[C@H](CC1)Nc(nc2)nc(c23)n(C(C)C)c(=O)cc3;7.8200002;Mitogen-activated protein kinase 10;519
1uu7;C[N@@H+]1CCC[C@@H]1CCn2cc(c(c23)cccc3)C4=C(C(=O)NC4=O)c5c[nH]c(c56)cccc6;4.8499999;3-PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE-1;BI2
1uu9;[NH3+]CCCn1cc(c(c12)cccc2)C3=C(C(=O)NC3=O)c4c[nH]c(c45)cccc5;5.4000001;3-PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE-1;BI3
3q32;Cc1cc([nH]n1)Nc2nc(nn(c23)ccc3)N4CCN(CC4)C(=O)Cc5c(F)cc(cc5F)OC;8.7399998;Tyrosine-protein kinase JAK2;J2I
4anb;[NH3+]CC1(O)CN(C1)C(=O)c(ccc(F)c2F)c2Nc3c(F)cc(I)cc3;8.1800003;DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1;YQY
4anx;CC(C)c1ccc(cc1)-c2nccnc2N3CCN(CC3)S(=O)(=O)c4cc(ccc4)-c5cnc(N)nc5;7.7399998;PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM;534
4anw;CNC(=O)c1nc(cnc1N)-c2cc(c(Cl)cc2)S(=O)(=O)Nc3cccc(F)c3F;7.7399998;PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM;O92
4anu;CNC(=O)c1nc(cnc1N)-c2cc(ccc2)-c3[nH]nnn3;7.6799998;PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM;EM7
4anq;Clc1ccc(F)c(Cl)c1[C@@H](C)Oc2cc(cnc2N)-c3cnn(c3)C4CC[NH2+]CC4;6.2199998;ALK TYROSINE KINASE RECEPTOR;VGH
3q3b;c1cc(O)c(C)cc1-c(nc2=O)cc([nH]2)-c3ccccc3;7.7600002;Glycogen synthase kinase-3 beta;55E
3qai;CSc1ccccc1Nc(nc(n2)N(C3)CC34C[NH2+]C4)c(c25)ncnc5NCC6CC6;8.1000004;Ketohexokinase;XNN
3amb;C[NH+]1CCN(CC1)c2cc(Nc3cc([nH]n3)C)nc(n2)Sc4ccc(cc4)NC(=O)C5CC5;6.1799998;cAMP-dependent protein kinase catalytic subunit alpha;VX6
3ama;O=S(=O)(N)c(cc1)ccc1Nc(nc2N)nn2C(=O)c3c(F)cccc3F;6.5300002;cAMP-dependent protein kinase catalytic subunit alpha;SKE
3v8s;c1ccccc1CCNC(=O)Nc(c2)ccc(c23)n[nH]c3;6.1900001;Rho-associated protein kinase 1;0HD
4an9;Fc1cc(I)ccc1Nc2c(ccc(F)c2F)C(=O)N3CC(O)C3;7.3600001;DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1;2P7
4d2s;C[N@H+]1CC[C@H](CC1)Oc2ccc(c(c2)OC)Nc3nccc(n3)-c(c[nH]4)c(c45)ccnc5;7.6999998;DUAL SPECIFICITY PROTEIN KINASE TTK;DYK
4d2p;COc1cc(O)cc(c1)Nc2ccc(cc2)C(=O)Nc(cc3)cc(c34)C[NH2+]CC4;5.6799998;MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE;6Z7
4d2v;c1[nH]ncc1-c(cc2OC)ccc2C(=O)Nc(cc3)cc(c34)CC[NH2+]CC4;7.4299998;MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE;45R
4an2;[NH2+]1CCCC[C@H]1C2(O)CN(C2)C(=O)c3ccc(F)c(F)c3Nc4ccc(I)cc4F;9.0500002;DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1;EUI
4d2t;[NH3+]CCCOc1cc(-c2cn[nH]c2)ccc1C(=O)Nc3ccccc3;6;MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE;3I7
4bdj;c1ccoc1-c2ccnc(c23)n[nH]c3C4C=C4;5.1399999;CHECKPOINT KINASE 2;Z2M
4bdk;COc(cc1)ccc1CNC(=O)c(c2)ccc(c23)nccn3;5.4400001;CHECKPOINT KINASE 2;RQQ
4bdh;[nH]1nc(C)c(c1N)-c2cccs2;4.1100001;SERINE/THREONINE-PROTEIN KINASE CHK2;WVI
4bdi;O=C(C)N1CCC(CC1)C(=O)Nc2ncc(C)cc2;3.6400001;SERINE/THREONINE-PROTEIN KINASE CHK2;HAU
4bdf;Cc1cc([nH]n1)-c2ccccc2;4.0900002;SERINE/THREONINE-PROTEIN KINASE CHK2;H3R
4bdg;Nc1cc(n[nH]1)-c2cnccc2;4.1199999;SERINE/THREONINE-PROTEIN KINASE CHK2;P3J
4bdd;CC(C)(C)NC(=O)Nc(cc1)cc(c12)nccn2;4.4299998;SERINE/THREONINE-PROTEIN KINASE CHK2;Z0O
4bde;Nc1ncnc(c12)ccc(c2)C;4.8000002;SERINE/THREONINE-PROTEIN KINASE CHK2;CWS
4bdb;O/N=C(\C)c1c(O)cc(O)cc1;4.0700002;SERINE/THREONINE-PROTEIN KINASE CHK2;ODO
4bdc;c1ccoc1CNC(=O)c(c2)ccc(c23)nccn3;4.9299998;SERINE/THREONINE-PROTEIN KINASE CHK2;ODH
4bda;n1c[nH]c(n2)n1c(c23)cccc3;5.5700002;SERINE/THREONINE-PROTEIN KINASE CHK2;VFB
4mro;Nc1ccc(cn1)S(=O)(=O)N2CCN(CC2)c3ccc(cc3)C(C(F)(F)F)(C(F)(F)F)O;7.0599999;Glucokinase regulatory protein;MG0
3qkm;Cc1cccc(C)c1S(=O)(=O)N(CCOCC)C[C@@H](O)C[N@H+](C2)CCC[C@@]23CCN(C3)c4ncnc(c45)cccc5;7.4200001;RAC-alpha serine/threonine-protein kinase;SM9
3qkl;c1n[nH]c(cc2)c1c(CC3)c2O[C@]34CCC[N@@H+](C4)C[C@H](O)CN(CCOCC)S(=O)(=O)c5c(C)cccc5C;8.0500002;RAC-alpha serine/threonine-protein kinase;SMR
3qkk;c1cc(O)cc(C(=O)C2)c1O[C@@]23C[N@H+](CCC3)C[C@H](O)CN(CCOCC)S(=O)(=O)c4c(C)cccc4C;6.52;RAC-alpha serine/threonine-protein kinase;SMH
4u43;c1ccncc1Nc2ncnn(c23)ccc3;4.3200002;Mitogen-activated protein kinase kinase kinase kinase 4;3D8
4u45;c1cnccc1Nc2ncnn(c23)cc(c3)-c4c[nH]nc4;8;Mitogen-activated protein kinase kinase kinase kinase 4;3DC
4u44;c1ccccc1-c(c2)cn(c23)ncnc3Nc4ccncc4;8.1000004;Mitogen-activated protein kinase kinase kinase kinase 4;3D9
5a6n;O=S(=O)(N)c1cccc(c1)-c2nn[nH]n2;4.2800002;DEATH-ASSOCIATED PROTEIN KINASE 3;U7E
1xbb;c1ncccc1-c2ccnc(n2)Nc3c(C)ccc(c3)NC(=O)c4ccc(cc4)C[N@H+]5CC[N@@H+](C)CC5;5.3000002;Tyrosine-protein kinase SYK;STI
3w33;c1csc(c12)cccc2Oc(c(Cl)c3)ccc3Nc4ncnc(c45)NCCC(=C5)C(=O)NCCO;7.4400001;Epidermal growth factor receptor;W19
3w32;FC(F)(F)c1cccc(c1)Oc(c(Cl)c2)ccc2Nc3ncnc(c34)NCCC(=C4)C(=O)NCCS(=O)(=O)C;7.1199999;Epidermal growth factor receptor;W32
4ebw;CCc1ccc(cc1)-c(cc2)cc(c23)c4c(S(=O)(=O)N3C)cnn4CC;5.0599999;Focal adhesion kinase 1;0PF
4ebv;CCc1ccc(cc1)-c(cc2)cc(c23)c4c(S(=O)(=O)N3C)cn[nH]4;5.3800001;Focal adhesion kinase 1;0O7
2v22;Clc1ccc(cc1)-n2nc(nc2C)C(=O)N[C@@H](CCC[NH+]=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(=O)N)Cc3ccc(F)cc3;5.3872161;CELL DIVISION PROTEIN KINASE 2;C35
2jds;[nH]1nc(C)c(c12)cc(cc2)-c3cncc(c3)OC[C@@H]([NH3+])Cc(c[nH]4)c(c45)cccc5;8.1999998;CAMP-DEPENDENT PROTEIN KINASE;L20
3i5n;c1ccccc1-c(n2)ccc(n23)nnc3CNc4ccnc(c45)cc(cn5)OC;7.8499999;Hepatocyte growth factor receptor;B2D
3i5z;c1ccccc1Nc(ncc2C)nc2-c3c[nH]c(c3)C(=O)N[C@H](CO)c4ccccc4;8.6999998;Mitogen-activated protein kinase 1;Z48
2duv;c1c(O)c(O)ccc1-c(o2)c(O)c(=O)c(c23)cc(C)cc3N(S4(=O)=O)CCC4;7.0599999;Cell division protein kinase 2;371
3eta;[NH3+]Cc1ccc(cc1)-c(cn2)cc(c23)c(c[nH]3)-c4cccc(c4)NC(=O)Nc5ccccc5Oc6ccccc6;7.8538718;insulin receptor, kinase domain;351
3bbt;c1cccc(c12)c(ncn2)Nc3ccc(c(Cl)c3)OCc4cccc(F)c4;6.154902;Receptor tyrosine-protein kinase erbB-4;FMM
3hll;c1cc(F)cc(F)c1COc2c(Br)c(=O)n(c(c2)C)-c3cc(C(=O)NC)ccc3C;8.2365723;Mitogen-activated protein kinase 14;I45
3bbf;OP([O-])(O)OP([O-])(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n(cn2)c(c23)[nH]c(=[NH2+])[nH]c3=O;5.2800002;Nucleoside diphosphate kinase B;GDP
3hl7;c1cc(Cl)ccc1-c2n[nH]c(c2-c3ccncn3)C4CCN(CC4)C(=O)CO;7.6382723;Mitogen-activated protein kinase 14;I47
4gcj;NS(=O)(=O)c(cc1)ccc1Nc(s2)nc(N)c2C(=O)c3c(N(=O)=O)cccc3;7.6999998;Cyclin-dependent kinase 2;X64
5dgz;n1[nH]c(C)c(c12)cc(cc2)-c3cncc(c3)OC[C@@H]([NH3+])Cc(c[nH]4)c(c45)cccc5;7.8499999;Serine/threonine-protein kinase pim-1;L20
3unz;Fc1ccccc1Nc(ccn2)nc2Nc(cc3)ccc3C(=O)[O-];7.8000002;Aurora kinase A;0BZ
3unj;O=C([O-])c1ccc(cc1)Nc2nccc(n2)Nc3ccccc3;4.96;Cyclin-dependent kinase 2;0BX
3unk;O=C([O-])c1ccc(cc1)Nc2nc(ccn2)Nc3ccccc3Cl;4.8200002;Cyclin-dependent kinase 2;0BY
2ghg;[nH]1cccc1C[C@H](C(=O)N2)c(c23)cc(cc3)-c4cncc(c4)OC[C@@H]([NH3+])Cc(c[nH]5)c(c56)cccc6;8.8199997;Serine/threonine-protein kinase Chk1;A53
3p9j;c1ccccc1-n(c2=O)[nH]c(\c(c23)cccc3)=N/c4cc([nH]n4)C;7.5100002;Serine/threonine-protein kinase 6;P9J
3r9h;Fc1cccc(F)c1NC(=O)c2c(N)nc(s2)Nc(cc3)ccc3S(=O)(=O)N;4;Cyclin-dependent kinase 2;Z67
1e9h;c1cccc(c12)C(=O)/C(N2)=C3/C(=O)Nc(c34)ccc(c4)S([O-])(O)O;7.46;CELL DIVISION PROTEIN KINASE 2;INR
4yht;Clc1c[nH]c(c12)ncnc2Nc3cc(S(=O)(=O)NC)ccc3N4CCOCC4;9.2200003;Serine/threonine-protein kinase B-raf;4EF
3thb;c1cc(Cl)cc(N=C(C2)S)c1c(c23)nc(nc3)Nc4cc(cnc4C)CCC[NH+](C)C;8.6999998;Serine/threonine-protein kinase PLK1;3TA
4yhf;CC(C)(C)C[C@H](C#N)C(=O)N(CCC1)C[C@@H]1n(c(c23)ncnc2N)nc3-c4ccc(cc4)Oc5ccccc5;8.3400002;Tyrosine-protein kinase BTK;4C9
3zrm;c1cc(O)ccc1-c(c[nH]c2=O)c(c23)sc(c3)-c4ccncc4;6.8899999;GLYCOGEN SYNTHASE KINASE-3 BETA;ZRM
3zrl;Brc1c[nH]c(=O)c(c12)cc(s2)-c3ccncc3;6.8000002;GLYCOGEN SYNTHASE KINASE-3 BETA;ZRL
3zrk;c1c[nH]c(=O)c(c12)cc(o2)-c3ccncc3;6.8899999;GLYCOGEN SYNTHASE KINASE-3 BETA;ZRK
5lwn;c1c[nH]c(c1c23)ncc3nc(n2[C@H]4CCCC[C@H]4C)-c5ccc(o5)/C=C(C#N)\C(=O)N(C)C;7.77;Tyrosine-protein kinase JAK3;79R
5lwm;c1c[nH]c(nc2)c1c(c23)n(C4CCCCC4)c(n3)-c5ccc(o5)C[C@@H](C#N)C(=O)N(C)C;8.8699999;Tyrosine-protein kinase JAK3;79T
5bue;c1cnccc1-c2n[nH]c(c23)CCN(C3)c4ccn(c(=O)c4)Cc5ccccc5;8.5200005;Mitogen-activated protein kinase 1;4V8
5buj;c1cnccc1-c2[nH]nc(c23)CCN(C3)C4=CC=NC(=O)C4;8.3000002;Mitogen-activated protein kinase 1;4VB
5bui;n1ccccc1N(C2)CCc(c23)n[nH]c3-c4ccc(F)cc4;7.0500002;Mitogen-activated protein kinase 1;4V9
5icp;Clc1ccc(cc1)[C@H]2N(CCC2)C(=O)c(s3)nn(c34)c(C)nc4;8.4200001;Cyclin-dependent kinase 8;69Z
4byi;CC(=O)NC[C@H](CC1)CN1c(c(Cl)cn2)c(c23)nc([nH]3)-c4cn(C)nc4C;8.0500002;AURORA KINASE A;FH3
4byj;CC(=O)N[C@@H](CC1)CN1c(c(Cl)cn2)c(c23)nc([nH]3)-c4cn(C)nc4C;6.5700002;AURORA KINASE A;FH5
2hz4;C[C@@]12n3c4c(cccc4)c5c3c6n([C@H](O2)C[C@@H]([NH2+]C)[C@H]1OC)c7c(CCCC7)c6c8c5CNC8=O;5.4699998;Proto-oncogene tyrosine-protein kinase ABL1;4ST
2hz0;CCCc(c(c1)C(F)(F)F)ccc1NC(=O)c2ccccc2NCC3=CCC(=O)N=C3;6.48;Proto-oncogene tyrosine-protein kinase ABL1;GIN
2hzi;Clc1cccc(Cl)c1-c(c(=O)n2C)cc(c23)cnc(n3)Nc4cc(C)c(F)cc4;7.1500001;Proto-oncogene tyrosine-protein kinase ABL1;JIN
5hcx;CC(C)n(c(n1)C)c(c12)cc(nc2)Nc3ccnc(n3)-c4cnn(c4)S(=O)(=O)C5CC5;8.3900003;Epidermal growth factor receptor;60B
5hcy;C1CC1S(=O)(=O)n(c2)ncc2-c(n3)nccc3Nc(nc4)cc(c45)n(C(C)C)cc5C(=O)NC6CCOCC6;8.9200001;Epidermal growth factor receptor;60D
4qp7;[nH]1ccc(c12)nc(cn2)-c3cn[nH]c3;5.23;Mitogen-activated protein kinase 1;363
4qp6;[nH]1ccc(c12)nccn2;3.46;Mitogen-activated protein kinase 1;36N
2pzy;O=C1NC[C@H](C)c2c1[nH]c(c23)ccc(c3)C(=O)Nc4scc(n4)C(=O)NCC[NH+](C)C;7.4699998;MAP kinase-activated protein kinase 2;B18
5knj;FC(F)(F)Oc1ccc(cc1)NC(=O)Nc2ccc(cc2)N(C)c3nc(ncc3)Nc4cc(S(=O)(=O)N)ccc4;6.9400001;Mixed lineage kinase domain-like protein;6UX
5hg7;Clc1c[nH]c(c12)nc(Nc3cn(C)nc3)nc2OC[C@H]([C@H]4OC)CN(C4)C(=O)CC;8.3999996;Epidermal growth factor receptor;630
5j7b;CC(C)(C)S(=O)(=O)c(cc1)cc(c12)c(ccn2)Nc([nH]n3)c(c34)cc(F)cc4;8.3000002;Receptor-interacting serine/threonine-protein kinase 2;6GD
1sm2;c1cccc(c1n2[C@]34C)c5c2c6n([C@H](O4)C[C@@H]([NH2+]C)[C@H]3OC)c7c(cccc7)c6c8c5CNC8=O;8;Tyrosine-protein kinase ITK/TSK;STU
3oy1;c1cccc(c12)cc(cc2)-n3c(nn(c3=O)C4CCOCC4)-c5ccnc(c5)NC6CCCCC6;7.8000002;Mitogen-activated protein kinase 10;589
4xs2;OC[C@@H](C1)[C@@H](O)[C@@H](O)[C@@H]1Nc2nc(NCCCOC)nc(Cl)c2-c(s3)nc(c34)cccc4;5.8200002;Interleukin-1 receptor-associated kinase 4;42P
4zy5;C1CC1c(n[nH]2)cc2Nc(ccn3)nc3NC[C@H](CC4)CC[C@@H]4[NH3+];7.5900002;Serine/threonine-protein kinase PAK 1;4T5
4zy4;C1CC([NH3+])CCN1c(nc(c23)ccs2)nc3Nc(n[nH]4)cc4C5CC5;7.6599998;Serine/threonine-protein kinase PAK 1;4T3
4zy6;n1c[nH]c(c12)ccc(c2Cl)CNc(n3)nccc3Nc4cc(n[nH]4)C5CC5;8.3000002;Serine/threonine-protein kinase PAK 1;4T6
4alw;C[N@@H+]1CC[N@H+](CC1)Cc(n2)[nH]c(=O)c3oc(c4c23)ccc(Br)c4;7.5700002;PIM-1 KINASE;HY7
4alv;C1C[NH2+]CCC1CNc2cc(Cl)c(cc2)-c(n3)[nH]c(=O)c4oc(c5c34)ccc(Br)c5;8.1499996;SERINE/THREONINE-PROTEIN KINASE PIM-1;R9P
3wyy;COCCNC(=O)\C=C\c(c1OCC#N)ccc(c1)Nc2nc(c(C#N)c(N)c2)NC34C[C@@H]5C[C@H](C4)C[C@@H](C5)C3;8.4899998;Dual specificity protein kinase TTK;O17
3wyx;N#CCOc1c(-c2cn(C)nc2)ccc(c1)Nc3nc(c(C#N)cc3)NC4CCCCC4;8.3699999;Dual specificity protein kinase TTK;O38
3aox;N#Cc(c1)ccc2c1[nH]c(c23)C(C)(C)c4c(C3=O)cc(CC)c(c4)N(CC5)CCC5[NH+]6CCOCC6;9.0799999;ALK tyrosine kinase receptor;EMH
3fup;N#CCC(=O)N(CC[C@H]1C)C[C@@H]1N(C)c2ncnc(c23)[nH]cc3;7.6635404;Tyrosine-protein kinase JAK2;MI1
5fdp;c1ncncc1N(C2)C[C@@H](C)c(c23)ccc(c3)C(=O)Nc4cc(C(F)(F)F)cc(c4)C[N@H+]5CC[N@H+](C)CC5;6.5100002;Epithelial discoidin domain-containing receptor 1;5WR
4q18;CC(C)(O)COc1cc(ccc1OC)-c2nc(c(s2)CCC)CSc3cc(N)nc(n3)N;6.1300001;Deoxycytidine kinase;2XJ
4q19;COc1c(O)cc(cc1)-c2nc(c(s2)CCC)CSc3nc(N)cc(n3)N;8.0500002;Deoxycytidine kinase;2XL
4kzc;FC(F)(F)c1c(N)ncc(c1)-c(cc2)cn(c23)cc(n3)NC(=O)C;8.0900002;Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;1UK
4q1f;CS(=O)(=O)NCCOc1cc(ccc1OC)-c2nc(c(s2)C)[C@@H](C)Sc3nc(N)cc(n3)N;8.04;Deoxycytidine kinase;2XN
4q1d;FCCOc1cc(ccc1OC)-c2nc(c(s2)CCC)[C@@H](C)Sc3nc(N)cc(n3)N;7.7800002;Deoxycytidine kinase;2Y1
4q1e;FCCOc1cc(ccc1OC)-c2nc(c(s2)C)[C@@H](C)Sc3nc(N)cc(n3)N;8.1700001;Deoxycytidine kinase;2Y8
4q1b;CS(=O)(=O)NCCOc1cc(ccc1)-c2nc(c(s2)CCC)CSc3nc(N)cc(n3)N;8.7200003;Deoxycytidine kinase;2Y0
4q1c;OCCOc1ccc(cc1OCCO)-c2nc(c(s2)CCC)CSc3nc(N)cc(n3)N;8.6999998;Deoxycytidine kinase;2XM
4q1a;OCCOc1cc(ccc1OC)-c2nc(c(s2)CCC)CSc3nc(N)cc(n3)N;9.3000002;Deoxycytidine kinase;2XZ
3g15;C[N+]1(C)C[C@@](O)(OCC1)c2ccc(cc2)-c3ccc(cc3)[C@@]4(O)C[N+](C)(C)CCO4;7;Choline kinase alpha;HC6
5fd2;CN(C)S(=O)(=O)Nc1c(F)c(c(F)cc1)Nc2ncccc2-c(ncn3)c(c34)nc[nH]4;7.0500002;Serine/threonine-protein kinase B-raf;5XJ
4n6y;O=C(C)Nc(sc1)nc1C(=O)Nc2c(cccc2)N3CCCCC3;7.04;Serine/threonine-protein kinase pim-1;2HV
4n6z;n1ccnc(N)c1C(=O)Nc2cnccc2N3CCC[C@@H](C3)[NH3+];7.8000002;Serine/threonine-protein kinase pim-1;2HW
2ayp;Oc1c(OC)cc(cc1)-c(c2)ccc(c23)/C(C(=O)N3)=C/c4[nH]ccc4;8.1499996;Serine/threonine-protein kinase Chk1;43A
4kz0;O=C(C)Nc(s1)nc(c12)ccc(c2)C(=O)OC;5.3800001;Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;1UJ
4mpn;Oc1cc(O)cc(c12)cn(c2)S(=O)(=O)c3ccc(O)cc3O;6.6199999;[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial;PV0
4mpe;c1cc(O)cc(c12)cn(c2)S(=O)(=O)[C@H]3C=CC(=O)C=C3O;6.3699999;[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial;PV8
4mpc;Oc1cc(O)ccc1S(=O)(=O)n(c2)cc(c23)cccc3;6.1500001;[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial;PV2
3rin;C1CC1NC(=O)c(ccc2C)cc2-c(cc3)cc(NC4=O)c3C45CCCC5;8.8900003;Mitogen-activated protein kinase 14;I2O
3w1f;O=S(=O)(N)c1cc(ccc1C)-c2[nH]nc(c23)cc(c(c3)OCC)-c4cnn(C)c4;8.4399996;Dual specificity protein kinase TTK;1O5
5a4l;O=C(C)Nc(n1)sc(c12)ccc(F)c2;5.4099998;DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION- REGULATED KINASE 1A;ZC3
5a4e;CC(=O)Nc(n1)sc(c12)ccc(c2)OC;6.4000001;DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE 1A;7QQ
3ri1;n1c(N)ncc(c12)C[C@@H](c3ccccc3)c4c2cccc4;5.3000002;Fibroblast growth factor receptor 2;3RH
4mp7;c1cccc(c12)cn(c2)C(=O)c3c(O)cc(O)cc3;5.7399998;[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial;PFT
4mp2;c1cccc(c12)CN(C2)C(=O)c(c3)c(O)cc(O)c3Br;5.4499998;[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial;PV1
2ds1;C[C@@H]1C[C@@H](C[N@H+]12)Oc3c4c(ccc3)NC(=O)[C@@H](N4)c5c6c(ccc5)c(=O)n([nH]6)CC2;8.4700003;Cell division protein kinase 2;1CD
1qpe;n1cnc(N)c(c12)c(nn2C(C)(C)C)-c3ccc(Cl)cc3;7.6999998;LCK KINASE;PP2
3zim;CC(C)CC(=O)CCC(=O)N1CC[NH+](CC1)Cc(c2)sc(c23)c(N4CCOCC4)nc(n3)-c(ccc5)c(c56)cn[nH]6;8.1700001;PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT ALPHA ISOFORM;KKR
4tw9;FC(F)(F)Oc1ccccc1C(=O)Nc(n2)scc2C(=O)Nc([nH]3)nc(c4)c3cc(c45)OC(F)(F)O5;7.6999998;Casein kinase I isoform delta;386
2uw8;Clc1ccc(cc1)[C@H](C[NH3+])c2ccccc2;4.1135092;CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT;GVQ
2uw7;Clc1ccc(cc1)C2(CC[NH2+]CC2)c3ccc(cc3)-c4c[nH]nc4;7.7447281;CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT;GVP
3ce3;c1cc(F)ccc1-n(ccc2)c(=O)c2C(=O)Nc(cc3F)ccc3Oc4ccnc(c45)[nH]cc5;8.7447271;Hepatocyte growth factor receptor;1FN
2zm1;c1cccc(c1Cl)Nc(c(n23)cnc3)ncc2-c4ccccc4;6.6575775;Proto-oncogene tyrosine-protein kinase LCK;KSF
4pte;c1nccc(c12)ccc(c2)-c3ccnc(c3)NC(=O)C4CC4;7.1300001;Glycogen synthase kinase-3 beta;2WF
4bhz;c1nccc(c12)cnc3c2ccs3;4.27;DUAL SPECIFICITY PROTEIN KINASE TTK;Z0B
3mb7;O=C([O-])c(o1)cc(c12)c3c(cc2)ccc4c3cc(o4)C([O-])=O;6.6999998;Casein kinase II subunit alpha;14I
4h58;COCC[NH2+]Cc1ccc(cc1)Nc(n2)ncc(c23)cc(cc3)-c4ccncc4;6.7199998;Serine/threonine-protein kinase B-raf;10Z
2zmd;c1cccc(c12)C(=O)c3c4c(n[nH]c24)ccc3;7.0100002;Dual specificity protein kinase TTK;537
3rwq;Nc1ncnc(c12)n(C(C)C)cc2C(=O)c3nc(cnc3)NCCc4cccnc4;7.46;3-phosphoinositide-dependent protein kinase 1;3RW
4xhk;Fc1cccc(F)c1-c(n2)scc2C(=O)Nc3cnccc3O[C@@H]4C[NH2+]CC4;8.3000002;Serine/threonine-protein kinase pim-1;3YR
5dia;C1[C@@H]([NH3+])CCC[C@@H]1Nc(n2)cccc2-c3n[nH]c(c34)cnc(c4)-c5cccnc5;10.46;Serine/threonine-protein kinase pim-1;5E6
4ph4;C1CC1Cc2nc(N)ncc2-c3nc(ncc3)Nc4ccncc4;7.7399998;Phosphatidylinositol 3-kinase catalytic subunit type 3;2UG
1p5e;Brc1c(Br)c(Br)c(Br)c(c12)nn[nH]2;4.8099999;Cell division protein kinase 2;TBS
2gni;c1nccc(c12)c(ccc2)S(=O)(=O)N3CC[NH2+]CCC3;5.6399999;cAMP-dependent protein kinase, alpha-catalytic subunit;M77
2of2;C1C[NH2+]CC[NH+]1CCNc(ccn2)c(c23)c(-c4ccccc4)c(o3)-c5ccccc5;6.6799998;Proto-oncogene tyrosine-protein kinase LCK;547
4jbo;C[NH+](C)CCOc1ccc(cc1)-c(c2)oc(c23)ncnc3NCCc4ccc(cc4)NC(=O)Nc5ccccc5;7.6199999;Aurora kinase A;WPH
4jbp;O[C@@H]1CC[N@H+](CC1)CCOc2ccc(cc2)-c(c3)oc(c34)ncnc4NCCc5ccc(cc5)NC(=O)Nc6ccccc6;7.3899999;Aurora Kinase A;YPH
5di1;c1cc(O)ccc1-c2cc(c(N)nc2)-c3ccc(cc3)S(=O)(=O)C;7.6799998;Mitogen-activated protein kinase kinase kinase kinase 4;5DF
4xh6;COc(c1O)c(O)cc(c12)oc(cc2=O)-c3ccc(O)cc3;5.5700002;Serine/threonine-protein kinase pim-1;HUL
1o5c;Fc(c1)c(C(=[NH2+])N)cc(c12)nc([nH]2)-c3cccc(c3O)O[C@H]4CCCC[C@H]4C;5.2199998;Urokinase-type plasminogen activator;CR9
1o5a;c1cc(C(=[NH2+])N)cc(c12)cc([nH]2)-c3cccc(c3O)-c4ccccc4;6.4200001;Urokinase-type plasminogen activator;696
2jbo;c1cccc(c12)ncc(c2)-c3cc(ccn3)-c(c4)[nH]c(c45)CCNC5=O;8.0699997;MAP KINASE-ACTIVATED PROTEIN KINASE 2;P4O
4awi;CC(C)c(c1)[nH]c(c12)nccc2-c3ccc(cc3)S(=O)(=O)NC(CC4)CCS4(=O)=O;6;MITOGEN-ACTIVATED PROTEIN KINASE 8;AQ2
2jbp;c1cccc(c12)ncc(c2)-c3cc(ccn3)-c(c4)[nH]c(c45)CCNC5=O;8.0699997;MAP KINASE-ACTIVATED PROTEIN KINASE 2;P4O
5ia5;C[N@H+]1CC[N@H+](CC1)C2CCN(CC2)C(=O)Nc3cc(ccn3)Oc4cc(F)c(cc4)NC(=O)C5(CC5)C(=O)Nc6ccc(F)cc6;7.5999999;Ephrin type-A receptor 2;GV0
4yff;C1COCCN1c2c(cc(cc2)S(=O)(=O)NC)Nc3ncnc(c34)[nH]cc4Br;8;Serine/threonine-protein kinase TNNI3K;4CV
5ia0;O=C([O-])c1ccc(cc1OC)Nc(nc2)nc(c23)c4c(cc(Cl)cc4)C(=NC3)c5c(F)cccc5OC;6.73;Ephrin type-A receptor 2;A5B
5ia3;CSc1cc(ccc1)Nc(n2)ncc(c23)cc(c(=O)n3C)-c4c(Cl)cccc4Cl;7.3400002;Ephrin type-A receptor 2;P17
5ia2;Cn1c(=O)[nH]c(=O)c(c12)n3c(n2)n(c(c3)-c4c(C)ccc(c4)O)-c5ccccc5OC;7.7199998;Ephrin type-A receptor 2;L66
4eny;COc(c1)c(O)ccc1\C=C\2SC(=NC2=O)Nc3ccccc3Cl;7.0500002;Serine/threonine-protein kinase pim-1;J19
3tv7;COc(c1)cccc1[C@@H](C)NC(=O)Nc2nc(cs2)-c3ccncc3;7.52;Rho-associated protein kinase 1;07Q
3tv6;COc1n[nH]c(c12)ncc(c2)NC(=O)c3c(F)c(ccc3F)NS(=O)(=O)CCC;8.3199997;Serine/threonine-protein kinase B-raf;B0R
3tv4;Nc1ncc(cc1Br)NC(=O)c2c(F)ccc(c2F)NS(=O)(=O)CCC;6.96;Serine/threonine-protein kinase B-raf;TV4
5hbe;O=C(O1)NCC12CCN(CC2)c3c(Cl)cncc3-c(cc4)cc(c45)CS(=O)(=O)N5C;8.6400003;Cyclin-dependent kinase 8;5Y6
4aw5;COc(c1)ccc(c12)[nH]c(n2)C(/c3ccccc3)=C(\C(=O)N4)c(c45)cc(cc5)N[C@H]6CC[N@H+](CC)CC6;6.1199999;EPHRIN TYPE-B RECEPTOR 4;30K
3l16;c1cc(N)ncc1-c(n2)nc(N3CCOCC3)c(c24)sc(c4)C[NH+]5CCN(S(=O)(=O)C)CC5;7.48;Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;JZX
3l17;Cc1nc(N)ncc1-c(n2)nc(N3CCOCC3)c(c24)sc(c4)C[NH+]5CCN(CC5)S(=O)(=O)C;8.2799997;Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;JZY
3l13;O=S(=O)(C)N(CC1)CC[NH+]1Cc(c2)sc(c23)c(N4CCOCC4)nc(n3)-c5cccc(c5)CO;7.8200002;Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;JZW
4ase;COc(c1)c(OC)cc(c12)c(ccn2)Oc3cc(Cl)c(cc3)NC(=O)Nc4cc(on4)C;11;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2;AV9
4kao;c1cc(C)ccc1-n2c(cc(n2)C(C)(C)C)NC(=O)Nc3ccc(cc3)-c4cccnc4;6.1100001;Focal adhesion kinase 1;KAO
4kab;[nH]1ncc(c12)[nH]nc2C;4.0300002;Focal adhesion kinase 1;4KA
5h8b;CC(=O)Nc1cc(ccc1C)Nc(n2)cc(NC3C=C3)n(c24)ncc4C#N;11.31;Casein kinase II subunit alpha;5Y2
5h8g;C[NH+](C)CCN(C)c1ccc(cc1NC(=O)C)Nc(n2)cc(NC3C=C3)n(c24)ncc4C#N;10.32;Casein kinase II subunit alpha;5Y4
5h8e;[NH3+]CCN(C)c1ccc(cc1NC(=O)C)Nc(n2)cc(NC3C=C3)n(c24)ncc4C#N;11.2;Casein kinase II subunit alpha;5Y3
2br1;COc1ccc(cc1)-c2c(-c3ccc(OC)cc3)oc(c24)ncnc4NCCO;5.1399999;SERINE/THREONINE-PROTEIN KINASE CHK1;PFP
2brn;c1ccccc1-c2c(-c3ccccc3)[nH]c(c24)ncnc4NC[C@@H](C)O;5.2600002;SERINE/THREONINE-PROTEIN KINASE CHK1;DF1
2bro;OC[C@H](O)CNc(ncn1)c(c12)c(-c3ccccc3)c([nH]2)-c4ccccc4;5.8499999;SERINE/THREONINE-PROTEIN KINASE CHK1;DF2
2brm;c1ccccc1-c(c(c23)c(ncn2)NCCO)c([nH]3)-c4ccccc4;5.8899999;SERINE/THREONINE-PROTEIN KINASE CHK1;DFZ
2brh;c1ccccc1-c(c(c23)c(ncn2)NCC(=O)[O-])c(o3)-c4ccccc4;4.6399999;SERINE/THREONINE-PROTEIN KINASE CHK1;DFW
2brg;c1ccccc1-c(c(c23)c(ncn2)N(C)CCO)c(o3)-c4ccccc4;5.21;SERINE/THREONINE-PROTEIN KINASE CHK1;DFY
2brb;c1ccccc1-c(c(c23)c(ncn2)NCCO)c(o3)-c4ccccc4;4.8600001;SERINE/THREONINE-PROTEIN KINASE CHK1;PFQ
2hxl;C1C[C@@H](C[NH3+])CC[N@@H+]1Cc(c2)ccc(c23)[nH]c(c3)-c4n[nH]c(c45)cc(C#N)cc5;7.9200001;Serine/threonine-protein kinase Chk1;422
2hxq;c1cccc(c12)[nH]c(=O)c(c2)-c([nH]3)cc(c34)cc(cc4)C[N@H+]5CC[C@@H](CC5)C[NH3+];6.8400002;Serine/threonine-protein kinase Chk1;373
5khx;[nH]1ccc(c12)c(ncn2)N(C)[C@H](C3)C[C@H]3NS(=O)(=O)C;7.8499999;Tyrosine-protein kinase JAK1;6TE
4daw;O=C1NC(=O)c(c2)c1cc(C=3N4C=CCC3)c2[Ru]456(N=C=S)S7CCS5CCS6CC7;7.0799999;Serine/threonine-protein kinase PAK 1;0H2
4bb9;OP([O-])(O)OC[C@]1(O)[C@@H](O)[C@H](O)[C@@H](CO1)O;6;GLUCOKINASE REGULATORY PROTEIN;F1P
5ar8;CS(=O)(=O)c1cccc(c1)Nc2nccc(n2)-c3sc(N4CCOCC4)nc3-c5cccc(c5)NS(=O)(=O)c6c(F)cccc6F;8.1000004;RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2;XYW
5ar5;COCCNC(=O)c(cc1)cc(c12)nc(n2CCOC)-c3c[nH]c(n3)-c4ccc(Cl)cc4;6.3000002;RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2;IQ7
4da5;Clc(s1)ccc1C(O)([C@@H](C[N@@H+]23)[C@H](CC2)CC3)c4ccc(Cl)s4;6.4400001;Choline kinase alpha;0H7
5ar7;CC(C)(C)c(on1)cc1NC(=O)Nc2ccc(cc2)Oc3ccncc3;6.4899998;RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2;SR8
4gii;C1CC1C(=O)Nc2cc(ccn2)NC(=O)c(c3Cl)c(Cl)cc(c3)C#N;8.7399998;Non-receptor tyrosine-protein kinase TYK2;0X6
3hub;CN(C)C(=O)C(=O)c1cn(C)c(c12)cc(Cl)c(c2)C(=O)N3[C@H](C)C[N@H+]([C@H](C3)C)Cc4ccc(F)cc4;8.0900002;Mitogen-activated protein kinase 14;469
3huc;c1ccccc1-c(n2)nc(Nc3ccn[nH]3)c(c24)ccc(c4)NC(=O)C=C;5.9899998;Mitogen-activated protein kinase 14;G97
2wpa;C1C[N@@H+](C)CC[C@@H]1C(=O)N(C2(C)C)Cc(c23)c(n[nH]3)NC(=O)CC(C)C;8.1000004;CELL DIVISION PROTEIN KINASE 2;889
2wu7;CCOC(=O)c(n1C)c(/C(C#N)=C\N)c(c12)ccc(Cl)c2Cl;6.2800002;DUAL SPECIFICITY PROTEIN KINASE CLK3;V25
5lmb;c1nc(N(C)C)ccc1-c(c2)nc(c(c23)nccn3)NC[C@H]4CCC[NH2+]C4;7.8000002;Tyrosine-protein kinase SYK;6ZF
4ijp;Clc1cc(ccn1)CNC(=O)c2sc(cc2)-c(ccc3)c(c34)cc(s4)C(=O)N;7.8000002;Serine/threonine-protein kinase PRP4 homolog;1EH
3rkb;c1ccncc1C(=O)c2c(N)nc(s2)NC3CCCCC3;6.4200001;Cyclin-dependent kinase 2;12Z
3rk9;CC(C)Nc1nc(N)c(s1)[C@H](O)c2cccnc2;6.2800002;Cyclin-dependent kinase 2;09Z
3rk7;c1cc(C(=O)N)ccc1Nc2nc(N)c(s2)[C@H](O)c3cccnc3;6.6999998;Cyclin-dependent kinase 2;08Z
3rk5;c1cc(C(=O)[O-])ccc1Nc2nc(N)c(s2)[C@H](O)c3cccnc3;5.4000001;Cyclin-dependent kinase 2;07Z
3nyn;n1cnc(N)c(c12)c(C(=O)N)cn2[C@H]3[C@H](O)[C@H](O)[C@H](O3)CO;6;G protein-coupled receptor kinase 6;SGV
4whz;C1[NH2+]CC[C@@H]1n(nc2)cc2NC(=O)c(c3)cccc3-n(c4)ncc4NC(=O)Nc5ccccc5Cl;9;Mitogen-activated protein kinase 10;3NL
2dq7;CO[C@@H]1[C@H]([NH2+]C)C[C@@H](O2)n3c(cccc4)c4c(c3c5n6[C@]12C)c7c(CNC7=O)c5c8c6cccc8;8.3199997;Proto-oncogene tyrosine-protein kinase Fyn;STU
1aq1;CO[C@@H]1[C@H]([NH2+]C)C[C@@H](O2)n3c(cccc4)c4c(c3c5n6[C@]12C)c7c(C=NC7=O)c5c8c6cccc8;8.1499996;CYCLIN-DEPENDENT PROTEIN KINASE 2;STU
5l3a;c1n[nH]c(c12)cccc2NS(=O)(=O)C;6.3499999;Tyrosine-protein kinase JAK2;6DP
2g9x;OCCC[NH2+]CCS(=O)(=O)c1ccc(cc1)Nc(nc(c23)nc[nH]3)nc2OCC4CCCCC4;7.3499999;Cell division protein kinase 2;NU5
2zoq;OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n(cc2I)c(c23)ncnc3N;6.0457573;Mitogen-activated protein kinase 3;5ID
4x7o;FC(F)(F)c1cc(cc(F)c1)CC(=O)n(cc2)c(c23)ccc(c3)-c4cn(C)c(c45)nc(C)nc5N;8.6999998;Eukaryotic translation initiation factor 2-alpha kinase 3,Eukaryotic translation initiation factor 2-alpha kinase 3;3Z6
4rll;O=C([O-])c1ccc(cc1)/C=N/N=C2c(cccc3)c3c(c24)cccc4;5.02;Casein kinase II subunit alpha;E91
3dtc;c1cccc(n2CCO)c1c(c23)c4c(C(=O)N=C4)c5c3ccc6c5ccc(c6)OC(C)C;7.5850267;Mitogen-activated protein kinase kinase kinase 9;VIN
5cu4;c1ccccc1-c(c(Cl)c2)ccc2C[NH2+]CCC(=O)NCCC(=O)Nc3cccc(c3)C(=O)[O-];6.4899998;Casein kinase II subunit alpha;54S
4h71;O/N=C1\C=C(C(C)C)C(=O)C=C1C;4.4499998;Serine/threonine-protein kinase PLK1;PXE
2uue;C1COCCN1c2ccc(cc2)Nc3nc(ccn3)-c4sc(N)nc4C;6.1300001;CELL DIVISION PROTEIN KINASE 2;MTZ
3jvs;c1cccc(c12)cccc2NC(=O)NNC(=O)c3cc(N(=O)=O)c(cc3)C(C)(C)C;6.5376019;Serine/threonine-protein kinase Chk1;AGY
3jvr;c1cccc(c12)nc([nH]2)[C@H](C)OC(=O)Nc3ccc(Cl)c(Cl)c3;5.7235384;Serine/threonine-protein kinase Chk1;AGX
4xj0;Clc1ccc(cc1F)[C@@H](CO)n2ccc(cc2=O)-c(n3)ccnc3NC4CCOCC4;9.5200005;Mitogen-activated protein kinase 1;41B
4j53;C1C[N@@H+](C)CC[C@@H]1NC(=O)c2cc(OC)c(cc2F)Nc(nc3)nc(c34)N(CC(F)(F)C(=O)N4C)C5CCCC5;8.6999998;Serine/threonine-protein kinase PLK1;1J4
4j52;C1C[N@@H+](C)CC[N@@H+]1NC(=O)c(cc2OC)ccc2Nc(nc3)nc(c34)N(C[C@](F)(C=C)C(=O)N4C)C5CCCC5;8.5200005;Serine/threonine-protein kinase PLK1;1J3
3dt1;C1COCC[NH+]1CCNc(nc2)nc(c23)ccc(c3)-c4cc(ccc4C)C(=O)NC5CC5;8.6197891;Mitogen-activated protein kinase 14;P40
4aua;c1cccc(c12)[nH]c(n2)C(=O)c3ccc[nH]3;5.1399999;CYCLIN-DEPENDENT KINASE 6;4AU
3c4e;c1ccccc1Nc2c[nH]c(c23)nccc3;4;Proto-oncogene serine/threonine-protein kinase Pim-1;C4E
3tti;C1C[C@H](O)CC[C@H]1Nc(n2)ncc(c23)nc(n3[C@@H]4COCC4)Nc5c(F)cc(F)cc5F;8.2200003;Mitogen-activated protein kinase 10;KBI
3ttj;c1cccc(F)c1Nc(n2C3CCCC3)nc(c24)cnc(n4)Nc5ccc(OC)cc5;6.6799998;Mitogen-activated protein kinase 10;JBI
1a9u;O=[S@@](C)c1ccc(cc1)-c2[nH]c(c(n2)-c(cc3)ccc3F)-c4ccncc4;7.3200002;MAP KINASE P38;SB2
4au8;c1cccc(c12)nc(s2)-c3cc(sc3)S(=O)(=O)N;6.2600002;CYCLIN-DEPENDENT KINASE 5;Z3R
5ho8;c1ccnc(c12)[nH]cc2-c3cc(nc(n3)N)CCCC;5.96;3-phosphoinositide-dependent protein kinase 1;63E
5ho6;c1cc(F)ccc1-c(cc2)nn(c23)c(nn3)Sc(cc4)cc(c45)sc(n5)NC(=O)NCC[NH+]6CCOCC6;6.6900001;Hepatocyte growth factor receptor;63K
5ho7;NC(=O)c1c(N)n(C(=O)N)nc1SC;4.77;3-phosphoinositide-dependent protein kinase 1;63L
4kcg;CS(=O)(=O)NCCOc1cc(ccc1OC)-c2nc(c(s2)CCC)CSc3nc(N)cc(n3)N;8.3000002;Deoxycytidine kinase;1QC
3eoc;c1ccccc1-c2nc(C)c(n23)cnc(n3)Nc(c4)cc(OC)c(OC)c4OC;6.6382718;Cell division protein kinase 2;T2A
5hor;c1cc(F)ccc1-c(cc2)nn(c23)c(nn3)Sc(cc4)cc(c45)sc(n5)NC(=O)NCC[NH+]6CCOCC6;8.2200003;Hepatocyte growth factor receptor;63K
5hoa;c1cc(F)ccc1-c(cc2)nn(c23)c(nn3)Sc(cc4)cc(c45)sc(n5)NC(=O)NCCN6CCOCC6;7.1900001;Hepatocyte growth factor receptor;63K
4dce;COc1c(OC)cc(cc1OC)Nc2nc(ccn2)N3C[C@H](CCC3)C(=O)NCc4ccc(C)cc4;6.7600002;ALK tyrosine kinase receptor;0JF
1sqt;C1[NH2+]N(S(=O)(=O)C)C[C@@H]1c(c(cc2)OC)c(c23)cc(cc3)C(=[NH2+])N;6.1999998;Urokinase-type plasminogen activator;UI3
3h30;c1c(Cl)c(Cl)cc(c12)ncn2[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O;4.5346169;Casein kinase II subunit alpha;RFZ
1sqa;[NH3+]Cc1ccc(cc1)NC(=O)c(cc(c23)ccc(c3)C(=[NH2+])N)cc2Nc4ncccn4;9.21;Urokinase-type plasminogen activator;UI1
1sqo;c1cc(C(=[NH2+])N)cc(c12)c(ccc2)Nc3ncccn3;7.46;Urokinase-type plasminogen activator;UI2
3h3c;CNS(=O)(=O)c(cc1)ccc1Nc2ncc(C(F)(F)F)c(n2)N[C@@H]3CCC[C@H]3[NH+](C)C;6.8538718;Protein tyrosine kinase 2 beta;P1E
5ap2;Cn(c1)ncc1-c(c2)n(C(=O)OC(C)C)c(c23)cc(nc3)Nc4ccc(cc4)-c5cnc(C)n5C;8.4799995;DUAL SPECIFICITY PROTEIN KINASE TTK;PWU
5ap3;C1CCCC1n(c(=O)n2C)c(c23)nc(nc3)Nc4c(OC)cc(cc4)O[C@@H]5CC[N@@H+](C)CC5;7.0300002;DUAL SPECIFICITY PROTEIN KINASE TTK;AU5
5ap0;C1CCCC1n(c(=O)n2C)c(c23)nc(nc3)Nc4c(OC)cc(cc4)O[C@@H]5CC[N@@H+](C)CC5;8.2600002;DUAL SPECIFICITY PROTEIN KINASE TTK;AU5
5ap1;N#CCOc1c(-c2cn(C)nc2)ccc(c1)Nc3nc(c(C#N)cc3)NC4CCCCC4;7.9699998;DUAL SPECIFICITY PROTEIN KINASE TTK;O38
5ap6;Cn(c1)ncc1-c(c2)n(C(=O)OC(C)C)c(c23)cc(nc3)Nc4ccc(cc4)-c5cnc(C)n5C;7.8800001;DUAL SPECIFICITY PROTEIN KINASE TTK;PWU
5ap7;CCc1cccc(CC)c1NC(=O)c2nn(C)c(c23)c4c(cc3)cnc(n4)Nc5c(OC(F)(F)F)cc(cc5)C(=O)N[C@H]6CC[N@H+](C)CC6;8.3999996;MONOPOLAR SPINDLE KINASE 1;SVE
5ap4;N#CCOc1c(-c2cn(C)nc2)ccc(c1)Nc3nc(c(C#N)cc3)NC4CCCCC4;6.46;DUAL SPECIFICITY PROTEIN KINASE TTK;O38
5ap5;CC(C)(C)OC(=O)n1c(-c2cnn(c2)C)cc(c13)cnc(c3)Nc4ccc(cc4Cl)C(=O)N(C)C;7.9699998;DUAL SPECIFICITY PROTEIN KINASE TTK;7RO
1q4l;Clc1cccc(c1)[C@@H]2[C@H](C(=O)NC2=O)Nc3ccc(Cl)c(c3)C(=O)[O-];7.4000001;GLYCOGEN SYNTHASE KINASE-3 BETA;679
1q41;c1cccc(c12)NC(\C\2=N\O)=C(/C(=O)N3)c(c34)cccc4;7.6599998;GLYCOGEN SYNTHASE KINASE-3 BETA;IXM
3fqe;C1CCC[C@H]([NH3+])[C@@H]1Nc2nc(c(cn2)C(=O)N)Nc3cccc(c3)C;8.3010302;Tyrosine-protein kinase SYK;P5C
3fqh;OCC(C)(C)NC(=O)c(cc1)cc(c12)c(cn2C)-c(c3)[nH]c(c34)nccc4;6.2441254;Tyrosine-protein kinase SYK;057
2qd9;Fc1cc(F)c(cc1)-c2ncc(n23)CN(CC3)C(=O)c(c(n4)OC)cc(c45)c(c[nH]5)C(=O)C(=O)N6C[C@H](O)CC6;7.8899999;Mitogen-activated protein kinase 14;LGF
3fqs;N1C(=O)C(C)(C)Oc(c12)ccc(n2)Nc3nc(ncc3F)Nc(cc4OC)cc(OC)c4OC;7.3872161;Tyrosine-protein kinase SYK;585
3vqu;O=C(N)c1ccc(cc1)Nc2cc(N)c(C#N)c(n2)OCC;7.4299998;Dual specificity protein kinase TTK;O22
2og8;c1nc(NC)nc(c12)ccc(c2)-c(c3)c(C)ccc3C(=O)Nc4c(ccc(c4)C(F)(F)F)NC(=O)C[NH+](CC)CC;9.3000002;Proto-oncogene tyrosine-protein kinase LCK;1N8
3w55;O=C1CC(OC)=CC(=C12)\C=C\C[C@H](O)[C@H](O)C(=O)CCC[C@H](C)OC2=O;7.0999999;Mitogen-activated protein kinase 1;1FM
3zmm;Cc1cc([nH]n1)Nc2nc(N3CCOCC3)c(F)c(n2)O[C@@H](C)c4ncc(F)cn4;9.1400003;TYROSINE-PROTEIN KINASE JAK2;F9J
3qa2;Cc1ccccc1Nc(nc(n2)N3CC[NH2+]CC3)c(c24)ncnc4NCC5CC5;6.6799998;Ketohexokinase;XNA
3rmf;NS(=O)(=O)c(cc1)ccc1Nc(s2)nc(N)c2C(=O)c(cc3)cc(c34)cccc4;4.0900002;Cyclin-dependent kinase 2;20Z
3zm9;CN(C)C1=CCN(C=C1)Cc2ccc(cc2)CCCCc3ccc(cc3)Cn(cn4)c(c45)ncnc5N;7.4200001;CHOLINE KINASE ALPHA;QMQ
3zm4;C1C[NH2+]C[C@H]1Oc(c(Cl)c2)cc(c23)CC=NC3=O;5.96;DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1;22T
5eyc;Cc1cc(on1)-c(c2)cc(F)c(n23)nnc3[C@@H](C)n(cc4)c(=O)c(c45)cccn5;8.5200005;Hepatocyte growth factor receptor;5SZ
5eyd;COCCOc(c1)cnc(c12)ccn(c2=O)[C@H](C)c3nnc(n34)c(F)cc(c4)-c5cn(C)nc5;9;Hepatocyte growth factor receptor;5T1
1w7h;Nc1ncccc1OCc2ccccc2;3;MITOGEN-ACTIVATED PROTEIN KINASE 14;3IP
4nzm;OP([O-])(O)O[C@H]1[C@@H](OP([O-])([O-])O)[C@@H](OP([O-])(O)O)[C@H](OP([O-])([O-])O)[C@H]([C@@H]1OP([O-])([O-])O)OC(=O)CP([O-])(O)O;6.8499999;Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2;0EJ
4nzn;OP([O-])(O)CC(=O)O[C@@H]1[C@@H](OP([O-])([O-])O)[C@H](OP([O-])(O)O)[C@@H]([C@H](OP([O-])(O)O)[C@H]1OP([O-])([O-])O)OCc2ccccc2;6.3800001;Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2;2OU
4nzo;c1ccccc1CO[C@@H]2[C@@H](OP([O-])(O)O)[C@H](OP([O-])([O-])O)[C@@H]([C@H](OP([O-])([O-])O)[C@H]2OP([O-])(O)O)OCc3ccccc3;6.77;Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2;2OV
3et7;C1CCCN1S(=O)(=O)c2ccccc2CNc3nc(ncc3C(F)(F)F)Nc(cc4)cc(c45)CC(=O)N5;7.7695513;Protein tyrosine kinase 2 beta;349
3lxk;N#CCC(=O)N(CC[C@H]1C)C[C@@H]1N(C)c2ncnc(c23)[nH]cc3;9.8000002;Tyrosine-protein kinase JAK3;MI1
1u59;c1cccc(c1n2[C@]34C)c5c2c6n([C@H](O4)C[C@@H]([NH2+]C)[C@H]3OC)c7c(cccc7)c6c8c5CNC8=O;7.25;Tyrosine-protein kinase ZAP-70;STU
3bv2;c1ccccc1[C@@H](C)NC(=O)c(c2)c(C)c(n23)c(ncn3)Nc4c(C)ccc(c4)NC(=O)c5cc(ncc5)N6CCOCC6;9.3565474;Mitogen-activated protein kinase 14;P38
2uw6;c1cc(Cl)ccc1[C@@H](C[NH3+])c2ccc(cc2)-c3c[nH]nc3;6.5528421;CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT;GVO
4h1j;Cc1ccc(cc1)-n(n2)c(cc2C(C)(C)C)NC(=O)Nc([nH]n3)cc3-c4ccc(OC)cc4C;5.9200001;Protein-tyrosine kinase 2-beta;0YH
2uw4;Cc1n[nH]cc1-c2ccc(cc2)CC[NH3+];5.2839971;CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT;L15
2uw5;c1cc(Cl)ccc1[C@H](C[NH3+])c2ccc(cc2)-c3c[nH]nc3;7.5086379;CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT;GVN
2uw3;n1[nH]cc(c1C)-c2ccccc2;4.09691;CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT;GVG
4h1m;Cc1ccc(cc1)-n(n2)c(cc2C(C)(C)C)NC(=O)Nc(ccc3)c(c34)[nH]c(c4)C(=O)NC(C)C;7.54;Protein-tyrosine kinase 2-beta;0YJ
4ptg;COc1c(C(=O)N)cnc(n1)-c2ccnc(c2)NC(=O)C3CC3;8.2299995;Glycogen synthase kinase-3 beta;2WG
4asd;c1cc(Cl)c(C(F)(F)F)cc1NC(=O)Nc2ccc(cc2)Oc(ccn3)cc3C(=O)NC;9.2799997;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2;BAX
3nlb;C1C[N@H+](C)CC[C@H]1NC(=O)c(c([nH]n2)C)c2-c([nH]3)nc(c34)cc(cc4)C(C)C;7.46;Serine/threonine-protein kinase Chk1;5BE
4gih;Clc1cccc(Cl)c1C(=O)Nc2ccnc(c2)NC(=O)C3CC3;8.3199997;Non-receptor tyrosine-protein kinase TYK2;0X5
2etk;c1c[nH]c(=O)c(c12)cccc2S(=O)(=O)N3CCC[NH2+]CC3;6.8200002;Rho-associated protein kinase 1;HFS
2etm;COc1c(OC)cc(cc1OC)Nc(n2)ncc(c23)ccn3-c4ccccn4;6.6700001;Focal adhesion kinase 1;7PY
2etr;C1C[C@@H]([C@@H](C)[NH3+])CC[C@@H]1C(=O)Nc2ccncc2;6.8200002;Rho-associated protein kinase 1;Y27
5lma;[NH3+]CCCCNc(c(c12)nccn2)nc(c1)-c(cc3)ccc3C;6.5999999;Tyrosine-protein kinase SYK;6ZG
4v24;c1ccccc1S(=O)(=O)Cc2cc(C)cc(c2)OCc3ccc(cc3)C[N@@H+]4[C@@H](CO)CCC4;8.3699999;SPHINGOSINE KINASE 1;GYR
4v25;Cc1cnc(Cl)nc1-c2ccc(cc2)N(C(=O)c3ccc(O)cc3O)Cc4ccc(cc4)CNC(=O)C(F)F;7.0799999;[PYRUVATE DEHYDROGENASE (ACETYL-TRANSFERRING)] KINASE ISOZYME 2, MITOCHONDRIAL;SZ6
3eid;C1COCCN1c(n2)ccc(n23)c(cn3)-c4ccnc(n4)Nc5ccc(cc5)OC[C@@H](O)C[NH+](C)C;6.346787;Cell division protein kinase 2;PO5
5e1s;c1ccccc1-c(n(n2)C)c3c2C[C@@H](C)c(c34)cnc(n4)Nc(n5)ccn5CC[N@@H+]6CC[N@H+](CC6)CCOC;7.9200001;Insulin receptor;5JA
5e1e;COc1c(OC)cc(F)c(c1)-c(n2)[nH]c(c23)c(c(Cl)cn3)NCC4CC[NH2+]CC4;7.6599998;Tyrosine-protein kinase JAK1;5JG
4deb;NC(=O)c1ccc(cc1)Nc2nc(ccn2)Nc3cccc(c3)C(F)(F)F;6.4299998;Aurora kinase A;NHJ
4dea;O=C([O-])c(cc1)ccc1Nc(ccn2)nc2Nc(cc3)ccc3C(=O)[O-];6.5900002;Aurora kinase A;NHI
4ded;NC(=O)c1ccc(cc1)Nc2nc(ccn2)Nc3ccccc3C(=O)N;7.4200001;Aurora kinase A;NHU
4qyg;O=C([O-])c(nc1)cc(c12)c3c([nH]2)ncc(c3)-c4ccc(cc4)N5CC[NH+](C)CC5;8.3900003;Serine/threonine-protein kinase Chk1;3DW
4rss;Cc1c(C)n(C)c(c12)ccc(c2)Nc3nc(ccn3)-n4cc(c(n4)C)C[N@@H+]5C[C@@H](C5)O;8.7700005;Tyrosine-protein kinase SYK;4MG
5av0;c1cc(O)cc(c12)occ(c2=O)-c3cc(O)c(O)cc3;3.55;Death-associated protein kinase 1;47X
1nhx;O=C(C)Nc1ccc(cc1)Cc([nH]2)nc(c23)c(=O)n(c(=O)n3CCCC)Cc4ccccc4F;5.6799998;PHOSPHOENOLPYRUVATE CARBOXYKINASE, CYTOSOLIC;FTB
3miy;CC[NH+](CC)CCNC(=O)c1c(C)[nH]c(c1C)\C=C\2C(=O)Nc(c23)ccc(F)c3;7.6799998;Tyrosine-protein kinase ITK/TSK;B49
3le6;Cc1nnc(n2)c1nc(c(c23)cc(N(=O)=O)cc3)-c4ccccc4Cl;7.46;Cell division protein kinase 2;2BZ
2iw8;NS(=O)(=O)c1ccc(cc1)Nc(nc(c23)[nH]cn3)nc2OCC4CCCCC4;6.9899998;CELL DIVISION PROTEIN KINASE 2;4SP
2iw9;NS(=O)(=O)c1ccc(cc1)Nc(nc(c23)[nH]cn3)nc2OCC4CCCCC4;8.0500002;CELL DIVISION PROTEIN KINASE 2;4SP
2iw6;C[NH+](C)C[C@@H](O)COc(cc1)ccc1Nc2cc(ncn2)N(CC#N)c(c3)c(Cl)ccc3C;6.8499999;CELL DIVISION PROTEIN KINASE 2;QQ2
3vs3;C1C[N@@H+](C)CC[N@H+]1[C@@H](CC2)CC[C@H]2n(c(c34)ncnc3N)cc4-c5ccc(cc5)Oc6ccccc6;9.3699999;Tyrosine-protein kinase HCK;VSE
2ywp;N#Cc1ncc(nc1)NC(=O)Nc2cc(Cl)c(OC)cc2OC;8.1499996;Serine/threonine-protein kinase Chk1;A42
4bi0;c1ncnc(c12)c3c([nH]2)cccc3;4.23;DUAL SPECIFICITY PROTEIN KINASE TTK;Z0W
3r2y;c1cccc(c12)ncc(c2)-c3cc(ccn3)-c(c4)[nH]c(c45)CCNC5=O;8.0699997;MAP kinase-activated protein kinase 2;P4O
4jg7;n1cccc(c12)c(c[nH]2)C(=O)c3cc(ccc3)C[C@H](C#N)C(=O)N;6.9200001;Ribosomal protein S6 kinase alpha-3;1LC
4jg6;N#C[C@@H](C(=O)N)Cc(cc1)cc(c12)cn[nH]2;6.4400001;Ribosomal protein S6 kinase alpha-3;1LB
4ez5;C[NH+](C)C1CCN(CC1)c(cc2)nc(c23)nc([nH]3)C(=O)c4ccnc(c4)-c(cnc5)c(c56)cccc6;6.52;Cyclin-dependent kinase 6;0RS
4ez3;Oc1[nH]c(=O)ccc1/N=N/c2ccc(S(=O)(=O)N)cc2;4.3499999;Cyclin-dependent kinase 2;0S0
2gu8;Clc1cc(Cl)ccc1C[C@@H](C[NH3+])NC(=O)c2sc(cc2)-c3ccnc(n3)NC;8.5900002;CAMP-dependent protein kinase, alpha-catalytic subunit;796
1xjd;c1cccc(c1n2[C@]34C)c5c2c6n([C@H](O4)C[C@@H]([NH2+]C)[C@H]3OC)c7c(cccc7)c6c8c5CNC8=O;9.4799995;Protein kinase C, theta type;STU
4ezl;CC(C)(O)[C@H]1CC[N@@H+](CC1)Cc(cc2)nc(c23)c(N4CCOCC4)nc(n3)-c5cnc(N)nc5;8.5900002;Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;0SE
4ezk;CC(O)(C)[C@H](CC1)CC[N@@H+]1Cc(cc2)nc(c23)c(nc(n3)-c(ccc4)c(c45)c[nH]n5)N6CCOCC6;8.1999998;Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;0SD
4ezj;[nH]1ccc(c12)c(c(F)cc2)-c(n3)nc(N4CCOCC4)c(c35)nc(cc5)C[N@@H+]6CC[C@H](CC6)C(O)(C)C;8.4200001;Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;0SC
2wtc;COc1cc(ccc1O)-c2cnc(N)c(c2)-c3ccc(C(=O)N)cc3;6.5086384;SERINE/THREONINE-PROTEIN KINASE CHK2;VGM
2wtd;NC(=O)c1ccc(cc1)-c2cc(-c(ccc3)c(c34)OCO4)cnc2N;6.6777806;SERINE/THREONINE-PROTEIN KINASE CHK2;ZZK
2wti;NC(=O)c1ccc(cc1)-c2cc(cnc2N)[C@H](SC3)[C@@H]([C@H]34)OCCO4;7.036212;CHECKPOINT KINASE 2;WTI
2wtj;C[NH+](C)CCNC(=O)c1cc(cnc1N)C(SC2)[C@@H]([C@H]23)OCCO3;6.154902;CHECKPOINT KINASE 2;WTJ
4uyn;CCOC(=O)c1[nH]cc(c12)[C@@H]([C@H]3C(=N2)CCCC3=O)c4oc(cc4)Sc([nH]5)nc(c56)cccc6;8.3999996;AURORA KINASE A;Y3M
3py0;c1[nH]cnc1/C=C(\C(=O)N2)c(c23)cc(cc3)OC;6.8899999;Cell division protein kinase 2;SU9
2wtw;c1ccc(F)c(c1F)[C@@H]2[NH2+]Cc(c3c(c24)ccc(Cl)c4)cnc(n3)Nc(cc5)ccc5C(=O)[O-];8.1899996;SERINE/THREONINE-PROTEIN KINASE 6 AURORA/IPL1-RELATED KINASE 1, BREAST TUMOR-AMPLIFIED KINASE, AURORA-A, AURORA-RELATED KINASE 1, HARK1;ZZL
2wtv;c1ccc(F)c(c1F)C2=NCc(c3c(c24)ccc(Cl)c4)cnc(n3)Nc(cc5)ccc5C(=O)[O-];8.7399998;SERINE/THREONINE-PROTEIN KINASE 6 AURORA/IPL1-RELATED KINASE 1, BREAST TUMOR-AMPLIFIED KINASE, AURORA-A, AURORA-RELATED KINASE 1, HARK1;ZZL
3qc4;[nH]1c(=O)[nH]c(c12)cc(cc2)OC[C@@H](c3ccccc3)NC(=O)c4cccn(c4=O)Cc5ccc(F)c(F)c5;8.6999998;3-phosphoinositide-dependent protein kinase 1;MP7
3zos;n1cccc(n12)ncc2C#Cc3c(C)ccc(c3)C(=O)Nc4ccc(c(c4)C(F)(F)F)C[N@@H+]5CC[N@@H+](C)CC5;8.8900003;EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1;0LI
4fxj;O=C([O-])[C@@H]([NH3+])Cc1ccccc1;3.6199999;Pyruvate kinase isozymes M1/M2;PHE
3ro4;c1ccccc1-n2nc(CC)c(c23)ccc(c3)N(C4)C[C@H]([C@H]45)C[NH2+]C5;6.23;Ketohexokinase;LJ9
3qcq;Nc1[nH]nc(c12)cc(cc2)-c3cc(nc(n3)N)NCC;6.8000002;3-phosphoinositide-dependent protein kinase 1;3Q0
3qcs;Nc1[nH]nc(c12)cc(cc2)-c3cc(nc(n3)N)N4CCOCC4;6.5;3-phosphoinositide-dependent protein kinase 1;3Q1
3qcy;c1ccccc1NC(=O)[C@@H]2CN(CCO2)c(nc(n3)N)cc3-c(cc4)cc(c45)n[nH]c5N;7.6999998;3-phosphoinositide-dependent protein kinase 1;3Q3
3qcx;Nc1[nH]nc(c12)cc(cc2)-c3cc(nc(n3)N)N4CCOC[C@H]4C;7.1999998;3-phosphoinositide-dependent protein kinase 1;3Q2
2zkj;OP([O-])(O)OP([O-])(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n(cn2)c(c23)ncnc3N;5.4814858;[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 4;ADP
1w1g;OC[C@@H](O)COP([O-])(O)O[C@@H]1[C@H](O)[C@H](OP([O-])(O)O)[C@@H](OP([O-])([O-])O)[C@@H]([C@H]1O)OP([O-])(O)O;7.6799998;3-PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE-1;4PT
1w13;[NH2+]=C(N)Nc1ccc(cc1)CNC(=O)[C@H](C)NC(=O)[C@@H](CO)NS(=O)(=O)Cc2ccccc2;8.6989698;UROKINASE-TYPE PLASMINOGEN ACTIVATOR;SM1
1w11;[NH2+]=C(N)c1ccc(cc1)CNC(=O)[C@H](C)NC(=O)[C@@H](CO)NS(=O)(=O)Cc2ccccc2;8.2218475;UROKINASE-TYPE PLASMINOGEN ACTIVATOR;SK1
1w10;[NH2+]=C(N)NCCC[C@@H](C=O)NC(=O)[C@H](C)NC(=O)[C@@H](CO)NC(=O)OCC(C)C;7.5528421;UROKINASE-TYPE PLASMINOGEN ACTIVATOR;SJ1
1w14;c1ccccc1CCS(=O)(=O)N[C@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](CO)CCC[NH+]=C(N)N;8.5228786;UROKINASE-TYPE PLASMINOGEN ACTIVATOR;SH1
5ew9;s1ccnc1Nc2cccc(n2)C[C@]3(C(=O)[O-])CC[C@@H](CC3)Oc4c(F)c(Cl)ccc4;11;Aurora kinase A;5VC
5ew3;c1ccc(C(F)(F)F)cc1NC(=O)c2ccccc2NCc3ccncc3;8.9200001;Vascular endothelial growth factor receptor 2;5T2
3uvp;C1CCCC(=O)c(c12)ccc(c2)Nc(ccc3F)cc3NC(=O)c4ccccc4;7.46;Mitogen-activated protein kinase 14;048
3uvq;c1ccccc1C(=O)Nc(c2)c(F)ccc2Nc(cc3)cc(CC4)c3C(=O)c(c45)cc(cc5)OC[C@H](O)CO;7.77;Mitogen-activated protein kinase 14;FS8
3dpd;CC(C)(C1)CC(=O)c(c12)sc(n2)N3CCOCC3;5.779892;Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;41A
4e20;c1ccc(Cl)cc1S(=O)(=O)Nc2ccc(cc2)-c(c3)ccc(c34)n[nH]c4N;8.2200003;Non-receptor tyrosine-protein kinase TYK2;0MY
2rku;C1CCCC1N2[C@H](CC)C(=O)N(C)c(c23)cnc(n3)Nc4ccc(cc4OC)C(=O)N[C@@H]5CC[N@@H+](C)CC5;8.3010302;Serine/threonine-protein kinase PLK1;R78
3nnu;Clc1cccc(c1Cl)NC(=O)Nc(cc2-c3sccc3)n(n2)-c4cc(ccc4)CC(=O)N;7.3200002;Mitogen-activated protein kinase 14;EDB
3nnw;NC(=O)Cc(c1)cccc1-n2nc(C(C)(C)C)cc2NC(=O)Nc3cccc(Cl)c3Cl;8.0500002;Mitogen-activated protein kinase 14;EDD
3nnx;NC(=O)Cc(c1)cccc1-n2nc(C(C)(C)C)cc2NC(=O)Nc3cccc(Cl)c3Cl;7.96;Mitogen-activated protein kinase 14;EDD
4w4y;Cc1ccc(cc1)NC(=O)Nc2cnn(c2)-c3cccc(c3)C(=O)Nc4ccnc(C)c4;4.77;c-jun NH2-terminal kinase 3;3HQ
4w4x;Cc1cc(ccn1)NC(=O)c2cccc(c2)-n3cc(cn3)NC(=O)Nc4ccc(F)cc4;6.9899998;c-jun NH2-terminal kinase 3;3HN
4w4w;Cc1cc(ccn1)NC(=O)c2cc(ccc2)-n3cc(cn3)NC(=O)Nc4ccccc4;7.46;c-Jun N-terminal kinase 3;3HJ
4w4v;Cc1nccc(c1)NC(=O)c(c2)cccc2-n(nc3)cc3NC(=O)Nc4ccccc4Cl;6.9400001;c-Jun N-terminal kinase 3;3H8
4aqc;O=S(=O)(C)c1ccc(cc1)-c2cccn(c23)nc(n3)Nc4ccc(cc4)N5CCOCC5;9.0500002;TYROSINE-PROTEIN KINASE JAK2;88A
5loh;CO[C@@H]1[C@H]([NH2+]C)C[C@@H](O2)n3c(cccc4)c4c(c3c5n6[C@]12C)c7c(CNC7=O)c5c8c6cccc8;5.04;Serine/threonine-protein kinase greatwall,Serine/threonine-protein kinase greatwall;STU
3v5l;COc1ccc(cc1)-c2c(-c3n[nH]c(c34)ccs4)[nH]c(c25)cc(cc5)C(O)(CC)CC;8.1499996;Tyrosine-protein kinase ITK/TSK;0G1
4qqc;C1C[NH+](C)CCN1c(cc2)ccc2Nc(n3)ncc(c34)CN(c5cc(OC)cc(c5)OC)C(=O)N4Cc6ccc(cc6)NC(=O)CC;7.3400002;Fibroblast growth factor receptor 4;37O
3v5j;C1COCC[NH+]1CCOc(cc(c2)C(O)(CC)CC)c(c23)cc([nH]3)-c4[nH]nc(c45)ccs5;7.96;Tyrosine-protein kinase ITK/TSK;0F2
1ucn;OP([O-])(O)OP([O-])(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n(cn2)c(c23)ncnc3N;5.2199998;nucleoside diphosphate kinase A;ADP
4v05;C1[C@H](C)[NH2+][C@H](C)CN1c2ccc(cc2)C(=O)Nc3[nH]nc(c3)CCc4cc(OC)cc(c4)OC;9.6999998;FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B;66T
3ekn;C1C[NH+](C(C)C)CCN1c(cc2OC)ccc2Nc(nc(c34)[nH]cc4)nc3Nc5cccc(F)c5C(=O)N;8.3979397;Insulin receptor;GS3
5hkm;c1[nH]ncc1-c(cn2)cc(c23)c(c[nH]3)-c4cc(CC)nc(n4)N;7.8899999;3-phosphoinositide-dependent protein kinase 1;61Y
2q8g;FC(F)(F)[C@@](O)(C)C(=O)Nc1ccc(cc1Cl)S(=O)(=O)c2ccc(cc2)C(=O)N(C)C;7.0604811;[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1;AZX
3wzu;Oc1cc(OC)cc(c12)\C=C\C[C@H](O)[C@H](O)C(=O)CCC[C@H](C)OC2=O;5.8899999;Dual specificity mitogen-activated protein kinase kinase 7;1FM
2q8i;O=C1O[C@H](C)C[C@@H](O2)[C@H]2/C=C\C=C\C(=O)Cc(c13)c(Cl)c(O)cc3O;3.3979399;[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3;RDC
2q8h;ClC(Cl)C(=O)[O-];3;[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1;TF4
4qq5;C1=CN(C)C=CN1c(cc2)ccc2Nc(n3)ncc(c34)CN(c5cc(OC)cc(c5)OC)[C@H](O)N4Cc6ccc(cc6)NC(=O)CC;6.3200002;Fibroblast growth factor receptor 4;37O
3vnt;C1CC1C(=O)Nc(n2)sc(c23)nc(cc3)Oc(ccc4F)cc4NC(=O)c5cccc(c5Cl)C6(C#N)CC6;8.6599998;Vascular endothelial growth factor receptor 2;0JA
4rqv;Clc(c1)ccc(c12)nc(s2)NS(=O)(=O)c(c3)sc(c34)cccc4;5.0500002;3-phosphoinositide-dependent protein kinase 1;R2S
4rqk;Clc(c1)ccc(c12)nc(s2)NS(=O)(=O)c(cs3)c(c34)cccc4;5.8200002;3-phosphoinositide-dependent protein kinase 1;R1S
2xru;C1C[NH+](C)CCN1c(cc2)ccc2C(=O)Nc3n[nH]c(c34)cc(s4)C(=O)N[C@H](CC)c5ccccc5;7.5100002;SERINE/THREONINE-PROTEIN KINASE 6;400
4d1s;C[NH+]1CCN(CC1)c2ccc(cc2)Nc3nc(ccn3)-c4n(C)c(c(c4)C(=O)N)-c5cc(Cl)ccc5C;7.6599998;TYROSINE-PROTEIN KINASE JAK2;BJG
2vtp;Fc1ccc(cc1)NC(=O)c2[nH]ncc2NC(=O)c3c(F)cccc3F;8.5200005;CELL DIVISION PROTEIN KINASE 2;LZ9
2vtq;C1C[NH2+]CCC1NC(=O)c2[nH]ncc2NC(=O)c3c(F)cccc3F;6.8499999;CELL DIVISION PROTEIN KINASE 2;LZA
2vtr;CC(C)Nc(cc(Cl)n1)n(c12)ncc2C#N;5.8200002;CELL DIVISION PROTEIN KINASE 2;LZB
2vts;N#Cc1cnn(c12)c(NC(C)C)cc(n2)N[C@H]3CC[C@H]([NH3+])CC3;7.52;CELL DIVISION PROTEIN KINASE 2;LZC
2vth;c1ccc(S(=O)(=O)N)c(c12)cccc2O;3.9200001;CELL DIVISION PROTEIN KINASE 2;LZ2
2vtj;NS(=O)(=O)c1ccc(cc1)Nc2cncc(Cl)n2;5.7199998;CELL DIVISION PROTEIN KINASE 2;LZ4
2vtl;[nH]1nccc1C(=O)Nc2ccccc2;4.0100002;CELL DIVISION PROTEIN KINASE 2;LZ5
2vtm;N#Cc(cn1)c(n12)nccc2;3;CELL DIVISION PROTEIN KINASE 2;LZM
2vtn;CC(=O)Nc1cn[nH]c1C(=O)Nc2ccc(F)cc2;6.0700002;CELL DIVISION PROTEIN KINASE 2;LZ7
2vto;Fc1ccc(cc1)NC(=O)c2[nH]ncc2NC(=O)c3ccccc3;6.8499999;CELL DIVISION PROTEIN KINASE 2;LZ8
2cgu;O=C([O-])COc(cc1)cc(c12)C(=NO)c3c2ccc(c3)OCC(=O)[O-];4.8699999;SERINE/THREONINE-PROTEIN KINASE CHK1;3A3
2cgv;n1cccc(c12)c(N(=O)=[O-])ccc2NC[C@@H](O)C[NH3+];4.5599999;SERINE/THREONINE-PROTEIN KINASE CHK1;3B3
2cgw;Nc1nonc1-c2nc(nn2CCC)-c3nonc3N;4.7600002;SERINE/THREONINE-PROTEIN KINASE CHK1;3C3
3iw5;O1CCOc(c12)cc(cc2)NC(=O)CSc3cn(c(c34)cccc4)CCNC(=O)c5cccc(c5)C(F)(F)F;6.0762382;Mitogen-activated protein kinase 14;DF3
3iw4;c1cccc(c12)[nH]cc2C3=C(C(=O)NC3=O)c(c(c45)cccc4)nc(n5)N6CC[NH+](C)CC6;8.6777811;Protein kinase C alpha type;LW4
3iw7;SCc1ccc(cc1)C(=O)N(CC2)CCC2Cc3ccccc3;5.6382723;Mitogen-activated protein kinase 14;IPK
3iw6;CCOC(=O)c1n(CC)c(C)c(c1C)C(=O)N(CC2)CC[NH+]2Cc3ccccc3;5.4828043;Mitogen-activated protein kinase 14;PP0
3iw8;c1ccccc1COC[C@@H]([NH3+])c2csc(n2)NC(=O)Nc(cc3Cl)ccc3F;4.8728952;Mitogen-activated protein kinase 14;HIZ
3lcd;Clc1cccc(Cl)c1CNc(n2)c(N)ncc2-c(cc3)ccc3C(=O)N4CCC[C@@H]4C[NH+]5CCCC5;7.4000001;Macrophage colony-stimulating factor 1 receptor;BDY
4a9t;NC(=O)c(c1)ccc(c12)nc([nH]2)-c3ccc(cc3)OCC4CC[NH2+]CC4;7.1500001;SERINE/THREONINE-PROTEIN KINASE CHK2;A9T
4a9u;NC(=O)c(c1)ccc(c12)nc([nH]2)-c3ccc(cc3)OCC4CC[NH2+]CC4;7.2199998;SERINE/THREONINE-PROTEIN KINASE CHK2;A9U
4a9r;NC(=O)c(c1)ccc(c12)[nH]c(n2)-c3ccc(cc3)Oc4ccc(Cl)cc4;7.8000002;SERINE/THREONINE-PROTEIN KINASE CHK2;RU5
3lco;c1cc(OC)ccc1COc(cn2)c(OC)cc2COc(n3)c(N)ncc3-c4cnn(C)c4;6.8400002;Macrophage colony-stimulating factor 1 receptor;LC0
3qxp;NS(=O)(=O)c(cc1)ccc1Nc(s2)nc(N)c2C(=O)c3c(N(=O)=O)cccc3;7.6999998;Cyclin-dependent kinase 2;X64
4k77;O=c1[nH]ccc(c12)c(ncn2)NC3CCCCC3;6.6300001;Tyrosine-protein kinase JAK1;1Q4
4idt;Brc(c1)ccc(c12)[nH]c3c2c4c(CCC3)cnc(n4)N;7;Mitogen-activated protein kinase kinase kinase 14;T28
4idv;COCCOc(cn1)c(nc1N)-c2c[nH]c(c23)ccc(c3)C#CC(C)(C)O;7.4000001;Mitogen-activated protein kinase kinase kinase 14;13V
4q9z;C1[NH2+]CC1Nc(c(C)c2)cc(c23)N4C(CO3)=NNC(=O)[C@H]4C;7.2600002;HUMAN PROTEIN KINASE C THETA;PZW
4crl;C[NH+](C)[C@@H](C1)[C@@H](O)[C@H](O)C([C@]123)=CC=4[C@](O3)(CC2)[C@H]5[C@](C)(CC4)[C@H](CC5)c(c6)ccc(c67)ccnc7;9.71;CYCLIN-DEPENDENT KINASE 8;C1I
4q9s;c1cccc(c12)OCC=3N2CC(=O)NN3;3.8099999;Focal adhesion kinase 1;30G
1zz2;Oc1ccccc1C[NH2+]C2CCN(CC2)S(=O)(=O)Nc3cc(ccc3)Oc4ccc(F)cc4;5.2199998;Mitogen-activated protein kinase 14;B11
1y8p;OP([O-])(O)OP([O-])(O)OP([O-])(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n(cn2)c(c23)ncnc3N;6.0799999;[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3;ATP
3bqc;Oc(c1)cc(O)c(c12)C(=O)c3c(C2=O)cc(C)cc3O;5.73;Casein kinase II subunit alpha;EMO
1zzl;CC(C)c(nn1)n(c12)cc(cc2)-c3ocnc3-c(cc4)ccc4F;8.3000002;Mitogen-activated protein kinase 14;TZY
5g2n;C1COCC[NH+]1CCCOc(c2OC)ccc(c23)c4n(ccn4)c(n3)NC(=O)c5cnc(N)nc5;7.0300002;PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM;6E2
4fvq;OP([O-])(O)OP([O-])(O)OP([O-])(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n(cn2)c(c23)ncnc3N;6;Tyrosine-protein kinase JAK2;ATP
4fvr;OP([O-])(O)OP([O-])(O)OP([O-])(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n(cn2)c(c23)ncnc3N;6;Tyrosine-protein kinase JAK2;ATP
4mxc;CS(=O)(=O)Cc1cc(ccc1)Nc(n2)nccc2Oc3c(F)cc(cc3)NC(=O)C4(C=C4)C(=O)Nc5ccc(F)cc5;8.1700001;Hepatocyte growth factor receptor;DWF
5tr6;Cn(c1)ncc1-c(c(c23)C(=O)NC3)nc(c2F)N[C@@H]([C@H]4[NH3+])CCCC4;8.4899998;Tyrosine-protein kinase SYK;7KG
2h8h;C1COCCC1Oc2cc(OCC[N@H+](CC3)CC[N@@H+]3C)cc(c24)ncnc4Nc5c(Cl)ccc(c56)OCO6;8.5699997;Proto-oncogene tyrosine-protein kinase Src;H8H
3py1;c1[nH]cnc1/C=C(\C(=O)N2)c(c23)cc(cc3)OC;6.8899999;Cell division protein kinase 2;SU9
2o3p;O=C1C=C(O)Cc(c12)oc(c(c2=O)O)-c3ccc(O)c(c3)O;5.96;Proto-oncogene serine/threonine-protein kinase Pim-1;QUE
3kf7;c1cc(F)cc(F)c1CCc(cc2)cn(c23)c(nn3)-c4cc(C(=O)N)ccc4C;7.3979402;Mitogen-activated protein kinase 14;L9G
4wnm;C1COCCC1Cc(ccc2)n(c23)nc(n3)Nc(cc4)cc(c45)n[nH]c5NC6CCOCC6;7.5900002;Tyrosine-protein kinase SYK;3RT
4wno;C1CC1c2cc(n[nH]2)Nc(c(c34)cccc4)nc(n3)Nc(cc5)ccc5N;6.8000002;Serine/threonine-protein kinase ULK1;3RF
1ouk;c1ccccc1[C@H](C)Nc2nccc(n2)-c3c(-c4cc(C(F)(F)F)ccc4)nc(n3C)C5CC[NH2+]CC5;9.8900003;Mitogen-activated protein kinase 14;084
4wnp;C1CCC1c([nH]n2)cc2Nc(c(c34)cccc3)nc(n4)Nc(c5)ccc(c56)nc[nH]6;8.1000004;Serine/threonine-protein kinase ULK1;3RJ
1ouy;C1=CNC=CC1c(c2)c(Sc(c(F)c3)ccc3F)nc(c24)cnc(=O)n4-c5c(Cl)cccc5Cl;8.3699999;Mitogen-activated protein kinase 14;094
4pp9;c1cccc(c12)c(n[nH]2)C(=O)Nc3cnn(c3)Cc4cccc(c4)C#N;7.3699999;Tyrosine-protein kinase ITK/TSK;2VT
5cs6;Clc1cc(C[NH3+])ccc1OCCC;3.2;Casein kinase II subunit alpha;K82
4pp7;n1cn(C)c(=O)c(c12)cc(cc2)N(C)c3c(F)c(ccc3F)NS(=O)(=O)CCC;7.96;Serine/threonine-protein kinase B-raf;2VX
2x8d;c1cccc(c12)N3C(C=C2C)NNC3=O;6.0999999;SERINE/THREONINE-PROTEIN KINASE CHK1;X8D
2x8e;c1cnccc1-c(cc2)cc(c23)N4C(C=C3C)NNC4=O;7.8499999;SERINE/THREONINE-PROTEIN KINASE CHK1;X8E
2x8i;c1c(O)cccc1-c(c2)ccc(c23)N4C(C=C3C)NNC4=O;6.7199998;SERINE/THREONINE-PROTEIN KINASE CHK1;X8I
4rj4;c1[nH]ncc1-c(n2C(C)C)cc(c23)cnc(c3)Nc4ccnc(n4)N5CCC(CC5)OC;7.8000002;Epidermal growth factor receptor;3QW
4rj5;COC1CCN(CC1)c2nccc(n2)Nc(c3)ncc(c34)cc([nH]4)-c5cn[nH]c5;7.1799998;Epidermal growth factor receptor;3QY
4rj3;COC1CCN(CC1)c2nccc(n2)Nc(c3)ncc(c34)ccn4C5CCCC5;7.0300002;Cyclin-dependent kinase 2;3QS
4rj8;COC1CCN(CC1)c2nccc(n2)Nc(c3)ncc(c34)ccn4C5CCCC5;7.77;Epidermal growth factor receptor;3QS
5csp;Oc1ccc(C)cc1C(=O)[O-];4.2399998;Casein kinase II subunit alpha;54G
2x81;c1ccc(F)c(c1F)C2=NCc(c3c(c24)ccc(Cl)c4)cnc(n3)Nc(cc5)ccc5C(=O)[O-];8.3000002;SERINE/THREONINE-PROTEIN KINASE 6;ZZL
5csw;n1ccc(nc1N)-c2sc(C(C)(C)C)nc2-c3c(F)c(ccc3)NS(=O)(=O)c4c(F)cccc4F;8.3999996;Serine/threonine-protein kinase B-raf;P06
3up2;c1cc(C(=O)[O-])ccc1Nc2nccc(n2)Nc3ccccc3OC(F)(F)F;7.4000001;Aurora kinase A;0C8
4ppa;N#Cc(c1)cccc1Cn2cc(cn2)NC(=O)c3n[nH]c(c34)cc(cc4)-c5cn[nH]c5;9.1000004;Tyrosine-protein kinase ITK/TSK;2VU
4ppb;c1ccccc1[C@H](CC[NH+](C)C)n2cc(cn2)NC(=O)c3n[nH]c(c34)cc(cc4)-c5cn[nH]c5;10;Tyrosine-protein kinase ITK/TSK;2VV
4ppc;c1ccccc1[C@@H](CC[NH+](C)C)n2cc(cn2)NC(=O)c3n[nH]c(c34)cc(cc4)-c5c[nH]nc5;9.0299997;Tyrosine-protein kinase ITK/TSK;2VW
3f7z;O1COc(c12)cc(cc2)-c3nnc(o3)SCc(c4)ccc(c4F)OC;7.1870866;Glycogen synthase kinase-3 beta;34O
4fxf;OP([O-])(O)OC[C@]1(O)[C@@H](O)[C@H](O)[C@H](O1)COP([O-])([O-])O;5.1900001;Pyruvate kinase isozymes M1/M2;FBP
5iis;Nc(n1)cc(cc1C)-c2ccncc2NC(=O)c3c(N)ccc(n3)-c4ccccc4F;9;Serine/threonine-protein kinase pim-1;6CB
4gmy;Clc1cccc(Cl)c1C(=O)Nc2ccnc(c2)NC(=O)C3CC3;7.5500002;Tyrosine-protein kinase JAK2;0X5
3uli;COc1ccc(cc1)-c([nH]2)nc(c23)c(c(Br)cn3)NCCCNC(=O)C4(C=C4)C[NH3+];7.1500001;Cyclin-dependent kinase 2;1N3
1gjd;NC(=[NH2+])c1c(Cl)cc(cc1)NC(=O)c2cc(C)cc(I)c2O;5.2199998;UROKINASE-TYPE PLASMINOGEN ACTIVATOR;136
1gja;NC(=[NH2+])c1ccc(cc1)NC(=O)c2ccccc2O;5.4200001;UROKINASE-TYPE PLASMINOGEN ACTIVATOR;135
5hu9;C[N@H+]1CC[N@@H+](CC1)Cc2c(C(F)(F)F)cc(cc2)C(=O)Nc3cc(c(C)cc3)OC4CCN(CC4)C(=O)c5cccnc5;7.6199999;Tyrosine-protein kinase ABL1;66K
4kin;C1CC1NC(=O)c2cc(c(C)cc2)NC(=O)c3ccc(s3)-c4ccccc4Cl;8.3199997;Mitogen-activated protein kinase 14;1M8
4kio;C=CC(=O)N1CC[C@@H](C1)Nc2nc(C[NH+]3CCOCC3)cc(n2)Nc(n4)sc(c45)nccc5;6.3000002;Tyrosine-protein kinase ITK/TSK;G5K
4kip;C1=CC1NC(=O)c(cc2)cc(c2C)NC(=O)c3cnc(s3)-c4ccccc4Cl;8.1499996;Mitogen-activated protein kinase 14;1R9
4kiq;C1=CC1NC(=O)c(cc2)cc(c2C)NC(=O)c(cc3)cc(c34)n(cc4)C(=O)OCC;7.6399999;Mitogen-activated protein kinase 14;1RA
3ej1;c1ccnn(c12)ncc2-c3ccnc(n3)NC4CC4;6.9208188;Cell division protein kinase 2;5BP
4r6v;CCC(=O)Nc1ccc(cc1)CN(C(=O)Nc2c(Cl)c(OC)cc(c2Cl)OC)c3cc(ncn3)Nc4ccc(cc4)N5CC[NH+](C)CC5;7.4499998;Fibroblast growth factor receptor 4;FI3
3vhk;c1ccccc1-c(n2)oc(C)c2COc(c3)cccc3CO;4.5999999;Vascular endothelial growth factor receptor 2;BPK
3e8n;c1c(I)ccc(c1F)Nc2c(c(OC)cc(F)c2F)NS(=O)(=O)C3(CC3)C[C@H](O)CO;7.7199998;Dual specificity mitogen-activated protein kinase kinase 1;VRA
1gj8;c1c(F)c(C(N)=[NH2+])cc(c12)[nH]c(n2)-c3cccc(c3O)OCC(C)C;6.96;UROKINASE-TYPE PLASMINOGEN ACTIVATOR;133
4aoi;N#Cc1ccc(cc1)-c(n2)cnc(n23)nnc3Cc4c[nH]c(c45)nccc5;8.3999996;HEPATOCYTE GROWTH FACTOR RECEPTOR;4K0
2w05;c1nc(C)n(C(C)C)c1-c2nc(ncc2)Nc3ccc(cc3)S(=O)(=O)NCCOC;9;CELL DIVISION PROTEIN KINASE 2;FRT
2w06;CNS(=O)(=O)c(cc1)ccc1Nc(n2)nccc2-c3cnc(C)n3C4CC4;7.0809221;CELL DIVISION PROTEIN KINASE 2;FRV
2xp2;Clc1ccc(F)c(Cl)c1[C@@H](C)Oc2cc(cnc2N)-c3cnn(c3)C4CC[NH2+]CC4;9;TYROSINE-PROTEIN KINASE RECEPTOR;VGH
4rwj;C1[C@H](C)[NH2+][C@H](C)CN1c2ccc(cc2)C(=O)Nc3n[nH]c(c3)CCc4cc(OC)cc(c4)OC;8.6999998;Fibroblast growth factor receptor 1;66T
3u8w;C1CC1NC(=O)c2cc(c(C)cc2)-c(c(=O)n3CC)cc(n34)nnc4-c5c(Cl)cccc5F;9;Mitogen-activated protein kinase 14;09J
2w0j;[NH2+]=C(N)/N=N/[C@H](C)c1ccc(cc1)NC(=O)Nc2ccc(cc2)/C(C)=N/[NH+]=C(N)N;6.6197886;SERINE/THREONINE-PROTEIN KINASE CHK2;ZAT
3o2m;c1c(C)nc(nc1C)N(CCCC)Cc2ccc(cc2)-c(cccc3)c3-c4nn[nH]n4;4.8000002;Mitogen-activated protein kinase 8;46A
3lau;CCCC(=O)Nc1[nH]nc(c12)cc(cc2)-c3ccc(O)cc3;4.52;Serine/threonine-protein kinase 6;OFI
4lyn;CC(C)(C)c1cnc(o1)CSc2cnc(s2)NC(=O)[C@@H](C)c3ccccc3;7.2199998;Cyclin-dependent kinase 2;1YG
4k18;N#Cc1ccc(cc1)Cc(cc2O)nc(n23)c(cn3)C(=O)Nc4ccc(F)cc4;8.96;Serine/threonine-protein kinase pim-1;1OB
3roc;c1cc(F)cc(F)c1COc2c(Cl)c(=O)n(cn2)-c3c(C)ccc(c3)C(=O)NCCO;8.1899996;Mitogen-activated protein kinase 14;29A
4ty1;CC(C)(C)Nc1nnc(o1)-c(cc2)cc(c23)c(c[nH]3)-c4nccc(n4)C5CC5;9.2600002;Serine/threonine-protein kinase pim-1;38W
2vv9;CC(C)n1c(C)ncc1-c2ccnc(n2)Nc3ccc(cc3)N4CCN(CC4)C(=O)CO;7.7695508;CELL DIVISION PROTEIN KINASE 2;IM9
4k1b;Fc1ccccc1-c(c2)cnc(c23)[nH]cc3NC(=O)c(cn4)c(n45)nc(cc5)NC[C@H]6CC[NH2+]C[C@@H]6F;11.52;Serine/threonine-protein kinase pim-1;1OC
4clj;N#Cc1n(C)nc(c1c23)CN(C)C(=O)c4c(cc(F)cc4)[C@@H](C)Oc(c2)c(N)nc3;9.1499996;ALK TYROSINE KINASE RECEPTOR;5P8
4cli;N#Cc1n(C)nc(c1c23)CN(C)C(=O)c4c(cc(F)cc4)[C@@H](C)Oc(c2)c(N)nc3;8.8900003;ALK TYROSINE KINASE RECEPTOR;5P8
2wxv;Cn1nc(C(=O)NC)c(c12)CCc3c2nc(nc3)NC4CCN(CC4)S(=O)(=O)C;8.6999998;CELL DIVISION PROTEIN KINASE 2;WXV
3zcl;CC(C)Nc(cc1)nn(c12)c(nn2)[C@@H](C)c(c[nH]3)c(c34)cccn4;8;HEPATOCYTE GROWTH FACTOR RECEPTOR;5TF
3qgy;C1CCCCN1c(cc2)ccc2C(=O)N[C@@H](C(=O)N=C3)C=C3c(n4)ccnc4NC;7.8000002;Tyrosine-protein kinase ITK/TSK;L7O
5tt7;c1c(C)cccc1Nc(c(c23)C(=O)NC3)nc(n2)N[C@@H]4CCCC[C@@H]4[NH3+];7.8899999;Tyrosine-protein kinase SYK;7KF
3qgw;c1ccccc1C(=O)/N=C(\C2)C(=O)NC=C2c3ccncc3;5.8899999;Tyrosine-protein kinase ITK/TSK;L7A
3zc5;n1cccc(c12)cc(cc2)[C@H](C)c3nnc(n34)ccc(n4)-c(c5)cnn5C;7.1300001;HEPATOCYTE GROWTH FACTOR RECEPTOR;W9Z
3kxz;CC1(C)[N@H+](O)C(C)(C)C[C@H](C1)NC(=O)c2cccc(c2)-c(n3)cc(n34)nccc4Nc5cccc(O)c5;7.46;Proto-oncogene tyrosine-protein kinase LCK;925
4rx5;C1[N@H+](C)CCn(c12)nc(c2)N[C@H](C(=O)NN3)C=C3c(c4C)ccc(F)c4NC(=O)c(c5)sc(c56)cccc6;8.5200005;Tyrosine-protein kinase BTK;3YO
3ctj;Fc1ccc(cc1)CC(=O)NC(=O)Nc2cc(F)c(cc2)Oc(ccn3)c(c34)cc[nH]4;7.4559321;Hepatocyte growth factor receptor;320
3cth;c1cc(F)ccc1CC(=O)NC(=O)Nc2ccc(c(F)c2)Oc3ccnc(c3)N;6.9586072;Hepatocyte growth factor receptor;319
1owi;[NH2+]=C(N)c(c1)ccc(c12)cc(cc2)C(=O)Nc3cccc(c3)OC4CCCC4;7.5500002;Urokinase-type plasminogen activator;426
1owh;[NH2+]=C(N)c(c1)ccc(c12)cc(cc2)C(=O)Nc3ccc(cc3)C[NH3+];7.4000001;Urokinase-type plasminogen activator;239
1owk;[NH2+]=C(N)c(c1)ccc(c12)cc(cc2)C(=O)Nc(c3)ccc(c34)CC[NH2+][C@H]4C(C)C;7.6300001;Urokinase-type plasminogen activator;303
1owj;[NH2+]=C(N)c(c1)ccc(c12)cc(cc2)C(=O)Nc(c3)ccc(c34)CCN=C4C(C)C;7.3200002;Urokinase-type plasminogen activator;155
1owe;[NH2+]=C(N)c(cc1)cc(c12)ccc(c2)C(=O)Nc3ccccc3;6.1999998;Urokinase-type plasminogen activator;675
1owd;C1[NH2+]C[C@H](CC)c(c12)cc(cc2)NC(=O)c(cc3)cc(c34)ccc(c4)C(=[NH2+])N;8.1999998;Urokinase-type plasminogen activator;497
3ctq;CC(C)(C)c1cc(NS(=O)(=O)C)c(OC)c(c1)NC(=O)c2ccc(C)c(c2)-n3cc(nn3)C(=O)NCc4ccccc4;7.3979402;Mitogen-activated protein kinase 14;337
2rg5;CONC(=O)c1ccc(C)c(c1)Nc2ncnn(c23)cc(c3C)C(=O)NCC;8.5086384;Mitogen-activated protein kinase 14;279
2rg6;c1ccccc1[C@H](C)NC(=O)c(c2C)cn(c23)ncnc3Nc(c4)c(C)ccc4C(=O)NOC;8.6575785;Mitogen-activated protein kinase 14;287
4prj;N#Cc(c1)cccc1Cn2cc(cn2)NC(=O)c3n[nH]c(c34)cc(cc4)-c5c[nH]nc5;7.1399999;Aurora kinase A;2VU
2rgp;c1c(F)cccc1Cn(nc2)c(c23)ccc(c3)Nc(ncn4)c(c4N)/C=N/N5CCCCC5;7.5228791;Epidermal growth factor receptor;HYZ
4e6q;c1c[nH]c(nc2)c1c(c23)n(cn3)[C@H](CC4)CC[N@@H+]4Cc5ccccc5;8.3599997;Tyrosine-protein kinase JAK2;0NV
4e6c;C[N+]1(C)CCC(CC1)OP([O-])(O)OCCC;4.8200002;Mitogen-activated protein kinase 14;0O8
4e6d;N#CCC(=O)N1CCC[C@H](C1)n2cnc3cnc(c4c23)[nH]cc4;8.9200001;Tyrosine-protein kinase JAK2;0NU
1di8;COc(c1)c(OC)cc(c12)c(ncn2)Nc3cc(O)ccc3;6;CYCLIN-DEPENDENT KINASE 2;DTQ
1di9;COc(c1)c(OC)cc(c12)c(ncn2)Nc3cc(SC)ccc3;5.3000002;P38 KINASE;MSQ
4l3p;C1C[NH2+]CCC1n(nc2)cc2-c(cnc3N)c(c34)cc(o4)-c5cccc(c56)ccs6;5.9200001;Mitogen-activated protein kinase kinase kinase 7, TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 chimera;1UH
3q96;C1CC(=O)Nc(c12)nccc2Oc(cc3)cc(c34)C[C@H](CC4)C(=O)Nc(c5)cc(C(F)(F)F)cc5C([NH3+])(C)C;8.54;Serine/threonine-protein kinase B-raf;0NF
5lcj;CCC(=O)Nc1ccccc1Nc2nc(ncc2Cl)Nc3ccnc(c3)C#CCCNC(=O)O[C@@H]4CCC/C=C\CC4;6.6399999;Mitogen-activated protein kinase 1;6TS
5lck;COc1cc(cnc1)Nc(ncc2C(F)(F)F)nc2Nc3ccccc3NC(=O)CC;8.1000004;Mitogen-activated protein kinase 1;6TT
5byz;CC(C)n(c1C)c(cn1)-c(n2)c(F)cnc2Nc3ccc(cc3)C(=O)NCC[NH+]4CCCCC4;7.3800001;Mitogen-activated protein kinase 7;4WE
5byy;CCOc1cc(N(CC2)CCC2O)ccc1Nc(n3)ncc(c34)N(C)C(=O)c5c(N4C)cccc5;7.0100002;Mitogen-activated protein kinase 7;4WG
4hgt;Fc1ccc(cc1F)OCc(ncc2OC)cc2-c(c3)[nH]c(c34)CCNC4=O;7.4000001;Casein kinase I isoform delta;15G
4hgs;Fc1ccc(cc1F)OCc(ncc2OC)cc2-c(c3)[nH]c(c34)CCNC4=O;8.3000002;Casein kinase I isoform gamma-3;15G
4hge;c1ccnc(n12)c(cn2)C(=O)Nc(cc3C)n(n3)-c4cccc(Cl)c4;7.9200001;Tyrosine-protein kinase JAK2;15V
4obq;n1cnc(N)c(c12)cc(cc2)-c3cc(cc(F)c3)NC(=O)C[NH+]4CCCC4;7.1900001;Mitogen-activated protein kinase kinase kinase kinase 4;2QT
2bdj;c1c(O)cccc1CCn(cn2)c(c23)nc(C4CCCC4)nc3Nc5ccc(cc5)P(=O)(C)C;9.3500004;Proto-oncogene tyrosine-protein kinase Src;HET
2bdf;[NH3+][C@H]1CC[C@@H](CC1)c(n2)nc(c(c23)ncn3CC)Nc4ccc(cc4)P([O-])(O)CP([O-])(O)O;7.1700001;Proto-oncogene tyrosine-protein kinase Src;24A
5kbr;Clc1ccc(cc1)C(=O)c(c[nH]2)c(c23)cc(cn3)-c4cnn(c4)C5CC[NH2+]CC5;6.5900002;Serine/threonine-protein kinase PAK 1;IPW
5kbq;Cc1ccc(CO)cc1N(C)c2ccnc(n2)Nc3cc(cc(c3)S(=O)(=O)C)N4CCOCC4;7;Serine/threonine-protein kinase PAK 1;IPV
1kv1;Cn1nc(C(C)(C)C)cc1NC(=O)Nc2ccc(Cl)cc2;5.9400001;p38 MAP kinase;BMU
5k5n;COc1ccc(cc1Cl)-c2c(nco2)C(=O)NCCCn3cncn3;8.0500002;Glycogen synthase kinase-3 beta;6QH
3o0g;Clc1ccc(cc1)Nc(s2)nc(N)c2C(=O)c3cccc(c3)N(=O)=O;6.2199998;Cell division protein kinase 5;3O0
4i5p;C1CCCC1N([C@H](CC)C(=O)N2C)c(c23)nc(nc3)-c4ccc[nH]4;6.4200001;Serine/threonine-protein kinase PLK2;1D1
3fi3;c1cccc(F)c1Nc(c2)ccc(c23)n(nc3)-c4cc(ccc4)C(=O)Nc5cc(OC)c(OC)c(c5)OC;7.9200001;Mitogen-activated protein kinase 10;JK2
4i5m;C1CCCC1N2[C@H](CC)C(=O)N(C)c(c23)cnc(n3)Nc4ccc(cc4OC)C(=O)N[C@H]5CC[N@H+](C)CC5;8.0600004;Serine/threonine-protein kinase PLK2;R78
4i5c;[nH]1ccc(c12)c3c(cn2)nnn3[C@@H]4CCCN(C4)C(=O)CC#N;8.8199997;Tyrosine-protein kinase JAK1;C5I
4z07;C1OP([O-])(O)O[C@H]([C@@H]12)[C@@H](O)[C@@H](O2)n(cn3)c(c34)nc(N)[nH]c4=O;7.9899998;cGMP-dependent protein kinase 1;PCG
4pv0;O=C([O-])c1ccc(cc1)NC(=O)c2cccc(c2)C(=CN(C34)C=CN4)N=C3Nc5cc(OC)c(cc5)OC;9.0699997;Tyrosine-protein kinase SYK;CG4
4cnh;COc1ccc(F)cc1[C@@H](C)Oc(c(N)nc2)cc2-c3cnnn3C;8.3999996;ALK TYROSINE KINASE RECEPTOR;3U9
3dpk;C1CCCCC1n2cc(C(=O)NOC)c(=O)c(c23)cnc(n3)Nc4ccc(cc4)CC[NH+]5CCCC5;8.3872166;Macrophage colony-stimulating factor 1 receptor, Fibroblast growth factor receptor 1;8C5
3psd;c1n[nH]c2c1Cc(c23)cc(cc3)-c4c(-c5ccncc5)nn(c4)C6CC[NH2+]CC6;8.5200005;B-RAF PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE;SM7
2ivu;C[N@@H+]1CC[C@H](CC1)COc(c(c2)OC)cc(c23)ncnc3Nc4ccc(Br)cc4F;6.4299998;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET PRECURSOR;ZD6
3ps6;Nc1nc(C)nc(c12)c(ccc2)C(=O)Nc3cnc(cc3)OC;7.7399998;Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform;3PS
3zep;C1CC1[C@H](C)NC(=O)c(c[nH]2)c(c23)nc(cn3)Oc(c4)ccc(c45)CC[C@H]5NC(=O)C;7.6599998;TYROSINE-PROTEIN KINASE JAK3;1NX
1m51;CCCCn1c(=O)n(CC=C)c(=O)c(c12)[nH]c(n2)Cc3ccc(cc3)NC(=O)C;4.73;phosphoenolpyruvate carboxykinase, cytosolic;TSX
3d2r;OP([O-])(O)OP([O-])(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n(cn2)c(c23)ncnc3N;5.4814858;[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 4;ADP
5eqy;C[N@H+]1CCC[N@@H+](CC1)Cc2cc(C#N)c(cc2)-c3ccc(cc3)C[N@H+]4CC[N@@H+](C)CCC4;8;Choline kinase alpha;5RA
5eqp;C[N@@H+]1CC[N@@H+](CCC1)Cc(cc2)cc(c23)cccn3;5.4000001;Choline kinase alpha;5R9
5eqe;C[N@@H+]1CC[N@H+](CCC1)Cc2ccc(cc2)C[NH3+];3.8800001;Choline kinase alpha;5R8
1wbn;CC(C)(C)c1cc(n[nH]1)NC(=O)Nc2ccc(Cl)c(c2)COc3cccnc3;6.46;MITOGEN-ACTIVATED PROTEIN KINASE 14;L09
1wbo;Oc1ccccc1Cl;3;MITOGEN-ACTIVATED PROTEIN KINASE 14;2CH
2yer;[nH]1cccc1-c(cc2)cc(c23)n4c(n[nH]c4=O)cc3CO;7.6999998;SERINE/THREONINE-PROTEIN KINASE CHK1;TQ1
1wbv;C1COCCN1c(cc2F)cc(c2)C(=O)Nc(cc3)cc(c34)cc[nH]4;3.79;MITOGEN-ACTIVATED PROTEIN KINASE 14;LI3
1wbw;Nc1ncccc1OCc2cccc(c23)cccc3;4.3600001;MITOGEN-ACTIVATED PROTEIN KINASE 14;LI4
1wbt;C1COCCN1c(cc2F)cc(c2)C(=O)Nc(cc3)cc(c34)n(cc4)CCc5ccncc5;6.4699998;MITOGEN-ACTIVATED PROTEIN KINASE 14;WBT
1wbs;C1COCCN1c(cc2F)cc(c2)C(=O)Nc(cc3)cc(c34)c(c[nH]4)CCc5ccncc5;6.1999998;MITOGEN-ACTIVATED PROTEIN KINASE 14;LI2
4wrs;Fc1cccc(F)c1-c(cc2)cc(c23)c(n[nH]3)-c4cncc(n4)O[C@H](C56CC6)C[NH2+]CC5;9.3999996;Serine/threonine-protein kinase pim-1;3U1
3kb7;Cn1nc(C(=O)N)c(CC2)c1c(c23)nc(nc3)Nc4cc(ccc4OC)N5CC[NH+](C)CC5;8.1499996;Serine/threonine-protein kinase PLK1;071
5cqu;[NH3+]CCCCn1cc(nn1)CCn(n2)nc(c23)c(Br)c(Br)c(Br)c3Br;5.1700001;Casein kinase II subunit alpha;JRJ
2e9n;c1cc(O)ccc1-c(cc2)ccc2-c(n[nH]3)c(c34)Cc5c4ccc(c5)C(=O)N[C@H]6CC[C@H](O)CC6;8.2076082;Serine/threonine-protein kinase Chk1;76A
2e9o;C1C[C@H](C)CC[C@@H]1[NH2+]Cc(c2)ccc(c23)c4c(C3)c([nH]n4)-c5ccc(C(=O)[O-])cc5;7.6989698;Serine/threonine-protein kinase Chk1;A58
2xk7;O=C([O-])[C@@H]1CCN(C[C@@H]1CC)c2nc(cnc2N)-c3cc(OC)c(OC)c(c3)OC;5.8200002;SERINE/THREONINE-PROTEIN KINASE NEK2;30E
2xk6;O=C([O-])[C@@H](CC1)CC[C@@H]1c2nc(cnc2N)[C@@H]3SCC[C@H]3C4CC4;5.8000002;SERINE/THREONINE-PROTEIN KINASE NEK2;EQH
2e9v;c1cnccc1CNc(c2)c(Cl)cc(c23)NC(=O)Nc4nc(c(C#N)nc4)OCCCCCO3;7.9000001;Serine/threonine-protein kinase Chk1;85A
2xk3;CCC1C=CSC1c2cnc(N)c(n2)[C@H]3CC[C@H](C(=O)[O-])CC3;5.6799998;SERINE/THREONINE-PROTEIN KINASE NEK2;XK3
2xk9;O=N(=O)c1cccc(c12)cc([nH]2)C(=O)Nc3ccc(cc3)/C(C)=N/[NH+]=C(/N)NO;10.15;CHECKPOINT KINASE 2;XK9
2xk8;O=C([O-])c1ccc(cc1OC)-c2nc(cnc2N)-c3cc(OC)c(OC)c(c3)OC;5.6199999;SERINE/THREONINE-PROTEIN KINASE NEK2;5R1
2xkf;COc1c(OC)cc(cc1OC)-c2cnc(N)c(n2)N3CCC(C(=O)[O-])CC3;6.0599999;SERINE/THREONINE-PROTEIN KINASE NEK2;BX1
2xke;O=C([O-])C1CCN(CC1)c2nc(cnc2N)-c3cc(OC)ccc3;5.3800001;SERINE/THREONINE-PROTEIN KINASE NEK2;WI2
2xkd;O=C([O-])c1ccc(cc1)-c2nc(cnc2N)-c3cc(OC)c(OC)c(c3)OC;5.6399999;SERINE/THREONINE-PROTEIN KINASE NEK2;T3M
2xkc;O=C([O-])c1ccc(cc1C)-c2nc(cnc2N)-c3cc(OC)c(OC)c(c3)OC;5.5900002;SERINE/THREONINE-PROTEIN KINASE NEK2;4VQ
4e4x;OCCCNc(n1)ncc(c12)cc(c(=O)n2C)-c3c(F)c(ccc3F)NS(=O)(=O)CCC;8.1499996;Serine/threonine-protein kinase B-raf;T1Q
3nnv;c1cccc(c12)c(ccc2)NC(=O)Nc3cc(C(C)(C)C)nn3-c4ccc(cc4)CO;7.5700002;Mitogen-activated protein kinase 14;437
4e4l;C1CN(S(=O)(=O)C)CCC1(C)n(cn2)c(c23)c4c(nc3)[nH]cc4;8.7700005;Tyrosine-protein kinase JAK1;0NH
4e4n;CC(C)(C)OC(=O)N[C@@H]1CC[C@H](C1)n(cn2)c(c23)c4c(nc3)[nH]cc4;9.0500002;Tyrosine-protein kinase JAK1;0NL
2f2c;OC[C@H](C(C)C)Nc(n1)nc(c(c12)ncn2C(C)C)Nc3cc(N)cc(Cl)c3;6.3499999;Cyclin homolog;AP9
1o3p;c1cc(C(=[NH2+])N)cc(c12)nc([nH]2)-c3cccc(c3O)OC4CCCC4;6.6599998;Urokinase-type plasminogen activator;655
3lzb;c1ccccc1CC(=O)Nc2cccc(c2)-c(n3)c(n(c34)ccs4)-c5ccnc(n5)Nc(cc6)ccc6N7CCOCC7;7.1999998;Epidermal growth factor receptor;ITI
4r3c;C[NH+]1CCN(CC1)c2cc(-c3ccncc3)c(nn2)-c(c4)ccc(c45)cccc5;7;Mitogen-activated protein kinase 14;3GF
4l53;O[C@H]1CC[C@@H](CC1)n2cc(cn2)-c(cnc3N)c(c34)c(Cl)c(o4)-c(ccc5)c(c56)snn6;7.5500002;Mitogen-activated protein kinase kinase kinase 7, TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 chimera;1UO
4l52;O=C(C)N1CCC(CC1)n2cc(cn2)-c(cnc3N)c(c34)cc(o4)-c5cccc(c56)nns6;8.3999996;Mitogen-activated protein kinase kinase kinase 7, TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 chimera;1UL
2r9s;CC(C)(C)NS(=O)(=O)c1ccc(cc1)[C@H](C[NH2+]2)CC(C23)C(CCC3)[NH2+]C4[NH2+]CCCC4;6.8200002;Mitogen-activated protein kinase 10;255
4bkz;[NH3+]CCCNC(=O)c1n[nH]c(c12)c3c(cc2)n[nH]c3Nc4cc(F)ccc4;7.5700002;MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE;1WS
4bky;c1ccccc1[C@@H](C[NH+]2CCCC2)NC(=O)N3Cc(c4C35CC5)c(n[nH]4)NC(=O)c6n(C)cc(Br)c6;7.9200001;MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE;82B
1dm2;Brc(c1)[nH]c(c12)C(=O)NCC[C@@H]2C3=NC(N)=NC3=O;7.1500001;CYCLIN-DEPENDENT KINASE 2;HMD
2yhw;O=C(C)N[C@H]([C@H]1O)[C@@H](O)[C@H](O)[C@H](O1)CO;5.5999999;BIFUNCTIONAL UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE/N-ACETYLMANNOSAMINE KINASE;BM3
3u4u;CC(=O)Nc(cc1)cc(c12)c(cn2CCC(=O)[O-])-c(nc(n34)c(cn4)C#N)cc3NC5CC5;8.5200005;Casein kinase II subunit alpha;LNH
3ma3;O=C([O-])c(c1)oc(c12)cc3c(c2)ccc4c3cc(o4)C([O-])=O;7.2199998;Proto-oncogene serine/threonine-protein kinase pim-1;01I
2p3g;O=C1NCCc(c12)[nH]c(c2)-c3cc(ncc3)-c4ccccc4F;6.9000001;MAP kinase-activated protein kinase 2;F10
3h9o;COCCOc(c1)c(OC)cc(c12)c3c(cn2)c(N)nc(c3)-n4ccnc4;7.154902;3-phosphoinositide-dependent protein kinase 1;9BD
3h9f;C1CCCC1N2CCC(=O)N(C)c(c23)cnc(n3)Nc(cc4)c(OC)cc4N(CC5)CCC5O;7.9200001;Dual specificity protein kinase TTK;92M
2waj;Clc(c1)c(OC)cc(c12)ccnc2-c3cc(Br)ccc3;6.4001169;MITOGEN-ACTIVATED PROTEIN KINASE 10;SNB
2p33;CCNC(=O)N1CCC(CC1)Nc2nc(c(Cl)cn2)-c3c[nH]c(c34)cccc4;7.2399998;c-Jun N-terminal kinase 3;J07
2c69;N1C=NC(N12)=NC(c(cc3Br)ccc3)=CC2NCc4ccncc4;4.5900002;CELL DIVISION PROTEIN KINASE 2;CT8
2c68;n1ccc(n12)nc(-c(cc3Br)ccc3)cc2NCc4ccncc4;5.7399998;CELL DIVISION PROTEIN KINASE 2;CT6
2a0c;Oc1ccccc1CNc2nc(N[C@H](CC)CO)nc(c23)n(cn3)C(C)C;7.3000002;Cell division protein kinase 2;CK9
4fod;CC(C)NC(=O)[C@H]1CC[C@H](CC1)n2c(NC(=O)c3ccc(F)cc3)nc(c24)ccc(c4)C[N@@H+]5CC[C@H](CC5)C(C)(C)O;8.9200001;ALK tyrosine kinase receptor;0UV
4foc;COC(=O)[C@@H]1CC[C@@H](CC1)n2c(NC(=O)c3ccccc3)nc(c24)ccc(c4)C[NH+]5CCCCC5;8.5200005;ALK tyrosine kinase receptor;0UU
4fob;C=CCNS(=O)(=O)c1cc(ccc1)C(=O)Nc(n2)n([C@H]3CC[C@H](CC3)CO)c(c24)ccc(c4)C[NH+]5CCCCC5;8.3000002;ALK tyrosine kinase receptor;0US
3umw;C1C[NH2+]CC[NH+]1Cc2c(OC)ccc(c23)C(=O)C(\O3)=C\c([nH]n4)c(c45)cccc5;8.5200005;Proto-oncogene serine/threonine-protein kinase pim-1;596
2io6;c1cccc(OC)c1-c2cc(c3c(c24)C(=O)NC4=O)n(CCCO)c5c3cc(O)cc5;7.52;Wee1-like protein kinase;330
2c6o;NS(=O)(=O)c1ccc(cc1)Nc(nc(c23)nc[nH]3)nc2OCC4CCCCC4;8.2200003;CELL DIVISION PROTEIN KINASE 2;4SP
2c6m;NS(=O)(=O)c1ccc(cc1)Nc2cc(nc(n23)ncn3)OC4CCCCC4;6.46;CELL DIVISION PROTEIN KINASE 2;DT5
2c6l;O=S(=O)(N)c1ccc(cc1)NC2=C[C@@H](N=C(N23)N=CN3)N[C@@H]4CC[C@@H]([NH3+])CC4;6.5700002;CELL DIVISION PROTEIN KINASE 2;DT4
2c6k;O=S(=O)(N)c1ccc(cc1)Nc2cc(nc(n23)ncn3)NC4CCCCC4;6.1399999;CELL DIVISION PROTEIN KINASE 2;DT2
2c6i;O=S(=O)(N)c1ccc(cc1)Nc2cc(nc(n23)ncn3)OCC4CCCCC4;4.96;CELL DIVISION PROTEIN KINASE 2;DT1
2c6e;C1CCCC[NH+]1C[C@H](O)COc(c(c2)OC)cc(c23)ncnc3Nc4cnc(nc4)NC(=O)c5ccccc5;9.1000004;SERINE/THREONINE-PROTEIN KINASE 6;HPM
4zk5;c1ccc(cc1F)-c(cc2)nc(c23)c(N)ncc3C(=O)NC4CN(C4)C(=O)C5C=C5;8.4300003;Mitogen-activated protein kinase kinase kinase kinase 4;4P4
5i5z;CNC(=O)c(n1)ccc(c12)cncc2-c(c3)ccc(c34)N(C)S(=O)(=O)C4;9.0500002;Cyclin-dependent kinase 8;68U
3coh;C1CCc(c(C)n[nH]2)c2c([nH]3)c1c(c34)cc5c(c4)C(C)(C)C(=O)N5CC;8.3979397;Serine/threonine-protein kinase 6;83H
4i3z;OP([O-])(O)OP([O-])(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n(cn2)c(c23)ncnc3N;4.29;Cyclin-dependent kinase 2;ADP
3ha6;Fc1ccccc1CCNc2nc(Nc(cc3)cc(c34)cccn4)nc(n2)Nc5ccc(OC)c(c5)OC;5.6799998;Serine/threonine-protein kinase 6;2JZ
4erw;CO[C@@H]1[C@H]([NH2+]C)C[C@@H](O2)n3c(cccc4)c4c(c3c5n6[C@]12C)c7c(C[NH2+][C@H]7O)c5c8c6cccc8;9.5200005;Cyclin-dependent kinase 2;STU
2vta;n1[nH]cc(c12)cccc2;3.73;CELL DIVISION PROTEIN KINASE 2;LZ1
3bwf;c1cc(O)cc2c1[NH+]3c4c2c(C(=O)NC5=O)c5c(C=CC6)c4N6[Os]13789([CH2]=O)[CH]2=[CH]7[CH]8=[CH]9[CH2]12;9.6989698;Proto-oncogene serine/threonine-protein kinase Pim-1;DWC
3sqq;NS(=O)(=O)c(cc1)ccc1Nc(s2)nc(N)c2C(=O)c3c(C)cccc3;5.3200002;Cyclin-dependent kinase 2;99Z
3rwp;c1cc(F)ccc1[C@H]2COC[C@H]2Nc(n3)cncc3C(=O)c4cn(C(C)C)c(c45)ncnc5N;9.2200003;3-phosphoinositide-dependent protein kinase 1;ABQ
4x7l;CNc(s1)nc(c12)ccc(c2)-c3c(N)c(ccc3C)C(=O)c4c(=O)n(-c5ccccc5)n(C)c4-c6ccccc6;8.0500002;Eukaryotic translation initiation factor 2-alpha kinase 3,Eukaryotic translation initiation factor 2-alpha kinase 3;3Z4
3d0e;C1CC[NH2+]C[C@H]1COc(cnc2C#CC(C)(C)O)c(c23)n(CC)c(n3)-c4nonc4N;8.3979397;RAC-beta serine/threonine-protein kinase;G93
4mbl;C1CCC[C@H]([C@@H]1[NH3+])Nc(cc2)nc(n23)c(cn3)-c(cc4)cc(c45)cccc5;8.54;Serine/threonine-protein kinase pim-1;26L
4mbj;[nH]1cnc(c12)ncc(c2)NC(=O)c3c(F)c(ccc3F)NS(=O)(=O)CCC;7.21;Serine/threonine-protein kinase B-raf;DFS
4mbi;C[NH+](C)CCNC(C=C1)N=C(N12)C(=CN2)c3c[nH]nc3;8.1499996;Serine/threonine-protein kinase pim-1;26K
3cp9;c1nc(N)nc(c12)ccc(c2)-c3c(=O)n(ccc3C)-c(cc4)cc(c45)NCC5(C)C;7.318759;Vascular endothelial growth factor receptor 2;C19
4wt6;C1CCCC1Nc2nc(ccc2)-c3c[nH]c(c34)ccc(c4)-c5sc(nn5)N;7.9200001;Serine/threonine-protein kinase pim-1;3U6
2o5k;CS(=O)(=O)Nc(cc1)ccc1CCNC(=O)c2ccc(O)c(c23)[nH]c(n3)-c4ccc(Cl)cc4Cl;7.8200002;Glycogen synthase kinase-3 beta;HBM
3d7z;C1=CC1NC(=O)c(ccc2C)cc2-c3ccc(cc3)C(=O)NCC4C=C4;7.9208188;Mitogen-activated protein kinase 14;GK5
3cpb;C1CCCC1CCNC(=O)c2cc(c(C)cc2)C(=O)Nc3ccc(N)nc3;4.6020598;Vascular endothelial growth factor receptor 2;C92
3cpc;c1nc(N)nc(c12)ccc(c2)-c3c(=O)n(ccc3C)-c4cc(C(F)(F)F)ccc4;5.3010302;Vascular endothelial growth factor receptor 2;C52
2x2l;COc1ccc(cc1)/C=C/2C(=O)Nc(c23)ccc(c3)N;5.2800002;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET;X2L
2x2m;c1cccc(c12)C(\C(=O)N2)=C\c3c(C)cc([nH]3)C;6.77;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET;X2M
2x2k;Cc1cc(C)[nH]c1/C=C/2C(=O)Nc(c23)ccc(c3)N;6.52;PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET;X2K
5cy3;Cn1cc(cn1)-c(c2)cc(c(c23)csn3)O[C@H](C)[C@H]4C=NC(=O)O4;7.8000002;Tyrosine-protein kinase SYK;55Y
4jln;FCCOc1cc(ccc1OC)-c2nc(c(s2)CCC)CSc3nc(N)cc(n3)N;7.7800002;Deoxycytidine kinase;18V
4jlm;FCCOc1cc(ccc1OC)-c2nc(c(s2)CC)CSc3nc(N)cc(n3)N;7.6399999;Deoxycytidine kinase;1NN
4jlj;FCCOc1cc(ccc1OC)-c2nc(cs2)CSc3nc(N)cc(n3)N;6.1300001;Deoxycytidine kinase;1NM
5cyi;CCS(=O)(=O)c(cc1)ccc1Nc(n2)nc(c(c23)[nH]cn3)OCC4CCCCC4;5.8800001;Cyclin-dependent kinase 2;55S
3r04;O=C([O-])c(c1)oc(c12)ccc(c2)-c3nc(cnc3)N[C@H]4CC[C@H]([NH3+])CC4;6.9200001;Proto-oncogene serine/threonine-protein kinase pim-1;UNQ
2xiy;OCc([nH]1)nc(c12)cccc2;2.4400001;PROTO-ONCOGENE SERINE/THREONINE PROTEIN KINASE PIM-1;XIY
2xix;Nc1nnc(N)[nH]1;2.3;PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE PIM-1;XIX
2xiz;O=C([O-])/C=C/c1ccncc1;3.8900001;PROTO-ONCOGENE SERINE/THREONINE PROTEIN KINASE PIM-1;XIZ
3r02;O=C([O-])c(c1)oc(c12)c(cc(Br)c2)N[C@H]3CC[C@@H]([NH3+])CC3;9;Proto-oncogene serine/threonine-protein kinase pim-1;UNM
4an3;Fc1cc(I)ccc1Nc2c(ccc(F)c2F)C(=O)NOC[C@@H](O)CO;9.2200003;DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1;5Y0
4d2w;Brc1ccc(cc1)C(=O)Nc(cc2)cc(c23)CC[NH2+]CC3;4.5100002;MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE;NF5
3txo;c1nccc(c12)c(NCC(C)([NH3+])C)nc(c2)-c3ccncc3;8.0500002;Protein kinase C eta type;07U
4l7f;Fc1ccc(cc1)C2(CC2)NC(=O)c(c3)ccc4nc(c(n5c34)ncc5)N[C@@H]6CC[C@@H](O)CC6;6.8000002;Mitogen-activated protein kinase 8;1V5
2f4j;C[NH+]1CCN(CC1)c2cc(Nc3cc([nH]n3)C)nc(n2)Sc4ccc(cc4)NC(=O)C5CC5;5.6599998;Proto-oncogene tyrosine-protein kinase ABL1;VX6
4r1v;c1ccc(C#N)cc1C2=CCC(=O)N(N2)Cc(ccc3)cc3-c4ncc(cn4)OC[C@@H]5CC[N@@H+](C)CC5;9;Hepatocyte growth factor receptor;3E8
4r1y;COc(c1)c(OC)ccc1C(CS2)=NN(C2=O)Cc(ccc3)cc3NC(=O)OCCC[NH+](CC)CC;6.4000001;Hepatocyte growth factor receptor;3EH
3lxl;C1C=NC(=O)c2c(cc(F)cc3)c3c(c4c12)[nH]c(n4)C(C)(C)C;8.3000002;Tyrosine-protein kinase JAK3;IZA
4kwp;Brc1c(Br)c(Br)c(Br)c(c12)ncn2[C@@H]3O[C@@H]([C@H](C3)O)CO;7.4899998;Casein kinase II subunit alpha;EXX
1e1x;O=Nc1c(N)nc(N)nc1OCC2CCCCC2;5.8899999;CYCLIN-DEPENDENT PROTEIN KINASE 2;NW1
1e1v;[nH]1cnc(c12)c(nc(n2)N)OCC3CCCCC3;4.9200001;CYCLIN-DEPENDENT PROTEIN KINASE 2;CMG
4hcu;CC(C)c1ccc(cc1)NC(=O)c(ccc2)cc2-c(c(c34)c(N)ncn3)nn4[C@@H]5CCCN(C5)C(=O)CC;8;Tyrosine-protein kinase ITK/TSK;13L
4hct;CC(C)(C)c1cc(ccc1)NC(=O)c(ccc2)cc2-c3nn(c(c34)ncnc4N)[C@@H](C5)CCCN5C(=O)C=C;7.1399999;Tyrosine-protein kinase ITK/TSK;18R
4hcv;CC(C)c1ccc(cc1)NC(=O)c(ccc2)cc2-c(c(c34)c(N)ncn3)nn4[C@H]5CCCN(C5)C(=O)CC;6.4000001;Tyrosine-protein kinase ITK/TSK;13J
4hco;CC1=CC(=O)C(=CC1=O)C(C)C;4.3200002;Serine/threonine-protein kinase PLK1;IMW
4bie;[NH3+]CCNS(=O)(=O)c(s1)ccc1-c2ccnc(c23)[nH]c(c3)C;6.5999999;MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5;IE6
4bid;c1ccccc1[C@H](C[NH3+])Oc2cnc(-c3ccoc3)c(c2)-c(c[nH]4)c(c45)cccn5;8.1000004;MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5;IE8
4qye;O=C([O-])c1ccc(cc1)-c2nc(cnc2)-c3cc(O)ccc3;5.9200001;Serine/threonine-protein kinase Chk1;3DL
4bic;c1ccnc(c12)[nH]cc2-c3ccc(s3)S(=O)(=O)NCC[NH3+];7.3000002;MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5;IE4
4bib;N#Cc1c[nH]c(c12)c(C(=O)N)ccc2OC3CC[NH2+]CC3;6.5999999;MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5;IEO
2qu5;CNC(=O)c1nccc(c1)Oc(c2)ccc(c23)nc([nH]3)Nc4cc(C(F)(F)F)c(Cl)cc4;8.0600004;Vascular endothelial growth factor receptor 2;276
2qu6;C[N@@H+]1CCC[C@H]1COc(c2)c(Cl)ccc2Nc(n3)oc(c34)ccc(c4)Oc(c5)ccnc5C(=O)NC;8.5200005;Vascular endothelial growth factor receptor 2;857
4bi1;s1ccc2ncc(c3c12)ccnc3;4.1599998;DUAL SPECIFICITY PROTEIN KINASE TTK;ZO6
4bi2;c1cncc(c12)cnc3c2ccs3;4.0300002;DUAL SPECIFICITY PROTEIN KINASE TTK;ZO8
3vf9;CC(C)(O)c(cc1)cc(c12)[nH]c(c2)-c([nH]n3)c(c34)scc4;8.7200003;Tyrosine-protein kinase SYK;477
3vf8;CCOc(c(F)c1)cc(c12)[nH]c(n2)-c3[nH]ncc3NC(=O)N(CC)CC;6.8200002;Tyrosine-protein kinase SYK;0JE
4bc5;OCC(=O)[C@@H](O)[C@H](O)CF;4.5999999;XYLULOSE KINASE;5FX
2wgj;Clc1ccc(F)c(Cl)c1[C@@H](C)Oc2cc(cnc2N)-c3cnn(c3)C4CC[NH2+]CC4;8.6999998;HEPATOCYTE GROWTH FACTOR RECEPTOR;VGH
2c4g;O=C(C)N(C1)Cc(c12)c(n[nH]2)NC(=O)c3ccccc3;5.9400001;CELL DIVISION PROTEIN KINASE 2;514
3feg;C[N+]1(C)C[C@@](O)(OCC1)c2ccc(cc2)-c3ccc(cc3)C(=O)C[N+](C)(C)CCOP([O-])(O)O;4.3499999;Choline/ethanolamine kinase;HC7
4zim;C1COCCN1C(=O)c(c2)ccc([nH]3)c2c(c34)cc(cc4C(=O)N)-c(c5)ccc(Cl)c5Cl;8.6199999;Tyrosine-protein kinase JAK2;4OK
1y8o;OP([O-])(O)OP([O-])(O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n(cn2)c(c23)ncnc3N;5.8899999;[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3;ADP
4ptc;Oc1c(C(=O)N)sc(n1)-c2ccnc(c2)NC(=O)C3CC3;8.96;Glycogen synthase kinase-3 beta;2WE
5bms;n1c[nH]c(c12)ccc(c2Cl)CNc(n3)nccc3Nc4cc([nH]n4)C5CC5;6.3400002;Serine/threonine-protein kinase PAK 4;4T6
5ehy;c1occc1-c(ncc2)c(c23)c([nH]n3)-c4ccccc4;6.0900002;Dual specificity protein kinase TTK;5O4
2j50;c1ccccc1[C@@H](OC)C(=O)N(C2)Cc(c23)c(n[nH]3)NC(=O)c4ccc(cc4)N5CC[NH+](C)CC5;7.8899999;SERINE/THREONINE-PROTEIN KINASE 6;627
4f64;COCCCc1cc(n[nH]1)Nc2nc(ncc2Br)NCc3cc(C)no3;7.1999998;Fibroblast growth factor receptor 1;0S8
4f65;c1ccccc1CCc2cc([nH]n2)Nc3nc(ncc3Br)NCc(on4)cc4C;8.6000004;Fibroblast growth factor receptor 1;0S9
4f63;Cc1cc([nH]n1)Nc2nc(ncc2Br)NCCc3cccnc3;6.3000002;Fibroblast growth factor receptor 1;0S7
5eh0;CC(C)(C)CNc(ncc1)c(c12)nc(nc2)Nc(c(c3)OC)ccc3-c4cnn(c4)C;7.7399998;Dual specificity protein kinase TTK;5NW
4f6u;C1COCC[NH+]1CCCNC(=O)Nc2cc(C(C)(C)C)nn2-c3ccc(C)cc3;6.1500001;Cyclin-dependent kinase 8;0SR
4f6w;c1cc(C)ccc1-n(nc(c2)C(C)(C)C)c2NC(=O)NCC[NH+]3CCN(CC3)C(=O)Nc4cc(C(C)(C)C)nn4-c5ccc(C)cc5;7.52;Cyclin-dependent kinase 8;0SS
2qhn;c1cccc(c12)c3c(c(C)n[nH]3)c(=O)n2CC;6.0087738;Serine/threonine-protein kinase Chk1;582
2qhm;n1cccc(c12)c(c[nH]2)C(=O)O[C@@H](C3)C[C@@H]([N@@H+]4C)CC[C@H]34;6.1804562;Serine/threonine-protein kinase Chk1;7CS
4f6s;O=C(N)Nc1cc(C(C)(C)C)nn1-c2ccc(C)cc2;5.4899998;Cyclin-dependent kinase 8;0SQ
3jya;n1c[nH]c(=O)c(c12)sc3c2c(Cl)ccc3Cl;6.8899999;Proto-oncogene serine/threonine-protein kinase Pim-1;LWG
4uwf;c1c(F)cc(F)cc1N2[C@H](C(F)(F)F)CCn(c23)c(=O)cc([nH+]3)N4CCOCC4;8.1499996;PHOSPHATIDYLINOSITOL 3-KINASE CATALYTIC SUBUNIT TYPE 3;EUT
4uwg;CC(C)OCCN1[C@H](C(F)(F)F)CCN(C1=2)C(=O)CC([NH+]2)=[N+]3CCOCC3;8.1499996;PHOSPHATIDYLINOSITOL 3-KINASE CATALYTIC SUBUNIT TYPE 3;RBQ
4uwh;c1ccccc1[C@@H](O)CN2[C@H](C(F)(F)F)CCn(c23)c(=O)cc([nH+]3)N4CCOCC4;8.5200005;PHOSPHATIDYLINOSITOL 3-KINASE CATALYTIC SUBUNIT TYPE 3;JXM
4uwk;c1cc(Cl)sc1C[N+]2[C@H](C(F)(F)F)CCN(C=23)C(=O)CC(N3)=[N+]4[C@H](C)COC[C@H]4C;9;PHOSPHATIDYLINOSITOL 3-KINASE CATALYTIC SUBUNIT TYPE 3;UJB
4uwl;CC(C)C(=O)C[N+]([C@H](C(F)(F)F)CC1)=C(N12)N=C(CC2=O)N3CCOC[C@H]3C;8.5699997;PHOSPHATIDYLINOSITOL 3-KINASE CATALYTIC SUBUNIT TYPE 3;7A5
3jy0;O[C@H]1CC[N@H+](C1)Cc(n2)[nH]c(=O)c3sc(c4c23)ccc(Cl)c4;8.3000002;Proto-oncogene serine/threonine-protein kinase Pim-1;LYG
3jy9;Oc1ccc(cc1)[C@H](C(=O)N2)c3c[nH]c(ncc4)c3c4c(c25)cccc5;9;Tyrosine-protein kinase JAK2;JZH
1zrz;C[NH+](C)CCCn1cc(c(c12)cccc2)C3=C(C(=O)NC3=O)c4c[nH]c(c45)cccc5;5.2399998;Protein kinase C, iota;BI1
5ftq;Fc1cc(F)cc(c1)Cc(cc2)cc(c23)c([nH]n3)NC(=O)c4c(N[C@H]5CC[C@H](O)CC5)cc(cc4)N6CC[NH+](C)CC6;8;ALK TYROSINE KINASE RECEPTOR;U4W
3byu;FC(F)(F)c(c1C)cccc1C(=O)Nc2ccc(C)c(c2)C(=O)Nc3cnc(nc3)Nc(cc4)ccc4N(CC5)CC[NH+]5C;9.0969105;Proto-oncogene tyrosine-protein kinase LCK;AM6
3bys;FC(F)(F)c(c1)cccc1NC(=O)c2ccc(C)c(c2)C(=O)Nc3cnc(nc3)Nc(cc4)ccc4N(CC5)CC[NH+]5C;9.3010302;Proto-oncogene tyrosine-protein kinase LCK;AM5
3bym;COc(c1)c(OC)c(OC)cc1Nc(n2)ncnc2-n(c(c34)cccc3)c(n4)Nc5ccccc5;8.2218475;Proto-oncogene tyrosine-protein kinase LCK;AM0
3byo;C1C[NH+](C)CCN1c(cc2)ccc2Nc(n3)ncc(c34)c(=O)n(-c5c(C)cccc5C)c6n4c7c(n6)cccc7;8.1549025;Proto-oncogene tyrosine-protein kinase LCK;AM9
5fto;C1COCCC1Nc2cc(N3CC[NH+](C)CC3)ccc2C(=O)Nc4[nH]nc(c45)ccc(c5)Cc6cc(F)cc(F)c6;8.21;ALK TYROSINE KINASE RECEPTOR;YMX
5ftg;CN(C)C1=CCN(C=C1)Cc2ccc(cc2)OCCOc3ccc(cc3)Cn4ccc(=[N+](C)C)cc4;6.1500001;CHOLINE KINASE ALPHA;NBR
3zya;Nc1ccccc1Nc(cc2)cc(CC3)c2[C@H](O)c(c34)cccc4;7;MITOGEN-ACTIVATED PROTEIN KINASE 14;2A8
3tcp;c1cc(F)ccc1-c2nn(C[C@H]3CC[C@H]([NH3+])CC3)c(c24)nc(nc4)NCCCC;8.3699999;Tyrosine-protein kinase Mer;CKJ
4gv1;Clc1ccc(cc1)[C@H](CCO)NC(=O)C2([NH3+])CCN(CC2)c3ncnc(c34)[nH]cc4;8.5200005;RAC-alpha serine/threonine-protein kinase;0XZ
2fgi;CC[NH+](CC)CCCCNc(nc1)nc(c12)nc(NC(=O)NC(C)(C)C)c(c2)-c3cc(OC)cc(c3)OC;7.3400002;PROTEIN (FIBROBLAST GROWTH FACTOR (FGF) RECEPTOR 1);PD1
5l6o;c1ccccc1Nc2ncnc(c23)cc(cc3)C(=O)C;8.2200003;Ephrin type-B receptor 3;6P6
3k54;Cc1cccc(Cl)c1NC(=O)c2cnc(s2)Nc3cc(nc(n3)C)N(CC4)CC[NH+]4CCO;9;Tyrosine-protein kinase BTK;1N1
3k5u;c1ccccc1-c(c(c23)c(ncn2)NCCO)c(o3)-c4ccccc4;6.5100002;Serine/threonine-protein kinase 6;PFQ
4qd6;c1ccccc1S(=O)(=O)c2cc(nc(c2)N[C@@H]3CC[C@@H](O)CC3)Nc4cc([nH]n4)-c5ccccc5;8.6400003;Tyrosine-protein kinase ITK/TSK;30T
4px6;[NH3+][C@H]1CCCC[C@H]1Nc(c2)nc(c(c23)c(=O)[nH]cn3)Nc(ccc4)c(c45)[nH]cc5;8.3999996;Tyrosine-protein kinase SYK;2X6
4jr3;CC(=O)Nc1cc(ccc1)-c2c(-c3ccccc3)oc(c24)ncnc4N[C@H](CO)c5ccccc5;6.6599998;Epidermal growth factor receptor;KJR
3orn;O=C1CCCON1Cc(cc2C(=O)NOCCO)c(F)c(F)c2Nc(cc3)c(F)cc3I;9.6199999;Dual specificity mitogen-activated protein kinase kinase 1;3OR
4jrv;C[NH+](C)CCCC(=O)Nc1cc(ccc1)-c2c(-c3ccccc3)oc(c24)ncnc4N[C@H](CO)c5ccccc5;7.54;Epidermal growth factor receptor;KJV
2vtt;C1[NH2+]CCC[C@@H]1NC(=O)c2[nH]ncc2NC(=O)c3c(F)cccc3F;7.3600001;CELL DIVISION PROTEIN KINASE 2;LZD
5j1v;c1cncc(c2)c1c(N)c(c23)nc(N)nc3;7.3899999;Dual specificity protein kinase CLK1;6FD
2vti;O=S(=O)(N)c1ccc(cc1)NC(=O)c2[nH]nc(c23)cccc3;6.1799998;CELL DIVISION PROTEIN KINASE 2;LZ3
4qyh;N#Cc(nc1)cc(c12)c3c([nH]2)ncc(c3)-c4ccc(cc4)N5CC[NH+](C)CC5;8.8900003;Serine/threonine-protein kinase Chk1;3DX
2cgx;O=C(N)CSc(n1)[nH]c(c12)c(N)ncn2;4.8099999;SERINE/THREONINE-PROTEIN KINASE CHK1;3D3
4agd;CC[NH+](CC)CCNC(=O)c1c(C)[nH]c(c1C)\C=C\2C(=O)Nc(c23)ccc(F)c3;8.4099998;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2;B49
4agc;CNC(=O)c1ccccc1Sc(c2)ccc(c23)c([nH]n3)/C=C/c4ncccc4;10.7;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2;AXI
3npc;c1cc(C)ccc1-n2nc(C(C)(C)C)cc2NC(=O)Nc3ccc(c(c34)cccc4)OCC[NH+]5CCOCC5;8.3400002;Mitogen-activated protein kinase 9;B96
4ag8;CNC(=O)c1ccccc1Sc(c2)ccc(c23)c(n[nH]3)/C=C/c4ncccc4;8.96;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2;AXI
3lvp;Clc1ccnc(c12)[nH]c(c2)-c3cn(C)c(c34)cc(OC)c(n4)OC;8.6999998;Insulin-like growth factor 1 receptor;PDR
3wbl;C1[NH2+]CCC[C@@H]1Nc(n2)c(C)c(n(c23)ncc3)Nc4ccc(cc4)OCC;4.6399999;Cyclin-dependent kinase 2;PDY
1xbc;c1cccc(c1n2[C@]34C)c5c2c6n([C@H](O4)C[C@@H]([NH2+]C)[C@H]3OC)c7c(cccc7)c6c8c5CNC8=O;7.9200001;Tyrosine-protein kinase SYK;STU
